Details of Disease

General Information of Disease (ID: DIS47Y1K)

• Disease Name: Obesity
• Synonyms: obesity; obesity disease
• Disease Class: 5B80-5B81: Obesity
• Definition: A disorder involving an excessive amount of body fat.|Obesity is a complex disease that may involve multiple environmental and genetic causes. See the subclass monogenic disease for genetic subtypes
• Disease Hierarchy:
  DISGAJIG: Overnutrition
  DISWD40R: Disease
  DIS47Y1K: Obesity
• ICD Code:
  ICD-11: ICD-11: 5B81
  ICD-10: ICD-10: E66
• Disease Identifiers:
  MONDO ID: MONDO_0011122
  MESH ID: D009765
  UMLS CUI: C0028754
  OMIM ID: 601665
  MedGen ID: 18127
  HPO ID: HP:0001513
  Orphanet ID: 521399
  SNOMED CT ID: 414915002

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 25 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Amfepramone	DM9YSNQ	Approved	Small molecular drug	[1]
Amphetamine	DMSZQAK	Approved	Small molecular drug	[2]
Anastrozole	DMNP60F	Approved	Small molecular drug	[3]
Benzphetamine	DMIJATC	Approved	Small molecular drug	[4]
Bupropion	DM5PCS7	Approved	Small molecular drug	[5]
Fenofibrate	DMFKXDY	Approved	Small molecular drug	[6]
Liraglutide	DM3FXPS	Approved	Small molecular drug	[7]
Lorcaserin	DMG6OYJ	Approved	Small molecular drug	[8]
Mazindol	DMZ36RN	Approved	Small molecular drug	[9]
Methamphetamine	DMPM4SK	Approved	Small molecular drug	[10]
Methylnaltrexone bromide	DMZTGN2	Approved	Small molecular drug	[11]
Metoprolol	DMOJ0V6	Approved	Small molecular drug	[12]
Naltrexone	DMUL45H	Approved	Small molecular drug	[13]
Orlistat	DMRJSP8	Approved	Small molecular drug	[4]
Phendimetrazine	DM6TS1N	Approved	Small molecular drug	[4]
Phenmetrazine	DMXYTN9	Approved	Small molecular drug	[14]
Phentermine	DMG60XN	Approved	Small molecular drug	[15]
Pioglitazone	DMKJ485	Approved	Small molecular drug	[16]
Propylhexedrine	DMTBW2O	Approved	Small molecular drug	[4]
Quercetin	DM3NC4M	Approved	Small molecular drug	[17]
Setmelanotide	DMPVRN9	Approved	NA	[18]
Sibutramine	DMFJTDI	Approved	Small molecular drug	[19]
SR141716A	DMCO5JZ	Approved	Small molecular drug	[4]
Topiramate	DM82Z30	Approved	Small molecular drug	[20]
Trihexyphenidyl	DMB19L8	Approved	Small molecular drug	[16]

This Disease is Treated as An Indication in 71 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
ALS-L1023	DMS6QGO	Phase 3	NA	[21]
Amitifadine	DMS1X67	Phase 3	Small molecular drug	[22]
ATX-101	DM64WYC	Phase 3	NA	[23]
Beloranib	DM71CK8	Phase 3	Small molecular drug	[24]
Cetilistat	DMWAHTN	Phase 3	Small molecular drug	[25]
Fenfluramine	DM0762O	Phase 3	Small molecular drug	[26]
GMA102	DMQIE7U	Phase 3	Antibody	[27]
GMA105	DM2XSG0	Phase 3	Antibody	[28]
Orforglipron	DMC50VB	Phase 3	Small molecule	[29]
Retatrutide	DM8WU0Q	Phase 3	Peptide	[30]
Second generation therapeutics	DM2LCO4	Phase 3	Small molecular drug	[31]
Tebipenem	DMVSX6O	Phase 3	Small molecular drug	[11]
MBX-8025	DMNTCV4	Phase 2/3	Small molecular drug	[32]
AMG 133	DMSRCIS	Phase 2	Antibody peptide conjugate	[33]
ARD-101	DMAB3EL	Phase 2	NA	[34]
ATHX-105	DM6ABD9	Phase 2	NA	[35]
AZ-40140	DM9LKYP	Phase 2	NA	[11]
CL-316,243	DMXH1KC	Phase 2	Small molecular drug	[36]
CP-741952	DMHJ7IG	Phase 2	NA	[37]
GSK2890457	DMT5YK7	Phase 2	NA	[38]
HTI-101	DMURXMJ	Phase 2	NA	[39]
ISIS-FGFR4	DMNVZDT	Phase 2	Antisense drug	[40]
JNJ-64565111	DMVSUH1	Phase 2	NA	[41]
LY-362884	DMD09CT	Phase 2	NA	[11]
LY-377604	DMZCU7I	Phase 2	Small molecular drug	[42]
LY3437943	DMN37M6	Phase 2	Peptide	[43]
MB-12066	DMRSN2C	Phase 2	NA	[44]
MBL949	DM16I0A	Phase 2	NA	[45]
MLR-1023	DM4RNOT	Phase 2	Small molecular drug	[46]
N-5984	DMUK6HC	Phase 2	Small molecular drug	[11]
OBE-101	DMJIBSG	Phase 2	NA	[47]
Oleoyl-estrone	DM0RA8F	Phase 2	Small molecular drug	[48]
Peptide YY 3-36	DMNU48O	Phase 2	NA	[49]
PF-07081532	DM9WHMF	Phase 2	Small molecule	[50]
PRX00933	DM1JNDV	Phase 2	NA	[51]
SR-147778	DMNAECP	Phase 2	Small molecular drug	[52]
TTP435	DMMNTOW	Phase 2	NA	[53]
Yso1	DM8RR54	Phase 2	Small molecule	[54]
PP-1420	DMQOW0H	Phase 1/2	NA	[55]
AMG 786	DMNQM73	Phase 1	Small molecule	[56]
AZD1979	DMQ1OX4	Phase 1	NA	[57]
AZD5658	DMV6DF3	Phase 1	NA	[58]
AZD6234	DM7KBD0	Phase 1	Peptide	[59]
AZD7687	DMS9I6A	Phase 1	Small molecular drug	[60]
AZD8329	DMTD57A	Phase 1	Small molecular drug	[61]
BMS-830216	DMCW71N	Phase 1	NA	[62]
BVT-74316	DMEP321	Phase 1	Small molecular drug	[63]
CIN-109	DMZTPX3	Phase 1	NA	[64]
CT-388	DMWHBE5	Phase 1	NA	[65]
DD01	DM0JKZ6	Phase 1	Peptide	[66]
ERX-1000	DMO18P9	Phase 1	NA	[67]
G530L	DMJ80WL	Phase 1	NA	[68]
GDC-0152	DM1B3UM	Phase 1	Small molecular drug	[69]
GSK1521498	DM2L7TH	Phase 1	Small molecular drug	[70]
GSK2374697	DMMLSZL	Phase 1	NA	[71]
KD3010	DMNFDYE	Phase 1	NA	[72]
L-796568	DMXKO1L	Phase 1	Small molecular drug	[73]
LA-GDF15	DMNK2UT	Phase 1	NA	[74]
LY 3541105	DMJ1X85	Phase 1	Monoclonal antibody	[75]
LY3841136	DMLT2EB	Phase 1	NA	[76]
NO-13065	DM7LGYI	Phase 1	NA	[77]
PegCNTF	DMW7VGZ	Phase 1	Small molecular drug	[11]
Pemvidutide	DMVOG8A	Phase 1	Small molecule	[78]
Prohibitin targeting peptide-1	DMK0WUP	Phase 1	NA	[79]
PRX-07034	DM5TLAP	Phase 1	Small molecular drug	[80]
PYY 1875	DMEB7D6	Phase 1	NA	[81]
S-309309	DMPQQ9B	Phase 1	Small molecule	[82]
TM38837	DMCFGD4	Phase 1	Small molecular drug	[83]
Trodusquemine	DMQ7UN6	Phase 1	Small molecular drug	[84]
ZP2929	DMRVDUM	Phase 1	NA	[85]
ZY01	DMSLPTO	Phase 1	NA	[86]

This Disease is Treated as An Indication in 149 Patented Agent(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
1,2,3-triazole derivative 1	DMKHF39	Patented	Small molecular drug	[87]
1,2,3-triazole derivative 2	DMFR23C	Patented	Small molecular drug	[87]
1,2,4,5-tetra-substituted imidazole derivative 1	DMLAYG7	Patented	Small molecular drug	[87]
1,2,4,5-tetra-substituted imidazole derivative 2	DMMCYI5	Patented	Small molecular drug	[87]
1,2,4-tri-substituted imidazoline derivative 1	DMMNVZ5	Patented	Small molecular drug	[87]
1,2,4-triazole derivative 1	DME8MN1	Patented	Small molecular drug	[87]
1,2,4-triazole derivative 2	DM91Z8B	Patented	Small molecular drug	[87]
1,5-diphenylpyrrolidin-2-one derivative 1	DMZY3HC	Patented	Small molecular drug	[87]
1,5-diphenylpyrrolidin-2-one derivative 2	DMBR2Y9	Patented	Small molecular drug	[87]
4-methyl-4,5-dihydro-1H-pyrazole-3-carboxamide derivative 1	DMNTOZV	Patented	Small molecular drug	[87]
Amide derivative 1	DMO64LA	Patented	Small molecular drug	[87]
Aminoazetidine derivative 1	DMNI0M1	Patented	Small molecular drug	[87]
Aminoazetidine derivative 2	DMHSNA5	Patented	Small molecular drug	[87]
Aminoazetidine derivative 3	DMOQHA9	Patented	Small molecular drug	[87]
Aminoazetidine derivative 4	DM50E4Y	Patented	Small molecular drug	[87]
Aminoazetidine derivative 5	DMYPD4Z	Patented	Small molecular drug	[87]
Aminoazetidine derivative 7	DM3LNQG	Patented	Small molecular drug	[87]
Aminoazetidine derivative 8	DMLOIHD	Patented	Small molecular drug	[87]
Aminoazetidine derivative 9	DMUASHT	Patented	Small molecular drug	[87]
Azetidine derivative 1	DMXEFUD	Patented	Small molecular drug	[87]
Azetidine derivative 3	DMIKSVG	Patented	Small molecular drug	[87]
Azetidine derivative 4	DMXL2V9	Patented	Small molecular drug	[87]
Azetidine-1-carboxamide derivative 1	DMZX8Y0	Patented	Small molecular drug	[87]
Azetidine-1-carboxamide derivative 2	DMONQ4L	Patented	Small molecular drug	[87]
Azetidine-1-carboxamide derivative 3	DM2UGK3	Patented	Small molecular drug	[87]
Benzimidazole derivative 1	DML8W16	Patented	Small molecular drug	[87]
Benzimidazole derivative 2	DM4ZUDY	Patented	Small molecular drug	[87]
Carboxamide derivative 1	DM5GEBH	Patented	Small molecular drug	[87]
Diaryl morpholine derivative 1	DMIQOY7	Patented	Small molecular drug	[87]
Diaryl piperazine derivative 1	DMERQ7V	Patented	Small molecular drug	[87]
Diaryl piperazine derivative 2	DMDOB20	Patented	Small molecular drug	[87]
Diphenyl purine derivative 1	DM2DYMS	Patented	Small molecular drug	[87]
Diphenyl purine derivative 2	DMG8MCJ	Patented	Small molecular drug	[87]
Diphenyl purine derivative 3	DMY5CFW	Patented	Small molecular drug	[87]
Diphenyl purine derivative 4	DMP3JF4	Patented	Small molecular drug	[87]
Diphenyl purine derivative 5	DMC2T4H	Patented	Small molecular drug	[87]
Furopyridine derivative 1	DM2QXVW	Patented	Small molecular drug	[87]
Furopyridine derivative 2	DMEU3J9	Patented	Small molecular drug	[87]
Heterocyclic-substituted 3-alkyl azetidine derivative 1	DMJEX3D	Patented	Small molecular drug	[87]
Heterocyclic-substituted 3-alkyl azetidine derivative 2	DMEX7PV	Patented	Small molecular drug	[87]
Heterocyclic-substituted 3-alkyl azetidine derivative 3	DMO1Y30	Patented	Small molecular drug	[87]
Hydrazide derivative 1	DMUA740	Patented	Small molecular drug	[87]
Imidazole derivative 1	DM14KHX	Patented	Small molecular drug	[87]
Imidazole derivative 2	DM8GCVO	Patented	Small molecular drug	[87]
Imidazole derivative 3	DMV1ER2	Patented	Small molecular drug	[87]
Imidazole derivative 4	DMPGMX2	Patented	Small molecular drug	[87]
Imidazole derivative 5	DMVSXUM	Patented	Small molecular drug	[87]
Imidazole derivative 6	DMOXHZJ	Patented	Small molecular drug	[87]
Imidazole derivative 7	DMLPQ7E	Patented	Small molecular drug	[87]
Imidazolidine-2,4-dione derivative 1	DMUFSQ2	Patented	Small molecular drug	[87]
Imidazolidine-2,4-dione derivative 2	DMVMD2O	Patented	Small molecular drug	[87]
N-(arylalkyl)-1H-indole-2-sulfonic acid amide derivative 1	DM6TYM0	Patented	Small molecular drug	[87]
N-(arylalkyl)-1H-indole-2-sulfonic acid amide derivative 2	DM2MPN0	Patented	Small molecular drug	[87]
N-phenyl-5-phenyl-pyrazolin-3-yl amide derivative 1	DM9A8L5	Patented	Small molecular drug	[87]
N-phenyl-5-phenyl-pyrazolin-3-yl amide derivative 2	DM8T2LV	Patented	Small molecular drug	[87]
N-phenyl-5-phenyl-pyrazolin-3-yl amide derivative 3	DMEH0RC	Patented	Small molecular drug	[87]
Piperazine derivative 1	DMJ7F1Q	Patented	Small molecular drug	[87]
Piperazine derivative 2	DM4JZ2T	Patented	Small molecular drug	[87]
PMID25470667-Compound-GO-CoA-Tat	DME40TS	Patented	Small molecular drug	[88]
PMID26161824-Compound-68	DMF9C4I	Patented	Small molecular drug	[87]
PMID26161824-Compound-69	DMKOSN5	Patented	Small molecular drug	[87]
Purine derivative 1	DMB65Z4	Patented	Small molecular drug	[87]
Purine derivative 2	DMNRG0P	Patented	Small molecular drug	[87]
Purine derivative 3	DMPI2S9	Patented	Small molecular drug	[87]
Pyrano[2,3-b]pyridine derivative 1	DMMVG2O	Patented	Small molecular drug	[87]
Pyrano[2,3-b]pyridine derivative 2	DMOJ8P1	Patented	Small molecular drug	[87]
Pyrazole derivative 1	DM3R9PL	Patented	Small molecular drug	[87]
Pyrazole derivative 11	DMH7PGU	Patented	Small molecular drug	[87]
Pyrazole derivative 12	DM7LFNG	Patented	Small molecular drug	[87]
Pyrazole derivative 13	DM5S3L0	Patented	Small molecular drug	[87]
Pyrazole derivative 14	DMEDXW9	Patented	Small molecular drug	[87]
Pyrazole derivative 15	DMJCX8M	Patented	Small molecular drug	[87]
Pyrazole derivative 16	DM5A8F3	Patented	Small molecular drug	[87]
Pyrazole derivative 17	DM7F9V4	Patented	Small molecular drug	[87]
Pyrazole derivative 18	DMVZ8KD	Patented	Small molecular drug	[87]
Pyrazole derivative 19	DMM7OR3	Patented	Small molecular drug	[87]
Pyrazole derivative 2	DMIS97T	Patented	Small molecular drug	[87]
Pyrazole derivative 20	DM2HO1S	Patented	Small molecular drug	[87]
Pyrazole derivative 21	DMUPNHA	Patented	Small molecular drug	[87]
Pyrazole derivative 22	DMCS08K	Patented	Small molecular drug	[87]
Pyrazole derivative 23	DMH2LFS	Patented	Small molecular drug	[87]
Pyrazole derivative 24	DMVX2D0	Patented	Small molecular drug	[87]
Pyrazole derivative 25	DMM2RYG	Patented	Small molecular drug	[87]
Pyrazole derivative 26	DMX92ZK	Patented	Small molecular drug	[87]
Pyrazole derivative 27	DMDB5FH	Patented	Small molecular drug	[87]
Pyrazole derivative 28	DMYEFW1	Patented	Small molecular drug	[87]
Pyrazole derivative 29	DM7DTYS	Patented	Small molecular drug	[87]
Pyrazole derivative 3	DMX2NQW	Patented	Small molecular drug	[87]
Pyrazole derivative 30	DMT1DJP	Patented	Small molecular drug	[87]
Pyrazole derivative 31	DMDTQCG	Patented	Small molecular drug	[87]
Pyrazole derivative 32	DMU59IJ	Patented	Small molecular drug	[87]
Pyrazole derivative 33	DMUNLK8	Patented	Small molecular drug	[87]
Pyrazole derivative 34	DMRH2EJ	Patented	Small molecular drug	[87]
Pyrazole derivative 35	DM6KROX	Patented	Small molecular drug	[87]
Pyrazole derivative 36	DMSDVI1	Patented	Small molecular drug	[87]
Pyrazole derivative 37	DMZJ5FN	Patented	Small molecular drug	[87]
Pyrazole derivative 38	DMPVDSC	Patented	Small molecular drug	[87]
Pyrazole derivative 39	DMMGWKE	Patented	Small molecular drug	[87]
Pyrazole derivative 4	DM2DK1E	Patented	Small molecular drug	[87]
Pyrazole derivative 40	DM7CMV6	Patented	Small molecular drug	[87]
Pyrazole derivative 5	DMDGSKH	Patented	Small molecular drug	[87]
Pyrazole derivative 53	DMMIOZ5	Patented	Small molecular drug	[87]
Pyrazole derivative 54	DM9PNTF	Patented	Small molecular drug	[87]
Pyrazole derivative 57	DMZ3J78	Patented	Small molecular drug	[87]
Pyrazole derivative 58	DMZIOW0	Patented	Small molecular drug	[87]
Pyrazole derivative 59	DMXZC8K	Patented	Small molecular drug	[87]
Pyrazole derivative 6	DMIDN6T	Patented	Small molecular drug	[87]
Pyrazole derivative 60	DMQ08BM	Patented	Small molecular drug	[87]
Pyrazole derivative 7	DMYKU0T	Patented	Small molecular drug	[87]
Pyrazole derivative 8	DMMRTAL	Patented	Small molecular drug	[87]
Pyrazoline derivative 1	DMGS2ET	Patented	Small molecular drug	[87]
Pyrazoline derivative 10	DMCZORA	Patented	Small molecular drug	[87]
Pyrazoline derivative 11	DMAB3YG	Patented	Small molecular drug	[87]
Pyrazoline derivative 2	DMOA8E4	Patented	Small molecular drug	[87]
Pyrazoline derivative 3	DMGH0LQ	Patented	Small molecular drug	[87]
Pyrazoline derivative 4	DMRT7I8	Patented	Small molecular drug	[87]
Pyrazoline derivative 5	DMEGS9U	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 1	DM0FPMV	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 10	DM07GEK	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 11	DM0O4WR	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 12	DMMLDUI	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 13	DMR5O7T	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 2	DMO3MJ7	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 3	DMHTV47	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 4	DMCAVF0	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 5	DM3UBG2	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 6	DM5E1KS	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 7	DMFUSPR	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 8	DMTQNYZ	Patented	Small molecular drug	[87]
Pyrazolo[1,5-a]pyrimidine derivative 9	DMXAW2S	Patented	Small molecular drug	[87]
Pyridotriazolopyrimidine derivative 1	DM71UYI	Patented	Small molecular drug	[87]
Pyridotriazolopyrimidine derivative 2	DM0VOY9	Patented	Small molecular drug	[87]
Pyridotriazolopyrimidine derivative 3	DMYVCTD	Patented	Small molecular drug	[87]
Pyrido[2,3-d]pyrimidine derivative 1	DMHZLSO	Patented	Small molecular drug	[87]
Pyrido[2,3-d]pyrimidine derivative 2	DMSM53I	Patented	Small molecular drug	[87]
Pyrrole derivative 1	DM0RC1Z	Patented	Small molecular drug	[87]
Pyrrole derivative 2	DMMNKFX	Patented	Small molecular drug	[87]
Pyrrole derivative 3	DMFV64B	Patented	Small molecular drug	[87]
Pyrrole derivative 4	DMQDL43	Patented	Small molecular drug	[87]
Pyrrole derivative 5	DMJUMC6	Patented	Small molecular drug	[87]
Pyrrole derivative 6	DM875RE	Patented	Small molecular drug	[87]
Sulfonamide derivative 1	DMTX21L	Patented	Small molecular drug	[87]
Sulfonylated piperazine derivative 1	DMCO8JD	Patented	Small molecular drug	[87]
Sulfonylated piperazine derivative 2	DMZYPV3	Patented	Small molecular drug	[87]
Sulfonylated piperazine derivative 3	DMOJAZ9	Patented	Small molecular drug	[87]
Sulfonylated piperazine derivative 4	DMZW2XP	Patented	Small molecular drug	[87]
Sulfonylated piperazine derivative 5	DM65NBS	Patented	Small molecular drug	[87]
Tetra-hydro-1H-1,2,6-triazaazulene derivative 1	DMUXNKG	Patented	Small molecular drug	[87]
Tetra-hydro-1H-1,2,6-triazaazulene derivative 2	DMVTZ6S	Patented	Small molecular drug	[87]

This Disease is Treated as An Indication in 50 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Dexfenfluramine	DMJ7YDS	Withdrawn from market	Small molecular drug	[16]
Phenylpropanolamine	DMTFK3O	Withdrawn from market	Small molecular drug	[1]
Amibegron	DMPS14M	Discontinued in Phase 3	Small molecular drug	[89]
Axokine	DMT5O8I	Discontinued in Phase 3	NA	[90]
CGP71683A	DMRYC08	Discontinued in Phase 3	Small molecular drug	[91]
CP-945598	DMOU173	Discontinued in Phase 3	Small molecular drug	[11]
KI-0805	DM81T1V	Discontinued in Phase 3	NA	[92]
Taranabant	DM5G9W0	Discontinued in Phase 3	Small molecular drug	[16]
AC 137-164594	DMQOX62	Discontinued in Phase 2	NA	[93]
AOD-9604	DMGDPSI	Discontinued in Phase 2	Small molecular drug	[11]
AZD2207	DM1TDWI	Discontinued in Phase 2	Small molecular drug	[94]
CE-326597	DMXO49B	Discontinued in Phase 2	Small molecular drug	[95]
Davalintide	DM9S3R8	Discontinued in Phase 2	NA	[96]
GI 181771	DMIUFS4	Discontinued in Phase 2	Small molecular drug	[97]
GT-389255	DMLFCNY	Discontinued in Phase 2	NA	[98]
HMR-1426	DMIJSB3	Discontinued in Phase 2	NA	[99]
Lintitript	DMS5X94	Discontinued in Phase 2	Small molecular drug	[100]
PYY3-36	DMTGFV6	Discontinued in Phase 2	NA	[101]
SLV319	DM0GKHX	Discontinued in Phase 2	Small molecular drug	[102]
TM30338	DMXNQLU	Discontinued in Phase 2	NA	[103]
Velneperit	DMROSHN	Discontinued in Phase 2	Small molecular drug	[104]
CYT-009-GhrQb	DMCWRYS	Discontinued in Phase 1/2	Small molecular drug	[11]
NN-9161	DM8ZAB6	Discontinued in Phase 1/2	NA	[105]
AC-162352	DME98LV	Discontinued in Phase 1	NA	[11]
AMG 076	DMIKQ40	Discontinued in Phase 1	Small molecular drug	[106]
Axovan-3	DM1JN6A	Discontinued in Phase 1	NA	[107]
AZD1175	DM65MUI	Discontinued in Phase 1	NA	[108]
JTT-553	DMI7Z1Y	Discontinued in Phase 1	NA	[109]
MX-68	DML58C4	Discontinued in Phase 1	Small molecular drug	[110]
NGD-4715	DMXDLUH	Discontinued in Phase 1	Small molecular drug	[111]
PF-3932295	DMZ888A	Discontinued in Phase 1	NA	[112]
PF-431499	DMTPSKQ	Discontinued in Phase 1	NA	[113]
PF-514273	DMS7M0U	Discontinued in Phase 1	Small molecular drug	[114]
R-1065	DMHPV1D	Discontinued in Phase 1	NA	[115]
S-234462	DM80P4U	Discontinued in Phase 1	NA	[116]
SR-146131	DML7KCO	Discontinued in Phase 1	Small molecular drug	[117]
SSR-125180	DMSOBW2	Discontinued in Phase 1	NA	[118]
SX-013	DM6E8NQ	Discontinued in Phase 1	NA	[119]
UCL-2000; butabindide	DML51D0	Discontinued in Phase 1	NA	[120]
A-68552	DM1BDHY	Terminated	Small molecular drug	[126]
A-71623	DMKZNTY	Terminated	Small molecular drug	[127]
A-798	DMXWG6Z	Terminated	NA	[128]
ALB-127158(a)	DMWNMYS	Terminated	NA	[129]
AZM-131	DMLCSRF	Terminated	NA	[130]
BRL 26830A	DMGX0E1	Terminated	Small molecular drug	[131]
BVT-24834	DMHLUFN	Terminated	NA	[132]
MPV-1743	DMQKDX4	Terminated	NA	[133]
NLC-002	DM5YF6T	Terminated	NA	[134]
RWJ-49815	DMUGZMO	Terminated	Small molecular drug	[107]
SNX-024	DMFU90V	Terminated	NA	[135]

This Disease is Treated as An Indication in 31 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
A-71378	DMZ4HMP	Preclinical	Small molecular drug	[121]
A-74498	DMAK6H3	Preclinical	NA	[11]
AR-R-1589	DMMD8VY	Preclinical	NA	[11]
BMS-192548	DMHAWBR	Preclinical	NA	[11]
CB1 antagonist, Bayer	DM53JW0	Preclinical	Small molecular drug	[11]
CIN-110	DMYMZQW	Preclinical	NA	[64]
CIN-209	DMBK5CQ	Preclinical	NA	[64]
CL-314698	DM6HADZ	Preclinical	NA	[11]
CP-114271	DMATUKO	Preclinical	NA	[11]
EP-01492	DM2K51E	Preclinical	Small molecular drug	[11]
FPL-14294	DMUHVEA	Preclinical	Small molecular drug	[11]
FR-79620	DMXR287	Preclinical	Small molecular drug	[11]
GCR-1087	DMFW0H9	Preclinical	NA	[11]
GG-8573	DMFQI38	Preclinical	NA	[11]
GI-264879A	DM25N8B	Preclinical	Small molecular drug	[11]
GNTI	DMTJRLU	Preclinical	Small molecular drug	[11]
GW-594884A	DMHUD27	Preclinical	NA	[11]
IDDB-41331	DMIYSD4	Preclinical	NA	[11]
IDDBCP-150101	DMQ3BXV	Preclinical	NA	[11]
JD-5037	DMTGI64	Preclinical	NA	[122]
L-742791	DMK3TXY	Preclinical	Small molecular drug	[123]
L-751250	DMOERXK	Preclinical	Small molecular drug	[11]
LY-25582	DM2N637	Preclinical	Small molecular drug	[11]
Melanotetan II	DMYK8MV	Preclinical	Small molecular drug	[11]
NPY5RA-972	DMXUCSN	Preclinical	Small molecular drug	[11]
PD-160170	DMB9Z4C	Preclinical	Small molecular drug	[11]
PD-170292	DMEOVDQ	Preclinical	Small molecular drug	[11]
Ro-27-3225	DMF3YQZ	Preclinical	Small molecular drug	[11]
SNAP-7941	DM5KE4R	Preclinical	Small molecular drug	[124]
T-226293	DM7Y4GT	Preclinical	Small molecular drug	[11]
T-226296	DMJ6P9U	Preclinical	Small molecular drug	[125]

This Disease is Treated as An Indication in 43 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
A-331440	DMPU3QR	Investigative	Small molecular drug	[136]
AC-163954	DM41CSR	Investigative	NA	[137]
Adiptin	DMIQWQH	Investigative	NA	[137]
AMR-SIX-1	DM7WTKJ	Investigative	NA	[138]
ANG-2004	DMK1IMC	Investigative	NA	[139]
Aom-0977	DMXKVRV	Investigative	NA	[137]
ATH-90879	DMSNBMQ	Investigative	NA	[140]
BMS-812204	DM1HBF5	Investigative	NA	[141]
BVT 933	DM8N7BA	Investigative	NA	[16]
C75	DMHGX1N	Investigative	Small molecular drug	[142]
Ciproxifan	DM9N8WM	Investigative	Small molecular drug	[143]
CO-18	DMT7X73	Investigative	NA	[137]
CSC-500297	DM6K123	Investigative	NA	[144]
Dry-powder peptide YY(3-36)	DMSZ9JY	Investigative	NA	[137]
EDP-21	DMMN0GO	Investigative	NA	[139]
FAS-115	DMI1Z58	Investigative	NA	[137]
FAS-89B	DM8TD75	Investigative	NA	[137]
JD-0100	DMLBX3Q	Investigative	NA	[145]
JNJ-1136	DM45ZNE	Investigative	NA	[137]
KDT-600	DMFV0CH	Investigative	NA	[137]
KI-0907	DM8QH84	Investigative	NA	[137]
Long-acting oxyntomodulin	DMLO4OT	Investigative	NA	[137]
MK-5596	DMLWMZ4	Investigative	Small molecular drug	[141]
MK-7725	DM3EP59	Investigative	Small molecular drug	[146]
MKC-180	DMIGHUQ	Investigative	NA	[137]
MOD-1002	DM1C4PL	Investigative	NA	[137]
NDM-10107	DMPD5CI	Investigative	NA	[137]
NOX-B11	DMFW8O5	Investigative	NA	[147]
Oxymera	DMFNECH	Investigative	NA	[137]
PEGylated leptin	DMZ01PS	Investigative	NA	[139]
PMI-008	DMHX704	Investigative	NA	[148]
PSN-842	DMOWMV9	Investigative	NA	[137]
PYN-22	DM065DZ	Investigative	NA	[137]
RO-6036	DM6B8ER	Investigative	NA	[137]
RP-1000	DMKARHF	Investigative	NA	[137]
S-100	DM209OB	Investigative	Small molecular drug	[137]
SJ-BRV	DM0GBHI	Investigative	NA	[137]
TG-1022	DMSG0TL	Investigative	NA	[149]
TPI-1361-17	DMW2FTP	Investigative	Small molecular drug	[150]
UGP-281	DMCYXLU	Investigative	NA	[137]
Weight regulating human endocrine peptide	DMTQ8UP	Investigative	NA	[137]
WIN-902A	DM08XK2	Investigative	NA	[137]
YD-501	DMWAMS1	Investigative	NA	[137]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 719 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ACACB	TTY84UG	Limited	Biomarker	[154]
ADAM17	TT6AZXG	Limited	Genetic Variation	[155]
AHR	TT037IE	Limited	Biomarker	[156]
AKR1B1	TTFBNVI	Limited	Altered Expression	[157]
APOL1	TTDB8PW	Limited	Biomarker	[158]
BACE1	TTJUNZF	Limited	Altered Expression	[159]
BLVRA	TTJBPN3	Limited	Biomarker	[160]
C5AR1	TTHXFA1	Limited	Therapeutic	[161]
CALCA	TTVSFJW	Limited	Biomarker	[162]
CCR2	TTFZYTO	Limited	Biomarker	[163]
CD200	TT0BE68	Limited	Genetic Variation	[164]
CD69	TTPQE9F	Limited	Biomarker	[165]
CES1	TTMF541	Limited	Genetic Variation	[166]
CFH	TTUW6OP	Limited	Genetic Variation	[167]
CPS1	TT42M75	Limited	Biomarker	[168]
CSE1L	TTTRULD	Limited	Genetic Variation	[169]
CTSC	TT4H0V2	Limited	Biomarker	[170]
CX3CR1	TT2T98G	Limited	Biomarker	[171]
CYBB	TT5T8MR	Limited	Altered Expression	[172]
DMD	TTWLFXU	Limited	Biomarker	[173]
EBP	TT4VQZX	Limited	Genetic Variation	[174]
EIF4EBP1	TTKGEBL	Limited	Genetic Variation	[175]
ESRRG	TT9ZRHB	Limited	Altered Expression	[176]
FFAR2	TT0FYAN	Limited	Altered Expression	[177]
FGG	TTR31L7	Limited	Biomarker	[178]
FSHB	TT13GFV	Limited	Biomarker	[179]
FSHR	TTZFDBT	Limited	Altered Expression	[180]
G6PD	TTKN8W0	Limited	Biomarker	[181]
GCH1	TTLSWP6	Limited	Biomarker	[182]
GFRAL	TTE61UB	Limited	Biomarker	[183]
GGT1	TTZVT7O	Limited	Biomarker	[184]
GJA5	TTFQKZ7	Limited	Biomarker	[185]
GPR12	TT3IPW2	Limited	Biomarker	[186]
GSK3A	TTQWAU1	Limited	Posttranslational Modification	[187]
HCAR2	TTWNV8U	Limited	Biomarker	[188]
HDAC11	TT8K17W	Limited	Biomarker	[189]
HDAC3	TT4YWTO	Limited	Biomarker	[190]
HMGCS1	TTQF4TK	Limited	Biomarker	[191]
HOXA5	TTXSVQP	Limited	Biomarker	[192]
HTR1B	TTK8CXU	Limited	Biomarker	[193]
IGFBP2	TTU4QSN	Limited	Posttranslational Modification	[194]
IL1R1	TTWOTEA	Limited	Biomarker	[195]
KCNK3	TTGR91N	Limited	Altered Expression	[196]
KCNMA1	TTE87WJ	Limited	Biomarker	[197]
KITLG	TTDJ51N	Limited	Biomarker	[198]
LAPTM4B	TTEJQT0	Limited	Biomarker	[199]
LGR5	TTTSGRH	Limited	Biomarker	[200]
LIPA	TTS8T1M	Limited	Biomarker	[201]
LRP5	TT7VMG4	Limited	Genetic Variation	[202]
MBL2	TTMQDZ5	Limited	Genetic Variation	[203]
MCHR2	TTS17MG	Limited	Biomarker	[204]
MOGAT2	TTN17BP	Limited	Biomarker	[205]
NOD2	TTYPUHA	Limited	Biomarker	[206]
NR0B1	TTTK36V	Limited	Genetic Variation	[207]
NR0B2	TT25A9Q	Limited	Altered Expression	[208]
NR4A3	TTJQB49	Limited	Biomarker	[209]
NTRK2	TTKN7QR	Limited	Biomarker	[210]
OLR1	TTKSND3	Limited	Biomarker	[211]
OTC	TT5KIO9	Limited	Biomarker	[212]
PDE3A	TT06AWU	Limited	Biomarker	[213]
PDE3B	TTN34SQ	Limited	Biomarker	[214]
PLA2G1B	TT9V5JH	Limited	Biomarker	[215]
PRDX4	TTPBL9I	Limited	Altered Expression	[216]
PRKAR1A	TTNAHEX	Limited	Biomarker	[217]
PRKCD	TT7A1BO	Limited	Biomarker	[218]
PTPRB	TT64I9Q	Limited	Altered Expression	[219]
RHOA	TTP2U16	Limited	Biomarker	[220]
RNASEL	TT7V0K4	Limited	Altered Expression	[221]
RXFP3	TT64ZVP	Limited	Genetic Variation	[222]
S100A9	TT0TMQG	Limited	Altered Expression	[223]
SCN10A	TT90XZ8	Limited	Altered Expression	[224]
SFRP4	TTX8I1Y	Limited	Biomarker	[225]
SLC2A12	TTZO36H	Limited	Biomarker	[226]
SLC38A2	TTUSC27	Limited	Altered Expression	[227]
SLC6A14	TTB6H2S	Limited	Genetic Variation	[228]
SLC9A3	TTFZVPO	Limited	Biomarker	[229]
SOD2	TT9O4C5	Limited	Biomarker	[230]
SOST	TTYRO4F	Limited	Biomarker	[231]
SRD5A1	TTTU72V	Limited	Biomarker	[232]
TH	TTUHP71	Limited	Altered Expression	[233]
TLR5	TTCXP8J	Limited	Biomarker	[234]
TSLP	TTHMW3T	Limited	Biomarker	[235]
TST	TT51OTS	Limited	Genetic Variation	[236]
VWF	TT3SZBT	Limited	Altered Expression	[237]
ABCG5	TTKZ7WY	Disputed	ModifyingMutation	[238]
CDKN1B	TTLGFVW	Disputed	Biomarker	[239]
EHMT1	TTOFXD7	Disputed	Biomarker	[240]
GIPR	TTYMKBE	Disputed	Biomarker	[241]
MAPT	TTS87KH	Disputed	Biomarker	[242]
SLC10A1	TTWZRY5	Disputed	ModifyingMutation	[238]
ADORA2A	TTM2AOE	moderate	Biomarker	[243]
AKT2	TTH24WI	moderate	Genetic Variation	[244]
ALPL	TTMR5UV	moderate	Biomarker	[245]
AR	TTKPW01	moderate	Genetic Variation	[246]
ARRB2	TT8SO2I	moderate	Biomarker	[247]
ATP2A2	TTE6THL	moderate	Genetic Variation	[248]
BCAT1	TTES57P	moderate	Biomarker	[249]
BCAT2	TTF9OQ6	moderate	Biomarker	[249]
C3	TTJGY7A	moderate	Altered Expression	[250]
CAV1	TTXUBN2	moderate	Altered Expression	[251]
CCL17	TTMPHAE	moderate	Genetic Variation	[252]
CCL5	TT9DWLC	moderate	Biomarker	[253]
CD248	TTYJWT7	moderate	Altered Expression	[254]
CDK8	TTBJR4L	moderate	Biomarker	[255]
CDKN2A	TTFTWQ8	moderate	Biomarker	[256]
CLCN3	TT8XNZ7	moderate	Biomarker	[257]
COMT	TTKWFB8	moderate	Genetic Variation	[258]
CPN1	TT8V2KD	moderate	Biomarker	[259]
CRY2	TTAO58M	moderate	Biomarker	[260]
CXCL2	TTZF0K2	moderate	Altered Expression	[261]
DAPK3	TTERVQN	moderate	Altered Expression	[262]
DDIT4	TTVEOY6	moderate	Altered Expression	[263]
F2RL2	TTVSEBF	moderate	Biomarker	[264]
FPR2	TTOJ1NF	moderate	Biomarker	[265]
GDF5	TT37XV9	moderate	Biomarker	[266]
HCAR1	TTVK4ZO	moderate	Biomarker	[267]
HNF1A	TT01M3K	moderate	Genetic Variation	[268]
HP	TTLC8E1	moderate	Biomarker	[269]
IFNL1	TTM624L	moderate	Biomarker	[270]
ITGB6	TTKQSXZ	moderate	Biomarker	[271]
KDM4C	TTV8CRH	moderate	Altered Expression	[272]
KHK	TTPAFR9	moderate	Genetic Variation	[157]
LALBA	TTBRLU3	moderate	Biomarker	[273]
MAPK7	TTU6FSC	moderate	Altered Expression	[274]
MELK	TTBZOTY	moderate	Biomarker	[275]
PIKFYVE	TTA4M1N	moderate	Biomarker	[276]
PNLIP	TTXMY0J	moderate	Biomarker	[277]
PRKCB	TTYPXQF	moderate	Biomarker	[278]
PTGDR	TTNVEIR	moderate	Biomarker	[279]
PTGES	TTYLQ8V	moderate	Biomarker	[280]
RASA1	TTPNZ1F	moderate	Biomarker	[281]
RPS6KB1	TTG0U4H	moderate	Biomarker	[282]
RSPO1	TTI9HL4	moderate	Altered Expression	[283]
SLC22A6	TTTYH7A	moderate	Altered Expression	[196]
SLC2A9	TTIF3GB	moderate	Genetic Variation	[284]
SPHK2	TTCN0M9	moderate	Biomarker	[285]
TAGLN2	TTP6BIJ	moderate	Biomarker	[286]
TMEM97	TT9NXW4	moderate	Biomarker	[287]
TNFRSF17	TTZ3P4W	moderate	Biomarker	[288]
TNFRSF25	TTDV6BQ	moderate	Genetic Variation	[289]
TPH2	TT3KLDP	moderate	Genetic Variation	[290]
TXNRD3	TTDYFVB	moderate	Biomarker	[291]
TYRO3	TTIEMFN	moderate	Biomarker	[292]
ABCA4	TTLB52K	Strong	Biomarker	[293]
ABCC8	TTP835K	Strong	Altered Expression	[294]
ABCG1	TTMWDGU	Strong	Altered Expression	[295]
ABHD6	TTSINOV	Strong	Biomarker	[296]
ACE2	TTUI5H7	Strong	Altered Expression	[297]
ACHE	TT1RS9F	Strong	Biomarker	[298]
ACKR3	TTRQJTC	Strong	Biomarker	[299]
ACLY	TT0Z6Y2	Strong	Biomarker	[154]
ADAMTS1	TTS2TEI	Strong	Biomarker	[300]
ADAMTS5	TTXSU2Y	Strong	Biomarker	[301]
ADCY5	TTN64VU	Strong	Altered Expression	[302]
ADCYAP1	TTW4LYC	Strong	Genetic Variation	[303]
ADM	TTV14YH	Strong	Altered Expression	[304]
ADM2	TTM642F	Strong	Biomarker	[305]
ADORA1	TTK25J1	Strong	Biomarker	[306]
ADORA2B	TTNE7KG	Strong	Altered Expression	[307]
ADORA3	TTJFY5U	Strong	Biomarker	[307]
ADRA1A	TTNGILX	Strong	Biomarker	[299]
ADRA2A	TTWG9A4	Strong	Genetic Variation	[308]
ADRA2B	TTWM4TY	Strong	Biomarker	[299]
AGER	TTMO9HF	Strong	Biomarker	[309]
AGPAT2	TT9AYVR	Strong	Biomarker	[310]
AIF1	TT12MEP	Strong	Biomarker	[311]
AIMP2	TTXWHGF	Strong	Altered Expression	[266]
AKR1C3	TT5ZWB6	Strong	Biomarker	[154]
AKT1	TTWTSCV	Strong	Biomarker	[312]
AKT3	TTO6SGY	Strong	Biomarker	[313]
ALOX12	TT12ABZ	Strong	Biomarker	[314]
AMACR	TTLN1AP	Strong	Altered Expression	[315]
AMD1	TTBFROQ	Strong	Genetic Variation	[316]
AMY2A	TTCGSZ4	Strong	Genetic Variation	[317]
ANGPT1	TTWNQ1T	Strong	Biomarker	[318]
ANGPTL3	TT59GO7	Strong	Altered Expression	[319]
ANGPTL4	TTWALY5	Strong	Altered Expression	[320]
ANPEP	TTPHMWB	Strong	Biomarker	[321]
ANTXR2	TTOD34I	Strong	Biomarker	[322]
AOC3	TT7HC21	Strong	Biomarker	[323]
APLNR	TTJ8E43	Strong	Genetic Variation	[324]
APOA1	TT5S8DR	Strong	Genetic Variation	[325]
APOA2	TTGQA9W	Strong	Biomarker	[326]
APOB	TTN1IE2	Strong	Biomarker	[327]
APOC3	TTXOZQ1	Strong	Genetic Variation	[328]
APP	TTE4KHA	Strong	Biomarker	[329]
AQP7	TTNGCRK	Strong	Biomarker	[330]
AQP9	TTQEI32	Strong	Altered Expression	[331]
ARG1	TT7ZQEV	Strong	Altered Expression	[332]
ARG2	TTV1AG6	Strong	Biomarker	[333]
ARSA	TTYQANR	Strong	Biomarker	[334]
ASPA	TT6TLZP	Strong	Altered Expression	[335]
ASRGL1	TT4WT91	Strong	Genetic Variation	[336]
ATF3	TTCE793	Strong	Biomarker	[337]
ATIC	TT9NVXQ	Strong	Biomarker	[338]
ATP7B	TTOPO51	Strong	Altered Expression	[339]
AURKB	TT9RTBL	Strong	Genetic Variation	[340]
AVP	TTJ8EWH	Strong	Altered Expression	[341]
AVPR1A	TT4TFGN	Strong	Biomarker	[342]
AVPR1B	TTL9MHW	Strong	Genetic Variation	[343]
AZGP1	TTUPYLV	Strong	Biomarker	[344]
BCHE	TT3MSAO	Strong	Genetic Variation	[345]
BCL2A1	TTGT9C7	Strong	Biomarker	[346]
BDKRB2	TTGY8IW	Strong	Genetic Variation	[347]
BGN	TT0JPVF	Strong	Altered Expression	[348]
BIRC2	TTQ5LRD	Strong	Altered Expression	[349]
BLK	TTNDSC3	Strong	Genetic Variation	[350]
BMP2K	TT32VXH	Strong	Biomarker	[351]
BMP4	TTD3BSX	Strong	Biomarker	[352]
BMPR2	TTGKF90	Strong	Biomarker	[353]
BRD2	TTDP48B	Strong	Biomarker	[180]
BRD7	TT07ZS1	Strong	Altered Expression	[354]
BRS3	TTKYEPM	Strong	Biomarker	[299]
C1QBP	TTWTD7F	Strong	Biomarker	[355]
C3AR1	TTI6B3F	Strong	Biomarker	[356]
CA3	TTXUK5D	Strong	Biomarker	[357]
CA5A	TT75WPO	Strong	Biomarker	[358]
CAD	TT2YT1K	Strong	Biomarker	[359]
CALCRL	TTY6O0Q	Strong	Altered Expression	[360]
CAMKK2	TTV298Y	Strong	Biomarker	[361]
CAPN1	TT1WBIJ	Strong	Biomarker	[362]
CAPN2	TTG5QB7	Strong	Genetic Variation	[362]
CASP1	TTCQIBE	Strong	Biomarker	[363]
CBR1	TTVG0SN	Strong	Biomarker	[364]
CBS	TTVZJ7G	Strong	Biomarker	[365]
CCKBR	TTVFO0U	Strong	Biomarker	[366]
CCL11	TTCF05Y	Strong	Biomarker	[367]
CCL2	TTNAY0P	Strong	Biomarker	[368]
CCL20	TT2XAZY	Strong	Genetic Variation	[252]
CCL22	TTBTWI1	Strong	Genetic Variation	[369]
CCNE1	TTCEJ4F	Strong	Biomarker	[370]
CCR9	TTIPS8B	Strong	Genetic Variation	[371]
CD14	TT6I7DC	Strong	Altered Expression	[372]
CD24	TTCTYNP	Strong	Altered Expression	[373]
CD33	TTJVYO3	Strong	Genetic Variation	[374]
CD38	TTPURFN	Strong	Altered Expression	[375]
CD40	TT1ERKL	Strong	Biomarker	[376]
CD59	TTBGTEJ	Strong	Genetic Variation	[377]
CD74	TTCMYP9	Strong	Biomarker	[378]
CDH11	TTRGWZC	Strong	Biomarker	[379]
CDH2	TT1WS0T	Strong	Genetic Variation	[380]
CEACAM1	TTA9CK4	Strong	Posttranslational Modification	[381]
CEACAM5	TTY6DTE	Strong	Biomarker	[382]
CEBPA	TT5LWG1	Strong	Biomarker	[383]
CEBPB	TTUI35N	Strong	Genetic Variation	[384]
CEL	TTTRNQW	Strong	Biomarker	[385]
CERK	TT9XRNV	Strong	Biomarker	[386]
CFB	TTA0P7K	Strong	Biomarker	[387]
CFD	TT8D13I	Strong	Biomarker	[388]
CHRM2	TTYEG6Q	Strong	Genetic Variation	[389]
CHRNA2	TTF4E0J	Strong	Altered Expression	[390]
CHRNA5	TTH2QRX	Strong	Genetic Variation	[391]
CHRNB4	TTTVAFQ	Strong	Genetic Variation	[392]
CLCN7	TTST1AJ	Strong	Biomarker	[393]
CLK2	TT85TPS	Strong	Biomarker	[394]
CLN3	TTORF9W	Strong	Biomarker	[395]
CMA1	TT8VUE0	Strong	Biomarker	[396]
CMKLR1	TT4UGZL	Strong	Biomarker	[397]
CNTF	TTGEM5Q	Strong	Biomarker	[398]
COL6A3	TT5WCAH	Strong	Biomarker	[399]
CPB2	TTP18AY	Strong	Biomarker	[400]
CPT1B	TTDL0NY	Strong	Altered Expression	[401]
CRHBP	TT3PKZE	Strong	Biomarker	[402]
CRHR2	TTIY658	Strong	Biomarker	[403]
CRK	TTFEUYR	Strong	Altered Expression	[266]
CRTC1	TT4GO0F	Strong	Biomarker	[404]
CRTC2	TTFWETR	Strong	Altered Expression	[405]
CRY1	TT5MLZR	Strong	Biomarker	[260]
CSK	TTX6F0Q	Strong	Genetic Variation	[406]
CTF1	TTXGTZU	Strong	Biomarker	[407]
CTSK	TTDZN01	Strong	Biomarker	[408]
CTSS	TTUMQVO	Strong	Biomarker	[409]
CXCL11	TTWG0RE	Strong	Biomarker	[410]
CXCR6	TT2BVUA	Strong	Biomarker	[299]
CYP1A2	TTS1DTU	Strong	Altered Expression	[411]
CYP1B1	TTI84H7	Strong	Genetic Variation	[412]
CYP21A2	TTP4GLG	Strong	Genetic Variation	[413]
CYP24A1	TT82UI1	Strong	Genetic Variation	[414]
CYP2A6	TTAQ6ZW	Strong	Biomarker	[415]
CYP2B6	TTMH124	Strong	Biomarker	[416]
CYP2C9	TTR40YJ	Strong	Genetic Variation	[417]
CYP2E1	TTWVHQ5	Strong	Biomarker	[418]
DAG1	TT4X7PG	Strong	Biomarker	[419]
DCN	TTB3XAN	Strong	Altered Expression	[420]
DGAT1	TT0GV3R	Strong	Biomarker	[421]
DIO1	TTU3X26	Strong	Altered Expression	[422]
DLK1	TTF4AVB	Strong	Biomarker	[423]
DPP4	TTDIGC1	Strong	Biomarker	[424]
DPYD	TTZPS91	Strong	Biomarker	[154]
DRD1	TTZFYLI	Strong	Genetic Variation	[425]
DRD5	TTS2PH3	Strong	Genetic Variation	[426]
DUSP1	TTG8HIM	Strong	Altered Expression	[427]
DUSP5	TTZN92A	Strong	Altered Expression	[428]
DUSP9	TT1GV6C	Strong	Biomarker	[429]
EDNRA	TTKRD0G	Strong	Biomarker	[299]
EGF	TTED8JB	Strong	Biomarker	[430]
EGFL6	TTXJGAR	Strong	Altered Expression	[431]
EGLN1	TT9ISBX	Strong	Biomarker	[432]
EIF2AK2	TTXEZJ4	Strong	Biomarker	[433]
EIF2AK4	TT9U4EP	Strong	Biomarker	[434]
EIF4EBP2	TTNBTCW	Strong	Biomarker	[435]
ELANE	TTPLTSQ	Strong	Biomarker	[436]
ENPEP	TT9PBIL	Strong	Biomarker	[437]
ENPP2	TTSCIM2	Strong	Altered Expression	[438]
EP300	TTGH73N	Strong	Biomarker	[439]
ERN1	TTKIAT3	Strong	Altered Expression	[440]
ESR2	TTOM3J0	Strong	Biomarker	[441]
ESRRA	TTPNQAC	Strong	Biomarker	[442]
ESRRB	TTKF0XS	Strong	Biomarker	[443]
F10	TTCIHJA	Strong	Biomarker	[444]
F11	TTDM4ZU	Strong	Biomarker	[445]
F11R	TT3C8EG	Strong	Genetic Variation	[446]
F13A1	TTXI2RA	Strong	Biomarker	[447]
F2	TT6L509	Strong	Genetic Variation	[448]
F2RL1	TTQR74A	Strong	Biomarker	[449]
FABP3	TT3TGLR	Strong	Biomarker	[450]
FABP4	TTHWMFZ	Strong	Biomarker	[451]
FADS2	TTT2VDU	Strong	Genetic Variation	[452]
FASN	TT7AOUD	Strong	Biomarker	[453]
FAT1	TTGUJYV	Strong	Biomarker	[454]
FBXO3	TTUX14L	Strong	Biomarker	[455]
FCGR1A	TTZK4I3	Strong	Biomarker	[456]
FCGR2B	TT5RWKQ	Strong	Biomarker	[457]
FDPS	TTIKWV4	Strong	Biomarker	[458]
FDXR	TT3W4IX	Strong	Genetic Variation	[459]
FES	TTLBY21	Strong	Biomarker	[458]
FFAR1	TTB8FUC	Strong	Biomarker	[460]
FFAR3	TTXDOHN	Strong	Posttranslational Modification	[461]
FFAR4	TT08JVB	Strong	Biomarker	[462]
FGF10	TTNPEFX	Strong	Biomarker	[463]
FGF18	TT6ICRA	Strong	Genetic Variation	[464]
FGF19	TTGCH11	Strong	Altered Expression	[465]
FGFR1	TTRLW2X	Strong	Altered Expression	[466]
FGFR3	TTST7KB	Strong	Biomarker	[467]
FOXO1	TTLRVIA	Strong	Biomarker	[468]
FST	TTDNM9W	Strong	Biomarker	[469]
FYN	TT2B9KF	Strong	Posttranslational Modification	[470]
GAL	TTXZAJ5	Strong	Biomarker	[471]
GALE	TTGRHIB	Strong	Genetic Variation	[472]
GAPDH	TTUGSWA	Strong	Altered Expression	[473]
GATA4	TT1VDN2	Strong	Genetic Variation	[474]
GCGR	TT9O6WS	Strong	Biomarker	[475]
GDF2	TTAP4T1	Strong	Altered Expression	[476]
GEM	TTAZF9M	Strong	Biomarker	[477]
GH1	TTT3YKH	Strong	Biomarker	[478]
GHR	TTHJWYD	Strong	Biomarker	[479]
GIP	TT40HS5	Strong	Biomarker	[480]
GJA3	TTFZRG0	Strong	Genetic Variation	[481]
GJA4	TTQO1VY	Strong	Biomarker	[482]
GJA8	TTJ7ATH	Strong	Genetic Variation	[481]
GJC1	TTEP7OC	Strong	Altered Expression	[482]
GLO1	TTV9A7R	Strong	Genetic Variation	[483]
GLRX	TTRJCNG	Strong	Biomarker	[484]
GLUL	TTURQ2G	Strong	Biomarker	[154]
GNAQ	TTL1SRG	Strong	Biomarker	[485]
GNRH1	TT0ID4A	Strong	Altered Expression	[486]
GNRHR	TT8R70G	Strong	Altered Expression	[487]
GPBAR1	TTSDVTR	Strong	Biomarker	[488]
GPD1	TTKTEAH	Strong	Genetic Variation	[489]
GPER1	TTDSB34	Strong	Biomarker	[490]
GPR119	TT7QNVC	Strong	Biomarker	[491]
GPR35	TT254XD	Strong	Altered Expression	[492]
GPR39	TTTPCNU	Strong	Biomarker	[493]
GPR55	TTNET8J	Strong	Altered Expression	[494]
GPR84	TTG0MQD	Strong	Altered Expression	[495]
GPRC6A	TTI1PRE	Strong	Biomarker	[356]
GPX1	TTYAHBP	Strong	Biomarker	[496]
GRIN1	TTLD29N	Strong	Biomarker	[497]
GRK2	TTAZ3MN	Strong	Altered Expression	[498]
GRK5	TTTCXO0	Strong	Biomarker	[499]
GSR	TTEP6RV	Strong	Altered Expression	[500]
GSTO1	TTWO3SH	Strong	Biomarker	[501]
GUCY2C	TTLDPRG	Strong	Biomarker	[502]
GUCY2D	TTWNFC2	Strong	Genetic Variation	[503]
HCAR3	TT8WFXV	Strong	Biomarker	[504]
HDAC4	TTTQGH8	Strong	Altered Expression	[166]
HEXA	TTJI5JW	Strong	Genetic Variation	[505]
HK2	TTK02H8	Strong	Biomarker	[154]
HLA-DRB1	TTUXSTW	Strong	Genetic Variation	[506]
HMBS	TTT0HW3	Strong	Biomarker	[507]
HMGB2	TTA78JQ	Strong	Biomarker	[154]
HMOX1	TTI6V2A	Strong	Altered Expression	[508]
HNRNPA1	TTPJ9XK	Strong	Biomarker	[509]
HRH3	TT9JNIC	Strong	Biomarker	[510]
HSD11B2	TT9H85R	Strong	Genetic Variation	[511]
HSD17B1	TTIWB6L	Strong	Genetic Variation	[512]
HSF1	TTN6STZ	Strong	Biomarker	[513]
HSPA5	TTW26OG	Strong	Altered Expression	[514]
HSPD1	TT9HL5R	Strong	Biomarker	[515]
HTR1D	TT6MSOK	Strong	Genetic Variation	[516]
HTR2A	TTJQOD7	Strong	Biomarker	[517]
HTR3A	TTPC4TU	Strong	Altered Expression	[518]
HTR6	TTJS8PY	Strong	Biomarker	[519]
ICAM1	TTA1L39	Strong	Altered Expression	[520]
ID1	TTBXVDE	Strong	Biomarker	[521]
IDE	TT2EDHU	Strong	Biomarker	[522]
IDO1	TTZJYKH	Strong	Altered Expression	[523]
IFNL3	TTRF4Q2	Strong	Genetic Variation	[524]
IGF1R	TTQFBMY	Strong	Genetic Variation	[525]
IGFBP1	TTCJTWF	Strong	Genetic Variation	[526]
IKBKB	TTJ3E9X	Strong	Biomarker	[433]
IL15	TTJFA35	Strong	Biomarker	[527]
IL16	TTW4R0B	Strong	Biomarker	[528]
IL17A	TTG0MT6	Strong	Altered Expression	[529]
IL18	TTRICUF	Strong	Altered Expression	[530]
IL1A	TTPM6HI	Strong	Altered Expression	[530]
IL1RAP	TTWS50K	Strong	Genetic Variation	[531]
IL1RN	TT6GSR3	Strong	Altered Expression	[532]
IL22	TTLDX4N	Strong	Biomarker	[533]
IL25	TTVMO5W	Strong	Altered Expression	[534]
IL2RB	TT9721Y	Strong	Genetic Variation	[464]
IL32	TTD4G7L	Strong	Altered Expression	[535]
IL33	TT5MD4P	Strong	Biomarker	[536]
IL37	TTQTX98	Strong	Biomarker	[537]
IRAK3	TTBPJOK	Strong	Biomarker	[538]
IRF3	TTYR7OH	Strong	Altered Expression	[539]
IRS2	TTF95B8	Strong	Biomarker	[540]
ITCH	TT5SEWD	Strong	Biomarker	[541]
ITGAM	TTB69FJ	Strong	Biomarker	[376]
ITPR2	TTK9OV3	Strong	Biomarker	[542]
ITPR3	TTH1769	Strong	Genetic Variation	[543]
JAK2	TTRMX3V	Strong	Altered Expression	[544]
JAK3	TTT7PJU	Strong	Altered Expression	[545]
KAT2B	TTVK7SB	Strong	Biomarker	[546]
KCNJ5	TTEO25X	Strong	Genetic Variation	[547]
KCNK9	TTL4FMB	Strong	Biomarker	[548]
KCNQ1	TT846HF	Strong	Biomarker	[549]
KDM3A	TTKXS4A	Strong	Biomarker	[550]
KDM6B	TTDIJUQ	Strong	Posttranslational Modification	[551]
KHDRBS1	TTAT6C7	Strong	Biomarker	[552]
KIR2DL1	TT4UXPE	Strong	Altered Expression	[553]
KIR2DS1	TTVWAGF	Strong	Biomarker	[554]
KIR3DL2	TTQH3N0	Strong	Biomarker	[554]
KISS1	TTU2O6T	Strong	Biomarker	[555]
KISS1R	TT3KBZY	Strong	Biomarker	[556]
KLB	TTARBVH	Strong	Genetic Variation	[557]
KLK7	TTE6GTB	Strong	Biomarker	[558]
KNG1	TTDJ4MY	Strong	Biomarker	[559]
LBP	TTVQJLY	Strong	Altered Expression	[560]
LCAT	TTGZ91P	Strong	Biomarker	[561]
LCT	TTA0OSE	Strong	Genetic Variation	[562]
LDLR	TTH0DUS	Strong	Biomarker	[563]
LGR4	TTY6C71	Strong	Genetic Variation	[564]
LIPE	TTLUQ8E	Strong	Altered Expression	[565]
LNPEP	TTY2KP7	Strong	Biomarker	[566]
LONP1	TTM1VPZ	Strong	Altered Expression	[567]
LPA	TTU9LGY	Strong	Biomarker	[568]
LPAR2	TTB7Y8I	Strong	Biomarker	[299]
LPAR3	TTE2YJR	Strong	Biomarker	[356]
LPAR4	TT7ZMY4	Strong	Biomarker	[569]
LPAR5	TTABCJ6	Strong	Altered Expression	[570]
LY75	TTG180Q	Strong	Biomarker	[571]
LY96	TT8S9AV	Strong	Biomarker	[572]
MAOA	TT3WG5C	Strong	Genetic Variation	[573]
MAOB	TTGP7BY	Strong	Genetic Variation	[574]
MAP2K5	TTV3O87	Strong	Genetic Variation	[575]
MAP3K3	TTJZNIG	Strong	Biomarker	[576]
MAP3K7	TTJQT60	Strong	Biomarker	[577]
MAP3K8	TTGECUM	Strong	Altered Expression	[578]
MAP4K4	TT6NI13	Strong	Biomarker	[579]
MAPK10	TT056SO	Strong	Altered Expression	[580]
MAPK9	TT3IVG2	Strong	Biomarker	[581]
MAPKAPK5	TT3UJ7Z	Strong	Altered Expression	[582]
MARK3	TT3DCYJ	Strong	Genetic Variation	[583]
MAS1	TTOISYB	Strong	Altered Expression	[584]
MBOAT4	TTSYOWR	Strong	Biomarker	[585]
MBP	TT2RY5P	Strong	Altered Expression	[586]
MC1R	TT0MV2T	Strong	Genetic Variation	[587]
MC2R	TTPWFDX	Strong	Altered Expression	[588]
MC5R	TT6QAJ3	Strong	Biomarker	[589]
MCHR1	TTX4RTB	Strong	Biomarker	[590]
MCL1	TTL53M6	Strong	Biomarker	[591]
METAP2	TTZL0OI	Strong	Biomarker	[592]
MGAM	TTXWASR	Strong	Altered Expression	[593]
MGAT1	TTYJRN5	Strong	Altered Expression	[594]
MGAT2	TTJOW1I	Strong	Biomarker	[205]
MGLL	TTZ963I	Strong	Biomarker	[595]
MKRN1	TTITER7	Strong	Biomarker	[596]
MLYCD	TT9Z4YD	Strong	Altered Expression	[597]
MME	TT5TKPM	Strong	Biomarker	[598]
MMP15	TTNSTO3	Strong	Biomarker	[599]
MPO	TTVCZPI	Strong	Biomarker	[600]
MRC1	TTKV8W5	Strong	Biomarker	[376]
MRGPRX1	TTIX6PK	Strong	Biomarker	[356]
MST1R	TTBQ3OC	Strong	Biomarker	[601]
MTOR	TTCJG29	Strong	Altered Expression	[593]
MTTP	TTUS1RD	Strong	Biomarker	[602]
MUSK	TT6SA0X	Strong	Genetic Variation	[603]
MYD88	TTB6Q2O	Strong	Biomarker	[604]
MYH7	TTNIMDP	Strong	Biomarker	[605]
NAAA	TTMN4HY	Strong	Biomarker	[606]
NAMPT	TTD1WIG	Strong	Altered Expression	[607]
NCF1	TTZ4JC3	Strong	Altered Expression	[608]
NCK1	TTMA3VF	Strong	Biomarker	[609]
NF2	TTZIK7P	Strong	Genetic Variation	[610]
NISCH	TT789FN	Strong	Altered Expression	[611]
NLRP3	TT4EN8X	Strong	Biomarker	[612]
NMUR2	TT2L6C5	Strong	Altered Expression	[613]
NNT	TTKIH76	Strong	Biomarker	[614]
NOS1	TTZUFI5	Strong	Biomarker	[615]
NOX4	TTQRBSJ	Strong	Biomarker	[616]
NPC1L1	TTPD1CN	Strong	Biomarker	[617]
NPEPPS	TT371QC	Strong	Biomarker	[618]
NPFFR2	TTXYNDJ	Strong	Genetic Variation	[619]
NPPB	TTY63XT	Strong	Altered Expression	[620]
NPPC	TTRK0B9	Strong	Altered Expression	[621]
NPR1	TTM9IYA	Strong	Biomarker	[622]
NPY1R	TTRK9JT	Strong	Biomarker	[623]
NPY4R	TTW4N16	Strong	Genetic Variation	[624]
NQO1	TT8XK6L	Strong	Biomarker	[625]
NR1D1	TTAD1O8	Strong	Biomarker	[626]
NR1H2	TTXA6PH	Strong	ModifyingMutation	[238]
NR1I2	TT7LCTF	Strong	Biomarker	[627]
NR1I3	TTRANFM	Strong	Biomarker	[217]
NR3C2	TT26PHO	Strong	Genetic Variation	[628]
NR4A1	TTMXE2Q	Strong	Biomarker	[629]
NR4A2	TT9HKN3	Strong	Biomarker	[630]
NRG4	TTWAGKJ	Strong	Biomarker	[631]
NTSR1	TTTUMEP	Strong	Biomarker	[632]
OGG1	TTRU01G	Strong	Genetic Variation	[633]
OLFM4	TTK1CX7	Strong	Genetic Variation	[634]
OPRD1	TT27RFC	Strong	Genetic Variation	[635]
OPRM1	TTKWM86	Strong	Genetic Variation	[636]
OSM	TTIVXSE	Strong	Biomarker	[637]
OXER1	TT7WBSV	Strong	Biomarker	[356]
OXTR	TTSCIUP	Strong	Altered Expression	[638]
P2RY12	TTZ1DT0	Strong	Genetic Variation	[639]
P2RY2	TTOZHQC	Strong	Biomarker	[640]
PADI4	TTQHAXM	Strong	Biomarker	[641]
PAM	TTF4ZPC	Strong	Biomarker	[642]
PARP1	TTVDSZ0	Strong	Biomarker	[643]
PARP2	TTQ4V96	Strong	Biomarker	[644]
PASK	TTC0V1J	Strong	Biomarker	[645]
PAX5	TTA4REJ	Strong	Genetic Variation	[646]
PCSK7	TTD30LY	Strong	Biomarker	[647]
PDE11A	TTTWC79	Strong	Genetic Variation	[648]
PDE4B	TTVIAT9	Strong	Biomarker	[649]
PDK1	TTCZOF2	Strong	Altered Expression	[650]
PDK2	TTJGCKM	Strong	Altered Expression	[651]
PDX1	TT8SGZK	Strong	Altered Expression	[652]
PDXK	TTXI3KF	Strong	Altered Expression	[653]
PEMT	TT735V2	Strong	Genetic Variation	[654]
PFKFB3	TTTHMQJ	Strong	Biomarker	[154]
PGC	TT7K6AD	Strong	Biomarker	[655]
PGR	TTUV8G9	Strong	Biomarker	[656]
PHB	TT6U071	Strong	Genetic Variation	[657]
PIK3CB	TT9H4P3	Strong	Biomarker	[658]
PIN1	TTJNTSI	Strong	Biomarker	[659]
PKM	TT4LOT8	Strong	Biomarker	[660]
PLA2G4A	TTT1JVS	Strong	Altered Expression	[661]
PLA2G7	TTDNFMT	Strong	Biomarker	[662]
PLD1	TT3T17P	Strong	Genetic Variation	[663]
PLG	TTP86E2	Strong	Biomarker	[664]
PLIN1	TTIV27N	Strong	Biomarker	[665]
PLOD2	TT8MEUD	Strong	Genetic Variation	[666]
PLTP	TTZF6SN	Strong	Biomarker	[667]
PPARD	TT2JWF6	Strong	Biomarker	[668]
PPARGC1B	TTKSQ3W	Strong	Biomarker	[230]
PPIB	TT6ZFQ4	Strong	Altered Expression	[669]
PPID	TTNAFOU	Strong	Altered Expression	[670]
PPIF	TTRFQTB	Strong	Altered Expression	[670]
PRCP	TTTJZ4M	Strong	Biomarker	[671]
PRDX5	TTLPJWH	Strong	Genetic Variation	[672]
PREP	TTNGKET	Strong	Genetic Variation	[673]
PRG4	TTSKF4V	Strong	Biomarker	[674]
PRKAR2B	TTW4Y2M	Strong	Biomarker	[675]
PRKCH	TTONI0R	Strong	Genetic Variation	[676]
PRKCZ	TTBSN0L	Strong	Biomarker	[677]
PRKD1	TTSLUMT	Strong	Biomarker	[678]
PRKDC	TTK3PY9	Strong	Biomarker	[679]
PRKG1	TT7IZSA	Strong	Altered Expression	[680]
PRL	TTJ2TSA	Strong	Genetic Variation	[681]
PROC	TTZUXYS	Strong	Biomarker	[682]
PSMB6	TT8EPLT	Strong	Genetic Variation	[384]
PTGES2	TTWU04I	Strong	Genetic Variation	[683]
PTGS2	TTVKILB	Strong	Biomarker	[684]
PTH	TT6F7GZ	Strong	Biomarker	[685]
PTPN2	TTY8PUS	Strong	Biomarker	[686]
PTPRJ	TTWMKXP	Strong	Biomarker	[687]
PTPRS	TTCWXFA	Strong	Biomarker	[688]
RAPGEF4	TTOS63B	Strong	Biomarker	[689]
REG3A	TTL4H8N	Strong	Biomarker	[690]
RENBP	TTZCG0Q	Strong	Genetic Variation	[691]
RGMA	TTURJV4	Strong	Genetic Variation	[692]
RGS2	TTKB7T3	Strong	Altered Expression	[693]
RGS4	TTGTKX9	Strong	Biomarker	[694]
RGS6	TTJ96M8	Strong	Biomarker	[281]
ROBO1	TTND1YP	Strong	Genetic Variation	[695]
ROBO4	TT3S9TY	Strong	Genetic Variation	[696]
RORC	TTGV6LY	Strong	Biomarker	[697]
ROS1	TTSZ6Y3	Strong	Altered Expression	[608]
S100A12	TTQ4ESF	Strong	Altered Expression	[698]
S100A6	TT716MY	Strong	Genetic Variation	[699]
S100A8	TT4AF6N	Strong	Biomarker	[700]
S1PR2	TTVSMOH	Strong	Biomarker	[701]
SAA1	TTY0DN9	Strong	Biomarker	[702]
SCARB1	TTRE324	Strong	Biomarker	[703]
SCD	TT6RIOV	Strong	Biomarker	[704]
SCG3	TTY5R9H	Strong	Genetic Variation	[705]
SDC1	TTYDSVG	Strong	Biomarker	[706]
SDC2	TT5H2F0	Strong	Biomarker	[706]
SELP	TTE5VG0	Strong	Altered Expression	[707]
SELPLG	TTS5K8U	Strong	Biomarker	[708]
SEMA4D	TT5UT28	Strong	Altered Expression	[709]
SERPINA6	TTJL8VG	Strong	Genetic Variation	[710]
SETD2	TTPC3H4	Strong	Altered Expression	[711]
SFTPD	TTGLMU7	Strong	Biomarker	[712]
SGK1	TTTV8EJ	Strong	Biomarker	[713]
SH3GL1	TTTYNAM	Strong	Biomarker	[714]
SIK2	TTCUGZR	Strong	Biomarker	[715]
SIK3	TTW6L4V	Strong	Genetic Variation	[716]
SIRT1	TTUF2HO	Strong	Biomarker	[717]
SIRT2	TTLKF5M	Strong	Biomarker	[717]
SIRT3	TTVZLIJ	Strong	Biomarker	[718]
SIRT5	TTH0IOD	Strong	Biomarker	[719]
SLC12A3	TTP362L	Strong	Genetic Variation	[720]
SLC15A1	TT5LF3C	Strong	Biomarker	[721]
SLC19A1	TT09I7D	Strong	Posttranslational Modification	[722]
SLC22A1	TTM5Q4V	Strong	Biomarker	[723]
SLC22A12	TTA592U	Strong	Genetic Variation	[724]
SLC22A2	TT0XOJN	Strong	Biomarker	[725]
SLC22A3	TTG2UMS	Strong	Biomarker	[725]
SLC22A8	TTTQR47	Strong	Altered Expression	[196]
SLC27A4	TT20AYF	Strong	Biomarker	[726]
SLC30A8	TTXIGT7	Strong	Biomarker	[727]
SLC33A1	TTL69WB	Strong	Biomarker	[728]
SLC37A4	TT1KPBZ	Strong	Altered Expression	[729]
SLC38A1	TT1YE9Z	Strong	Biomarker	[730]
SLC38A5	TTC8YPT	Strong	Altered Expression	[731]
SLC5A1	TT2UE56	Strong	Biomarker	[732]
SLC5A2	TTF8JAT	Strong	Biomarker	[733]
SLC6A12	TTQBMPI	Strong	Biomarker	[734]
SLC6A2	TTAWNKZ	Strong	Biomarker	[696]
SLC8A1	TTCF82X	Strong	Genetic Variation	[676]
SLIT2	TTDWK85	Strong	Genetic Variation	[735]
SMAD6	TTON5JB	Strong	Altered Expression	[736]
SNAP25	TTYQWA0	Strong	Genetic Variation	[737]
SNCG	TT5TQNZ	Strong	Altered Expression	[738]
SOCS1	TT8COJM	Strong	Biomarker	[739]
SOD1	TTP9K3Q	Strong	Biomarker	[740]
SORT1	TTRX9AV	Strong	Biomarker	[741]
SOX2	TTCNOT6	Strong	Biomarker	[742]
SPARC	TTBQFM7	Strong	Biomarker	[743]
SPDEF	TT2ZUPY	Strong	Biomarker	[744]
SPHK1	TTOHFIY	Strong	Biomarker	[745]
SPRY1	TT0PSN6	Strong	Biomarker	[746]
SPTBN1	TTS9BDA	Strong	Biomarker	[747]
SQSTM1	TTOT2RY	Strong	Biomarker	[552]
SREBF1	TTER0UB	Strong	Altered Expression	[748]
SREBF2	TTRQ4AP	Strong	Genetic Variation	[749]
SSTR2	TTZ6T9E	Strong	Genetic Variation	[750]
SSTR4	TTAE1BR	Strong	Biomarker	[299]
STC1	TTDLUER	Strong	Biomarker	[751]
STK33	TTP34DQ	Strong	Genetic Variation	[752]
STK39	TTYQTIU	Strong	Biomarker	[753]
STS	TTHM0R1	Strong	Altered Expression	[754]
SUCNR1	TT4FX9Y	Strong	Biomarker	[755]
SULF2	TTLQTHB	Strong	Genetic Variation	[756]
SUV39H1	TTUWQTK	Strong	Biomarker	[757]
SYVN1	TT8XKYM	Strong	Biomarker	[758]
TAAR1	TTIU98M	Strong	Biomarker	[759]
TAOK3	TTO7L0V	Strong	Posttranslational Modification	[470]
TBK1	TTMP03S	Strong	Biomarker	[760]
TBL1X	TTAL6S1	Strong	Altered Expression	[761]
TBL1XR1	TTYXT16	Strong	Altered Expression	[761]
TBXA2R	TT2O84V	Strong	Genetic Variation	[762]
TEK	TT9VGXW	Strong	Altered Expression	[763]
TF	TT8WXAV	Strong	Biomarker	[154]
TFRC	TT8MG4S	Strong	Biomarker	[764]
TGFB3	TTWOMY8	Strong	Altered Expression	[765]
THBD	TTAPV67	Strong	Biomarker	[766]
THBS1	TTKI0H1	Strong	Biomarker	[767]
THRA	TTTSEPU	Strong	Genetic Variation	[768]
THRB	TTGER3L	Strong	Genetic Variation	[769]
TICAM1	TT2GQT6	Strong	Altered Expression	[770]
TIE1	TTT4236	Strong	Biomarker	[771]
TKTL1	TTNQ1J3	Strong	Biomarker	[772]
TLR3	TTD24Y0	Strong	Biomarker	[773]
TLR8	TT8CWFK	Strong	Biomarker	[774]
TMPRSS15	TTXL0GC	Strong	Biomarker	[775]
TMPRSS2	TT1GM2Z	Strong	Biomarker	[776]
TMPRSS6	TTL9KE7	Strong	Biomarker	[777]
TNFRSF12A	TTKPS7V	Strong	Biomarker	[778]
TNFRSF1A	TTG043C	Strong	Biomarker	[779]
TNFRSF4	TTL31H0	Strong	Altered Expression	[780]
TNFSF12	TTBTDM1	Strong	Altered Expression	[781]
TNFSF14	TTKVENM	Strong	Altered Expression	[782]
TNKS	TTVUSO7	Strong	Genetic Variation	[783]
TNNI3	TTNLDK6	Strong	Biomarker	[784]
TREM1	TTHZQP0	Strong	Altered Expression	[785]
TREM2	TTQRMSJ	Strong	Altered Expression	[785]
TRH	TT2Z39D	Strong	Biomarker	[786]
TRIM24	TT9Q7AE	Strong	Biomarker	[787]
TRIM28	TTQ2BKV	Strong	Biomarker	[788]
TRPC1	TTA76X0	Strong	Biomarker	[789]
TRPC3	TTNVC34	Strong	Genetic Variation	[790]
TRPM2	TTEBMN7	Strong	Biomarker	[791]
TRPM5	TT1N8F3	Strong	Biomarker	[792]
TRPM8	TTXDKTO	Strong	Biomarker	[793]
TRPV1	TTMI6F5	Strong	Biomarker	[794]
TUSC2	TTJ8O14	Strong	Biomarker	[795]
TYK2	TTBYWP2	Strong	Biomarker	[796]
TYRP1	TTFRV98	Strong	Biomarker	[789]
UBE3A	TTUZX6V	Strong	Biomarker	[797]
UGT1A1	TT34ZAF	Strong	Genetic Variation	[798]
ULK1	TT4D7MJ	Strong	Biomarker	[799]
USP10	TT5IH09	Strong	Altered Expression	[800]
UTS2	TTERU0T	Strong	Biomarker	[801]
UTS2R	TTW5UDX	Strong	Biomarker	[801]
VCAM1	TTHCEF6	Strong	Biomarker	[802]
VKORC1	TTEUC8H	Strong	Biomarker	[803]
WAS	TTE8T73	Strong	Biomarker	[804]
WNT5A	TTKG7F8	Strong	Biomarker	[805]
WNT7A	TT8NARC	Strong	Biomarker	[806]
WRN	TT2H5WQ	Strong	Genetic Variation	[807]
WT1	TTZ8UT4	Strong	Biomarker	[808]
XDH	TT7RJY8	Strong	Altered Expression	[809]
ZFP36L1	TT8QVJO	Strong	Biomarker	[810]
PREPL	TT3HYDO	Definitive	Genetic Variation	[811]

This Disease Is Related to 24 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC25A19	DTT82QK	Limited	Biomarker	[812]
ABCC5	DTYVM24	moderate	Biomarker	[813]
ABCC11	DTWN7FC	Strong	Altered Expression	[294]
ABCC6	DT582KR	Strong	Biomarker	[814]
ATP10A	DTTQ8WI	Strong	Biomarker	[815]
SLC16A7	DTLT3UG	Strong	Biomarker	[154]
SLC24A3	DTO18LP	Strong	Altered Expression	[816]
SLC25A3	DTCRIWV	Strong	Altered Expression	[817]
SLC27A1	DTKDTML	Strong	Altered Expression	[818]
SLC27A2	DTXK9WA	Strong	Altered Expression	[819]
SLC27A5	DT0TQS3	Strong	Biomarker	[385]
SLC27A6	DTG4CWJ	Strong	Altered Expression	[820]
SLC2A2	DTUJPOL	Strong	Altered Expression	[821]
SLC2A3	DT9SQ3L	Strong	Biomarker	[822]
SLC2A5	DTOR02F	Strong	Altered Expression	[823]
SLC30A10	DTYBI73	Strong	Biomarker	[727]
SLC35B4	DTMALXP	Strong	Biomarker	[824]
SLC35D3	DT63MZQ	Strong	Genetic Variation	[425]
SLC39A13	DTOTKBS	Strong	Biomarker	[825]
SLC45A2	DTNCJAT	Strong	Genetic Variation	[340]
SLC4A4	DTWDEIL	Strong	Biomarker	[826]
SLC5A11	DT2CAPQ	Strong	Biomarker	[827]
SLC9A6	DTN0JXW	Strong	Genetic Variation	[828]
SLC35A1	DTVZIRG	Definitive	Biomarker	[829]

This Disease Is Related to 55 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
PON3	DETXQZ1	Limited	Biomarker	[830]
PSAT1	DEBS17P	Limited	Biomarker	[618]
PTGDS	DER3H9C	Limited	Biomarker	[831]
SULT2A1	DE0P6LK	Limited	Biomarker	[832]
GSTT1	DE3PKUG	Disputed	Biomarker	[833]
CYP4F3	DEFCMPI	moderate	Altered Expression	[834]
DHRS9	DEGTU5I	moderate	Altered Expression	[263]
MAT2B	DEKF1OH	moderate	Biomarker	[291]
MTRR	DE6NIY9	moderate	Genetic Variation	[835]
ACP3	DEDW5H6	Strong	Biomarker	[795]
ACP5	DESITDW	Strong	Biomarker	[154]
ACSS2	DEE76VW	Strong	Genetic Variation	[836]
ADH1B	DEEN9RD	Strong	Biomarker	[837]
AKR1C2	DEOY5ZM	Strong	Altered Expression	[838]
AS3MT	DE9KJP3	Strong	Biomarker	[839]
BAAT	DERA3OF	Strong	Altered Expression	[840]
CEPT1	DEL87ZT	Strong	Biomarker	[841]
CES2	DETHCPD	Strong	Biomarker	[842]
CHDH	DEAHED0	Strong	Biomarker	[843]
CHST3	DEQIZP2	Strong	Biomarker	[844]
CYB5A	DE9A2LB	Strong	Biomarker	[154]
CYP26B1	DEZT8FM	Strong	Biomarker	[154]
CYP27A1	DEBS639	Strong	Altered Expression	[845]
CYP4F2	DE3GT9C	Strong	Biomarker	[846]
DCXR	DE3FEV8	Strong	Biomarker	[154]
DHRS3	DEXPVUN	Strong	Biomarker	[847]
FADS1	DE05S8C	Strong	Biomarker	[848]
FARS2	DE0WGR8	Strong	Genetic Variation	[676]
FMO3	DEP76YL	Strong	Biomarker	[849]
GLDC	DEIN8FB	Strong	Altered Expression	[850]
GSTA4	DEH7XYP	Strong	Altered Expression	[851]
GSTO2	DEHMPZR	Strong	Genetic Variation	[852]
HIF1AN	DEY1CBW	Strong	Biomarker	[853]
HK1	DEDMAGE	Strong	Biomarker	[854]
ME1	DE97WM8	Strong	Biomarker	[855]
MSMO1	DE5FUD0	Strong	Altered Expression	[856]
MSRA	DEU2ZBY	Strong	Genetic Variation	[857]
MT2A	DEFKGT7	Strong	Altered Expression	[858]
NNMT	DECVGJ3	Strong	Biomarker	[859]
NT5C2	DE1DOKJ	Strong	Biomarker	[860]
PER1	DE9HF0I	Strong	Biomarker	[861]
SAT1	DEMWO83	Strong	Biomarker	[862]
SCLY	DEH4TD6	Strong	Genetic Variation	[863]
SI	DE5EO4Y	Strong	Altered Expression	[593]
SULT1A1	DEYWLRK	Strong	Genetic Variation	[864]
SULT1E1	DESTKG6	Strong	Altered Expression	[865]
UGT1A10	DEL5N6Y	Strong	Genetic Variation	[798]
UGT1A3	DEF2WXN	Strong	Genetic Variation	[798]
UGT1A4	DELOY3P	Strong	Genetic Variation	[798]
UGT1A5	DEPF954	Strong	Genetic Variation	[798]
UGT1A6	DESD26P	Strong	Genetic Variation	[798]
UGT1A7	DEZO4N3	Strong	Genetic Variation	[798]
UGT1A8	DE2GB8N	Strong	Genetic Variation	[798]
UGT1A9	DE85D2P	Strong	Genetic Variation	[798]
VKORC1L1	DERQV72	Strong	Genetic Variation	[866]

This Disease Is Related to 978 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
AACS	OTGGPR6J	Limited	Biomarker	[867]
ACKR2	OTWYY14H	Limited	Altered Expression	[868]
ACVR1C	OTOTYERF	Limited	Biomarker	[869]
ADARB1	OTGKSZEV	Limited	Biomarker	[870]
ADCY3	OTGOQM6B	Limited	Biomarker	[871]
APOBEC1	OTY8QX2R	Limited	Biomarker	[872]
APOC1	OTA58CED	Limited	Biomarker	[873]
ARID1A	OTRWDV3P	Limited	Biomarker	[546]
ARRDC3	OTAKW7R9	Limited	Biomarker	[874]
ASAH1	OT1DNGXL	Limited	Biomarker	[875]
BCAR1	OTKT2C2N	Limited	Genetic Variation	[169]
BEST1	OTWHE1ZC	Limited	Biomarker	[173]
BMS1	OTEGQ8ZO	Limited	Biomarker	[876]
BNIP3	OT4SO7J4	Limited	Biomarker	[877]
C1QL3	OT4TZH3J	Limited	Altered Expression	[878]
C1QTNF6	OT57EPQC	Limited	Biomarker	[879]
CADM1	OTRWG9QS	Limited	Biomarker	[853]
CAPN5	OTQ8QM7K	Limited	Genetic Variation	[880]
CAV2	OT1FGRQX	Limited	Biomarker	[881]
CCN3	OTOW5YL4	Limited	Altered Expression	[882]
CD1D	OT3ROU4J	Limited	Biomarker	[883]
CEACAM8	OTLL9WWO	Limited	Biomarker	[884]
CERS6	OTOP4GV1	Limited	Biomarker	[885]
CISH	OT8T5NYL	Limited	Altered Expression	[478]
CPT1A	OTI862QH	Limited	Biomarker	[886]
CTNND1	OTUMPSHR	Limited	Genetic Variation	[169]
CYBA	OT16N9ZO	Limited	Altered Expression	[887]
CYP2W1	OTXSB1AE	Limited	Genetic Variation	[888]
DDT	OTF5HTYL	Limited	Biomarker	[889]
DEFB1	OT5SV0E4	Limited	Biomarker	[890]
DENR	OTXP9HOY	Limited	Biomarker	[891]
DOC2B	OTRUMZ8C	Limited	Biomarker	[892]
EHD1	OTDMEKLV	Limited	Biomarker	[893]
ETV3	OTEN03BM	Limited	Biomarker	[894]
FADD	OTV7GFHH	Limited	Biomarker	[895]
FAIM2	OT6QINVO	Limited	Genetic Variation	[854]
FETUB	OT7V07NI	Limited	Biomarker	[526]
FLVCR1	OT9XCFOC	Limited	Altered Expression	[896]
FSTL1	OT6KEZUD	Limited	Altered Expression	[897]
FTSJ3	OT3J8P0B	Limited	Biomarker	[898]
GALNT2	OTZZ5386	Limited	Altered Expression	[899]
GDF11	OTOSNMND	Limited	Biomarker	[900]
GEMIN5	OTSF03K2	Limited	Biomarker	[901]
GNAS	OTMH8BKJ	Limited	Biomarker	[902]
GPAM	OTR1XD9B	Limited	Biomarker	[903]
GPRC5B	OTF3S5E3	Limited	Genetic Variation	[374]
GUCA2B	OTZERX04	Limited	Altered Expression	[502]
HIF3A	OTPWAAMC	Limited	Biomarker	[904]
HSPA12A	OTFOCDD6	Limited	Biomarker	[905]
IKBKE	OT5VYOSM	Limited	Altered Expression	[906]
IL6ST	OT1N9C70	Limited	Biomarker	[907]
INSIG1	OTZF5X1D	Limited	Genetic Variation	[908]
IP6K1	OTKS4P2T	Limited	Biomarker	[909]
IRF5	OT8SIIAP	Limited	Altered Expression	[910]
IRF6	OTKJ44EV	Limited	Biomarker	[911]
KLF15	OTGMQMVR	Limited	Biomarker	[912]
LCE1C	OTQY73YS	Limited	Genetic Variation	[913]
LEAP2	OTUOPIS5	Limited	Biomarker	[914]
LPIN2	OTRRTMXX	Limited	Biomarker	[915]
LRP1B	OT4YZG2N	Limited	Biomarker	[916]
LRPPRC	OTXSK5LP	Limited	Biomarker	[907]
LRRC8A	OT23OE7H	Limited	Biomarker	[917]
LRRFIP1	OTN7XAUD	Limited	Biomarker	[918]
MED13	OTP5LEJE	Limited	Altered Expression	[919]
MIP	OTEBLU3E	Limited	Biomarker	[920]
MLKL	OTDSLC81	Limited	Biomarker	[921]
MRAP2	OTCQS7DB	Limited	Genetic Variation	[922]
MSC	OTBRPZL5	Limited	Biomarker	[923]
MYOD1	OTV2S79X	Limited	Biomarker	[924]
MYOG	OTPLJKFA	Limited	Biomarker	[925]
NCF2	OTAUW7L2	Limited	Biomarker	[926]
NDN	OTYBYJ82	Limited	Biomarker	[927]
NDUFAB1	OTF906UR	Limited	Biomarker	[276]
NDUFB6	OTIXNT91	Limited	Biomarker	[928]
NHLH2	OT88N84O	Limited	Biomarker	[929]
NOCT	OTVSYP2D	Limited	Altered Expression	[930]
NOX1	OTZPJQCC	Limited	Biomarker	[616]
NPC1	OTRIPICX	Limited	Biomarker	[931]
NR5A1	OTOULYR4	Limited	Genetic Variation	[932]
NRIP1	OTIZOJQV	Limited	Genetic Variation	[933]
NUCKS1	OTL4VJC5	Limited	Altered Expression	[934]
OGT	OT1Z1ZXE	Limited	Altered Expression	[935]
OXCT1	OT536PE7	Limited	Biomarker	[867]
PC	OT6O0V51	Limited	Biomarker	[936]
PCSK1N	OT7ZRW2F	Limited	Biomarker	[937]
PDCD4	OTZ6NXUX	Limited	Altered Expression	[938]
PER2	OTU2B1DJ	Limited	Genetic Variation	[939]
PHPT1	OTFYWNFX	Limited	Biomarker	[875]
PIK3R1	OT5BZ1J9	Limited	Biomarker	[940]
PLCB2	OTPAHDGO	Limited	Altered Expression	[941]
PLEK	OTB73XXA	Limited	Biomarker	[942]
PLSCR3	OTJ6K2XJ	Limited	Biomarker	[943]
PNOC	OTJEAADN	Limited	Biomarker	[944]
PTBP2	OTF4S7NE	Limited	Altered Expression	[945]
PTPRU	OTHDO0QG	Limited	Altered Expression	[946]
PYCARD	OT67RON3	Limited	Altered Expression	[754]
RAPGEF5	OT53VS75	Limited	Biomarker	[947]
RLN3	OTQSQMUQ	Limited	Genetic Variation	[222]
RMC1	OT7K8MTJ	Limited	Altered Expression	[948]
RSC1A1	OT54EM29	Limited	Biomarker	[949]
RYR2	OT0PF19E	Limited	Biomarker	[950]
SELENOP	OT02B8IR	Limited	Biomarker	[951]
SEMA3C	OTEGUY7F	Limited	Biomarker	[952]
SEMA3E	OTD4S36H	Limited	Biomarker	[952]
SEMA3G	OTBLVF8V	Limited	Biomarker	[953]
SERPINA12	OTS1E6IP	Limited	Biomarker	[954]
SFTPA1	OT87XL1U	Limited	Biomarker	[955]
SFTPB	OTOHS07E	Limited	Biomarker	[955]
SIT1	OT7MDF09	Limited	Biomarker	[956]
SORBS1	OTWH8762	Limited	Biomarker	[957]
SPAG8	OTZC5XP9	Limited	Altered Expression	[958]
SPRED2	OTUX685J	Limited	Biomarker	[959]
STAT4	OTAK3VFR	Limited	Therapeutic	[960]
STAU1	OTTR5311	Limited	Genetic Variation	[901]
STK11	OT1YZSP3	Limited	Biomarker	[961]
TAFA5	OT2SWBT6	Limited	Altered Expression	[962]
TAS2R38	OTX5MM36	Limited	Biomarker	[963]
TFEB	OTJUJJQY	Limited	Biomarker	[964]
THRAP3	OTG25JOG	Limited	Biomarker	[965]
THY1	OTVONVTB	Limited	Biomarker	[966]
TLE3	OTR9PH95	Limited	Biomarker	[967]
ATP4B	OTIP2EYJ	Disputed	Therapeutic	[968]
ATP5F1D	OTXTAG2V	Disputed	Therapeutic	[969]
FAM3A	OTK1X62Z	Disputed	Biomarker	[970]
KIFBP	OT1XADKG	Disputed	Biomarker	[971]
AFF4	OTTL5Y8R	moderate	Genetic Variation	[972]
AIM2	OT86QUI8	moderate	Biomarker	[973]
ANGPTL5	OTC6AFVO	moderate	Altered Expression	[974]
ANGPTL6	OTOQ5W67	moderate	Biomarker	[975]
APLP2	OTTFE53M	moderate	Biomarker	[976]
APPL1	OT8VR95S	moderate	Biomarker	[190]
ARL13B	OT9PYPV1	moderate	Biomarker	[977]
ARL15	OT00YSWZ	moderate	Biomarker	[978]
ARSD	OTAHW9M8	moderate	Biomarker	[979]
ATG16L1	OTEOYC5D	moderate	Biomarker	[980]
ATP2A3	OTFYDEES	moderate	Biomarker	[981]
B4GALT5	OTHMZY12	moderate	Altered Expression	[982]
BRAP	OTB7BAFQ	moderate	Genetic Variation	[983]
C1QTNF3	OTOJMWW0	moderate	Altered Expression	[984]
CAND2	OTOMOG3R	moderate	Biomarker	[985]
CCDC57	OTSLDWUQ	moderate	Biomarker	[412]
CCL14	OT8QETQU	moderate	Biomarker	[986]
CERS5	OT5A2DNI	moderate	Biomarker	[987]
CILP2	OTAFSWG1	moderate	Altered Expression	[988]
CNTN3	OTC1274J	moderate	Biomarker	[989]
CPN2	OTYOYP14	moderate	Biomarker	[259]
CPT1C	OT8F1MBF	moderate	Altered Expression	[990]
CREBRF	OT2GK1HI	moderate	Genetic Variation	[991]
CSTA	OT1K68KE	moderate	Altered Expression	[992]
CTRL	OTB6NA5O	moderate	Biomarker	[993]
CXCL14	OTM189TA	moderate	Biomarker	[994]
CYTB	OTAHB98A	moderate	Genetic Variation	[995]
DPT	OTINRFC7	moderate	Genetic Variation	[289]
DUSP22	OTEZ3U85	moderate	Biomarker	[996]
ERFE	OTSES1HA	moderate	Biomarker	[997]
ETV5	OTE2OBM4	moderate	Genetic Variation	[998]
EXOC4	OT5EWXAN	moderate	Biomarker	[999]
FAM13A	OTZ6GN0Q	moderate	Biomarker	[1000]
FLNC	OT3F8J6Y	moderate	Altered Expression	[1001]
FOXA2	OTJOCVOY	moderate	Altered Expression	[1002]
FZD5	OTXFFY56	moderate	Altered Expression	[805]
GABPB1	OTEXDEJN	moderate	Genetic Variation	[1003]
GLS2	OT08MSHL	moderate	Biomarker	[1004]
GOT2	OT6XBWN0	moderate	Biomarker	[1005]
GPX4	OTRAFFX2	moderate	Altered Expression	[1006]
ID3	OTUULW5Z	moderate	Biomarker	[1007]
IMMP2L	OT9WGAFD	moderate	Biomarker	[1008]
IMPACT	OTQ923OB	moderate	Biomarker	[434]
INSL5	OTLUI3PV	moderate	Biomarker	[1009]
IRF7	OTC1A2PQ	moderate	Altered Expression	[850]
IRX5	OT05J514	moderate	Altered Expression	[329]
KBTBD11	OTBOY3WH	moderate	Biomarker	[1010]
KCNE2	OTUO214Y	moderate	Genetic Variation	[1011]
KCTD7	OTRU3EOK	moderate	Genetic Variation	[1012]
KMT2B	OTMMAZQX	moderate	Biomarker	[797]
KSR2	OTSMUL59	moderate	Genetic Variation	[1013]
LIPC	OTZY5SC9	moderate	Biomarker	[1014]
LTBP3	OTME98V7	moderate	Biomarker	[1015]
LUM	OTSRC874	moderate	Biomarker	[1016]
MAGEE1	OTOQQO2X	moderate	Biomarker	[267]
MAP2K4	OTZPZX11	moderate	Biomarker	[1017]
MARCHF8	OTH7PNN2	moderate	Biomarker	[1018]
MARK4	OT6Z2TGV	moderate	Biomarker	[1019]
MBOAT7	OTHRCBLK	moderate	Genetic Variation	[1020]
MFN2	OTPYN8A3	moderate	Biomarker	[1021]
MFSD2A	OTVG1VG0	moderate	Biomarker	[1022]
MLXIP	OT30UNI7	moderate	Biomarker	[1018]
MOGS	OT99MBGB	moderate	Biomarker	[355]
MSN	OTZJ4J6G	moderate	Biomarker	[1023]
MSS51	OTDWY1RO	moderate	Biomarker	[1024]
MT1B	OTUA4FFH	moderate	Biomarker	[602]
MYLIP	OTL0PFGV	moderate	Biomarker	[1018]
NAA10	OTYB9R6I	moderate	Altered Expression	[1025]
NABP2	OTQU8081	moderate	Genetic Variation	[1026]
ND1	OTCLGIXV	moderate	Biomarker	[1027]
NFAT5	OTKIE59S	moderate	Biomarker	[1028]
NLRC4	OTAIA3NA	moderate	Altered Expression	[1029]
NMB	OT4NLN6H	moderate	Genetic Variation	[1030]
NMBR	OTBJEGPN	moderate	Biomarker	[1031]
NMU	OTW9X7BQ	moderate	Biomarker	[1032]
NOX3	OT0FFJH8	moderate	Biomarker	[1033]
OR10A4	OTYYB8SY	moderate	Biomarker	[1034]
P4HB	OTTYNYPF	moderate	Biomarker	[1035]
PARD3	OTH5BPLO	moderate	Biomarker	[264]
PERM1	OTZJW04C	moderate	Altered Expression	[1036]
PHACTR1	OTAMPX9V	moderate	Genetic Variation	[1011]
PHETA2	OTR0Z4U5	moderate	Altered Expression	[1037]
PIEZO1	OTBG1FU4	moderate	Biomarker	[1038]
PKHD1	OTAH8SMF	moderate	Genetic Variation	[1039]
PLAAT2	OTI5RMWB	moderate	Altered Expression	[1040]
PM20D1	OTXXNQ5K	moderate	Biomarker	[1041]
PMAIP1	OTXEE550	moderate	Genetic Variation	[1011]
POC1A	OTXAG4PL	moderate	Biomarker	[1017]
PPP1R13L	OTNCPLWE	moderate	Biomarker	[477]
PPP1R14A	OTQODWZB	moderate	Altered Expression	[1042]
PPP1R3B	OTVCRXEZ	moderate	Genetic Variation	[1043]
PVALB	OTZW1WVQ	moderate	Biomarker	[1044]
REEP5	OTZU4TJI	moderate	Biomarker	[279]
RETREG1	OTYOSLZX	moderate	Altered Expression	[1045]
RND3	OTXMXPIH	moderate	Altered Expression	[1046]
RNF41	OTN1DQOY	moderate	Biomarker	[1047]
S100A16	OT3ERKQI	moderate	Altered Expression	[1048]
SAGE1	OT4H6FFA	moderate	Biomarker	[1049]
SCARB2	OTN929M8	moderate	Altered Expression	[1050]
SCRN2	OTSG9EUS	moderate	Altered Expression	[1037]
SDS	OT5WTJ2M	moderate	Biomarker	[1051]
SEL1L	OTC0FB7T	moderate	Biomarker	[1052]
SELENOW	OTVSKPAN	moderate	Biomarker	[1053]
SPPL3	OT2HLJF6	moderate	Biomarker	[1008]
SPSB1	OTGY26U4	moderate	Genetic Variation	[1026]
SYNPO	OTICDJAB	moderate	Biomarker	[1054]
TAPT1	OT3Z51KH	moderate	Biomarker	[287]
TFAP2B	OTR1T8E9	moderate	Genetic Variation	[1055]
TFDP1	OT6RZ7VT	moderate	Biomarker	[279]
TFF3	OTJJDRTU	moderate	Altered Expression	[1056]
TRAM1	OT3I0H8E	moderate	Genetic Variation	[289]
A1CF	OTJBKFA1	Strong	Biomarker	[1057]
A2M	OTFTX90K	Strong	Biomarker	[1058]
AAAS	OTJT9T23	Strong	Biomarker	[1059]
ABHD15	OTG98AB1	Strong	Biomarker	[1060]
ABHD5	OTY829Z3	Strong	Biomarker	[1061]
ACACA	OT5CQPZY	Strong	Biomarker	[876]
ACAD8	OT3JI5GB	Strong	Biomarker	[1062]
ACADM	OTA4P0FC	Strong	Biomarker	[154]
ACAN	OTUOCW8K	Strong	Biomarker	[1063]
ACAT2	OTZ092ZJ	Strong	Altered Expression	[1064]
ACCS	OTHIHI9D	Strong	Genetic Variation	[836]
ACOT11	OTGPB0SM	Strong	Biomarker	[1065]
ACSL1	OTB06ESI	Strong	Altered Expression	[401]
ACSL5	OT3L9XO3	Strong	Genetic Variation	[1066]
ACSM3	OT0AE1IV	Strong	Genetic Variation	[1067]
ADA2	OTGCV24S	Strong	Genetic Variation	[1068]
ADAM11	OTPTVW5W	Strong	Genetic Variation	[369]
ADAM12	OTZKOTDB	Strong	Genetic Variation	[380]
ADAM19	OTH88TXU	Strong	Biomarker	[1069]
ADAM28	OT3GBVHL	Strong	Altered Expression	[1070]
ADCY10	OTYSTB0R	Strong	Biomarker	[504]
ADCY8	OTR1WCZX	Strong	Biomarker	[1071]
ADCY9	OT1IZT5K	Strong	Genetic Variation	[1072]
ADGRV1	OTLVXHHP	Strong	Genetic Variation	[1073]
ADIPOR1	OT65ZFZN	Strong	Altered Expression	[1074]
AGAP2	OTEYO9TM	Strong	Altered Expression	[438]
AHI1	OT8K2YWY	Strong	Biomarker	[1075]
AHRR	OTSJ12W6	Strong	Posttranslational Modification	[1076]
AHSA1	OTC7AFHT	Strong	Altered Expression	[266]
AIDA	OTMRLWGT	Strong	Biomarker	[1077]
AIRE	OTA7G1Y1	Strong	Biomarker	[1078]
AKAP1	OTIIB2JB	Strong	Biomarker	[623]
AKAP13	OTOZAR14	Strong	Altered Expression	[1079]
ALDH1L1	OT15HOJX	Strong	Biomarker	[154]
ALDH6A1	OT8LCZCT	Strong	Biomarker	[154]
ALMS1	OTW66JKS	Strong	Biomarker	[1080]
ALOXE3	OT76J52A	Strong	Altered Expression	[1081]
ALPK1	OTBW6SGD	Strong	Genetic Variation	[1082]
AMBP	OTLU8GU8	Strong	Biomarker	[1083]
AMH	OT5FH4BD	Strong	Altered Expression	[1084]
AMPD1	OTU17BCI	Strong	Genetic Variation	[1085]
AMY2B	OTG93YV0	Strong	Genetic Variation	[317]
ANGPTL2	OTB6JG41	Strong	Biomarker	[1086]
ANK2	OTWB4R1Y	Strong	Biomarker	[1087]
ANKH	OTCN25R5	Strong	Biomarker	[1088]
ANKK1	OT0OM1O0	Strong	Genetic Variation	[1089]
ANKRD26	OT2ENKKV	Strong	Posttranslational Modification	[1090]
ANOS1	OTZJT4KN	Strong	Biomarker	[487]
ANXA6	OT9KIQ0Y	Strong	Altered Expression	[1091]
AP3S2	OTN8P9OE	Strong	Biomarker	[1092]
APCDD1	OTV9AD0L	Strong	Biomarker	[383]
APH1A	OT97F1TU	Strong	Altered Expression	[1093]
APOA5	OTEVKLVA	Strong	Biomarker	[1094]
APOD	OTT77XW8	Strong	Altered Expression	[1095]
APOM	OTI3FQQC	Strong	Altered Expression	[1096]
APOO	OTAHHRGZ	Strong	Genetic Variation	[1097]
ARHGAP21	OT6XY8Y9	Strong	Biomarker	[281]
ARID2	OTIRJXWM	Strong	Biomarker	[1098]
ARL6IP5	OTYZ6BEQ	Strong	Biomarker	[1099]
ARNT2	OTAQD3YV	Strong	Biomarker	[1100]
ARR3	OTRZ00CH	Strong	Biomarker	[217]
ARTN	OTWIWGL6	Strong	Genetic Variation	[1101]
ASAH2	OT47TIF3	Strong	Genetic Variation	[1102]
ASAP1	OT4DLRYY	Strong	Biomarker	[795]
ASAP2	OTGEXULW	Strong	Biomarker	[795]
ASCL1	OTI4X44G	Strong	Biomarker	[1103]
ASPG	OT5E2EKR	Strong	Biomarker	[1104]
ASPM	OTKXQMNA	Strong	Altered Expression	[335]
ASPSCR1	OTXTOD10	Strong	Biomarker	[1105]
ATF6	OTAFHAVI	Strong	Biomarker	[1106]
ATP10D	OT3JPE4H	Strong	Biomarker	[1107]
ATP5F1A	OT3FZDLX	Strong	Biomarker	[1108]
ATP5F1B	OTLFZUQK	Strong	Altered Expression	[1109]
ATP5F1E	OTMPLAIS	Strong	Genetic Variation	[1110]
ATP6	OTPHOGLX	Strong	Genetic Variation	[1111]
ATP6AP2	OT0IABVV	Strong	Biomarker	[1112]
ATP8B3	OTZOGEJO	Strong	Biomarker	[815]
ATPAF1	OTG1V44F	Strong	Biomarker	[154]
ATRN	OTTCLOPV	Strong	Biomarker	[1113]
BAD	OT63ERYM	Strong	Genetic Variation	[710]
BAMBI	OTCEJ8W5	Strong	Biomarker	[1114]
BBS1	OTXSXB1K	Strong	Genetic Variation	[1115]
BBS10	OTL1TTWX	Strong	Biomarker	[1116]
BBS2	OTPF9JIB	Strong	Genetic Variation	[1117]
BBS4	OT0D3JC0	Strong	Biomarker	[1118]
BBS9	OT23V9YF	Strong	Genetic Variation	[1119]
BCAP31	OTKSACR4	Strong	Biomarker	[1120]
BCL2L11	OTNQQWFJ	Strong	Biomarker	[1121]
BCS1L	OT5PY5CY	Strong	Biomarker	[1122]
BHLHE40	OTITX14U	Strong	Biomarker	[1123]
BHMT	OTYB6PXZ	Strong	Genetic Variation	[1124]
BID	OTOSHSHU	Strong	Biomarker	[1125]
BMPR1A	OTQOA4ZH	Strong	Biomarker	[1126]
BRWD3	OT3BM9B0	Strong	Biomarker	[1127]
BUB1B	OT8KME51	Strong	Biomarker	[1128]
C1QTNF1	OT7I7KHC	Strong	Biomarker	[1129]
C1QTNF12	OTFAIQHR	Strong	Altered Expression	[1130]
C1QTNF5	OTLKU5I2	Strong	Biomarker	[1131]
C1QTNF7	OTN1IFTK	Strong	Biomarker	[1132]
C1QTNF9	OTLI3VA3	Strong	Biomarker	[1133]
C2CD5	OTI495RD	Strong	Biomarker	[1134]
CADM2	OT45PVKC	Strong	Genetic Variation	[1135]
CALD1	OTNJKJ6Q	Strong	Genetic Variation	[1136]
CAMK2A	OTJGX19T	Strong	Genetic Variation	[1137]
CAPN3	OTCHG3YK	Strong	Biomarker	[362]
CAPNS1	OT95EBBD	Strong	Biomarker	[599]
CARD9	OTJ81AWD	Strong	Biomarker	[1138]
CARF	OTWE0T6Q	Strong	Biomarker	[1139]
CAST	OTBXZZGF	Strong	Biomarker	[1140]
CAVIN1	OTFO915U	Strong	Biomarker	[1141]
CBLL2	OTB4AD3V	Strong	Biomarker	[1142]
CCAR2	OTLUDG5T	Strong	Biomarker	[1143]
CCDC77	OTQQT2IC	Strong	Genetic Variation	[676]
CCDC80	OTOZSYEM	Strong	Biomarker	[1144]
CCHCR1	OT22C116	Strong	Genetic Variation	[1145]
CCL18	OT7JYSK9	Strong	Biomarker	[1146]
CCL19	OTQ2UJMH	Strong	Altered Expression	[1147]
CCL27	OTUZYC61	Strong	Biomarker	[1148]
CCL28	OTY6XNQ7	Strong	Genetic Variation	[1149]
CCL4	OT6B8P25	Strong	Genetic Variation	[1150]
CCL7	OTDIS99H	Strong	Biomarker	[1151]
CCL8	OTCTWYN8	Strong	Altered Expression	[1152]
CCN4	OT69BER9	Strong	Altered Expression	[1153]
CCN5	OTADU8JJ	Strong	Biomarker	[1154]
CD180	OTITK5E6	Strong	Biomarker	[1155]
CD48	OT83ZNPP	Strong	Biomarker	[1156]
CD5L	OTPY4WQR	Strong	Biomarker	[165]
CD68	OTOYEY3J	Strong	Biomarker	[376]
CD79A	OTOJC8DV	Strong	Genetic Variation	[1157]
CD81	OTQFXNAZ	Strong	Altered Expression	[1158]
CD8A	OTDWQJXK	Strong	Biomarker	[355]
CDAN1	OTCVZRG6	Strong	Genetic Variation	[1159]
CDH13	OTD2CYM5	Strong	Altered Expression	[1160]
CDKAL1	OTA0SGNE	Strong	Genetic Variation	[1161]
CEBPD	OTNBIPMY	Strong	Altered Expression	[1162]
CELF1	OT6JQ5RS	Strong	Genetic Variation	[374]
CELF4	OT4FS4F5	Strong	Biomarker	[1163]
CENPJ	OTZCQZN5	Strong	Altered Expression	[1164]
CEP19	OTL2WXOR	Strong	Genetic Variation	[1165]
CFAP410	OTJ94J99	Strong	Genetic Variation	[1166]
CFAP61	OTF1LAS4	Strong	Altered Expression	[816]
CFAP97	OT0RSQO4	Strong	Biomarker	[1167]
CGRRF1	OTLMNRCL	Strong	Biomarker	[1168]
CHAF1A	OTXSSY4H	Strong	Biomarker	[1169]
CHD2	OTRKL6YC	Strong	Genetic Variation	[692]
CHD8	OTS7A6AF	Strong	Genetic Variation	[1170]
CHGA	OTXYX5JH	Strong	Biomarker	[829]
CHPT1	OT4FJ0K3	Strong	Biomarker	[886]
CHRNA3	OTCZQY1U	Strong	Genetic Variation	[392]
CIDEA	OTDUTSOV	Strong	Altered Expression	[1171]
CIDEC	OTMDZ56K	Strong	Biomarker	[1172]
CISD1	OT0MTVGF	Strong	Altered Expression	[1173]
CISD2	OTVS7S2H	Strong	Biomarker	[1174]
CITED2	OT812TV7	Strong	Biomarker	[1175]
CLDN10	OT2CVAKY	Strong	Biomarker	[1176]
CLEC7A	OTRTBH27	Strong	Biomarker	[1177]
CLTA	OTLHOXMQ	Strong	Genetic Variation	[503]
CMAS	OTFQJG3C	Strong	Genetic Variation	[1178]
CMIP	OTZN8Z4A	Strong	Genetic Variation	[1179]
CNBP	OTTGM9NK	Strong	Biomarker	[1180]
CNDP1	OTOYSQG7	Strong	Genetic Variation	[1181]
CNDP2	OTJR9436	Strong	Genetic Variation	[1181]
CNTN4	OTULXVE0	Strong	Biomarker	[1182]
CNTN5	OTWU5FLZ	Strong	Biomarker	[1183]
COL12A1	OTHLTV53	Strong	Altered Expression	[826]
COL25A1	OT7M23Z9	Strong	Biomarker	[1184]
COL6A1	OTYKSCOB	Strong	Biomarker	[1185]
COL9A3	OTCUJOEK	Strong	Genetic Variation	[790]
COMP	OTS2FPMI	Strong	Biomarker	[1186]
COPA	OTZ1DTXU	Strong	Biomarker	[1187]
CORT	OTX3GUHB	Strong	Biomarker	[1188]
COX4I1	OTU0FC24	Strong	Biomarker	[1189]
COX7C	OTREWSBF	Strong	Biomarker	[154]
COX8A	OTU0NR39	Strong	Genetic Variation	[1190]
CPNE5	OTU882I6	Strong	Genetic Variation	[1191]
CPT2	OTIN6G20	Strong	Biomarker	[886]
CRABP1	OTISDG5X	Strong	Biomarker	[1192]
CREB3L4	OTSGQGT2	Strong	Altered Expression	[438]
CREG1	OTRHJ8HK	Strong	Biomarker	[1193]
CREM	OTJIJ5AL	Strong	Altered Expression	[1194]
CRISP2	OT8HLTV5	Strong	Biomarker	[1195]
CRTC3	OTVIGVUW	Strong	Biomarker	[1196]
CRYBG1	OTIPDI15	Strong	Genetic Variation	[340]
CUL4B	OT2QX4DO	Strong	Biomarker	[1197]
CXADR	OT9ZP02A	Strong	Biomarker	[217]
CXCL16	OTD49T9R	Strong	Genetic Variation	[1198]
CXCL5	OTZOUPCA	Strong	Biomarker	[1199]
CYCS	OTBFALJD	Strong	Biomarker	[1200]
CYP2D7	OTYJTL3S	Strong	Genetic Variation	[1201]
DACH1	OTMKNAGG	Strong	Biomarker	[1202]
DACT1	OT19Z704	Strong	Biomarker	[742]
DAPK2	OTWODUQG	Strong	Biomarker	[891]
DBI	OT884QY9	Strong	Genetic Variation	[1203]
DCDC2	OTSUFH1H	Strong	Biomarker	[1122]
DCP1B	OTX7PHCI	Strong	Genetic Variation	[1204]
DCTN4	OTM7C943	Strong	Biomarker	[552]
DDAH2	OT8Q40G2	Strong	Genetic Variation	[1205]
DDHD2	OTUP0WHF	Strong	CausalMutation	[1206]
DDIT3	OTI8YKKE	Strong	Biomarker	[1106]
DECR1	OTCDIR6X	Strong	Altered Expression	[805]
DENND1A	OTONDAA0	Strong	Genetic Variation	[1207]
DESI1	OTFNIW98	Strong	Altered Expression	[1208]
DGKE	OTWS86AS	Strong	Genetic Variation	[1209]
DGKG	OTBL32T3	Strong	Genetic Variation	[1072]
DHX40	OTOL02QN	Strong	Biomarker	[641]
DMRTA1	OTRZY9E9	Strong	Genetic Variation	[1210]
DNAH8	OTGES2OU	Strong	Biomarker	[1211]
DNAJB3	OTODJZY9	Strong	Biomarker	[1212]
DNAJB9	OT38EQT6	Strong	Biomarker	[1213]
DNAJC27	OTJRPCUR	Strong	Biomarker	[1214]
DNAJC6	OT1P6ZIE	Strong	Genetic Variation	[1215]
DNM3	OTDMUGCR	Strong	Genetic Variation	[583]
DOCK2	OTZTS3PA	Strong	Biomarker	[1216]
DOCK5	OT63I0CL	Strong	Biomarker	[1217]
DOK5	OT2XWUPN	Strong	Biomarker	[1218]
DPYSL4	OT3SBS2S	Strong	Biomarker	[1219]
DST	OTHZBM4X	Strong	Biomarker	[1220]
DUSP6	OT4H6RKW	Strong	Genetic Variation	[1221]
EAF2	OTSOET5L	Strong	Biomarker	[1222]
EBF2	OTFWZE51	Strong	Biomarker	[521]
ECHS1	OTS0593S	Strong	Biomarker	[154]
ECT2	OTQDUCT6	Strong	Biomarker	[1098]
EDEM1	OTWHN69S	Strong	Altered Expression	[1223]
EFNB1	OT7JJW8P	Strong	Biomarker	[1224]
EIF2S1	OTM0GDTP	Strong	Biomarker	[1225]
EIF2S2	OTXF0B09	Strong	Biomarker	[1225]
EIF2S3	OTARRES9	Strong	Biomarker	[1225]
EIF6	OTEXMUED	Strong	Altered Expression	[1226]
ELN	OTFSO7PG	Strong	Altered Expression	[1227]
ELOVL5	OT375W1Z	Strong	Altered Expression	[1228]
ELOVL6	OTB26UJJ	Strong	Biomarker	[1229]
EMD	OTR8ZANE	Strong	Biomarker	[1230]
EML6	OTE1MUQS	Strong	Genetic Variation	[543]
ENTPD6	OT94M6A7	Strong	Biomarker	[1013]
ERCC4	OTFIOPG1	Strong	Genetic Variation	[1231]
ERG	OTOTX9VU	Strong	Biomarker	[776]
ETFA	OTXX61VZ	Strong	Genetic Variation	[1201]
ETFDH	OTOSKSFH	Strong	Biomarker	[154]
EXOSC4	OTG4TICP	Strong	Genetic Variation	[1232]
FAM3B	OTC2S91N	Strong	Altered Expression	[1233]
FANCB	OTMZTXB5	Strong	Biomarker	[1234]
FAT2	OTRGT3E8	Strong	Genetic Variation	[1235]
FBL	OTRODIE5	Strong	Biomarker	[1236]
FBN1	OTYCJT63	Strong	Biomarker	[1237]
FCGR3B	OTSLSPZG	Strong	Biomarker	[376]
FERMT2	OTZNPWWX	Strong	Genetic Variation	[374]
FGF13	OTHNNVSG	Strong	Biomarker	[463]
FGF5	OTQXGHBY	Strong	Genetic Variation	[406]
FGGY	OTLNEC2X	Strong	Biomarker	[1238]
FGL1	OTT0QHQ1	Strong	Biomarker	[1239]
FLAD1	OTY8R02L	Strong	Genetic Variation	[603]
FN3KRP	OT9HR05S	Strong	Biomarker	[1240]
FNDC5	OT5CSK9X	Strong	Altered Expression	[1241]
FOXO3	OTHXQG4P	Strong	Biomarker	[1242]
FPGT-TNNI3K	OTJ6CWUN	Strong	Genetic Variation	[1072]
FTL	OTYQA8A6	Strong	Biomarker	[1243]
FTSJ1	OTNE7W96	Strong	Biomarker	[898]
FUNDC1	OTA6IVKQ	Strong	Biomarker	[1244]
FUZ	OTC427QQ	Strong	Biomarker	[1245]
FZD4	OTGLZIE0	Strong	Biomarker	[356]
G0S2	OT8FL49L	Strong	Altered Expression	[1246]
GAB2	OTBFN705	Strong	Biomarker	[1247]
GABPA	OT9YB2SA	Strong	Biomarker	[1248]
GABRA6	OTX4UC3O	Strong	Biomarker	[1249]
GALP	OTW25XLK	Strong	Biomarker	[1250]
GAS7	OT0M5TNY	Strong	Biomarker	[855]
GC	OTWS63BY	Strong	Biomarker	[1251]
GCA	OTAJ7ZHG	Strong	Genetic Variation	[1252]
GCKR	OTSIWXGG	Strong	Genetic Variation	[1253]
GDF10	OTEVXGJ7	Strong	Biomarker	[1254]
GFER	OTVK43OK	Strong	Biomarker	[1255]
GFI1	OT9HB9H8	Strong	Altered Expression	[1256]
GFPT1	OTQBDO45	Strong	Biomarker	[154]
GGTLC1	OTWJKUHQ	Strong	Genetic Variation	[1257]
GH2	OT32TR4C	Strong	Biomarker	[1258]
GHRH	OT94U6MO	Strong	Altered Expression	[1259]
GK	OTK2YRA0	Strong	Altered Expression	[1260]
GLRA3	OTC8C2NC	Strong	Genetic Variation	[1261]
GNA12	OT3IRZH3	Strong	Biomarker	[1262]
GNA13	OTVDL515	Strong	Biomarker	[1263]
GNAT2	OTD9Y4UH	Strong	Genetic Variation	[1072]
GNAT3	OTS96V19	Strong	Genetic Variation	[1264]
GOLGA6A	OTHU9MRX	Strong	Biomarker	[1265]
GOLGB1	OT2S0GK8	Strong	Biomarker	[1266]
GORASP2	OTL3PLD2	Strong	Biomarker	[1267]
GPAT3	OTJUGPK0	Strong	Biomarker	[1268]
GPC4	OTUJ14DW	Strong	Altered Expression	[1269]
GPCPD1	OTFE3RCV	Strong	Biomarker	[1270]
GPD1L	OTVLWW9T	Strong	Biomarker	[1271]
GPIHBP1	OTDF8R2M	Strong	Biomarker	[1272]
GPR151	OT7EACU6	Strong	Biomarker	[356]
GPR42	OTEB0ROY	Strong	Biomarker	[299]
GPR50	OT0EJBM4	Strong	Genetic Variation	[1273]
GPR83	OT7A2FE8	Strong	Biomarker	[1274]
GPS2	OT065FSS	Strong	Altered Expression	[1275]
GPX3	OT6PK94R	Strong	Altered Expression	[1276]
GRAP2	OTS5NIZ3	Strong	Altered Expression	[266]
GRB14	OTFET2YM	Strong	Genetic Variation	[1277]
GRK4	OTUU8V2S	Strong	Genetic Variation	[720]
GRP	OT8JDFNI	Strong	Biomarker	[385]
GTF2H1	OTCRXC6B	Strong	Biomarker	[552]
GTF3A	OTVROUVQ	Strong	Biomarker	[1278]
GUCA2A	OTUSF75G	Strong	Biomarker	[1279]
H2AX	OT18UX57	Strong	Biomarker	[1280]
H6PD	OTO7TNDD	Strong	Altered Expression	[1281]
HADH	OTJDOL20	Strong	Biomarker	[1282]
HAS2	OTTD3PAL	Strong	Altered Expression	[1283]
HAUS1	OTBML7XD	Strong	Biomarker	[1284]
HELZ2	OTM6HVO6	Strong	Biomarker	[1285]
HESX1	OT5E2Z4G	Strong	Biomarker	[487]
HHEX	OTLIUVYX	Strong	Biomarker	[1286]
HHIP	OT77RQYS	Strong	Biomarker	[1287]
HID1	OTVJIFSU	Strong	Altered Expression	[1288]
HJV	OT4235J2	Strong	Biomarker	[1289]
HLA-DRB3	OT5PM9N7	Strong	Altered Expression	[1290]
HMG20A	OTASVPIF	Strong	Genetic Variation	[1277]
HNRNPH1	OTFRWOLM	Strong	Biomarker	[509]
HOOK2	OTPO4NQV	Strong	Biomarker	[1291]
HOPX	OTBSR6C9	Strong	Biomarker	[393]
HORMAD1	OT7DR5T2	Strong	Biomarker	[1092]
HOXB3	OT9UC5PE	Strong	Genetic Variation	[1082]
HOXB5	OTU74TB8	Strong	Genetic Variation	[634]
HOXC10	OT5WF17M	Strong	Biomarker	[1292]
HOXC9	OT60K4M0	Strong	Biomarker	[1292]
HOXD13	OTWSC8TF	Strong	Genetic Variation	[1293]
HPR	OTXSC9UB	Strong	Biomarker	[1294]
HS6ST3	OTTW9PDL	Strong	Genetic Variation	[1072]
HSPA14	OTZCA5LK	Strong	Biomarker	[1295]
HYOU1	OTBGBSOV	Strong	Biomarker	[1296]
IARS1	OT9WXH5N	Strong	Genetic Variation	[1297]
ICAM3	OTTZ5A5D	Strong	Biomarker	[779]
IFI30	OT9DERT1	Strong	Genetic Variation	[1298]
IFNGR1	OTCTQBWW	Strong	Biomarker	[1299]
IGF2BP2	OT4ZSEEE	Strong	Biomarker	[1008]
IGFALS	OTTWCZYM	Strong	Biomarker	[1300]
IL10RA	OTOX3D1D	Strong	Genetic Variation	[371]
IL1F10	OTJAASGC	Strong	Biomarker	[1301]
IL34	OTZ15VVK	Strong	Altered Expression	[1302]
IL6R	OTCQL07Z	Strong	Altered Expression	[1303]
ING2	OT6H0EWF	Strong	Biomarker	[355]
INPP5E	OTJF2AZ9	Strong	Therapeutic	[1304]
INPPL1	OTCDAVBQ	Strong	Biomarker	[1305]
INTU	OTXB13E6	Strong	Biomarker	[488]
IQCK	OT4QNL67	Strong	Genetic Variation	[374]
IRX3	OTLJ48FG	Strong	Genetic Variation	[1306]
ITGAD	OTNS69WO	Strong	Altered Expression	[1307]
ITGAX	OTOGIMHE	Strong	Altered Expression	[1308]
ITIH5	OTP46PZM	Strong	Altered Expression	[1309]
ITLN1	OT7ZLJVV	Strong	Genetic Variation	[1310]
ITPRID2	OTO3JDX5	Strong	Biomarker	[1311]
JAKMIP3	OT4EDANR	Strong	Biomarker	[1312]
JPH3	OTHTJO2I	Strong	Biomarker	[1313]
KAT5	OTL7257A	Strong	Biomarker	[1314]
KCP	OTIS86DZ	Strong	Altered Expression	[1315]
KDM4B	OT5P1UPY	Strong	Biomarker	[1316]
KIDINS220	OTLBH2MA	Strong	Genetic Variation	[1317]
KLF13	OTMIKHZ4	Strong	Biomarker	[1318]
KLF14	OT8BXLBS	Strong	Altered Expression	[1319]
KLF7	OTS3YVA0	Strong	Altered Expression	[1320]
KMT2D	OTTVHCLY	Strong	Biomarker	[797]
KRIT1	OT58AP1I	Strong	Genetic Variation	[1321]
KRT18	OTVLQFIP	Strong	Biomarker	[1322]
KRT31	OTB6RCAH	Strong	Genetic Variation	[1323]
KRT7	OTLT3JFN	Strong	Biomarker	[505]
LACTB	OTRWGNBF	Strong	Biomarker	[1324]
LAT2	OTWJDKIH	Strong	Biomarker	[1325]
LCE1A	OT4WBMO3	Strong	Genetic Variation	[1157]
LDB1	OT20EAPR	Strong	Biomarker	[1326]
LETM1	OT8N4MRU	Strong	Altered Expression	[1327]
LGALS12	OTNTQULB	Strong	Altered Expression	[1328]
LGALS13	OTEV3DD7	Strong	Altered Expression	[1329]
LGR6	OTPZ1PWR	Strong	Biomarker	[356]
LHFPL3	OTG1EI22	Strong	Genetic Variation	[1330]
LHX3	OTQ5BAJ9	Strong	Altered Expression	[487]
LINGO2	OT3N88Q1	Strong	Genetic Variation	[1331]
LITAF	OTT5JX1F	Strong	Altered Expression	[1332]
LMO3	OTR7AJHN	Strong	Biomarker	[1333]
LPGAT1	OTN4HEJ4	Strong	Biomarker	[1334]
LPIN1	OTQ75KF2	Strong	Biomarker	[1335]
LRG1	OTLD0KWA	Strong	Biomarker	[1336]
LRRN1	OT6MMO6L	Strong	Biomarker	[1182]
LRRN4	OTC2T1MP	Strong	Genetic Variation	[1337]
LSR	OTR8Y32X	Strong	Biomarker	[1338]
LUC7L3	OTKDED8A	Strong	Biomarker	[1339]
LY86	OTTZB64A	Strong	Genetic Variation	[1340]
LYPD4	OTYNO8BS	Strong	Genetic Variation	[1341]
LYPLAL1	OT8F2DCV	Strong	Biomarker	[1342]
LZTFL1	OTIEIOEW	Strong	Biomarker	[1343]
MACROD2	OTNQCHC6	Strong	Genetic Variation	[1344]
MAD2L2	OT24ZO59	Strong	Biomarker	[1128]
MAF	OT1GR3IZ	Strong	Genetic Variation	[1345]
MAF1	OTKB0N8Q	Strong	Biomarker	[1346]
MAGEC3	OT0KDWZN	Strong	Biomarker	[504]
MAGED1	OT6EOLFC	Strong	Biomarker	[1347]
MAGEE2	OTL3E0G7	Strong	Biomarker	[504]
MAGEL2	OTXEL4R7	Strong	Genetic Variation	[1348]
MAP2K3	OTI2OREX	Strong	Altered Expression	[582]
MAP2K6	OTK13JKC	Strong	Biomarker	[1349]
MAP4K5	OTUFGLXE	Strong	Genetic Variation	[1350]
MAP9	OTZD5099	Strong	Biomarker	[1351]
MARCHF1	OTI2EYO6	Strong	Altered Expression	[1352]
MARCHF10	OTAYGHDM	Strong	Biomarker	[1353]
MARK1	OTP7KL47	Strong	Altered Expression	[1354]
MBD2	OTUQPP0R	Strong	Altered Expression	[1355]
MBD5	OTFHT4MO	Strong	Genetic Variation	[1356]
MCAT	OTH07FIW	Strong	Biomarker	[396]
MCIDAS	OTK1JVAH	Strong	Genetic Variation	[1357]
MCTP2	OTFMZ8I2	Strong	Biomarker	[1358]
MCTS1	OT7SAOJP	Strong	Biomarker	[396]
MCU	OTQZAYWQ	Strong	Biomarker	[1359]
MDFIC	OTSRYBWZ	Strong	Biomarker	[1360]
MED12	OTQZ4D2X	Strong	Genetic Variation	[1361]
MEST	OT8Q4U8Y	Strong	Biomarker	[1362]
METRN	OTI2645G	Strong	Altered Expression	[1363]
METRNL	OTB0DDL0	Strong	Biomarker	[1364]
METTL14	OT6TPQMH	Strong	Biomarker	[1365]
METTL21C	OTEMLDE6	Strong	Genetic Variation	[1366]
METTL3	OTSXP1M3	Strong	Biomarker	[1365]
MFAP2	OTMHVBTV	Strong	Biomarker	[1367]
MFAP5	OT46VXSG	Strong	Biomarker	[1368]
MFRP	OTHY9ZA5	Strong	Biomarker	[1131]
MGAT3	OTXI5X4T	Strong	Biomarker	[1369]
MIOX	OTDD9G4E	Strong	Biomarker	[1370]
MLH3	OT91PPBI	Strong	Biomarker	[822]
MLXIPL	OTR9MLLW	Strong	Genetic Variation	[1253]
MMP19	OTLSTT2B	Strong	Biomarker	[1371]
MMUT	OTBBBV70	Strong	Biomarker	[154]
MOB1A	OTSPBZ4Z	Strong	Biomarker	[1372]
MOB4	OTOQRMAS	Strong	Biomarker	[1372]
MOK	OTQK7M9V	Strong	Biomarker	[473]
MRGPRX3	OTRKCCDS	Strong	Biomarker	[356]
MRGPRX4	OTOBHZVA	Strong	Biomarker	[356]
MRPL33	OTA3YDH0	Strong	Biomarker	[1373]
MRPS22	OTIVNAJL	Strong	Genetic Variation	[646]
MRPS30	OTDXIAGG	Strong	Biomarker	[795]
MTHFD1	OTMKHVWC	Strong	Genetic Variation	[1374]
MTIF3	OTPQ7FPQ	Strong	Genetic Variation	[1375]
MTMR11	OTHL2O08	Strong	Biomarker	[1339]
MTMR14	OTUUEY6Q	Strong	Biomarker	[1376]
MTMR9	OTGCBJHD	Strong	Genetic Variation	[1377]
MTPAP	OT6HQ02S	Strong	Biomarker	[795]
MVP	OTJGHJRB	Strong	Biomarker	[1378]
MYCL	OT1MFQ5U	Strong	Biomarker	[1379]
MYDGF	OT9HRPL6	Strong	Altered Expression	[534]
MYH6	OT3YNCH1	Strong	Biomarker	[605]
MYL2	OT78PC0C	Strong	Genetic Variation	[1380]
MYT1L	OTV45MAS	Strong	Genetic Variation	[1381]
MZB1	OT071TET	Strong	Biomarker	[1382]
NANS	OTMQ2FUH	Strong	Biomarker	[1383]
NAP1L5	OTF4Q6ZW	Strong	Genetic Variation	[1384]
NBEAL1	OTLJ11N3	Strong	Biomarker	[1139]
NBEAL2	OTMCAXWR	Strong	Biomarker	[1385]
NBR1	OTVRL7J9	Strong	Biomarker	[576]
NCAM2	OT8LBJN8	Strong	Genetic Variation	[1330]
NCOA1	OTLIUJQD	Strong	Altered Expression	[272]
NCOA2	OTMQFPBB	Strong	Genetic Variation	[1386]
NCOR1	OT04XNOU	Strong	Biomarker	[1387]
NCR2	OT2H13BX	Strong	Biomarker	[1388]
NCS1	OT6JHAWM	Strong	Biomarker	[1389]
NDRG4	OTJBOTD8	Strong	Altered Expression	[1390]
NEDD4L	OT1B19RU	Strong	Genetic Variation	[1391]
NEIL1	OTHBU5DJ	Strong	Biomarker	[1392]
NEUROD1	OTZQ7QJ2	Strong	Genetic Variation	[1393]
NEUROG3	OT6DIPWC	Strong	Biomarker	[1103]
NFATC3	OTYOORME	Strong	Biomarker	[1394]
NFE2L1	OT1QHOS2	Strong	Biomarker	[1395]
NFYA	OTWFFOVH	Strong	Altered Expression	[1396]
NHS	OTKE8QAT	Strong	Biomarker	[1397]
NINJ1	OTLRZ1EU	Strong	Genetic Variation	[676]
NLGN2	OTHDYL3H	Strong	Genetic Variation	[1398]
NLRP12	OTGR132Z	Strong	Biomarker	[1399]
NLRP6	OTEREN4W	Strong	Biomarker	[1400]
NNAT	OTNRLO7G	Strong	Altered Expression	[1401]
NOB1	OTW0YNSL	Strong	Genetic Variation	[1402]
NOG	OTGRHHPG	Strong	Genetic Variation	[1403]
NPNT	OTFZAO1G	Strong	Biomarker	[1404]
NPPA	OTMQNTNX	Strong	Genetic Variation	[1405]
NPTN	OTAQKSAU	Strong	Genetic Variation	[1406]
NPVF	OTIMUS0X	Strong	Genetic Variation	[1407]
NR2C2	OTDZWVOJ	Strong	Biomarker	[1408]
NRF1	OTOXWNV8	Strong	Biomarker	[1409]
NTS	OTPGDNQS	Strong	Biomarker	[1410]
NUCB2	OTHO6JWN	Strong	Biomarker	[1411]
NUDT11	OTFDXJA1	Strong	Biomarker	[1078]
NUP62	OTMN63DH	Strong	Biomarker	[552]
NUPR1	OT4FU8C0	Strong	Genetic Variation	[1412]
NXPH1	OTGKX860	Strong	Biomarker	[1413]
OGA	OT7ZBWT1	Strong	Biomarker	[1414]
OIP5	OTI5C2DE	Strong	Biomarker	[1415]
OLFM1	OTOYPEWW	Strong	Biomarker	[1184]
OMG	OTXA5C6L	Strong	Biomarker	[1416]
OPN1MW	OTPJ7LX4	Strong	Biomarker	[1266]
ORM1	OTZKSBRE	Strong	Altered Expression	[1108]
OSBPL11	OTU2IC5O	Strong	Genetic Variation	[1417]
OSCP1	OTZ4IFGJ	Strong	Biomarker	[209]
OTP	OTS0JN6Y	Strong	Genetic Variation	[1418]
PACS1	OT9TMQL3	Strong	Genetic Variation	[1419]
PAK3	OT80M3BV	Strong	Biomarker	[814]
PANX1	OTXPEDOK	Strong	Biomarker	[1420]
PAPOLA	OTPHD65D	Strong	Biomarker	[795]
PAQR3	OTTKJ9Y4	Strong	Biomarker	[1421]
PARP9	OT7K4494	Strong	Biomarker	[385]
PAX6	OTOC9876	Strong	Genetic Variation	[1422]
PCDH9	OTX3BFV4	Strong	Genetic Variation	[1330]
PCK2	OTJ8LX4N	Strong	Genetic Variation	[472]
PDAP1	OTJSWMOD	Strong	Biomarker	[795]
PDC	OT1UUVYY	Strong	Biomarker	[1423]
PDK4	OTCMHMBZ	Strong	Biomarker	[1424]
PEG3	OTHQW98S	Strong	Altered Expression	[1425]
PELI3	OTCBUSKJ	Strong	Altered Expression	[438]
PER3	OTVKYVJA	Strong	Biomarker	[1426]
PEX1	OTQJF0V7	Strong	Biomarker	[1427]
PEX11A	OT8MJ9CJ	Strong	Biomarker	[1428]
PGAM5	OT6Q5M0C	Strong	Biomarker	[1429]
PHF2	OTJCIQR2	Strong	Biomarker	[1430]
PHF6	OT8DXI40	Strong	Genetic Variation	[1431]
PHLPP1	OTIFXW8D	Strong	Biomarker	[1432]
PIAS1	OTZVAHZI	Strong	Altered Expression	[1433]
PIAS3	OT3TWH9R	Strong	Altered Expression	[1433]
PICALM	OTQVRPMQ	Strong	Genetic Variation	[374]
PID1	OT5YJ7FI	Strong	Altered Expression	[1434]
PITX3	OTE2KT8P	Strong	Biomarker	[407]
PIWIL4	OTDA9MY0	Strong	Posttranslational Modification	[470]
PLA2G15	OT6VJTPA	Strong	Genetic Variation	[836]
PLA2G2E	OTGJ5XJR	Strong	Biomarker	[1435]
PLA2G5	OTQRSKCZ	Strong	Biomarker	[1435]
PLA2G6	OT5FL0WU	Strong	Altered Expression	[1436]
PLAG1	OTT9AJQY	Strong	Biomarker	[618]
PLAGL1	OTZAO900	Strong	Genetic Variation	[1437]
PLIN2	OTRXJ9UN	Strong	Genetic Variation	[1438]
PLIN3	OT9ZA7MR	Strong	Biomarker	[1439]
PLIN5	OTV8G50L	Strong	Genetic Variation	[1440]
PLXNA1	OTN0BING	Strong	Biomarker	[1441]
PLXNA3	OTMZIBVG	Strong	Biomarker	[1442]
PMCH	OT3D9SA4	Strong	Biomarker	[1443]
PNPLA1	OTUI609X	Strong	Genetic Variation	[1444]
POC5	OTHD4FIH	Strong	Genetic Variation	[1072]
POLD3	OTEQEFQ2	Strong	Genetic Variation	[1445]
POLDIP2	OT8SZSJ6	Strong	Altered Expression	[266]
POLE3	OTOELRF6	Strong	Genetic Variation	[1445]
POLG	OTDUCT04	Strong	CausalMutation	[1446]
POLR1B	OTKREU8M	Strong	Genetic Variation	[1445]
POTEF	OTV3WXYE	Strong	Altered Expression	[1447]
POU3F2	OT30NFOC	Strong	Genetic Variation	[1448]
PPARGC1A	OTHCDQ22	Strong	Altered Expression	[1241]
PPIG	OTZ8BTTM	Strong	Biomarker	[1449]
PPM1L	OTGGNG6M	Strong	Biomarker	[1324]
PPP1R15A	OTYG179K	Strong	Biomarker	[1450]
PPP1R3G	OTFXJK3V	Strong	Biomarker	[1451]
PPP2R2A	OT9297OG	Strong	Biomarker	[1072]
PPP2R5C	OTF7CGO2	Strong	Altered Expression	[1452]
PRB1	OTV0SYMD	Strong	Biomarker	[1453]
PRDM16	OT0BGA27	Strong	Biomarker	[1454]
PRDM2	OT8L7CGX	Strong	Biomarker	[1455]
PRDM4	OTD9PAZJ	Strong	Altered Expression	[1456]
PRDM6	OTKY12D9	Strong	Genetic Variation	[583]
PRDX3	OTLB2WEU	Strong	Genetic Variation	[1457]
PRKAG2	OTHTAM54	Strong	Posttranslational Modification	[1458]
PRLH	OTJBP360	Strong	Biomarker	[1459]
PRLHR	OT1THGOP	Strong	Biomarker	[1460]
PRMT6	OT5V3XIN	Strong	Biomarker	[1461]
PROK2	OT70IFEZ	Strong	Biomarker	[1462]
PROP1	OT8GF6N8	Strong	Biomarker	[487]
PROS1	OTXQWNOI	Strong	Biomarker	[618]
PROX1	OT68R6IO	Strong	Genetic Variation	[1463]
PRRT2	OTCJUBDO	Strong	Biomarker	[278]
PRRX1	OTTZK5G8	Strong	Altered Expression	[765]
PRSS55	OTXXWI5Y	Strong	Biomarker	[1195]
PSD3	OTTN9B9O	Strong	Genetic Variation	[1464]
PSENEN	OTJ7M7G9	Strong	Genetic Variation	[1465]
PSG5	OTHTU98X	Strong	Altered Expression	[1466]
PSMD9	OT6Y5CC3	Strong	Biomarker	[1467]
PSPC1	OTYS6WQ8	Strong	Biomarker	[1468]
PTER	OTBYJHDG	Strong	Genetic Variation	[1469]
PTOV1	OT94WT5X	Strong	Biomarker	[1470]
PTPN22	OTDCNTC3	Strong	Genetic Variation	[673]
PTPRE	OTOD5NID	Strong	Biomarker	[1471]
PTPRF	OTH5KF2D	Strong	Genetic Variation	[1472]
PTX3	OTPXHRKU	Strong	Biomarker	[1473]
PUM1	OTTMWP8L	Strong	Genetic Variation	[583]
PYGO2	OTZHB2OI	Strong	Biomarker	[1474]
QPCTL	OTJD4K8A	Strong	Genetic Variation	[1475]
QRSL1	OTJDU2UG	Strong	Genetic Variation	[1476]
RAB18	OTNMAQLS	Strong	Biomarker	[1477]
RAB21	OTH3WGLG	Strong	Biomarker	[1013]
RAB4B	OTTT4DY3	Strong	Altered Expression	[1478]
RABEP2	OTO61X27	Strong	Genetic Variation	[1072]
RABGEF1	OTWC3Z3R	Strong	Biomarker	[1479]
RAMP2	OTGQXLH5	Strong	Altered Expression	[360]
RAMP3	OTX6XLLM	Strong	Biomarker	[490]
RAP1A	OT5RH6TI	Strong	Biomarker	[1479]
RAPSN	OTGMSWDQ	Strong	Genetic Variation	[603]
RARRES2	OT1BJE8K	Strong	Biomarker	[1480]
RASA2	OTL06RG2	Strong	Genetic Variation	[853]
RAX2	OT1HD6CF	Strong	Genetic Variation	[166]
RBFOX1	OTFPKEL7	Strong	Genetic Variation	[1481]
RBM6	OTI99KAZ	Strong	Biomarker	[1092]
RBMS1	OTD13PJN	Strong	Genetic Variation	[1482]
RCAN1	OT1MVXC7	Strong	Altered Expression	[1483]
RCAN2	OTGGWTWS	Strong	Biomarker	[1484]
RCBTB1	OTAYELI8	Strong	Biomarker	[1265]
REPIN1	OTVTPXNX	Strong	Biomarker	[1485]
RFC2	OTJ9N6BD	Strong	Altered Expression	[1486]
RFX7	OTKFNW3A	Strong	Biomarker	[1487]
RGMB	OT2DROYU	Strong	Biomarker	[1488]
RGS14	OTYN79AG	Strong	Biomarker	[1489]
RIN3	OT5Z6F8O	Strong	Genetic Variation	[1490]
RNASE2	OT8Z4FNE	Strong	Genetic Variation	[1491]
RNF19A	OTKWCV80	Strong	Altered Expression	[266]
RNF216	OTR1XEZ3	Strong	Altered Expression	[1492]
ROPN1L	OTRWZJ68	Strong	Altered Expression	[335]
RPGRIP1	OTABESO9	Strong	Biomarker	[1493]
RPGRIP1L	OT6Z069I	Strong	Genetic Variation	[1494]
RPL10	OTBHOZGC	Strong	Biomarker	[1441]
RPL11	OT3VZ6OE	Strong	Biomarker	[1495]
RPL29	OTUFIBJL	Strong	Biomarker	[690]
RPTOR	OT4TQZ9F	Strong	Genetic Variation	[1496]
RRAS	OTBBF28C	Strong	Genetic Variation	[347]
RRS1	OTTNCZN6	Strong	Biomarker	[1497]
RSRC1	OTFCJ4S0	Strong	Biomarker	[1072]
RTL1	OTOT33IM	Strong	Biomarker	[1498]
RTN3	OTGZ51QF	Strong	Biomarker	[1499]
S100A7	OTJFVJRF	Strong	Biomarker	[1500]
SAA2	OTYAVJWG	Strong	Biomarker	[1501]
SCAPER	OT7S3B3P	Strong	CausalMutation	[1502]
SCGN	OTGD7SKH	Strong	Biomarker	[1503]
SDCCAG8	OTV2ZGV9	Strong	Genetic Variation	[1504]
SEC16A	OTFNQ1ZU	Strong	Genetic Variation	[634]
SELENBP1	OT3NZNTR	Strong	Genetic Variation	[1145]
SELENOS	OTUEWIU9	Strong	Biomarker	[1505]
SENP2	OTPQJXIR	Strong	Biomarker	[1506]
SEPTIN11	OTX2O0ZX	Strong	Biomarker	[1507]
SEPTIN9	OT1VMRFQ	Strong	Biomarker	[822]
SERF1A	OT9F7AMT	Strong	Biomarker	[1508]
SERPINA4	OTBK0GG7	Strong	Genetic Variation	[1509]
SERPINA5	OTTZXPGD	Strong	Biomarker	[1510]
SERPINB2	OT72QLZB	Strong	Biomarker	[1511]
SESN2	OT889IXY	Strong	Altered Expression	[405]
SETMAR	OTE2MIMZ	Strong	Biomarker	[1498]
SFPQ	OTLCIAPJ	Strong	Altered Expression	[1093]
SFRP1	OT0U9G41	Strong	Altered Expression	[1512]
SFRP2	OT8GZ0CA	Strong	Altered Expression	[1513]
SFRP5	OTLCVVSH	Strong	Biomarker	[1514]
SFXN1	OTL66767	Strong	Biomarker	[1515]
SGIP1	OTQW6R3Z	Strong	Biomarker	[1516]
SGMS1	OTZQE7PW	Strong	Biomarker	[1372]
SGMS2	OT3NHO99	Strong	Biomarker	[1517]
SGSM3	OTIB1P8A	Strong	Biomarker	[1518]
SHC1	OT1J5IRN	Strong	Biomarker	[1519]
SIGLEC12	OTC36XP9	Strong	Biomarker	[1520]
SIRT4	OT5S0J23	Strong	Altered Expression	[1521]
SIRT7	OT5M4OT4	Strong	Biomarker	[1522]
SLC35G1	OTKZUA8O	Strong	Altered Expression	[1208]
SLN	OTERIU75	Strong	Biomarker	[1523]
SMARCA2	OTSGJ8SV	Strong	Biomarker	[1524]
SNAP29	OTT30ZON	Strong	Biomarker	[1525]
SNED1	OTBQVXY5	Strong	Biomarker	[1526]
SNRNP70	OTP52YZ3	Strong	Biomarker	[1527]
SNRPN	OTQB1ID1	Strong	Genetic Variation	[1528]
SOCS2	OTBPNKJQ	Strong	Biomarker	[1529]
SOCS7	OT503VJG	Strong	Genetic Variation	[1530]
SOD3	OTIOZQAB	Strong	Biomarker	[1531]
SORBS3	OTVEUODC	Strong	Biomarker	[1532]
SORCS1	OTP8PAKU	Strong	Biomarker	[1533]
SORL1	OTQ8FFNS	Strong	Biomarker	[1534]
SOX3	OT1CRCOB	Strong	Biomarker	[875]
SOX6	OTT0W0LE	Strong	Biomarker	[1535]
SPG7	OT8OY9ST	Strong	Biomarker	[217]
SPI1	OTVCA1D0	Strong	Biomarker	[1536]
SPINK1	OTSUVAL2	Strong	Biomarker	[1537]
SPINK4	OTHTCW94	Strong	Biomarker	[1538]
SPTA1	OT1YMP65	Strong	Biomarker	[1539]
SPZ1	OTQH8HJ5	Strong	Biomarker	[1195]
SRSF1	OTF61HOV	Strong	Biomarker	[1540]
ST13	OTNML6UP	Strong	Biomarker	[690]
ST3GAL2	OT8WM21E	Strong	Biomarker	[1541]
ST6GAL1	OT7US3NO	Strong	Genetic Variation	[1277]
STAP2	OTEB1VVI	Strong	Genetic Variation	[1542]
STEAP4	OTFTLAEZ	Strong	Altered Expression	[1543]
STING1	OTDAP4G0	Strong	Biomarker	[1544]
STX16	OTM7TAOE	Strong	Genetic Variation	[1545]
STX8	OTFOJCHI	Strong	Biomarker	[1546]
STXBP3	OTTTYMAQ	Strong	Altered Expression	[1547]
SUCLA2	OTMZD4PW	Strong	Biomarker	[154]
SUCLG2	OT0KHLY2	Strong	Biomarker	[154]
SUGP1	OT7W0EB8	Strong	Genetic Variation	[798]
SUMO4	OT9B447E	Strong	Biomarker	[1548]
SYT4	OTA1D7VL	Strong	Altered Expression	[1549]
TAC3	OTOJGM38	Strong	Biomarker	[1550]
TADA2A	OTXUMEL9	Strong	Genetic Variation	[1068]
TAL1	OTX4K6QZ	Strong	Biomarker	[505]
TANK	OTZSGFIK	Strong	Genetic Variation	[1482]
TAS2R14	OTWA9CYC	Strong	Altered Expression	[1551]
TAT	OT2CJ91O	Strong	Biomarker	[1552]
TBC1D4	OTK66C40	Strong	Genetic Variation	[1553]
TBCE	OTGBSTKS	Strong	Genetic Variation	[1554]
TBL1Y	OTA0F7TM	Strong	Altered Expression	[761]
TBPL1	OT4I143E	Strong	Biomarker	[789]
TBX1	OTQLBPRA	Strong	Genetic Variation	[818]
TBX15	OTAZ9QDX	Strong	Biomarker	[1555]
TCEA1	OTBFO594	Strong	Biomarker	[1556]
TCERG1L	OTSBSCLF	Strong	Biomarker	[856]
TCF21	OT393IMA	Strong	Altered Expression	[1557]
TCN2	OT41D0L3	Strong	Genetic Variation	[1558]
TERF2IP	OT3M5P3G	Strong	Biomarker	[1479]
TFAM	OTXXV5V7	Strong	Biomarker	[818]
TFF2	OTRXB19X	Strong	Biomarker	[1559]
THADA	OTYZQX0F	Strong	Genetic Variation	[1560]
THBS2	OTXET551	Strong	Biomarker	[1561]
THEM4	OTSIZU8Y	Strong	Biomarker	[1562]
THEMIS	OTXODBXJ	Strong	Genetic Variation	[1563]
THRSP	OTKYE01L	Strong	Biomarker	[1564]
THSD7A	OT7249HH	Strong	Biomarker	[1565]
TIGAR	OTR7NMRJ	Strong	Biomarker	[1566]
TIMM44	OTXP7MXN	Strong	Biomarker	[1278]
TIMP4	OT8A68SW	Strong	Altered Expression	[1567]
TLR10	OTQ1KVJO	Strong	Altered Expression	[1568]
TM7SF2	OTILU5S7	Strong	Biomarker	[318]
TMEM160	OTWVIV7I	Strong	Genetic Variation	[1267]
TMEM26	OTHZCXYB	Strong	Altered Expression	[1569]
TMTC1	OTZ7NW96	Strong	Biomarker	[1570]
TNFSF9	OTV9L89D	Strong	Biomarker	[1571]
TNMD	OTHLVA9G	Strong	Genetic Variation	[1572]
TOB1	OTNW949D	Strong	Biomarker	[999]
TOMM40	OTZDQ29F	Strong	Genetic Variation	[374]
TRA2B	OTZYQW52	Strong	Altered Expression	[1573]
TRIB1	OTPEO17G	Strong	Altered Expression	[1551]
TRIM13	OTQIUACB	Strong	Biomarker	[217]
TRIM32	OTJOV0PG	Strong	Biomarker	[1574]
TRIM66	OT0VJCP6	Strong	Genetic Variation	[1072]
TRIM69	OTTEGTRD	Strong	Altered Expression	[770]
TRPS1	OT7XPPEL	Strong	Genetic Variation	[583]
TSC1	OTFF4YZ7	Strong	Biomarker	[1575]
TSC22D3	OT03UM03	Strong	Altered Expression	[1576]
TSPAN31	OT8WQ83R	Strong	Biomarker	[1383]
TSPAN8	OT1F68WQ	Strong	Genetic Variation	[1577]
TSPYL5	OT7QEI2X	Strong	Biomarker	[1482]
TTC28	OTFOOYC3	Strong	Genetic Variation	[1330]
ALDOB	OT7FR69A	Definitive	Biomarker	[854]
CASZ1	OTWJ2OR8	Definitive	Biomarker	[829]
GAL3ST1	OTSFFZRD	Definitive	Biomarker	[829]
MMRN1	OT7ZNYHT	Definitive	Biomarker	[1578]

References

• [1] Pharmacotherapy for obesity. Drugs. 2005;65(10):1391-418.
• [2] Amphetamine FDA Label
• [3] Anastrozole FDA Label
• [4] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [5] Bupropion FDA Label
• [6] Fenofibrate FDA Label
• [7] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1133).
• [8] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2941).
• [9] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4797).
• [10] Methamphetamine FDA Label
• [11] Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60.
• [12] Metoprolol FDA Label
• [13] Naltrexone FDA Label
• [14] Drug information of Phenmetrazine, 2008. eduDrugs.
• [15] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7269).
• [16] Obesity: pathophysiology and clinical management. Curr Med Chem. 2009;16(4):506-21.
• [17] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5346).
• [18] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [19] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2586).
• [20] Topiramate FDA Label
• [21] ClinicalTrials.gov (NCT01872182) Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome. U.S. National Institutes of Health.
• [22] DOV 216,303, a "triple" reuptake inhibitor: safety, tolerability, and pharmacokinetic profile. J Clin Pharmacol. 2004 Dec;44(12):1360-7.
• [23] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 610).
• [24] 2011 Pipeline of Zafgen.
• [25] Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients. Int J Obes (Lond). 2007 Mar;31(3):494-9.
• [26] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4613).
• [27] Clinical pipeline report, company report or official report of Gmax Biopharm.
• [28] Clinical pipeline report, company report or official report of Gmax Biopharm.
• [29] ClinicalTrials.gov (NCT05869903) A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1). U.S.National Institutes of Health.
• [30] ClinicalTrials.gov (NCT05882045) A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants With Severe Obesity and Established Cardiovascular Disease. U.S.National Institutes of Health.
• [31] ClinicalTrials.gov (NCT02179151) Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome. U.S. National Institutes of Health.
• [32] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024671)
• [33] ClinicalTrials.gov (NCT05669599) A Phase 2 Randomized, Placebo-controlled, Double-blind, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus. U.S.National Institutes of Health.
• [34] ClinicalTrials.gov (NCT05121441) A Phase 2, Placebo-Controlled, Randomized, Blinded Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of ARD-101 in Adults With Obesity. U.S.National Institutes of Health.
• [35] ClinicalTrials.gov (NCT00735683) A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety. U.S. National Institutes of Health.
• [36] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3462).
• [37] ClinicalTrials.gov (NCT00367783) Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity. U.S. National Institutes of Health.
• [38] ClinicalTrials.gov (NCT01725126) To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes. U.S. National Institutes of Health.
• [39] Clinical pipeline report, company report or official report of Hemodynamic Therapeutics.
• [40] ClinicalTrials.gov (NCT02476019) A Safety, Tolerability, PK, and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients.
• [41] ClinicalTrials.gov (NCT03486392) A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants. U.S. National Institutes of Health.
• [42] ClinicalTrials.gov (NCT00993421) A Weight Loss Study in Overweight Men and Women. U.S. National Institutes of Health.
• [43] ClinicalTrials.gov (NCT04881760) A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities. U.S.National Institutes of Health.
• [44] ClinicalTrials.gov (NCT02029586) Therapeutic Exploratory Phase 2 Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease(NAFLD) Except Cirrhosis. U.S. National Institutes of Health.
• [45] ClinicalTrials.gov (NCT05199090) A Randomized, Placebo-controlled, Participant-and-investigator- Blinded, Sponsor Open-label Study to Evaluate the Safety, Tolerability, and Efficacy With Different Dosing Regimens of Subcutaneously Administered MBL949 in Obese Participants With or Without Type 2 Diabetes Mellitus. U.S.National Institutes of Health.
• [46] ClinicalTrials.gov (NCT02317796) Adult Subjects With Uncontrolled Type 2 Diabetes. U.S. National Institutes of Health.
• [47] ClinicalTrials.gov (NCT00409305) The Effect of Betahistine on Body Weight in Obese Subjects. U.S. National Institutes of Health.
• [48] ClinicalTrials.gov (NCT00449202) Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101). U.S. National Institutes of Health.
• [49] ClinicalTrials.gov (NCT00537420) A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects. U.S. National Institutes of Health.
• [50] ClinicalTrials.gov (NCT05579977) A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, DOSE RANGING, DOSE FINDING, PARALLEL GROUP STUDY TO ASSESS EFFICACY AND SAFETY OF PF-07081532, AND OPEN LABEL ORAL SEMAGLUTIDE, IN ADULTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED ON METFORMIN, AND SEPARATELY PF-07081532 COMPARED TO MATCHING PLACEBO IN ADULTS WITH OBESITY BUT WITHOUT T2DM. U.S.National Institutes of Health.
• [51] 2011 Pipeline of Proximagen Group plc.
• [52] ClinicalTrials.gov (NCT00239174) A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients. U.S. National Institutes of Health.
• [53] Clinical pipeline report, company report or official report of TransTech Pharma (2011).
• [54] Clinical pipeline report, company report or official report of YSOPIA Bioscience
• [55] ClinicalTrials.gov (NCT02221765) Safety, Tolerability and Efficacy Study of PP1420 in HV. U.S. National Institutes of Health.
• [56] ClinicalTrials.gov (NCT05406115) A Phase 1, Randomized, Double-blind, Placebo Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 786 in Healthy Subjects and Subjects With Obesity. U.S.National Institutes of Health.
• [57] ClinicalTrials.gov (NCT02072993) A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males. U.S. National Institutes of Health.
• [58] Clinical pipeline report, company report or official report of AstraZeneca (2011).
• [59] ClinicalTrials.gov (NCT05511025) A Phase I Randomized Single-blind Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese. U.S.National Institutes of Health.
• [60] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7827).
• [61] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7715).
• [62] 2011 Pipeline of Bristol-Myers Squibb.
• [63] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023034)
• [64] Clinical pipeline report, company report or official report of CinFina Pharma
• [65] ClinicalTrials.gov (NCT04838405) A Phase 1 Randomized, Double Blind, Placebo Controlled, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CT-388 in Otherwise Healthy Overweight and Obese Adult Participants and in Obese Patients With Type 2 Diabetes Mellitus. U.S.National Institutes of Health.
• [66] ClinicalTrials.gov (NCT04812262) A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DD01 in Overweight/Obese Subjects With T2DM and NAFLD. U.S.National Institutes of Health.
• [67] ClinicalTrials.gov (NCT04890873) ERX1000 - A Phase I, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Male and Female Subjects With Obesity. U.S.National Institutes of Health.
• [68] ClinicalTrials.gov (NCT02235961) Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects. U.S. National Institutes of Health.
• [69] Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). J Med Chem. 2012 May 10;55(9):4101-13.
• [70] Clinical pipeline report, company report or official report of GlaxoSmithKline (2011).
• [71] ClinicalTrials.gov (NCT01545570) A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers. U.S. National Institutes of Health.
• [72] Kalypsys nearing completion of phase Ia study of KD3010 for metabolic disorders. Kalypsys. 2007.
• [73] Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am J Clin Nutr. 2002 Oct;76(4):780-8.
• [74] Clinical pipeline report, company report or official report of Novo Nordisk
• [75] ClinicalTrials.gov (NCT05380323) A Phase 1, Randomized, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, and PK of LY3541105 Following Single Doses in Healthy/Overweight Participants and Multiple Doses in Overweight Participants. U.S.National Institutes of Health.
• [76] ClinicalTrials.gov (NCT05295940) A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3841136 in Healthy and Overweight Participants. U.S.National Institutes of Health.
• [77] ClinicalTrials.gov (NCT04838639) A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 When Administered Orally to Healthy and Obese Adult Subjects. U.S.National Institutes of Health.
• [78] ClinicalTrials.gov (NCT05292911) A 12-Week Extension Study of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD). U.S.National Institutes of Health.
• [79] Prohibitin 1 (PHB; PHB1). SciBX 4(45); doi:10.1038/scibx.2011.1269. Nov. 17 2011
• [80] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021329)
• [81] Clinical pipeline report, company report or official report of Novo Nordisk
• [82] ClinicalTrials.gov (NCT05247970) A Phase 1 Randomized, Double-blind, Single and Multiple-dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of S-309309 in Healthy and Obese Adult Study Participants. U.S.National Institutes of Health.
• [83] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8705).
• [84] ClinicalTrials.gov (NCT00806338) An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers. U.S. National Institutes of Health.
• [85] 2011 Pipeline of Zealand Pharma.
• [86] 2011 Pipeline of Zydus Cadila Group.
• [87] A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents. Expert Opin Ther Pat. 2015 Oct;25(10):1093-116.
• [88] Acyltransferase inhibitors: a patent review (2010-present).Expert Opin Ther Pat. 2015 Feb;25(2):145-58.
• [89] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 568).
• [90] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007390)
• [91] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1562).
• [92] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033560)
• [93] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031688)
• [94] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025707)
• [95] ClinicalTrials.gov (NCT00542009) A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight. U.S. National Institutes of Health.
• [96] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025197)
• [97] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013294)
• [98] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011891)
• [99] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015990)
• [100] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 890).
• [101] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1554).
• [102] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017654)
• [103] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023122)
• [104] New and emerging drug molecules against obesity. J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):65-76.
• [105] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031455)
• [106] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019931)
• [107] Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs. 2006 May;11(2):315-36.
• [108] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024090)
• [109] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026874)
• [110] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006083)
• [111] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025311)
• [112] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029079)
• [113] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025588)
• [114] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025584)
• [115] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017316)
• [116] Clinical pipeline report, company report or official report of Shionogi (2011).
• [117] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 868).
• [118] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015967)
• [119] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012981)
• [120] Clinical pipeline report, company report or official report of University College London.
• [121] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 894).
• [122] 2011 Pipeline of Jenrin Discovery.
• [123] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3467).
• [124] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1313).
• [125] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1314).
• [126] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001851)
• [127] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 858).
• [128] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021828)
• [129] Clinical pipeline report, company report or official report of Albany Molecular Research (2011).
• [130] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008694)
• [131] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000393)
• [132] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021433)
• [133] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003426)
• [134] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017024)
• [135] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006045)
• [136] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4023).
• [137] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
• [138] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 11).
• [139] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1712).
• [140] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 264).
• [141] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 56).
• [142] C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9498-502.
• [143] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1265).
• [144] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 8).
• [145] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2490).
• [146] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8502).
• [147] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 246).
• [148] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2593).
• [149] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1540).
• [150] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1315).
• [151] A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013 May;21(5):935-43.
• [152] Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy. J Clin Pharm Ther. 2008 Oct;33(5):513-9.
• [153] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024638)
• [154] Orchestrated downregulation of genes involved in oxidative metabolic pathways in obese vs. lean high-fat young male consumers.J Physiol Biochem. 2011 Mar;67(1):15-26. doi: 10.1007/s13105-010-0044-4. Epub 2010 Sep 30.
• [155] ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study.Nutr Metab Cardiovasc Dis. 2010 Dec;20(10):698-705. doi: 10.1016/j.numecd.2009.06.011. Epub 2009 Oct 9.
• [156] Inducible Loss of the Aryl Hydrocarbon Receptor Activates Perigonadal White Fat Respiration and Brown Fat Thermogenesis via Fibroblast Growth Factor 21.Int J Mol Sci. 2019 Feb 22;20(4):950. doi: 10.3390/ijms20040950.
• [157] High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism.Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):3138-3143. doi: 10.1073/pnas.1713837115. Epub 2018 Mar 5.
• [158] Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.Nephrol Dial Transplant. 2018 Jun 1;33(6):992-1001. doi: 10.1093/ndt/gfx230.
• [159] The BACE1 product sAPP induces ER stress and inflammation and impairs insulin signaling.Metabolism. 2018 Aug;85:59-75. doi: 10.1016/j.metabol.2018.03.005. Epub 2018 Mar 9.
• [160] Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1490-1501. doi: 10.1016/j.bbadis.2019.02.021. Epub 2019 Feb 28.
• [161] C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling.FASEB J. 2013 Feb;27(2):822-31. doi: 10.1096/fj.12-220582. Epub 2012 Nov 1.
• [162] Calcitonin gene-related peptide: neuroendocrine communication between the pancreas, gut, and brain in regulation of blood glucose.Ann Transl Med. 2017 Nov;5(21):419. doi: 10.21037/atm.2017.08.27.
• [163] Dual CCR2/5 Antagonist Attenuates Obesity-Induced Insulin Resistance by Regulating Macrophage Recruitment and M1/M2 Status.Obesity (Silver Spring). 2018 Feb;26(2):378-386. doi: 10.1002/oby.22103. Epub 2017 Dec 27.
• [164] Respiratory chain polymorphisms and obesity in the Spanish population, a cross-sectional study.BMJ Open. 2019 Feb 19;9(2):e027004. doi: 10.1136/bmjopen-2018-027004.
• [165] Independent modes of disease repair by AIM protein distinguished in AIM-felinized mice.Sci Rep. 2018 Sep 3;8(1):13157. doi: 10.1038/s41598-018-31580-6.
• [166] Genome-wide analysis reveals that altered methylation in specific CpG loci is associated with childhood obesity.J Cell Biochem. 2018 Sep;119(9):7490-7497. doi: 10.1002/jcb.27059. Epub 2018 May 24.
• [167] Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies.JAMA Ophthalmol. 2014 Jan;132(1):84-95. doi: 10.1001/jamaophthalmol.2013.5506.
• [168] Regulation of ammonia-metabolizing enzymes expression in the liver of obese rats: differences between genetic and nutritional obesities.Int J Obes Relat Metab Disord. 1997 Aug;21(8):681-5. doi: 10.1038/sj.ijo.0800460.
• [169] Obesity, visceral adiposity and carotid atherosclerosis.J Diabetes Complications. 2019 Apr;33(4):302-306. doi: 10.1016/j.jdiacomp.2019.01.002. Epub 2019 Jan 17.
• [170] [Effect of neonatal nutrition on the enzyme activity of liver lysosomes, adipocytes and thrombocytes in young and old rats].Vopr Pitan. 1986 Mar-Apr;(2):43-7.
• [171] Synergistic Modulation of Inflammatory but not Metabolic Effects of High-Fat Feeding by CCR2 and CX3CR1.Obesity (Silver Spring). 2017 Aug;25(8):1410-1420. doi: 10.1002/oby.21900. Epub 2017 Jun 26.
• [172] Maternal Diet-Induced Obesity Compromises Oxidative Stress Status and Angiogenesis in the Porcine Placenta by Upregulating Nox2 Expression.Oxid Med Cell Longev. 2019 Oct 1;2019:2481592. doi: 10.1155/2019/2481592. eCollection 2019.
• [173] Suboptimal bone microarchitecure in adolescent girls with obesity compared to normal-weight controls and girls with anorexia nervosa.Bone. 2019 May;122:246-253. doi: 10.1016/j.bone.2019.03.007. Epub 2019 Mar 7.
• [174] Factors associated with elevated blood pressure or hypertension in Afro-Caribbean youth: a cross-sectional study.PeerJ. 2018 Feb 13;6:e4385. doi: 10.7717/peerj.4385. eCollection 2018.
• [175] Altered anabolic signalling and reduced stimulation of myofibrillar protein synthesis after feeding and resistance exercise in people with obesity.J Physiol. 2018 Nov;596(21):5119-5133. doi: 10.1113/JP276210. Epub 2018 Sep 30.
• [176] Inverse agonist of ERR reduces cannabinoid receptor type 1-mediated induction of fibrinogen synthesis in mice with a high-fat diet-intoxicated liver.Arch Toxicol. 2018 Sep;92(9):2885-2896. doi: 10.1007/s00204-018-2270-4. Epub 2018 Jul 17.
• [177] Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women.Sci Rep. 2018 Nov 20;8(1):17135. doi: 10.1038/s41598-018-35230-9.
• [178] Profiling of gender-specific rat plasma proteins associated with susceptibility or resistance to diet-induced obesity.J Proteomics. 2012 Feb 2;75(4):1386-400. doi: 10.1016/j.jprot.2011.11.012. Epub 2011 Nov 20.
• [179] Epitope-specific monoclonal antibodies to FSH increase bone mass.Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2192-2197. doi: 10.1073/pnas.1718144115. Epub 2018 Feb 12.
• [180] Insulin Reduces Reaction of Follicular Granulosa Cells to FSH Stimulation in Women With Obesity-Related Infertility During IVF.J Clin Endocrinol Metab. 2019 Jul 1;104(7):2547-2560. doi: 10.1210/jc.2018-00686.
• [181] Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver.Free Radic Biol Med. 2009 Aug 1;47(3):219-28. doi: 10.1016/j.freeradbiomed.2009.01.028. Epub 2009 Feb 20.
• [182] Activation of Nrf2 attenuates delayed gastric emptying in obesity induced diabetic (T2DM) female mice.Free Radic Biol Med. 2019 May 1;135:132-143. doi: 10.1016/j.freeradbiomed.2019.02.029. Epub 2019 Mar 1.
• [183] GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans.Cell Metab. 2019 Mar 5;29(3):707-718.e8. doi: 10.1016/j.cmet.2018.12.016. Epub 2019 Jan 10.
• [184] Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet.Nutrients. 2018 Jan 31;10(2):157. doi: 10.3390/nu10020157.
• [185] Reduced EDHF responses and connexin activity in mesenteric arteries from the insulin-resistant obese Zucker rat.Diabetologia. 2008 May;51(5):872-81. doi: 10.1007/s00125-008-0934-y. Epub 2008 Mar 7.
• [186] G protein-coupled receptor 12 deficiency results in dyslipidemia and obesity in mice.Biochem Biophys Res Commun. 2006 Sep 22;348(2):359-66. doi: 10.1016/j.bbrc.2006.07.090. Epub 2006 Jul 28.
• [187] Glycogen Synthase Kinase-3 Promotes Fatty Acid Uptake and Lipotoxic Cardiomyopathy.Cell Metab. 2019 May 7;29(5):1119-1134.e12. doi: 10.1016/j.cmet.2019.01.005. Epub 2019 Feb 7.
• [188] Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis.Aging (Albany NY). 2019 Jan 18;11(2):386-400. doi: 10.18632/aging.101743.
• [189] Histone deacetylase 11 as a key regulator of metabolism and obesity.EBioMedicine. 2018 Sep;35:27-28. doi: 10.1016/j.ebiom.2018.08.008. Epub 2018 Aug 17.
• [190] Adaptor protein APPL1 coordinates HDAC3 to modulate brown adipose tissue thermogenesis in mice.Metabolism. 2019 Nov;100:153955. doi: 10.1016/j.metabol.2019.153955. Epub 2019 Aug 4.
• [191] The effects of the intestinal glucosidase inhibitor acarbose on cholesterogenesis in corpulent rats.Comp Biochem Physiol A Comp Physiol. 1991;100(3):763-8. doi: 10.1016/0300-9629(91)90405-2.
• [192] Hoxa5 alleviates obesity-induced chronic inflammation by reducing ER stress and promoting M2 macrophage polarization in mouse adipose tissue.J Cell Mol Med. 2019 Oct;23(10):7029-7042. doi: 10.1111/jcmm.14600. Epub 2019 Aug 23.
• [193] Increased binding at 5-HT(1A), 5-HT(1B), and 5-HT(2A) receptors and 5-HT transporters in diet-induced obese rats.Brain Res. 1999 Nov 13;847(1):90-7. doi: 10.1016/s0006-8993(99)02055-7.
• [194] Analyses of IGFBP2 DNA methylation and mRNA expression in visceral and subcutaneous adipose tissues of obese subjects.Growth Horm IGF Res. 2019 Apr;45:31-36. doi: 10.1016/j.ghir.2019.03.002. Epub 2019 Mar 20.
• [195] IL1R1 is required for celastrol's leptin-sensitization and antiobesity effects.Nat Med. 2019 Apr;25(4):575-582. doi: 10.1038/s41591-019-0358-x. Epub 2019 Mar 4.
• [196] Systematic Investigation of the Effects of Long-Term Administration of a High-Fat Diet on Drug Transporters in the Mouse Liver, Kidney and Intestine.Curr Drug Metab. 2019;20(9):742-755. doi: 10.2174/1389200220666190902125435.
• [197] Attenuated BK channel function promotes overactive bladder in a rat model of obesity.Aging (Albany NY). 2019 Aug 21;11(16):6199-6216. doi: 10.18632/aging.102182. Epub 2019 Aug 21.
• [198] High fat diet induced obesity alters ovarian phosphatidylinositol-3 kinase signaling gene expression.Reprod Toxicol. 2013 Dec;42:68-77. doi: 10.1016/j.reprotox.2013.07.026. Epub 2013 Aug 14.
• [199] Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in mice.Nutr Res. 2019 Jul;67:78-89. doi: 10.1016/j.nutres.2019.03.008. Epub 2019 Mar 20.
• [200] Apc inactivation, but not obesity, synergizes with Pten deficiency to drive intestinal stem cell-derived tumorigenesis.Endocr Relat Cancer. 2017 Jun;24(6):253-265. doi: 10.1530/ERC-16-0536. Epub 2017 Mar 28.
• [201] Phytochemical and Biological Profile of Moricandia arvensis (L.) DC.: An Inhibitor of Pancreatic Lipase.Molecules. 2018 Oct 31;23(11):2829. doi: 10.3390/molecules23112829.
• [202] Impact of genetic variants of IL-6, IL6R, LRP5, ESR1 and SP7 genes on bone mineral density in postmenopausal Mexican-Mestizo women with obesity.Gene. 2013 Oct 10;528(2):216-20. doi: 10.1016/j.gene.2013.07.008. Epub 2013 Jul 24.
• [203] Genetic variations of the bitter taste receptor TAS2R38 are associated with obesity and impact on single immune traits.Mol Nutr Food Res. 2016 Jul;60(7):1673-83. doi: 10.1002/mnfr.201500804. Epub 2016 May 27.
• [204] DNA sequencing and copy number variation analysis of MCHR2 in a cohort of Prader Willi like (PWL) patients.Obes Res Clin Pract. 2018 Mar-Apr;12(2):158-166. doi: 10.1016/j.orcp.2017.10.001. Epub 2017 Oct 20.
• [205] Inhibition of MGAT2 modulates fat-induced gut peptide release and fat intake in normal mice and ameliorates obesity and diabetes in ob/ob mice fed on a high-fat diet.FEBS Open Bio. 2020 Mar;10(3):316-326. doi: 10.1002/2211-5463.12778. Epub 2020 Feb 5.
• [206] Author Correction: Nod2 and Nod2-regulated microbiota protect BALB/c mice from diet-induced obesity and metabolic dysfunction.Sci Rep. 2018 Apr 16;8(1):6302. doi: 10.1038/s41598-018-24594-7.
• [207] Molecular pathogenesis of Kallmann's syndrome.Horm Res. 2007;67(5):231-42. doi: 10.1159/000098156. Epub 2006 Dec 21.
• [208] Activation of peroxisome proliferator-activated receptor gamma/small heterodimer partner pathway prevents high fat diet-induced obesity and hepatic steatosis in Sprague-Dawley rats fed soybean meal.J Nutr Biochem. 2020 Jan;75:108250. doi: 10.1016/j.jnutbio.2019.108250. Epub 2019 Oct 15.
• [209] The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss.Int J Obes (Lond). 2012 Sep;36(9):1195-202. doi: 10.1038/ijo.2011.240. Epub 2011 Dec 6.
• [210] Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells.Food Funct. 2019 Aug 1;10(8):5215-5227. doi: 10.1039/c9fo01007f. Epub 2019 Aug 6.
• [211] Paraoxonase 1: The Lectin-Like Oxidized LDL Receptor Type I and Oxidative Stress in the Blood of Men with Type II Obesity.Dis Markers. 2019 Oct 15;2019:6178017. doi: 10.1155/2019/6178017. eCollection 2019.
• [212] Adaptation in enzyme (metabolic) pathways to obesity, carbohydrate diet and to the occurrence of NIDDM in male and female SHR/N-cp rats.Int J Obes Relat Metab Disord. 1992 Oct;16(10):765-74.
• [213] Cyclic nucleotide phosphodiesterase 3 expression in vivo: evidence for tissue-specific expression of phosphodiesterase 3A or 3B mRNA and activity in the aorta and adipose tissue of atherosclerosis-prone insulin-resistant rats.Diabetes. 1998 Jul;47(7):1135-44. doi: 10.2337/diabetes.47.7.1135.
• [214] White to beige conversion in PDE3B KO adipose tissue through activation of AMPK signaling and mitochondrial function.Sci Rep. 2017 Jan 13;7:40445. doi: 10.1038/srep40445.
• [215] Group 1B phospholipase A(2) in metabolic and inflammatory disease modulation.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):784-788. doi: 10.1016/j.bbalip.2018.07.001. Epub 2018 Jul 9.
• [216] Peroxiredoxin 4 levels in patients with PCOS and/or obesity.J Gynecol Obstet Hum Reprod. 2019 Nov;48(9):739-743. doi: 10.1016/j.jogoh.2019.04.002. Epub 2019 Apr 11.
• [217] The Role of Xenobiotic Receptors on Hepatic Glycolipid Metabolism.Curr Drug Metab. 2019;20(1):29-35. doi: 10.2174/1389200219666180918152241.
• [218] Obesity is associated with impaired ventricular protein kinase C-MAP kinase signaling and altered ANP mRNA expression in the heart of adult Zucker rats.J Investig Med. 2001 Jul;49(4):310-8. doi: 10.2310/6650.2001.33895.
• [219] Protein Tyrosine Phosphatase, Receptor Type B (PTPRB) Inhibits Brown Adipocyte Differentiation through Regulation of VEGFR2 Phosphorylation.J Microbiol Biotechnol. 2019 Apr 28;29(4):645-650. doi: 10.4014/jmb.1810.10033.
• [220] Rho-kinase as a molecular target for insulin resistance and hypertension.FASEB J. 2006 Jan;20(1):169-71. doi: 10.1096/fj.05-4197fje. Epub 2005 Nov 2.
• [221] Human serum RNase-L level is inversely associated with metabolic syndrome and age.Cardiovasc Diabetol. 2017 Apr 11;16(1):46. doi: 10.1186/s12933-017-0522-x.
• [222] Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.Bioorg Med Chem Lett. 2019 Apr 15;29(8):991-994. doi: 10.1016/j.bmcl.2019.02.013. Epub 2019 Feb 11.
• [223] MRP14 enhances the ability of macrophage to recruit T cells and promotes obesity-induced insulin resistance.Int J Obes (Lond). 2019 Dec;43(12):2434-2447. doi: 10.1038/s41366-019-0366-4. Epub 2019 Apr 30.
• [224] Role of melanocortin 4 receptor in hypertension induced by chronic intermittent hypoxia.Acta Physiol (Oxf). 2019 Apr;225(4):e13222. doi: 10.1111/apha.13222. Epub 2018 Dec 23.
• [225] Secreted frizzled-related protein 4 and its implication in obesity and type-2 diabetes.IUBMB Life. 2019 Nov;71(11):1701-1710. doi: 10.1002/iub.2123. Epub 2019 Jul 13.
• [226] GLUT12 and adipose tissue: Expression, regulation and its relation with obesity in mice.Acta Physiol (Oxf). 2019 Aug;226(4):e13283. doi: 10.1111/apha.13283. Epub 2019 May 11.
• [227] Effects of Sodium and Amino Acid Substrate Availability upon the Expression and Stability of the SNAT2 (SLC38A2) Amino Acid Transporter.Front Pharmacol. 2018 Feb 7;9:63. doi: 10.3389/fphar.2018.00063. eCollection 2018.
• [228] Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians.Diabetes. 2004 Sep;53(9):2483-6. doi: 10.2337/diabetes.53.9.2483.
• [229] Rosiglitazone regulates ENaC and Na-K-2Cl cotransporter (NKCC2) abundance in the obese Zucker rat.Am J Nephrol. 2006;26(3):245-57. doi: 10.1159/000093783. Epub 2006 Jun 2.
• [230] Mitochondrial-related gene associated to obesity can be modulated by in utero hyperglycemic environment.Reprod Toxicol. 2019 Apr;85:59-64. doi: 10.1016/j.reprotox.2019.02.001. Epub 2019 Feb 6.
• [231] The Bone Markers Sclerostin, Osteoprotegerin, and Bone-Specific Alkaline Phosphatase Are Related to Insulin Resistance in Children and Adolescents, Independent of Their Association with Growth and Obesity.Horm Res Paediatr. 2019;91(1):1-8. doi: 10.1159/000497113. Epub 2019 Mar 22.
• [232] Effects of proportions of dietary macronutrients on glucocorticoid metabolism in diet-induced obesity in rats.PLoS One. 2010 Jan 19;5(1):e8779. doi: 10.1371/journal.pone.0008779.
• [233] Regulation of tyrosine hydroxylase in periodontal fibroblasts and tissues by obesity-associated stimuli.Cell Tissue Res. 2019 Mar;375(3):619-628. doi: 10.1007/s00441-018-2941-8. Epub 2018 Oct 25.
• [234] Toll-like receptor 5 in obesity: the role of gut microbiota and adipose tissue inflammation.Obesity (Silver Spring). 2015 Mar;23(3):581-90. doi: 10.1002/oby.20993. Epub 2015 Jan 22.
• [235] Obesity promotes prolonged ovalbumin-induced airway inflammation modulating T helper type 1 (Th1), Th2 and Th17 immune responses in BALB/c mice.Clin Exp Immunol. 2017 Jul;189(1):47-59. doi: 10.1111/cei.12958. Epub 2017 Mar 31.
• [236] MC4R and ENPP1 gene polymorphisms and their implication in maternal and neonatal risk for obesity.Sci Rep. 2019 Jul 26;9(1):10858. doi: 10.1038/s41598-019-47402-2.
• [237] Hemostasis at Extremes of Body Weight.Semin Thromb Hemost. 2018 Oct;44(7):632-639. doi: 10.1055/s-0038-1661385. Epub 2018 Jul 9.
• [238] Effect of a high-fat diet on the hepatic expression of nuclear receptors and their target genes: relevance to drug disposition.Br J Nutr. 2015 Feb 14;113(3):507-16. doi: 10.1017/S0007114514003717. Epub 2015 Jan 23.
• [239] Expression of p27Kip1, a cell cycle repressor protein, is inversely associated with potential carcinogenic risk in the genetic rodent models of obesity and long-lived Ames dwarf mice.Metabolism. 2013 Jun;62(6):873-87. doi: 10.1016/j.metabol.2013.01.001. Epub 2013 Jan 26.
• [240] GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity.J Clin Endocrinol Metab. 2020 May 1;105(5):1552-63. doi: 10.1210/clinem/dgz140.
• [241] Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists?.Endocr Rev. 2020 Jan 1;41(1):bnz002. doi: 10.1210/endrev/bnz002.
• [242] Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats.BMC Neurosci. 2014 Sep 25;15:111. doi: 10.1186/1471-2202-15-111.
• [243] Endothelial Adora2a Activation Promotes Blood-Brain Barrier Breakdown and Cognitive Impairment in Mice with Diet-Induced Insulin Resistance.J Neurosci. 2019 May 22;39(21):4179-4192. doi: 10.1523/JNEUROSCI.2506-18.2019. Epub 2019 Mar 18.
• [244] Modeling the Effects of Severe Metabolic Disease by Genome Editing of hPSC-Derived Endothelial Cells Reveals an Inflammatory Phenotype.Int J Mol Sci. 2019 Dec 9;20(24):6201. doi: 10.3390/ijms20246201.
• [245] Discovery and Validation of a Novel Neutrophil Activation Marker Associated with Obesity.Sci Rep. 2019 Mar 5;9(1):3433. doi: 10.1038/s41598-019-39764-4.
• [246] Reintroducing testosterone in the db/db mouse partially restores normal glucose metabolism and insulin resistance in a leptin-independent manner.BMC Endocr Disord. 2018 Jun 13;18(1):38. doi: 10.1186/s12902-018-0266-y.
• [247] Adipocyte -arrestin-2 is essential for maintaining whole body glucose and energy homeostasis.Nat Commun. 2019 Jul 3;10(1):2936. doi: 10.1038/s41467-019-11003-4.
• [248] Sleeve gastrectomy in obese Wistar rats improves diastolic function and promotes cardiac recovery independent of weight loss.Surg Obes Relat Dis. 2019 Jun;15(6):837-842. doi: 10.1016/j.soard.2019.03.036. Epub 2019 Mar 23.
• [249] Design, screening and biological evaluation of novel fatty acid chain-modified oxyntomodulin-based derivatives with prolonged glucose-lowering ability and potent anti-obesity effects.Org Biomol Chem. 2019 Sep 7;17(33):7760-7771. doi: 10.1039/c9ob01132c. Epub 2019 Aug 7.
• [250] Associations of immunological factors with metabolic syndrome and its characteristic elements in Chinese centenarians.J Transl Med. 2018 Nov 19;16(1):315. doi: 10.1186/s12967-018-1691-4.
• [251] Fenofibrate reverses changes induced by high-fat diet on metabolism in mice muscle and visceral adipocytes.J Cell Physiol. 2018 Apr;233(4):3515-3528. doi: 10.1002/jcp.26203. Epub 2017 Nov 1.
• [252] Chemokine gene polymorphisms association with increased risk of type 2 diabetes mellitus in Tatar ethnic group, Russia.Mol Biol Rep. 2019 Feb;46(1):887-896. doi: 10.1007/s11033-018-4544-6. Epub 2018 Dec 10.
• [253] PACAP ameliorates hepatic metabolism and inflammation through up-regulating FAIM in obesity.J Cell Mol Med. 2019 Sep;23(9):5970-5980. doi: 10.1111/jcmm.14453. Epub 2019 Jul 3.
• [254] Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammation.EBioMedicine. 2019 Jun;44:489-501. doi: 10.1016/j.ebiom.2019.05.057. Epub 2019 Jun 17.
• [255] Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila.Adv Exp Med Biol. 2019;1167:129-155. doi: 10.1007/978-3-030-23629-8_8.
• [256] Cdkn2a deficiency promotes adipose tissue browning.Mol Metab. 2018 Feb;8:65-76. doi: 10.1016/j.molmet.2017.11.012. Epub 2017 Dec 1.
• [257] Clcn3 deficiency ameliorates high-fat diet-induced obesity and adipose tissue macrophage inflammation in mice.Acta Pharmacol Sin. 2019 Dec;40(12):1532-1543. doi: 10.1038/s41401-019-0229-5. Epub 2019 Jun 5.
• [258] Effect of the catechol-O-methyltransferase Val (158) Met polymorphism on theory of mind in obesity.Eur Eat Disord Rev. 2019 Jul;27(4):401-409. doi: 10.1002/erv.2665. Epub 2019 Feb 13.
• [259] Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity.Cell Metab. 2019 Oct 1;30(4):754-767.e9. doi: 10.1016/j.cmet.2019.07.010. Epub 2019 Aug 15.
• [260] Time-Restricted Feeding Prevents Obesity and Metabolic Syndrome in Mice Lacking a Circadian Clock.Cell Metab. 2019 Feb 5;29(2):303-319.e4. doi: 10.1016/j.cmet.2018.08.004. Epub 2018 Aug 30.
• [261] CXCL2, a new critical factor and therapeutic target for cardiovascular diseases.Clin Exp Hypertens. 2020 Jul 3;42(5):428-437. doi: 10.1080/10641963.2019.1693585. Epub 2019 Nov 21.
• [262] Consumer credit, chronic disease and risk behaviours.J Epidemiol Community Health. 2019 Jan;73(1):73-78. doi: 10.1136/jech-2018-211160. Epub 2018 Oct 15.
• [263] Gene expression profile following an oral unsaturated fat load in abdominal obese subjects.Eur J Nutr. 2019 Apr;58(3):1331-1337. doi: 10.1007/s00394-018-1659-4. Epub 2018 Mar 8.
• [264] Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary gland.Oncogene. 2019 May;38(20):3855-3870. doi: 10.1038/s41388-019-0687-8. Epub 2019 Jan 22.
• [265] Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization.Diabetes. 2019 Jun;68(6):1130-1142. doi: 10.2337/db18-0469. Epub 2019 Mar 12.
• [266] GDF5 Promotes White Adipose Tissue Thermogenesis via p38 MAPK Signaling Pathway.DNA Cell Biol. 2019 Nov;38(11):1303-1312. doi: 10.1089/dna.2019.4724. Epub 2019 Sep 25.
• [267] Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors.Bioorg Chem. 2019 Feb;82:117-122. doi: 10.1016/j.bioorg.2018.10.005. Epub 2018 Oct 5.
• [268] HNF1A variant, energy-reduced diets and insulin resistance improvement during weight loss: The POUNDS Lost trial and DIRECT.Diabetes Obes Metab. 2018 Jun;20(6):1445-1452. doi: 10.1111/dom.13250. Epub 2018 Mar 5.
• [269] Haptoglobin phenotype influences the effectiveness of diet-induced weight loss in middle-age abdominally obese women with metabolic abnormalities.Clin Nutr. 2020 Jan;39(1):225-233. doi: 10.1016/j.clnu.2019.01.019. Epub 2019 Jan 26.
• [270] IL-29 promoted obesity-induced inflammation and insulin resistance.Cell Mol Immunol. 2020 Apr;17(4):369-379. doi: 10.1038/s41423-019-0262-9. Epub 2019 Jul 30.
• [271] Absence of 6 Integrin Reduces Influenza Disease Severity in Highly Susceptible Obese Mice.J Virol. 2019 Jan 4;93(2):e01646-18. doi: 10.1128/JVI.01646-18. Print 2019 Jan 15.
• [272] Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity.Eur Heart J. 2019 Jan 21;40(4):383-391. doi: 10.1093/eurheartj/ehx615.
• [273] Bovine -lactalbumin hydrolysates ameliorate obesity-associated endotoxemia and inflammation in high-fat diet-fed mice through modulation of gut microbiota.Food Funct. 2019 Jun 19;10(6):3368-3378. doi: 10.1039/c8fo01967c.
• [274] MAPK Erk5 in Leptin ReceptorExpressing Neurons Controls Body Weight and Systemic Energy Homeostasis in Female Mice.Endocrinology. 2019 Dec 1;160(12):2837-2848. doi: 10.1210/en.2019-00090.
• [275] Thr55 phosphorylation of p21 by MPK38/MELK ameliorates defects in glucose, lipid, and energy metabolism in diet-induced obese mice.Cell Death Dis. 2019 May 16;10(6):380. doi: 10.1038/s41419-019-1616-z.
• [276] NDUFAB1 protects against obesity and insulin resistance by enhancing mitochondrial metabolism.FASEB J. 2019 Dec;33(12):13310-13322. doi: 10.1096/fj.201901117RR. Epub 2019 Sep 21.
• [277] Anti-Microbiological, Anti-Hyperglycemic and Anti-Obesity Potency of Natural Antioxidants in Fruit Fractions of Saskatoon Berry.Antioxidants (Basel). 2019 Sep 13;8(9):397. doi: 10.3390/antiox8090397.
• [278] Swimming training reduces glucose-amplifying pathway and cholinergic responses in islets from lean- and MSG-obese rats.Clin Exp Pharmacol Physiol. 2020 Feb;47(2):286-293. doi: 10.1111/1440-1681.13197. Epub 2019 Nov 12.
• [279] DP1 receptor agonist, BW245C inhibits diet-induced obesity in ApoE(-/-) mice.Obes Res Clin Pract. 2018 Mar-Apr;12(2):229-241. doi: 10.1016/j.orcp.2017.05.003. Epub 2017 Jun 8.
• [280] Inflammation increases MMP levels via PGE(2) in human vascular wall and plasma of obese women.Int J Obes (Lond). 2019 Sep;43(9):1724-1734. doi: 10.1038/s41366-018-0235-6. Epub 2018 Oct 22.
• [281] Whole-Body ARHGAP21-Deficiency Improves Energetic Homeostasis in Lean and Obese Mice.Front Endocrinol (Lausanne). 2019 May 29;10:338. doi: 10.3389/fendo.2019.00338. eCollection 2019.
• [282] Transcriptome profiling in preadipocytes identifies long noncoding RNAs as Sam68 targets.Oncotarget. 2017 May 11;8(47):81994-82005. doi: 10.18632/oncotarget.17813. eCollection 2017 Oct 10.
• [283] Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance.Diabetes Metab J. 2019 Jun;43(3):368-376. doi: 10.4093/dmj.2018.0066. Epub 2018 Oct 23.
• [284] Genetic contributors to serum uric acid levels in Mexicans and their effect on premature coronary artery disease.Int J Cardiol. 2019 Mar 15;279:168-173. doi: 10.1016/j.ijcard.2018.09.107. Epub 2018 Oct 1.
• [285] Sphk2(-/-) mice are protected from obesity and insulin resistance.Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):570-576. doi: 10.1016/j.bbadis.2018.12.012. Epub 2018 Dec 26.
• [286] Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function.FASEB J. 2019 Aug;33(8):9656-9671. doi: 10.1096/fj.201900479R. Epub 2019 May 30.
• [287] About the existence of common determinants of gene expression in the porcine liver and skeletal muscle.BMC Genomics. 2019 Jun 24;20(1):518. doi: 10.1186/s12864-019-5889-5.
• [288] Unravelled facets of milk derived opioid peptides: a focus on gut physiology, fractures and obesity.Int J Food Sci Nutr. 2020 Feb;71(1):36-49. doi: 10.1080/09637486.2019.1614540. Epub 2019 Jun 3.
• [289] Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.PLoS One. 2019 Jun 12;14(6):e0218126. doi: 10.1371/journal.pone.0218126. eCollection 2019.
• [290] Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour.Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2426-43. doi: 10.1098/rstb.2012.0039.
• [291] Development of obesity can be prevented in rats by chronic icv infusions of AngII but less by Ang(1-7).Pflugers Arch. 2018 Jun;470(6):867-881. doi: 10.1007/s00424-018-2117-0. Epub 2018 Feb 11.
• [292] Plasma Growth Arrest-Specific 6 Protein and Genetic Variations in the GAS6 Gene in Patients with Metabolic Syndrome.Metab Syndr Relat Disord. 2019 Feb;17(1):22-28. doi: 10.1089/met.2017.0143. Epub 2018 Oct 20.
• [293] The prevalence of sarcopenic obesity and its association with cognitive performance in type 2 diabetes in Singapore.Clin Nutr. 2020 Jul;39(7):2274-2281. doi: 10.1016/j.clnu.2019.10.019. Epub 2019 Nov 4.
• [294] Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases.PLoS One. 2014 Feb 18;9(2):e88942. doi: 10.1371/journal.pone.0088942. eCollection 2014.
• [295] Critical Role of the Human ATP-Binding Cassette G1 Transporter in Cardiometabolic Diseases.Int J Mol Sci. 2017 Sep 2;18(9):1892. doi: 10.3390/ijms18091892.
• [296] /-Hydrolase Domain 6 Deletion Induces Adipose Browning and Prevents Obesity and Type 2 Diabetes.Cell Rep. 2016 Mar 29;14(12):2872-88. doi: 10.1016/j.celrep.2016.02.076. Epub 2016 Mar 17.
• [297] Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice.Biol Sex Differ. 2019 Sep 4;10(1):45. doi: 10.1186/s13293-019-0260-8.
• [298] Obesity-related acetylcholinesterase elevation is reversed following laparoscopic sleeve gastrectomy.Int J Obes (Lond). 2019 Feb;43(2):297-305. doi: 10.1038/s41366-018-0014-4. Epub 2018 Feb 3.
• [299] Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.Cell. 2019 Apr 18;177(3):597-607.e9. doi: 10.1016/j.cell.2019.03.044.
• [300] The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling.Cell Death Differ. 2016 Nov 1;23(11):1778-1791. doi: 10.1038/cdd.2016.66. Epub 2016 Jul 22.
• [301] Loss of ADAMTS5 enhances brown adipose tissue mass and promotes browning of white adipose tissue via CREB signaling.Mol Metab. 2017 May 10;6(7):715-724. doi: 10.1016/j.molmet.2017.05.004. eCollection 2017 Jul.
• [302] ADCY5 gene expression in adipose tissue is related to obesity in men and mice.PLoS One. 2015 Mar 20;10(3):e0120742. doi: 10.1371/journal.pone.0120742. eCollection 2015.
• [303] Sibpair studies implicate chromosome 18 in essential hypertension.Am J Med Genet A. 2004 Apr 30;126A(3):241-7. doi: 10.1002/ajmg.a.20586.
• [304] Plasma adrenomedullin level in children with obesity: relationship to left ventricular function.World J Pediatr. 2018 Feb;14(1):84-91. doi: 10.1007/s12519-017-0106-6. Epub 2018 Feb 6.
• [305] Intermedin in Paraventricular Nucleus Attenuates Ang II-Induced Sympathoexcitation through the Inhibition of NADPH Oxidase-Dependent ROS Generation in Obese Rats with Hypertension.Int J Mol Sci. 2019 Aug 28;20(17):4217. doi: 10.3390/ijms20174217.
• [306] Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications.Clin Exp Pharmacol Physiol. 1998 Feb;25(2):79-87. doi: 10.1111/j.1440-1681.1998.tb02181.x.
• [307] The elevated gene expression level of the A(2B) adenosine receptor is associated with hyperglycemia in women with gestational diabetes mellitus.Diabetes Metab Res Rev. 2014 Jan;30(1):42-53. doi: 10.1002/dmrr.2446.
• [308] Genetic association of adrenergic receptor alpha 2A with obesity and type 2 diabetes.Obesity (Silver Spring). 2013 Aug;21(8):1720-5. doi: 10.1002/oby.20162. Epub 2013 Jun 11.
• [309] S100 proteins in obesity: liaisons dangereuses.Cell Mol Life Sci. 2020 Jan;77(1):129-147. doi: 10.1007/s00018-019-03257-4. Epub 2019 Jul 30.
• [310] Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways.Trends Endocrinol Metab. 2003 Jul;14(5):214-21. doi: 10.1016/s1043-2760(03)00078-x.
• [311] Loss of IBA1-Expression in brains from individuals with obesity and hepatic dysfunction.Brain Res. 2019 May 1;1710:220-229. doi: 10.1016/j.brainres.2019.01.006. Epub 2019 Jan 4.
• [312] Loss of Endothelial FTO Antagonizes Obesity-Induced Metabolic and Vascular Dysfunction.Circ Res. 2020 Jan 17;126(2):232-242. doi: 10.1161/CIRCRESAHA.119.315531. Epub 2019 Dec 5.
• [313] Akt3 inhibits adipogenesis and protects from diet-induced obesity via WNK1/SGK1 signaling.JCI Insight. 2017 Nov 16;2(22):e95687. doi: 10.1172/jci.insight.95687. eCollection 2017 Nov 16.
• [314] Adipose tissue 12/15 lipoxygenase pathway in human obesity and diabetes.J Clin Endocrinol Metab. 2014 Sep;99(9):E1713-20. doi: 10.1210/jc.2013-4461. Epub 2014 Jun 23.
• [315] Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.Biochem Soc Trans. 2007 Nov;35(Pt 5):881-6. doi: 10.1042/BST0350881.
• [316] Common variants in LEPR, IL6, AMD1, and NAMPT do not associate with risk of juvenile and childhood obesity in Danes: a case-control study.BMC Med Genet. 2015 Nov 11;16:105. doi: 10.1186/s12881-015-0253-3.
• [317] Obesity, starch digestion and amylase: association between copy number variants at human salivary (AMY1) and pancreatic (AMY2) amylase genes.Hum Mol Genet. 2015 Jun 15;24(12):3472-80. doi: 10.1093/hmg/ddv098. Epub 2015 Mar 18.
• [318] Angiotensin-(1-7), Adipokines and Inflammation.Metabolism. 2019 Jun;95:36-45. doi: 10.1016/j.metabol.2019.03.006. Epub 2019 Mar 21.
• [319] Reduced miR-181d level in obesity and its role in lipid metabolism via regulation of ANGPTL3.Sci Rep. 2019 Aug 14;9(1):11866. doi: 10.1038/s41598-019-48371-2.
• [320] The association of angiopoietin-like peptide 4 levels with obesity and hepatosteatosis in adolescents.Cytokine. 2020 Jan;125:154802. doi: 10.1016/j.cyto.2019.154802. Epub 2019 Aug 13.
• [321] Adiponectin as Link Factor between Adipose Tissue and Cancer.Int J Mol Sci. 2019 Feb 15;20(4):839. doi: 10.3390/ijms20040839.
• [322] Testosterone Deprivation Aggravates Left-Ventricular Dysfunction in Male Obese Insulin-Resistant Rats via Impairing Cardiac Mitochondrial Function and Dynamics Proteins.Gerontology. 2018;64(4):333-343. doi: 10.1159/000487188. Epub 2018 Mar 22.
• [323] Vascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulant.Int Urol Nephrol. 2017 May;49(5):875-879. doi: 10.1007/s11255-016-1497-3. Epub 2017 Jan 2.
• [324] Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor.Peptides. 2019 Nov;121:170139. doi: 10.1016/j.peptides.2019.170139. Epub 2019 Aug 28.
• [325] Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1351-1360. doi: 10.1016/j.bbadis.2019.02.003. Epub 2019 Feb 10.
• [326] Epigenomics and metabolomics reveal the mechanism of the APOA2-saturated fat intake interaction affecting obesity.Am J Clin Nutr. 2018 Jul 1;108(1):188-200. doi: 10.1093/ajcn/nqy081.
• [327] Sleep duration and apolipoprotein B in metabolically healthy and unhealthy overweight/obese phenotypes: a cross-sectional study in Chinese adults.BMJ Open. 2019 Feb 11;9(2):e023817. doi: 10.1136/bmjopen-2018-023817.
• [328] Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents.J Pediatr Endocrinol Metab. 2019 Jul 26;32(7):749-758. doi: 10.1515/jpem-2018-0543.
• [329] IRX5 regulates adipocyte amyloid precursor protein and mitochondrial respiration in obesity.Int J Obes (Lond). 2019 Nov;43(11):2151-2162. doi: 10.1038/s41366-018-0275-y. Epub 2018 Dec 11.
• [330] Cardioprotective effect of hyperkalemic cardioplegia in an aquaporin 7-deficient murine heart.Gen Thorac Cardiovasc Surg. 2020 Jun;68(6):578-584. doi: 10.1007/s11748-019-01243-y. Epub 2019 Nov 9.
• [331] Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver.Obes Surg. 2008 Jun;18(6):695-701. doi: 10.1007/s11695-008-9453-7. Epub 2008 Apr 10.
• [332] Early obesity leads to increases in hepatic arginase I and related systemic changes in nitric oxide and L-arginine metabolism in mice.J Physiol Biochem. 2018 Feb;74(1):9-16. doi: 10.1007/s13105-017-0597-6. Epub 2017 Nov 3.
• [333] Hepatic arginase 2 (Arg2) is sufficient to convey the therapeutic metabolic effects of fasting.Nat Commun. 2019 Apr 8;10(1):1587. doi: 10.1038/s41467-019-09642-8.
• [334] Patient Characteristics Influence Revision Rate of Total Hip Arthroplasty: American Society of Anesthesiologists Score and Body Mass Index Were the Strongest Predictors for Short-Term Revision After Primary Total Hip Arthroplasty.J Arthroplasty. 2020 Jan;35(1):188-192.e2. doi: 10.1016/j.arth.2019.08.024. Epub 2019 Aug 14.
• [335] The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein.J Clin Invest. 2002 Nov;110(10):1449-59. doi: 10.1172/JCI16131.
• [336] Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.J Clin Oncol. 2018 Sep 14:JCO2018784595. doi: 10.1200/JCO.2018.78.4595. Online ahead of print.
• [337] Atf3 induction is a therapeutic target for obesity and metabolic diseases.Biochem Biophys Res Commun. 2018 Oct 12;504(4):903-908. doi: 10.1016/j.bbrc.2018.09.048. Epub 2018 Sep 14.
• [338] Kinase Suppressor of Ras 2 (KSR2) expression in the brain regulates energy balance and glucose homeostasis.Mol Metab. 2016 Dec 18;6(2):194-205. doi: 10.1016/j.molmet.2016.12.004. eCollection 2017 Feb.
• [339] Targeted inactivation of copper transporter Atp7b in hepatocytes causes liver steatosis and obesity in mice.Am J Physiol Gastrointest Liver Physiol. 2017 Jul 1;313(1):G39-G49. doi: 10.1152/ajpgi.00312.2016. Epub 2017 Apr 20.
• [340] Multimorbidity of overweight and obesity alongside anxiety and depressive disorders in individuals with spinal cord injury.J Spinal Cord Med. 2021 Nov;44(6):992-1000. doi: 10.1080/10790268.2018.1507801. Epub 2018 Sep 5.
• [341] Copeptin relates to a fatty liver and measures of obesity in a South African population with mixed ethnicities.Endocrine. 2019 Aug;65(2):304-311. doi: 10.1007/s12020-019-01977-y. Epub 2019 Jun 22.
• [342] Relation between human vasopressin 1a gene variance, fat intake, and diabetes.Am J Clin Nutr. 2009 Jan;89(1):400-6. doi: 10.3945/ajcn.2008.26382. Epub 2008 Dec 3.
• [343] Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus.Eur J Endocrinol. 2016 Jan;174(1):69-75. doi: 10.1530/EJE-15-0781. Epub 2015 Oct 26.
• [344] Role of Zinc in Zinc-2-Glycoprotein Metabolism in Obesity: a Review of Literature.Biol Trace Elem Res. 2020 Jan;193(1):81-88. doi: 10.1007/s12011-019-01702-w. Epub 2019 Mar 30.
• [345] Effect of BCHE single nucleotide polymorphisms on lipid metabolism markers in women.Genet Mol Biol. 2017 Apr-Jun;40(2):408-414. doi: 10.1590/1678-4685-GMB-2016-0123. Epub 2017 May 11.
• [346] Causal association of body mass index with hypertension using a Mendelian randomization design.Medicine (Baltimore). 2018 Jul;97(30):e11252. doi: 10.1097/MD.0000000000011252.
• [347] Contributions of renin-angiotensin system-related gene interactions to obesity in a Chinese population.PLoS One. 2012;7(8):e42881. doi: 10.1371/journal.pone.0042881. Epub 2012 Aug 6.
• [348] Enhanced biglycan gene expression in the adipose tissues of obese women and its association with obesity-related genes and metabolic parameters.Sci Rep. 2016 Jul 28;6:30609. doi: 10.1038/srep30609.
• [349] Cellular inhibitors of apoptosis (cIAP) 1 and 2 are increased in placenta from obese pregnant women.Placenta. 2014 Oct;35(10):831-8. doi: 10.1016/j.placenta.2014.07.011. Epub 2014 Aug 1.
• [350] Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes.Diabetologia. 2013 Mar;56(3):492-6. doi: 10.1007/s00125-012-2794-8. Epub 2012 Dec 6.
• [351] Anti-inflammatory effects of active commuting and leisure time exercise in overweight and obese women and men: A randomized controlled trial.Atherosclerosis. 2017 Oct;265:318-324. doi: 10.1016/j.atherosclerosis.2017.06.923. Epub 2017 Jun 28.
• [352] Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes.Aging (Albany NY). 2019 Dec 12;11(23):11520-11540. doi: 10.18632/aging.102552. Epub 2019 Dec 12.
• [353] Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity.PLoS One. 2011 Feb 2;6(2):e16155. doi: 10.1371/journal.pone.0016155.
• [354] BRD7 deficiency leads to the development of obesity and hyperglycemia.Sci Rep. 2019 Mar 29;9(1):5327. doi: 10.1038/s41598-019-41713-0.
• [355] p32 regulates ER stress and lipid homeostasis by down-regulating GCS1 expression.FASEB J. 2018 Jul;32(7):3892-3902. doi: 10.1096/fj.201701004RR. Epub 2018 Feb 20.
• [356] Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21.Cell Rep. 2019 Sep 3;28(10):2567-2580.e6. doi: 10.1016/j.celrep.2019.07.101.
• [357] Carbonic anhydrase III (Car3) is not required for fatty acid synthesis and does not protect against high-fat diet induced obesity in mice.PLoS One. 2017 Apr 24;12(4):e0176502. doi: 10.1371/journal.pone.0176502. eCollection 2017.
• [358] Understanding the Role and Mechanism of Carbonic Anhydrase V in Obesity and its Therapeutic Implications.Curr Protein Pept Sci. 2018;19(9):909-923. doi: 10.2174/1389203718666170810145436.
• [359] Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesity.J Nucl Cardiol. 2019 Feb;26(1):275-283. doi: 10.1007/s12350-017-0855-6. Epub 2017 Mar 29.
• [360] Concomitant expression of adrenomedullin and its receptor components in rat adipose tissues.Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E56-62. doi: 10.1152/ajpendo.00586.2003. Epub 2004 Aug 17.
• [361] Calcium/calmodulin-dependent protein kinase kinase 2 regulates macrophage-mediated inflammatory responses.J Biol Chem. 2012 Mar 30;287(14):11579-91. doi: 10.1074/jbc.M111.336032. Epub 2012 Feb 14.
• [362] Calpains and their multiple roles in diabetes mellitus.Ann N Y Acad Sci. 2006 Nov;1084:452-80. doi: 10.1196/annals.1372.011.
• [363] Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans.Mol Immunol. 2012 Mar;50(3):142-9. doi: 10.1016/j.molimm.2012.01.005. Epub 2012 Feb 8.
• [364] Carbonyl reductase 1 catalyzes 20-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesity.Sci Rep. 2017 Sep 6;7(1):10633. doi: 10.1038/s41598-017-10410-1.
• [365] Cystathionine beta synthase-hydrogen sulfide system in paraventricular nucleus reduced high fatty diet induced obesity and insulin resistance by brain-adipose axis.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3281-3291. doi: 10.1016/j.bbadis.2018.07.014. Epub 2018 Jul 20.
• [366] Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients.Pharmacogenetics. 2002 Jan;12(1):23-30. doi: 10.1097/00008571-200201000-00004.
• [367] A novel approach to childhood obesity: circulating chemokines and growth factors as biomarkers of insulin resistance.Pediatr Obes. 2019 Mar;14(3):e12473. doi: 10.1111/ijpo.12473. Epub 2018 Oct 22.
• [368] Hypoxic adipocytes induce macrophages to release inflammatory cytokines that render skeletal muscle cells insulin resistant.Biochem Biophys Res Commun. 2020 Jan 15;521(3):625-631. doi: 10.1016/j.bbrc.2019.10.162. Epub 2019 Oct 31.
• [369] Do Genetic Factors Modify the Relationship Between Obesity and Hypertriglyceridemia? Findings From the GLACIER and the MDC Studies.Circ Cardiovasc Genet. 2016 Apr;9(2):162-71. doi: 10.1161/CIRCGENETICS.115.001218. Epub 2016 Feb 10.
• [370] miR-26a Mediates Adipogenesis of Amniotic Fluid Mesenchymal Stem/Stromal Cells via PTEN, Cyclin E1, and CDK6.Stem Cells Dev. 2017 Apr 1;26(7):482-494. doi: 10.1089/scd.2016.0203. Epub 2017 Feb 13.
• [371] Inflammation polymorphisms and prostate cancer risk in Jamaican men: Role of obesity/body size.Gene. 2017 Dec 15;636:96-102. doi: 10.1016/j.gene.2017.09.016. Epub 2017 Sep 10.
• [372] Sex-based differences in phagocyte metabolic profile in rats with monosodium glutamate-induced obesity.Sci Rep. 2018 Apr 3;8(1):5419. doi: 10.1038/s41598-018-23664-0.
• [373] Twist2 and CD24 expression alters renal microenvironment in obesity associated kidney cancer.Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):358-364. doi: 10.26355/eurrev_201801_14180.
• [374] Genetic variation at the CELF1 (CUGBP, elav-like family member 1 gene) locus is genome-wide associated with Alzheimer's disease and obesity.Am J Med Genet B Neuropsychiatr Genet. 2014 Jun;165B(4):283-93. doi: 10.1002/ajmg.b.32234. Epub 2014 May 1.
• [375] The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.Trends Pharmacol Sci. 2018 Apr;39(4):424-436. doi: 10.1016/j.tips.2018.02.001. Epub 2018 Feb 23.
• [376] Expression of macrophage genes within skeletal muscle correlates inversely with adiposity and insulin resistance in humans.Appl Physiol Nutr Metab. 2018 Feb;43(2):187-193. doi: 10.1139/apnm-2017-0228. Epub 2017 Oct 16.
• [377] Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.Mol Nutr Food Res. 2020 Feb;64(4):e1900824. doi: 10.1002/mnfr.201900824. Epub 2019 Dec 15.
• [378] Targetted inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin resistance.Clin Sci (Lond). 2018 Jul 31;132(14):1581-1596. doi: 10.1042/CS20180041. Print 2018 Jul 31.
• [379] Stromal cell cadherin-11 regulates adipose tissue inflammation and diabetes.J Clin Invest. 2017 Sep 1;127(9):3300-3312. doi: 10.1172/JCI86881. Epub 2017 Jul 31.
• [380] Large-scale in silico mapping of complex quantitative traits in inbred mice.PLoS One. 2007 Jul 25;2(7):e651. doi: 10.1371/journal.pone.0000651.
• [381] CEACAM1 in Liver Injury, Metabolic and Immune Regulation.Int J Mol Sci. 2018 Oct 11;19(10):3110. doi: 10.3390/ijms19103110.
• [382] Obesity as an independent predictive factor for pathologic complete response after neoadjuvant chemoradiation in rectal cancer.Ann Surg Treat Res. 2019 Mar;96(3):116-122. doi: 10.4174/astr.2019.96.3.116. Epub 2018 Feb 26.
• [383] A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.J Biol Chem. 2017 Apr 14;292(15):6312-6324. doi: 10.1074/jbc.M116.758078. Epub 2017 Feb 27.
• [384] CCAAT/enhancer binding protein alpha, beta and delta gene variants: associations with obesity related phenotypes in the Leeds Family Study.Diab Vasc Dis Res. 2010 Jul;7(3):195-203. doi: 10.1177/1479164110366274. Epub 2010 May 11.
• [385] Augmented Responses to Ozone in Obese Mice Require IL-17A and Gastrin-Releasing Peptide.Am J Respir Cell Mol Biol. 2018 Mar;58(3):341-351. doi: 10.1165/rcmb.2017-0071OC.
• [386] Regulation of adipogenesis by ceramide 1-phosphate.Exp Cell Res. 2018 Nov 15;372(2):150-157. doi: 10.1016/j.yexcr.2018.09.021. Epub 2018 Sep 27.
• [387] Complement factor H is expressed in adipose tissue in association with insulin resistance.Diabetes. 2010 Jan;59(1):200-9. doi: 10.2337/db09-0700. Epub 2009 Oct 15.
• [388] Reduced adipsin mRNA and circulating adipsin protein are modulated by adrenal steroids in obese Zucker rats.Am J Physiol. 1990 Jul;259(1 Pt 2):R184-8. doi: 10.1152/ajpregu.1990.259.1.R184.
• [389] Functional and genetic epidemiological characterisation of the FFAR4 (GPR120) p.R270H variant in the Danish population.J Med Genet. 2016 Sep;53(9):616-23. doi: 10.1136/jmedgenet-2015-103728. Epub 2016 Apr 11.
• [390] An immune-beige adipocyte communication via nicotinic acetylcholine receptor signaling.Nat Med. 2018 Jun;24(6):814-822. doi: 10.1038/s41591-018-0032-8. Epub 2018 May 21.
• [391] CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users.Addiction. 2013 Oct;108(10):1818-28. doi: 10.1111/add.12250. Epub 2013 Jul 5.
• [392] Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium.BMJ Open. 2015 Aug 11;5(8):e008808. doi: 10.1136/bmjopen-2015-008808.
• [393] T-HOD: a literature-based candidate gene database for hypertension, obesity and diabetes.Database (Oxford). 2013 Feb 12;2013:bas061. doi: 10.1093/database/bas061. Print 2013.
• [394] Cdc2-like kinase 2 in the hypothalamus is necessary to maintain energy homeostasis.Int J Obes (Lond). 2017 Feb;41(2):268-278. doi: 10.1038/ijo.2016.174. Epub 2016 Oct 13.
• [395] Promotive effect of Bofutsushosan (Fangfengtongshengsan) on lipid and cholesterol excretion in feces in mice treated with a high-fat diet.J Ethnopharmacol. 2018 Jun 28;220:1-8. doi: 10.1016/j.jep.2018.03.028. Epub 2018 Mar 24.
• [396] Monocarboxylate transporters: new players in body weight regulation.Obes Rev. 2015 Feb;16 Suppl 1:55-66. doi: 10.1111/obr.12256.
• [397] Involvement of obesity-associated upregulation of chemerin/chemokine-like receptor 1 in oxidative stress and apoptosisin ovaries and granulosa cells.Biochem Biophys Res Commun. 2019 Mar 12;510(3):449-455. doi: 10.1016/j.bbrc.2019.01.125. Epub 2019 Feb 2.
• [398] gp130 receptor ligands as potential therapeutic targets for obesity.J Clin Invest. 2007 Apr;117(4):841-9. doi: 10.1172/JCI30453.
• [399] COL6A3 is regulated by leptin in human adipose tissue and reduced in obesity.Endocrinology. 2015 Jan;156(1):134-46. doi: 10.1210/en.2014-1042.
• [400] Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity. Clin Appl Thromb Hemost. 2006 Jul;12(3):364-8. doi: 10.1177/1076029606291403.
• [401] SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle.Diabetes. 2015 Jul;64(7):2420-31. doi: 10.2337/db15-0115. Epub 2015 Mar 17.
• [402] Corticotropin-releasing hormone-binding protein in brain and pituitary of food-deprived obese (fa/fa) Zucker rats.Am J Physiol. 1999 Dec;277(6):R1749-59. doi: 10.1152/ajpregu.1999.277.6.R1749.
• [403] An epigenome-wide study of body mass index and DNA methylation in blood using participants from the Sister Study cohort.Int J Obes (Lond). 2017 Jan;41(1):194-199. doi: 10.1038/ijo.2016.184. Epub 2016 Oct 24.
• [404] Gender-specific alteration of energy balance and circadian locomotor activity in the Crtc1 knockout mouse model of depression.Transl Psychiatry. 2017 Dec 8;7(12):1269. doi: 10.1038/s41398-017-0023-4.
• [405] Effect of exercise and butyrate supplementation on microbiota composition and lipid metabolism.J Endocrinol. 2019 Nov;243(2):125-135. doi: 10.1530/JOE-19-0122.
• [406] Gene-gene interactions and associations of six hypertension related single nucleotide polymorphisms with obesity risk in a Chinese children population.Gene. 2018 Dec 30;679:320-327. doi: 10.1016/j.gene.2018.09.019. Epub 2018 Sep 12.
• [407] Potential prognostic biomarkers of cardiovascular disease in fetal macrosomia: the impact of gestational diabetes.J Matern Fetal Neonatal Med. 2018 Apr;31(7):895-900. doi: 10.1080/14767058.2017.1300651. Epub 2017 Mar 15.
• [408] Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice.Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2202-8. doi: 10.1161/ATVBAHA.108.172320. Epub 2008 Sep 25.
• [409] Elevated circulating cathepsin S levels are associated with metabolic syndrome in overweight and obese individuals.Diabetes Metab Res Rev. 2019 Mar;35(3):e3117. doi: 10.1002/dmrr.3117. Epub 2019 Jan 7.
• [410] Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis.Int J Obes (Lond). 2018 Aug;42(8):1406-1417. doi: 10.1038/s41366-018-0102-5. Epub 2018 May 24.
• [411] Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism.Obes Surg. 2017 Dec;27(12):3194-3201. doi: 10.1007/s11695-017-2745-z.
• [412] Haplotypes of CYP1B1 and CCDC57 genes in an Afro-Caribbean female population with uterine leiomyoma.Mol Biol Rep. 2019 Jun;46(3):3299-3306. doi: 10.1007/s11033-019-04790-y. Epub 2019 Apr 13.
• [413] Inter- and intrafamilial variability in premature pubarche and polycystic ovary syndrome.Fertil Steril. 2002 Sep;78(3):473-8. doi: 10.1016/s0015-0282(02)03252-1.
• [414] Genetic association analysis of vitamin D pathway with obesity traits.Int J Obes (Lond). 2013 Oct;37(10):1399-406. doi: 10.1038/ijo.2013.6. Epub 2013 Feb 5.
• [415] CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model.Int J Obes (Lond). 2019 Mar;43(3):475-486. doi: 10.1038/s41366-018-0037-x. Epub 2018 Feb 20.
• [416] Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis.J Nutr Biochem. 2019 Aug;70:125-137. doi: 10.1016/j.jnutbio.2019.05.004. Epub 2019 May 21.
• [417] Obesity is associated with a slower response to initial phenprocoumon therapy whereas CYP2C9 genotypes are not.Eur J Clin Pharmacol. 2006 Sep;62(9):713-20. doi: 10.1007/s00228-006-0158-3. Epub 2006 Jul 18.
• [418] Comparing the protective effects of three sulfur compounds against acrylonitrile-induced acute toxicity in CYP2E1-induced rats.Toxicol Ind Health. 2019 May;35(5):387-397. doi: 10.1177/0748233719839847. Epub 2019 Apr 16.
• [419] Consumption of alpha-linolenic acid-enriched diacylglycerol induces increase in dietary fat oxidation compared with alpha-linolenic acid-enriched triacylglycerol: A randomized, double-blind trial.Nutr Res. 2017 Dec;48:85-92. doi: 10.1016/j.nutres.2017.10.012. Epub 2017 Oct 13.
• [420] Decorin is a secreted protein associated with obesity and type 2 diabetes.Int J Obes (Lond). 2008 Jul;32(7):1113-21. doi: 10.1038/ijo.2008.41. Epub 2008 Apr 15.
• [421] Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model.Bioorg Med Chem Lett. 2018 Jun 1;28(10):1686-1692. doi: 10.1016/j.bmcl.2018.04.051. Epub 2018 Apr 21.
• [422] Role of miR-383 and miR-146b in different propensities to obesity in male mice.J Endocrinol. 2017 Aug;234(2):201-216. doi: 10.1530/JOE-17-0044. Epub 2017 Jun 2.
• [423] The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle glucose uptake.EBioMedicine. 2019 Aug;46:368-380. doi: 10.1016/j.ebiom.2019.07.070. Epub 2019 Aug 3.
• [424] Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes.Front Endocrinol (Lausanne). 2019 Feb 15;10:80. doi: 10.3389/fendo.2019.00080. eCollection 2019.
• [425] Mutation of SLC35D3 causes metabolic syndrome by impairing dopamine signaling in striatal D1 neurons.PLoS Genet. 2014 Feb 13;10(2):e1004124. doi: 10.1371/journal.pgen.1004124. eCollection 2014 Feb.
• [426] A Study of Short- and Long-term mRNA Levels of the Retn, Iapp, and Drd5 Genes in Obese Mice Induced with High-fat Diet.In Vivo. 2018 Jul-Aug;32(4):813-817. doi: 10.21873/invivo.11312.
• [427] Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance.Diabetes. 2018 Apr;67(4):624-635. doi: 10.2337/db17-0826. Epub 2018 Jan 9.
• [428] DUSP5 functions as a feedback regulator of TNF-induced ERK1/2 dephosphorylation and inflammatory gene expression in adipocytes.Sci Rep. 2017 Oct 10;7(1):12879. doi: 10.1038/s41598-017-12861-y.
• [429] Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals. Toxicology. 2013 Jan 7;303:17-24.
• [430] Elevated serum neuregulin 4 levels in patients with hyperthyroidism.Endocr Connect. 2019 Jun 1;8(6):728-735. doi: 10.1530/EC-19-0175.
• [431] EGFL6 is increasingly expressed in human obesity and promotes proliferation of adipose tissue-derived stromal vascular cells.Mol Cell Biochem. 2010 Oct;343(1-2):257-69. doi: 10.1007/s11010-010-0521-7. Epub 2010 Jun 25.
• [432] Prolyl Hydroxylase Domain-2 Inhibition Improves Skeletal Muscle Regeneration in a Male Murine Model of Obesity.Front Endocrinol (Lausanne). 2017 Jul 5;8:153. doi: 10.3389/fendo.2017.00153. eCollection 2017.
• [433] Metaflammasome components in the human brain: a role in dementia with Alzheimer's pathology?.Brain Pathol. 2017 May;27(3):266-275. doi: 10.1111/bpa.12388. Epub 2016 Jun 8.
• [434] The GCN2 inhibitor IMPACT contributes to diet-induced obesity and body temperature control.PLoS One. 2019 Jun 5;14(6):e0217287. doi: 10.1371/journal.pone.0217287. eCollection 2019.
• [435] Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.J Clin Invest. 2007 Feb;117(2):387-96. doi: 10.1172/JCI29528.
• [436] Neutrophil elastase and myeloperoxidase mRNA expression in overweight and obese subjects.Mol Biol Rep. 2018 Oct;45(5):1245-1252. doi: 10.1007/s11033-018-4279-4. Epub 2018 Jul 28.
• [437] Obesity and aging affects skeletal muscle renin-angiotensin system and myosin heavy chain proportions in pre-diabetic Zucker rats.J Physiol Biochem. 2019 Aug;75(3):351-365. doi: 10.1007/s13105-019-00689-1. Epub 2019 Jun 13.
• [438] Genome-wide analysis identifies colonic genes differentially associated with serum leptin and insulin concentrations in C57BL/6J mice fed a high-fat diet.PLoS One. 2017 Feb 7;12(2):e0171664. doi: 10.1371/journal.pone.0171664. eCollection 2017.
• [439] Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity.Front Pharmacol. 2015 Sep 15;6:199. doi: 10.3389/fphar.2015.00199. eCollection 2015.
• [440] IRE1 prevents hepatic steatosis by processing and promoting the degradation of select microRNAs.Sci Signal. 2018 May 15;11(530):eaao4617. doi: 10.1126/scisignal.aao4617.
• [441] Selective estrogen receptor (ER) activation provokes a redistribution of fat mass and modifies hepatic triglyceride composition in obese male mice.Mol Cell Endocrinol. 2020 Feb 15;502:110672. doi: 10.1016/j.mce.2019.110672. Epub 2019 Dec 5.
• [442] Identification of Estrogen-Related Receptor Agonists in the Tox21 Compound Library.Endocrinology. 2018 Feb 1;159(2):744-753. doi: 10.1210/en.2017-00658.
• [443] The 2.3 genotype of ESRRA23 of the ERR alpha gene is associated with a higher BMI than the 2.2 genotype.Obes Res. 2005 Oct;13(10):1843-4. doi: 10.1038/oby.2005.225.
• [444] Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.Nature. 2018 Mar 29;555(7698):673-677. doi: 10.1038/nature26138. Epub 2018 Mar 21.
• [445] Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs.Obesity (Silver Spring). 2012 Jan;20(1):88-94. doi: 10.1038/oby.2011.287. Epub 2011 Sep 29.
• [446] Association of F11 receptor gene polymorphisms with central obesity and blood pressure.J Intern Med. 2008 Mar;263(3):322-32. doi: 10.1111/j.1365-2796.2007.01886.x. Epub 2007 Dec 6.
• [447] Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet.Sci Rep. 2016 Oct 19;6:35574. doi: 10.1038/srep35574.
• [448] Risk Factors for Thrombosis Development in Mexican Patients.Ann Vasc Surg. 2015 Nov;29(8):1625-32. doi: 10.1016/j.avsg.2015.05.035. Epub 2015 Aug 24.
• [449] Biased Signaling by Agonists of Protease Activated Receptor 2.ACS Chem Biol. 2017 May 19;12(5):1217-1226. doi: 10.1021/acschembio.6b01088. Epub 2017 Mar 14.
• [450] Fatty acid-binding protein 3 stimulates glucose uptake by facilitating AS160 phosphorylation in mouse muscle cells.Genes Cells. 2011 Jun;16(6):681-91. doi: 10.1111/j.1365-2443.2011.01517.x. Epub 2011 Apr 18.
• [451] Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.J Atheroscler Thromb. 2019 Mar 1;26(3):216-232. doi: 10.5551/jat.48710. Epub 2019 Feb 7.
• [452] Interorgan cross talk between fatty acid metabolism, tissue inflammation, and FADS2 genotype in humans with obesity.Obesity (Silver Spring). 2017 Mar;25(3):545-552. doi: 10.1002/oby.21753. Epub 2017 Feb 1.
• [453] Synthesis, biological activities, and docking studies of d-pantolactone derivatives as novel FAS inhibitors.Bioorg Med Chem. 2019 Oct 15;27(20):115069. doi: 10.1016/j.bmc.2019.115069. Epub 2019 Aug 24.
• [454] Exercise Training Reduces Reward for High-Fat Food in Adults with Overweight/Obesity.Med Sci Sports Exerc. 2020 Apr;52(4):900-908. doi: 10.1249/MSS.0000000000002205.
• [455] Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice.Diabetes. 2017 May;66(5):1405-1418. doi: 10.2337/db16-0924. Epub 2017 Feb 21.
• [456] Adipose Tissue Dendritic Cells Are Independent Contributors to Obesity-Induced Inflammation and Insulin Resistance.J Immunol. 2016 Nov 1;197(9):3650-3661. doi: 10.4049/jimmunol.1600820. Epub 2016 Sep 28.
• [457] Hyposialylated IgG activates endothelial IgG receptor FcRIIB to promote obesity-induced insulin resistance.J Clin Invest. 2018 Jan 2;128(1):309-322. doi: 10.1172/JCI89333. Epub 2017 Nov 27.
• [458] Layered stigma? Co-occurring depression and obesity in the public eye.J Psychosom Res. 2018 Mar;106:29-33. doi: 10.1016/j.jpsychores.2018.01.003. Epub 2018 Jan 9.
• [459] Association of a mutation in the beta3-adrenergic receptor gene with obesity and response to dietary intervention in Chinese children.Acta Paediatr. 2001 Nov;90(11):1233-7. doi: 10.1080/080352501317130245.
• [460] A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling.Transl Psychiatry. 2019 May 10;9(1):141. doi: 10.1038/s41398-019-0470-1.
• [461] Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.Gene. 2014 Mar 1;537(1):85-92. doi: 10.1016/j.gene.2013.11.081. Epub 2013 Dec 8.
• [462] Novel GPR120 agonist TUG891 modulates fat taste perception and preference and activates tongue-brain-gut axis in mice.J Lipid Res. 2020 Feb;61(2):133-142. doi: 10.1194/jlr.RA119000142. Epub 2019 Dec 5.
• [463] Childhood Obesity, Genetic Variation, and Dental Age.Pediatr Dent. 2019 Mar 15;41(2):132-135.
• [464] Epigenome-wide association study of adiposity and future risk of obesity-related diseases.Int J Obes (Lond). 2018 Dec;42(12):2022-2035. doi: 10.1038/s41366-018-0064-7. Epub 2018 May 1.
• [465] Association of serum fibroblast growth factor 19 levels with visceral fat accumulation is independent of glucose tolerance status.Nutr Metab Cardiovasc Dis. 2018 Feb;28(2):119-125. doi: 10.1016/j.numecd.2017.10.009. Epub 2017 Oct 18.
• [466] Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animals.MAbs. 2017 Nov/Dec;9(8):1379-1388. doi: 10.1080/19420862.2017.1373923. Epub 2017 Sep 12.
• [467] Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia.PLoS One. 2018 Apr 13;13(4):e0195876. doi: 10.1371/journal.pone.0195876. eCollection 2018.
• [468] Role of the mTORFOXO1 pathway in obesityassociated renal tubulointerstitial inflammation.Mol Med Rep. 2019 Feb;19(2):1284-1293. doi: 10.3892/mmr.2018.9727. Epub 2018 Dec 5.
• [469] Intraperitoneal administration of follistatin promotes adipocyte browning in high-fat diet-induced obese mice.PLoS One. 2019 Jul 31;14(7):e0220310. doi: 10.1371/journal.pone.0220310. eCollection 2019.
• [470] Genome-wide methylation analysis identifies differentially methylated CpG loci associated with severe obesity in childhood.Epigenetics. 2015;10(11):995-1005. doi: 10.1080/15592294.2015.1080411.
• [471] Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.Saudi Med J. 2019 Jan;40(1):19-25. doi: 10.15537/smj.2019.1.22825.
• [472] Adverse Childhood Experiences, Epigenetic Measures, and Obesity in Youth.J Pediatr. 2018 Nov;202:150-156.e3. doi: 10.1016/j.jpeds.2018.06.051. Epub 2018 Aug 31.
• [473] Expression of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) in obesity and insulin resistance.Iran J Basic Med Sci. 2019 Jun;22(6):623-630. doi: 10.22038/ijbms.2019.34571.8206.
• [474] A study of the role of GATA4 polymorphism in cardiovascular metabolic disorders.Hum Genomics. 2013 Dec 12;7(1):25. doi: 10.1186/1479-7364-7-25.
• [475] DR10601, a novel recombinant long-acting dual glucagon-like peptide-1 and glucagon receptor agonist for the treatment of obesity and type 2 diabetes mellitus.J Endocrinol Invest. 2020 May;43(5):653-662. doi: 10.1007/s40618-019-01153-z. Epub 2019 Nov 30.
• [476] BMP-9 enhances fibroblast growth factor 21 expression and suppresses obesity.Biochim Biophys Acta. 2016 Jul;1862(7):1237-46. doi: 10.1016/j.bbadis.2016.04.006. Epub 2016 Apr 13.
• [477] Identification of key regulatory genes connected to NF-B family of proteins in visceral adipose tissues using gene expression and weighted protein interaction network.PLoS One. 2019 Apr 23;14(4):e0214337. doi: 10.1371/journal.pone.0214337. eCollection 2019.
• [478] Growth hormone signaling and action in obese versus lean human subjects.Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E333-E344. doi: 10.1152/ajpendo.00431.2018. Epub 2018 Dec 21.
• [479] Adipocyte-Specific GH Receptor-Null (AdGHRKO) Mice Have Enhanced Insulin Sensitivity With Reduced Liver Triglycerides.Endocrinology. 2019 Jan 1;160(1):68-80. doi: 10.1210/en.2018-00850.
• [480] Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury.Exp Neurol. 2020 Feb;324:113113. doi: 10.1016/j.expneurol.2019.113113. Epub 2019 Nov 12.
• [481] Distinctive actions of connexin 46 and connexin 50 in anterior pituitary folliculostellate cells.PLoS One. 2017 Jul 31;12(7):e0182495. doi: 10.1371/journal.pone.0182495. eCollection 2017.
• [482] Impact of obesity on 7,12-dimethylbenz[a]anthracene-induced altered ovarian connexin gap junction proteins in female mice.Toxicol Appl Pharmacol. 2015 Jan 1;282(1):1-8. doi: 10.1016/j.taap.2014.10.020. Epub 2014 Nov 8.
• [483] Copy number variation of glyoxalase I.Biochem Soc Trans. 2014 Apr;42(2):500-3. doi: 10.1042/BST20140011.
• [484] Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1. Antioxid Redox Signal. 2017 Aug 20;27(6):313-327.
• [485] A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome.Pharmacogenet Genomics. 2010 Aug;20(8):476-84. doi: 10.1097/FPC.0b013e32833b7497.
• [486] Obesity-related cellular stressors regulate gonadotropin releasing hormone gene expression via c-Fos/AP-1.Mol Cell Endocrinol. 2018 Dec 15;478:97-105. doi: 10.1016/j.mce.2018.07.011. Epub 2018 Jul 29.
• [487] Hypogonadotropic hypogonadism.Semin Reprod Med. 2002 Nov;20(4):327-38. doi: 10.1055/s-2002-36707.
• [488] FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity. J Am Soc Nephrol. 2018 Jan;29(1):118-137.
• [489] Biallelic mutations in GPD1 gene in a Chinese boy mainly presented with obesity, insulin resistance, fatty liver, and short stature.Am J Med Genet A. 2017 Dec;173(12):3189-3194. doi: 10.1002/ajmg.a.38473. Epub 2017 Sep 25.
• [490] RAMP3 deficiency enhances postmenopausal obesity and metabolic disorders.Peptides. 2018 Dec;110:10-18. doi: 10.1016/j.peptides.2018.10.006. Epub 2018 Oct 29.
• [491] Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine.Br J Pharmacol. 2019 May;176(10):1443-1454. doi: 10.1111/bph.14175. Epub 2018 Apr 2.
• [492] The weight of nutrients: kynurenine metabolites in obesity and exercise.J Intern Med. 2018 Nov;284(5):519-533. doi: 10.1111/joim.12830. Epub 2018 Sep 25.
• [493] Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes.J Diabetes. 2017 Apr;9(4):353-361. doi: 10.1111/1753-0407.12417. Epub 2016 Jul 28.
• [494] Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands.Trends Pharmacol Sci. 2018 Jun;39(6):586-604. doi: 10.1016/j.tips.2018.02.011. Epub 2018 Mar 24.
• [495] Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets.Eur J Nutr. 2018 Aug;57(5):1737-1746. doi: 10.1007/s00394-017-1456-5. Epub 2017 Apr 20.
• [496] Deficiency of glutathione peroxidase-1 and catalase attenuated diet-induced obesity and associated metabolic disorders.Acta Diabetol. 2020 Feb;57(2):151-161. doi: 10.1007/s00592-019-01388-5. Epub 2019 Aug 1.
• [497] Pharmacogenetics and obesity: common gene variants influence weight loss response of the norepinephrine/dopamine transporter inhibitor GW320659 in obese subjects. Pharmacogenet Genomics. 2005 Dec;15(12):883-9.
• [498] Alteration of myocardial GRK2 produces a global metabolic phenotype.JCI Insight. 2019 Apr 4;5(10):e123848. doi: 10.1172/jci.insight.123848.
• [499] Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in Humans.Sci Rep. 2018 May 17;8(1):7745. doi: 10.1038/s41598-018-26055-7.
• [500] ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese.Metabolism. 2009 Oct;58(10):1415-23. doi: 10.1016/j.metabol.2009.05.007. Epub 2009 Jul 1.
• [501] GSTO1-1 plays a pro-inflammatory role in models of inflammation, colitis and obesity.Sci Rep. 2017 Dec 19;7(1):17832. doi: 10.1038/s41598-017-17861-6.
• [502] Immunohistochemical Staining for Uroguanylin, a Satiety Hormone, is Decreased in Intestinal Tissue Specimens From Female Adolescents With Obesity.Pediatr Dev Pathol. 2018 May-Jun;21(3):285-295. doi: 10.1177/1093526617722912. Epub 2017 Aug 29.
• [503] Thromboembolic Occlusion of the Left Coronary Artery During Transcatheter Aortic Valve Implantation.J Invasive Cardiol. 2018 Feb;30(2):E21-E22.
• [504] Hydroxycarboxylic Acid Receptor Ligands Modulate Proinflammatory Cytokine Expression in Human Macrophages and Adipocytes without Affecting Adipose Differentiation.Biol Pharm Bull. 2018;41(10):1574-1580. doi: 10.1248/bpb.b18-00301.
• [505] Validation of the Italian version of the Laval questionnaire: health-related quality of life in subjects with obesity.Health Qual Life Outcomes. 2017 May 15;15(1):101. doi: 10.1186/s12955-017-0671-3.
• [506] Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.Haematologica. 2018 Jul;103(7):1099-1109. doi: 10.3324/haematol.2016.151407. Epub 2018 Apr 19.
• [507] Heme Biosynthetic Pathway is Functionally Linked to Adipogenesis via Mitochondrial Respiratory Activity.Obesity (Silver Spring). 2017 Oct;25(10):1723-1733. doi: 10.1002/oby.21956. Epub 2017 Aug 31.
• [508] HO-1 overexpression and underexpression: Clinical implications.Arch Biochem Biophys. 2019 Sep 30;673:108073. doi: 10.1016/j.abb.2019.108073. Epub 2019 Aug 16.
• [509] Subcutaneous fat shows higher thyroid hormone receptor-alpha1 gene expression than omental fat.Obesity (Silver Spring). 2009 Dec;17(12):2134-41. doi: 10.1038/oby.2009.110. Epub 2009 Apr 9.
• [510] Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).Bioorg Med Chem Lett. 2013 Jun 1;23(11):3416-20. doi: 10.1016/j.bmcl.2013.03.080. Epub 2013 Mar 29.
• [511] Variants of 11-hydroxysteroid dehydrogenase (HSD11B) gene type 1 and 2 in Chinese obese adolescents.J Endocrinol Invest. 2014 Jun;37(6):565-73. doi: 10.1007/s40618-014-0075-8. Epub 2014 Apr 11.
• [512] Genetic polymorphisms and obesity influence estradiol decline during the menopause.Clin Endocrinol (Oxf). 2011 May;74(5):618-23. doi: 10.1111/j.1365-2265.2010.03968.x.
• [513] Modulation of Heat Shock Factor 1 Activity through Silencing of Ser303/Ser307 Phosphorylation Supports a Metabolic Program Leading to Age-Related Obesity and Insulin Resistance.Mol Cell Biol. 2018 Aug 28;38(18):e00095-18. doi: 10.1128/MCB.00095-18. Print 2018 Sep 15.
• [514] The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario.J Clin Med. 2019 Oct 26;8(11):1793. doi: 10.3390/jcm8111793.
• [515] Physical Exercise Enhanced Heat Shock Protein 60 Expression and Attenuated Inflammation in the Adipose Tissue of Human Diabetic Obese.Front Endocrinol (Lausanne). 2018 Feb 6;9:16. doi: 10.3389/fendo.2018.00016. eCollection 2018.
• [516] Finite mixture regression model analysis on antipsychotics induced weight gain: investigation of the role of the serotonergic genes.Eur Neuropsychopharmacol. 2013 Mar;23(3):224-8. doi: 10.1016/j.euroneuro.2012.05.008. Epub 2012 Jul 26.
• [517] Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction.PLoS One. 2018 Aug 29;13(8):e0203137. doi: 10.1371/journal.pone.0203137. eCollection 2018.
• [518] Altered intestinal neuroendocrine gene expression in humans with obesity.Obesity (Silver Spring). 2015 Nov;23(11):2278-85. doi: 10.1002/oby.21253. Epub 2015 Sep 18.
• [519] AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.J Alzheimers Dis. 2017;58(4):1043-1063. doi: 10.3233/JAD-161262.
• [520] Omega-3 Polyunsaturated Fatty Acids Inhibit IL-17A Secretion through Decreased ICAM-1 Expression in TCells Co-Cultured with Adipose-Derived Stem Cells Harvested from Adipose Tissues of Obese Subjects.Mol Nutr Food Res. 2019 Jun;63(11):e1801148. doi: 10.1002/mnfr.201801148. Epub 2019 Mar 20.
• [521] Id1 Promotes Obesity by Suppressing Brown Adipose Thermogenesis and White Adipose Browning.Diabetes. 2017 Jun;66(6):1611-1625. doi: 10.2337/db16-1079. Epub 2017 Mar 7.
• [522] Interleukin-6 increases the expression and activity of insulin-degrading enzyme.Sci Rep. 2017 Apr 21;7:46750. doi: 10.1038/srep46750.
• [523] Associations Among Obesity, Inflammation, and Tryptophan Catabolism in Pregnancy.Biol Res Nurs. 2018 May;20(3):284-291. doi: 10.1177/1099800417738363. Epub 2017 Nov 15.
• [524] Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of disease.Am J Transplant. 2013 Sep;13(9):2450-7. doi: 10.1111/ajt.12355. Epub 2013 Jul 16.
• [525] A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma.Cancer Epidemiol. 2009 Jul;33(1):37-40. doi: 10.1016/j.canep.2009.04.014. Epub 2009 May 28.
• [526] Contribution of Liver Fat to Weight Loss-Induced Changes in Serum Hepatokines: A Randomized Controlled Trial.J Clin Endocrinol Metab. 2019 Jul 1;104(7):2719-2727. doi: 10.1210/jc.2018-02378.
• [527] Serum interleukin 15 in anorexia nervosa: Comparison to normal weight and obese girls.World J Biol Psychiatry. 2020 Mar;21(3):203-211. doi: 10.1080/15622975.2019.1583370. Epub 2019 Mar 25.
• [528] Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons.Psychol Health Med. 2017 Mar;22(3):289-302. doi: 10.1080/13548506.2016.1199887. Epub 2016 Jun 20.
• [529] Elevated O-GlcNAcylation enhances pro-inflammatory Th17 function by altering the intracellular lipid microenvironment.J Biol Chem. 2019 May 31;294(22):8973-8990. doi: 10.1074/jbc.RA119.008373. Epub 2019 Apr 22.
• [530] Perivascular adipose tissue dysfunction aggravates adventitial remodeling in obese mini pigs via NLRP3 inflammasome/IL-1 signaling pathway.Acta Pharmacol Sin. 2019 Jan;40(1):46-54. doi: 10.1038/s41401-018-0068-9. Epub 2018 Jul 12.
• [531] Plasma levels of soluble interleukin 1 receptor accessory protein are reduced in obesity.J Clin Endocrinol Metab. 2014 Sep;99(9):3435-43. doi: 10.1210/jc.2013-4475. Epub 2014 Jun 10.
• [532] Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis.Sci Rep. 2019 Jul 18;9(1):10420. doi: 10.1038/s41598-019-46927-w.
• [533] Interleukin-22 Induces the Infiltration of Visceral Fat Tissue by a Discrete Subset of Duffy Antigen Receptor for Chemokine-Positive M2-Like Macrophages in Response to a High Fat Diet.Cells. 2019 Dec 6;8(12):1587. doi: 10.3390/cells8121587.
• [534] IL-25 stimulates M2 macrophage polarization and thereby promotes mitochondrial respiratory capacity and lipolysis in adipose tissues against obesity.Cell Mol Immunol. 2018 May;15(5):493-505. doi: 10.1038/cmi.2016.71. Epub 2017 Feb 13.
• [535] Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF- and IL-6.Cytokine. 2020 Jan;125:154832. doi: 10.1016/j.cyto.2019.154832. Epub 2019 Aug 31.
• [536] Maternal and fetal Leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsia.J Matern Fetal Neonatal Med. 2020 Dec;33(23):3942-3948. doi: 10.1080/14767058.2019.1593359. Epub 2019 Mar 27.
• [537] Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases.Front Immunol. 2019 Aug 27;10:2014. doi: 10.3389/fimmu.2019.02014. eCollection 2019.
• [538] Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome.PLoS One. 2012;7(1):e30414. doi: 10.1371/journal.pone.0030414. Epub 2012 Jan 17.
• [539] Interferon regulatory factor 3 constrains IKK/NF-B signaling to alleviate hepatic steatosis and insulin resistance.Hepatology. 2014 Mar;59(3):870-85. doi: 10.1002/hep.26751. Epub 2014 Jan 30.
• [540] Deletion of myeloid IRS2 enhances adipose tissue sympathetic nerve function and limits obesity.Mol Metab. 2019 Feb;20:38-50. doi: 10.1016/j.molmet.2018.11.010. Epub 2018 Nov 28.
• [541] ITCH deficiency protects from diet-induced obesity.Diabetes. 2014 Feb;63(2):550-61. doi: 10.2337/db13-0802. Epub 2013 Oct 29.
• [542] Joint association of genome-wide association study-identified susceptibility loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites.Am J Epidemiol. 2014 Sep 1;180(5):499-507. doi: 10.1093/aje/kwu158. Epub 2014 Jul 22.
• [543] Common body mass index-associated variants confer risk of extreme obesity.Hum Mol Genet. 2009 Sep 15;18(18):3502-7. doi: 10.1093/hmg/ddp292. Epub 2009 Jun 24.
• [544] Phenethyl isothiocyanate activates leptin signaling and decreases food intake.PLoS One. 2018 Nov 1;13(11):e0206748. doi: 10.1371/journal.pone.0206748. eCollection 2018.
• [545] Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity.J Biol Chem. 2019 Nov 29;294(48):18337-18348. doi: 10.1074/jbc.RA119.007758. Epub 2019 Oct 25.
• [546] Common variants of ARID1A and KAT2B are associated with obesity in Indian adolescents.Sci Rep. 2018 Mar 2;8(1):3964. doi: 10.1038/s41598-018-22231-x.
• [547] Influence of age on the association of GIRK4 with metabolic syndrome.Ann Clin Biochem. 2012 Jul;49(Pt 4):369-76. doi: 10.1258/acb.2011.011129. Epub 2012 May 29.
• [548] Genome-wide association studies suggest sex-specific loci associated with abdominal and visceral fat.Int J Obes (Lond). 2016 Apr;40(4):662-74. doi: 10.1038/ijo.2015.217. Epub 2015 Oct 20.
• [549] An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss.Genome Biol. 2015 Jan 22;16(1):8. doi: 10.1186/s13059-014-0569-x.
• [550] Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.Atherosclerosis. 2017 Feb;257:152-163. doi: 10.1016/j.atherosclerosis.2016.12.007. Epub 2016 Dec 9.
• [551] Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid -oxidation.J Clin Invest. 2018 Jul 2;128(7):3144-3159. doi: 10.1172/JCI97736. Epub 2018 Jun 18.
• [552] p62/SQSTM1 and Selective Autophagy in Cardiometabolic Diseases.Antioxid Redox Signal. 2019 Aug 20;31(6):458-471. doi: 10.1089/ars.2018.7649. Epub 2019 Feb 11.
• [553] Maternal obesity alters uterine NK activity through a functional KIR2DL1/S1 imbalance.Immunol Cell Biol. 2018 Sep;96(8):805-819. doi: 10.1111/imcb.12041. Epub 2018 Apr 16.
• [554] Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.Mol Immunol. 2008 Aug;45(14):3857-62. doi: 10.1016/j.molimm.2008.06.004. Epub 2008 Jul 15.
• [555] SIRT1 mediates obesity- and nutrient-dependent perturbation of pubertal timing by epigenetically controlling Kiss1 expression.Nat Commun. 2018 Oct 10;9(1):4194. doi: 10.1038/s41467-018-06459-9.
• [556] Cre/lox generation of a novel whole-body Kiss1r KO mouse line recapitulates a hypogonadal, obese, and metabolically-impaired phenotype.Mol Cell Endocrinol. 2019 Dec 1;498:110559. doi: 10.1016/j.mce.2019.110559. Epub 2019 Aug 20.
• [557] KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese.Aging (Albany NY). 2019 Sep 23;11(18):7847-7858. doi: 10.18632/aging.102293. Epub 2019 Sep 23.
• [558] Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of highfat diet-induced obesity by counteracting adipose tissue inflammation in vivo.Cell Mol Life Sci. 2018 Feb;75(4):727-742. doi: 10.1007/s00018-017-2658-y. Epub 2017 Sep 20.
• [559] Exposure to omentum adipose tissue conditioned medium from obese pregnant women promotes myometrial artery dysfunction.J Obstet Gynaecol Res. 2018 Jan;44(1):124-133. doi: 10.1111/jog.13482. Epub 2017 Oct 13.
• [560] Impact of Laparoscopic Sleeve Gastrectomy on Gut Permeability in Morbidly Obese Subjects.Obes Surg. 2019 Jul;29(7):2132-2143. doi: 10.1007/s11695-019-03815-6.
• [561] Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT.Atherosclerosis. 2015 Sep;242(1):236-42. doi: 10.1016/j.atherosclerosis.2015.07.019. Epub 2015 Jul 10.
• [562] The lactase -13910C>T polymorphism (rs4988235) is associated with overweight/obesity and obesity-related variables in a population sample of Portuguese young adults.Eur J Clin Nutr. 2017 Jan;71(1):21-24. doi: 10.1038/ejcn.2016.164. Epub 2016 Aug 31.
• [563] GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr(-/-) mice.Int J Obes (Lond). 2018 Jun;42(5):1062-1072. doi: 10.1038/s41366-018-0011-7. Epub 2018 Jan 30.
• [564] Association of a gain-of-function variant in LGR4 with central obesity.Obesity (Silver Spring). 2017 Jan;25(1):252-260. doi: 10.1002/oby.21704. Epub 2016 Dec 7.
• [565] Ishige okamurae Extract Suppresses Obesity and Hepatic Steatosis in High Fat Diet-Induced Obese Mice.Nutrients. 2018 Nov 20;10(11):1802. doi: 10.3390/nu10111802.
• [566] Hypooxytocinaemia in obese Zucker rats relates to oxytocin degradation in liver and adipose tissue.J Endocrinol. 2014 Feb 10;220(3):333-43. doi: 10.1530/JOE-13-0417. Print 2014 Mar.
• [567] Placental Pim-1 expression is increased in obesity and regulates cytokine- and toll-like receptor-mediated inflammation.Placenta. 2017 May;53:101-112. doi: 10.1016/j.placenta.2017.04.010. Epub 2017 Apr 13.
• [568] Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort.Clin Res Cardiol. 2020 Mar;109(3):315-323. doi: 10.1007/s00392-019-01511-0. Epub 2019 Jul 19.
• [569] The G12/13-coupled receptor LPA4 limits proper adipose tissue expansion and remodeling in diet-induced obesity.JCI Insight. 2018 Dec 20;3(24):e97293. doi: 10.1172/jci.insight.97293.
• [570] Lysophosphatidic acid receptor mRNA levels in heart and white adipose tissue are associated with obesity in mice and humans.PLoS One. 2017 Dec 13;12(12):e0189402. doi: 10.1371/journal.pone.0189402. eCollection 2017.
• [571] Genetic identification of Ly75 as a novel quantitative trait gene for resistance to obesity in mice.Sci Rep. 2018 Dec 5;8(1):17658. doi: 10.1038/s41598-018-36073-0.
• [572] Blockade of myeloid differentiation protein 2 prevents obesity-induced inflammation and nephropathy.J Cell Mol Med. 2017 Dec;21(12):3776-3786. doi: 10.1111/jcmm.13287. Epub 2017 Aug 2.
• [573] Are dopaminergic genotypes risk factors for eating behavior and obesity in adults?.Neurosci Lett. 2017 Jul 27;654:28-32. doi: 10.1016/j.neulet.2017.06.023. Epub 2017 Jun 16.
• [574] Obesity is associated with genetic variants that alter dopamine availability.Ann Hum Genet. 2006 May;70(Pt 3):293-303. doi: 10.1111/j.1529-8817.2005.00228.x.
• [575] Association of common variants identified by recent genome-wide association studies with obesity in Chinese children: a case-control study.BMC Med Genet. 2016 Jan 22;17:7. doi: 10.1186/s12881-016-0268-4.
• [576] A macrophage NBR1-MEKK3 complex triggers JNK-mediated adipose tissue inflammation in obesity.Cell Metab. 2014 Sep 2;20(3):499-511. doi: 10.1016/j.cmet.2014.06.008. Epub 2014 Jul 17.
• [577] Exercise ameliorates insulin resistance via regulating TGF-activated kinase 1 (TAK1)-mediated insulin signaling in liver of high-fat diet-induced obese rats.J Cell Physiol. 2019 May;234(5):7467-7474. doi: 10.1002/jcp.27508. Epub 2018 Oct 26.
• [578] MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.PLoS One. 2014 Feb 24;9(2):e89615. doi: 10.1371/journal.pone.0089615. eCollection 2014.
• [579] Map4k4 impairs energy metabolism in endothelial cells and promotes insulin resistance in obesity.Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E303-E313. doi: 10.1152/ajpendo.00037.2017. Epub 2017 Jun 13.
• [580] JNK at the crossroad of obesity, insulin resistance, and cell stress response.Mol Metab. 2016 Dec 8;6(2):174-184. doi: 10.1016/j.molmet.2016.12.001. eCollection 2017 Feb.
• [581] JNK2 in myeloid cells impairs insulin's vasodilator effects in muscle during early obesity development through perivascular adipose tissue dysfunction.Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H364-H374. doi: 10.1152/ajpheart.00663.2018. Epub 2019 May 31.
• [582] Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice.J Cell Biochem. 2017 Aug;118(8):2395-2408. doi: 10.1002/jcb.25902. Epub 2017 Apr 25.
• [583] Identification of Novel Potentially Pleiotropic Variants Associated With Osteoporosis and Obesity Using the cFDR Method.J Clin Endocrinol Metab. 2018 Jan 1;103(1):125-138. doi: 10.1210/jc.2017-01531.
• [584] Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.Kidney Int. 2013 Nov;84(5):931-9. doi: 10.1038/ki.2013.193. Epub 2013 Jul 3.
• [585] Ghrelin Reduces TNF--Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD.J Clin Endocrinol Metab. 2019 Jan 1;104(1):21-37. doi: 10.1210/jc.2018-01171.
• [586] Association between urinary phthalates and metabolic abnormalities in obese Thai children and adolescents.J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):931-938. doi: 10.1515/jpem-2017-0172.
• [587] A novel MC4R deletion coexisting with FTO and MC1R gene variants, causes severe early onset obesity.Hormones (Athens). 2016 Jul;15(3):445-452. doi: 10.14310/horm.2002.1686.
• [588] Whole genome microarray analysis of gene expression in Prader-Willi syndrome.Am J Med Genet A. 2007 Mar 1;143A(5):430-42. doi: 10.1002/ajmg.a.31606.
• [589] Exacerbation of autoimmune uveitis by obesity occurs through the melanocortin 5 receptor.J Leukoc Biol. 2019 Oct;106(4):879-887. doi: 10.1002/JLB.MA0119-030RR. Epub 2019 Jul 9.
• [590] SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [(18)F]FE@SNAP and [(11)C]SNAP-7941.Mol Imaging Biol. 2019 Apr;21(2):257-268. doi: 10.1007/s11307-018-1212-0.
• [591] Controlling Obesity and Metabolic Diseases by Hydrodynamic Delivery of a Fusion Gene of Exendin-4 and 1 Antitrypsin.Sci Rep. 2019 Sep 17;9(1):13427. doi: 10.1038/s41598-019-49757-y.
• [592] Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors.J Pharmacol Exp Ther. 2019 Nov;371(2):299-308. doi: 10.1124/jpet.119.259028. Epub 2019 Sep 19.
• [593] High-Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry (HPLC-ESI-MS(n)) Analysis and Bioactivity Useful for Prevention of "Diabesity" of Allium commutatum Guss.Plant Foods Hum Nutr. 2020 Mar;75(1):124-130. doi: 10.1007/s11130-019-00782-2.
• [594] Metabolic importance of adipose tissue monoacylglycerol acyltransferase 1 in mice and humans.J Lipid Res. 2018 Sep;59(9):1630-1639. doi: 10.1194/jlr.M084947. Epub 2018 May 31.
• [595] Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB(1) cannabinoid receptor-deficient mice.FASEB J. 2019 Feb;33(2):2484-2497. doi: 10.1096/fj.201801203R. Epub 2018 Sep 28.
• [596] Loss of the E3 ubiquitin ligase MKRN1 represses diet-induced metabolic syndrome through AMPK activation.Nat Commun. 2018 Aug 24;9(1):3404. doi: 10.1038/s41467-018-05721-4.
• [597] Expression of genes regulating malonyl-CoA in human skeletal muscle.J Cell Biochem. 2006 Oct 15;99(3):860-7. doi: 10.1002/jcb.20944.
• [598] Derangements in adrenergic-adipokine signalling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction.Eur J Heart Fail. 2018 May;20(5):873-878. doi: 10.1002/ejhf.1167. Epub 2018 Mar 1.
• [599] Obesity-associated dysregulation of calpastatin and MMP-15 in adipose-derived stromal cells results in their enhanced invasion.Stem Cells. 2012 Dec;30(12):2774-83. doi: 10.1002/stem.1229.
• [600] Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling.Sci Rep. 2019 Dec 10;9(1):18765. doi: 10.1038/s41598-019-55263-y.
• [601] The Ron Receptor Tyrosine Kinase Regulates Macrophage Heterogeneity and Plays a Protective Role in Diet-Induced Obesity, Atherosclerosis, and Hepatosteatosis.J Immunol. 2016 Jul 1;197(1):256-65. doi: 10.4049/jimmunol.1600450. Epub 2016 May 27.
• [602] Syzygium cumini Leaf Extract Reverts Hypertriglyceridemia via Downregulation of the Hepatic XBP-1s/PDI/MTP Axis in Monosodium L-Glutamate-Induced Obese Rats.Oxid Med Cell Longev. 2019 Mar 21;2019:9417498. doi: 10.1155/2019/9417498. eCollection 2019.
• [603] The combined effects of FADS gene variation and dietary fats in obesity-related traits in a population from the far north of Sweden: the GLACIER Study.Int J Obes (Lond). 2019 Apr;43(4):808-820. doi: 10.1038/s41366-018-0112-3. Epub 2018 May 24.
• [604] TLR4, TRIF, and MyD88 are essential for myelopoiesis and CD11c(+) adipose tissue macrophage production in obese mice.J Biol Chem. 2018 Jun 8;293(23):8775-8786. doi: 10.1074/jbc.RA117.001526. Epub 2018 Apr 10.
• [605] Maternal diet-induced obesity programmes cardiac dysfunction in male mice independently of post-weaning diet.Cardiovasc Res. 2018 Aug 1;114(10):1372-1384. doi: 10.1093/cvr/cvy082.
• [606] Hookah smoking is strongly associated with diabetes mellitus, metabolic syndrome and obesity: a population-based study.Diabetol Metab Syndr. 2018 Apr 19;10:33. doi: 10.1186/s13098-018-0335-4. eCollection 2018.
• [607] Plasma concentration and expression of adipokines in epicardial and subcutaneous adipose tissue are associated with impaired left ventricular filling pattern.J Transl Med. 2019 Sep 18;17(1):310. doi: 10.1186/s12967-019-2060-7.
• [608] Oxidative Stress in Response to Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.J Clin Endocrinol Metab. 2019 Nov 1;104(11):5360-5371. doi: 10.1210/jc.2019-00987.
• [609] Deletion of Nck1 attenuates hepatic ER stress signaling and improves glucose tolerance and insulin signaling in liver of obese mice.Am J Physiol Endocrinol Metab. 2011 Mar;300(3):E423-34. doi: 10.1152/ajpendo.00088.2010. Epub 2010 Jun 29.
• [610] Overweight condition and waist circumference and a candidate gene within the 12q24 locus.Cardiovasc Diabetol. 2013 Jan 3;12:2. doi: 10.1186/1475-2840-12-2.
• [611] Development of insulin resistance in Nischarin mutant female mice.Int J Obes (Lond). 2019 May;43(5):1046-1057. doi: 10.1038/s41366-018-0241-8. Epub 2018 Dec 13.
• [612] Compound C attenuates NLRP3 inflammasome despite AMPK knockdown in LPS plus palmitate-induced THP-1 cells.Naunyn Schmiedebergs Arch Pharmacol. 2020 Jan;393(1):67-76. doi: 10.1007/s00210-019-01712-4. Epub 2019 Aug 16.
• [613] Transnasal Delivery of the Peptide Agonist Specific to Neuromedin-U Receptor 2 to the Brain for the Treatment of Obesity.Mol Pharm. 2020 Jan 6;17(1):32-39. doi: 10.1021/acs.molpharmaceut.9b00571. Epub 2019 Dec 9.
• [614] Saturated Fatty Acid Activates T Cell Inflammation Through a Nicotinamide Nucleotide Transhydrogenase (NNT)-Dependent Mechanism.Biomolecules. 2019 Feb 25;9(2):79. doi: 10.3390/biom9020079.
• [615] iNOS as a metabolic enzyme under stress conditions.Free Radic Biol Med. 2020 Jan;146:16-35. doi: 10.1016/j.freeradbiomed.2019.10.411. Epub 2019 Oct 28.
• [616] Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity.Redox Biol. 2020 Jan;28:101330. doi: 10.1016/j.redox.2019.101330. Epub 2019 Sep 20.
• [617] Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.Annu Rev Physiol. 2011;73:239-59. doi: 10.1146/annurev-physiol-012110-142233.
• [618] Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.Int J Clin Oncol. 2020 Mar;25(3):472-478. doi: 10.1007/s10147-019-01527-6. Epub 2019 Aug 22.
• [619] Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects.Obesity (Silver Spring). 2011 Nov;19(11):2241-7. doi: 10.1038/oby.2011.239. Epub 2011 Aug 4.
• [620] Differential protein profiling as a potential multi-marker approach for obese patients with heart failure: A retrospective study.Sci Rep. 2018 May 21;8(1):7894. doi: 10.1038/s41598-018-26118-9.
• [621] C-type natriuretic peptide plasma levels and whole blood mRNA expression show different trends in adolescents with different degree of endothelial dysfunction.Peptides. 2020 Feb;124:170218. doi: 10.1016/j.peptides.2019.170218. Epub 2019 Nov 30.
• [622] Transcriptional control of human adipose tissue blood flow.Obesity (Silver Spring). 2009 Apr;17(4):681-8. doi: 10.1038/oby.2008.606. Epub 2009 Jan 22.
• [623] A dysregulation in CES1, APOE and other lipid metabolism-related genes is associated to cardiovascular risk factors linked to obesity.Obes Facts. 2010 Oct;3(5):312-8. doi: 10.1159/000321451. Epub 2010 Oct 15.
• [624] CNV analysis and mutation screening indicate an important role for the NPY4R gene in human obesity.Obesity (Silver Spring). 2016 Apr;24(4):970-6. doi: 10.1002/oby.21435. Epub 2016 Feb 27.
• [625] The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction.J Clin Endocrinol Metab. 2007 Jun;92(6):2346-52. doi: 10.1210/jc.2006-2476. Epub 2007 Apr 3.
• [626] Intake of an Obesogenic Cafeteria Diet Affects Body Weight, Feeding Behavior, and Glucose and Lipid Metabolism in a Photoperiod-Dependent Manner in F344 Rats.Front Physiol. 2018 Nov 26;9:1639. doi: 10.3389/fphys.2018.01639. eCollection 2018.
• [627] Aberrant DNA methylation of pregnane X receptor underlies metabolic gene alterations in the diabetic kidney.Am J Physiol Renal Physiol. 2018 Apr 1;314(4):F551-F560. doi: 10.1152/ajprenal.00390.2017. Epub 2017 Dec 6.
• [628] Carbohydrate restriction in the morning increases weight loss effect of a hypocaloric Mediterranean type diet: a randomized, parallel group dietary intervention in overweight and obese subjects.Nutrition. 2020 Mar;71:110578. doi: 10.1016/j.nut.2019.110578. Epub 2019 Sep 5.
• [629] Dual targeting of Nur77 and AMPK by isoalantolactone inhibits adipogenesis in vitro and decreases body fat mass in vivo.Int J Obes (Lond). 2019 May;43(5):952-962. doi: 10.1038/s41366-018-0276-x. Epub 2018 Dec 11.
• [630] NURR1 activation in skeletal muscle controls systemic energy homeostasis.Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11299-11308. doi: 10.1073/pnas.1902490116. Epub 2019 May 20.
• [631] A systematic review of the association of neuregulin 4, a brown fat-enriched secreted factor, with obesity and related metabolic disturbances.Obes Rev. 2020 Feb;21(2):e12952. doi: 10.1111/obr.12952. Epub 2019 Nov 28.
• [632] Neurotensin Receptor-1 Identifies a Subset of Ventral Tegmental Dopamine Neurons that Coordinates Energy Balance.Cell Rep. 2017 Aug 22;20(8):1881-1892. doi: 10.1016/j.celrep.2017.08.001.
• [633] OGG1 Ser326Cys polymorphism, HIV, obesity and air pollution exposure influences adverse birth outcome susceptibility, within South African Women.Reprod Toxicol. 2018 Aug;79:8-15. doi: 10.1016/j.reprotox.2018.04.012. Epub 2018 Apr 27.
• [634] Association study of common polymorphisms in MSRA, TFAP2B, MC4R, NRXN3, PPARGC1A, TMEM18, SEC16B, HOXB5 and OLFM4 genes with obesity-related traits among Portuguese children.J Hum Genet. 2014 Jun;59(6):307-13. doi: 10.1038/jhg.2014.23. Epub 2014 Mar 27.
• [635] Sex-specific effects of weight-affecting gene variants in a life course perspective--The HUNT Study, Norway.Int J Obes (Lond). 2013 Sep;37(9):1221-9. doi: 10.1038/ijo.2012.220. Epub 2013 Jan 15.
• [636] -opioid receptor system mediates reward processing in humans.Nat Commun. 2018 Apr 16;9(1):1500. doi: 10.1038/s41467-018-03848-y.
• [637] A Role for Oncostatin M in the Impairment of Glucose Homeostasis in Obesity.J Clin Endocrinol Metab. 2020 Mar 1;105(3):e337-48. doi: 10.1210/clinem/dgz090.
• [638] Oxytocin in metabolic homeostasis: implications for obesity and diabetes management.Obes Rev. 2019 Jan;20(1):22-40. doi: 10.1111/obr.12757. Epub 2018 Sep 25.
• [639] Predictors of Groin Access Pseudoaneurysm Complication: A 10-Year Institutional Experience.Vasc Endovascular Surg. 2020 Jan;54(1):42-46. doi: 10.1177/1538574419879568. Epub 2019 Oct 2.
• [640] Myeloid P2Y2 receptor promotes acute inflammation but is dispensable for chronic high-fat diet-induced metabolic dysfunction.Purinergic Signal. 2018 Mar;14(1):19-26. doi: 10.1007/s11302-017-9589-9. Epub 2017 Oct 30.
• [641] Epidemiological investigation into the prevalence of abnormal inter-arm blood pressure differences among different ethnicities in Xinjiang, China.PLoS One. 2018 Jan 18;13(1):e0188546. doi: 10.1371/journal.pone.0188546. eCollection 2018.
• [642] A Positive Allosteric Modulator of the Serotonin 5-HT(2C) Receptor for Obesity.J Med Chem. 2017 Dec 14;60(23):9575-9584. doi: 10.1021/acs.jmedchem.7b00994. Epub 2017 Nov 17.
• [643] The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms.Nutr J. 2013 Jun 25;12:89. doi: 10.1186/1475-2891-12-89.
• [644] PARP-2 regulates SIRT1 expression and whole-body energy expenditure.Cell Metab. 2011 Apr 6;13(4):450-460. doi: 10.1016/j.cmet.2011.03.013.
• [645] PAS kinase drives lipogenesis through SREBP-1 maturation.Cell Rep. 2014 Jul 10;8(1):242-55. doi: 10.1016/j.celrep.2014.06.006. Epub 2014 Jul 4.
• [646] Genome-wide scan for loci of adolescent obesity and their relationship with blood pressure.J Clin Endocrinol Metab. 2012 Jan;97(1):E145-50. doi: 10.1210/jc.2011-1801. Epub 2011 Oct 19.
• [647] Lipidomics reveals a link between CYP1B1 and SCD1 in promoting obesity.J Proteome Res. 2014 May 2;13(5):2679-87. doi: 10.1021/pr500145n. Epub 2014 Apr 10.
• [648] A stop-codon of the phosphodiesterase 11A gene is associated with elevated blood pressure and measures of obesity.J Hypertens. 2016 Mar;34(3):445-51; discussion 451. doi: 10.1097/HJH.0000000000000821.
• [649] Molecular characterization of an interstitial deletion of 1p31.3 in a patient with obesity and psychiatric illness and a review of the literature.Am J Med Genet A. 2011 Apr;155A(4):825-32. doi: 10.1002/ajmg.a.33869. Epub 2011 Mar 17.
• [650] Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors.J Med Chem. 2017 Feb 9;60(3):1142-1150. doi: 10.1021/acs.jmedchem.6b01540. Epub 2017 Jan 31.
• [651] Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects.Mol Genet Metab. 1998 Oct;65(2):181-6. doi: 10.1006/mgme.1998.2748.
• [652] GPR120 protects lipotoxicity-induced pancreatic -cell dysfunction through regulation of PDX1 expression and inhibition of islet inflammation.Clin Sci (Lond). 2019 Jan 11;133(1):101-116. doi: 10.1042/CS20180836. Print 2019 Jan 15.
• [653] Metabolomics uncovers the role of adipose tissue PDXK in adipogenesis and systemic insulin sensitivity.Diabetologia. 2016 Apr;59(4):822-32. doi: 10.1007/s00125-016-3863-1. Epub 2016 Feb 2.
• [654] Gene-by-environment interactions of the CLOCK, PEMT, and GHRELINloci with average sleep duration in relation to obesity traitsusing a cohort of 643 New Zealand European children.Sleep Med. 2017 Sep;37:19-26. doi: 10.1016/j.sleep.2017.05.017. Epub 2017 Jun 24.
• [655] Small molecule PGC-11 protein stabilizers induce adipocyte Ucp1 expression and uncoupled mitochondrial respiration.Mol Metab. 2018 Mar;9:28-42. doi: 10.1016/j.molmet.2018.01.017. Epub 2018 Feb 3.
• [656] Progesterone receptor status modifies the association between body mass index and prognosis in women diagnosed with estrogen receptor positive breast cancer.Int J Cancer. 2020 May 15;146(10):2736-2745. doi: 10.1002/ijc.32621. Epub 2019 Aug 23.
• [657] Prohibitin: a prime candidate for a pleiotropic effector that mediates sex differences in obesity, insulin resistance, and metabolic dysregulation.Biol Sex Differ. 2019 May 22;10(1):25. doi: 10.1186/s13293-019-0239-5.
• [658] Enhanced -adrenergic signalling underlies an age-dependent beneficial metabolic effect of PI3K p110 inactivation in adipose tissue.Nat Commun. 2019 Apr 4;10(1):1546. doi: 10.1038/s41467-019-09514-1.
• [659] Prolyl Isomerase Pin1 Suppresses Thermogenic Programs in Adipocytes by Promoting Degradation of Transcriptional Co-activator PRDM16.Cell Rep. 2019 Mar 19;26(12):3221-3230.e3. doi: 10.1016/j.celrep.2019.02.066.
• [660] Leptin regulation of the p53-HIF1/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link.Int J Obes (Lond). 2018 Apr;42(4):711-720. doi: 10.1038/ijo.2017.273. Epub 2017 Nov 6.
• [661] A collective diabetes cross in combination with a computational framework to dissect the genetics of human obesity and Type 2 diabetes.Hum Mol Genet. 2018 Sep 1;27(17):3099-3112. doi: 10.1093/hmg/ddy217.
• [662] Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids.Diabetologia. 2018 May;61(5):1155-1166. doi: 10.1007/s00125-018-4558-6. Epub 2018 Feb 9.
• [663] Genome-Wide Association Studies of the Human Gut Microbiota.PLoS One. 2015 Nov 3;10(11):e0140301. doi: 10.1371/journal.pone.0140301. eCollection 2015.
• [664] A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes.Am J Pathol. 2019 Jul;189(7):1413-1422. doi: 10.1016/j.ajpath.2019.04.004. Epub 2019 May 2.
• [665] Obesity-associated inflammation triggers an autophagy-lysosomal response in adipocytes and causes degradation of perilipin 1.Cell Death Dis. 2019 Feb 11;10(2):121. doi: 10.1038/s41419-019-1393-8.
• [666] Laparoscopic hysterectomy in the overweight and obese: does 3D imaging make a change?.Arch Gynecol Obstet. 2017 Jan;295(1):125-131. doi: 10.1007/s00404-016-4215-6. Epub 2016 Oct 13.
• [667] Phospholipid transfer protein (PLTP) deficiency attenuates high fat diet induced obesity and insulin resistance.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1305-1313. doi: 10.1016/j.bbalip.2019.06.012. Epub 2019 Jun 17.
• [668] Phillyrin lowers body weight in obese mice via the modulation of PPAR<beta>/<delta>-ANGPTL 4 pathway.Obes Res Clin Pract. 2018 Jan-Feb;12(Suppl 2):71-79. doi: 10.1016/j.orcp.2017.02.002. Epub 2017 Mar 17.
• [669] Elevated Serum Cyclophilin B Levels Are Associated with the Prevalence and Severity of Metabolic Syndrome.Front Endocrinol (Lausanne). 2017 Dec 22;8:360. doi: 10.3389/fendo.2017.00360. eCollection 2017.
• [670] Mitochondrial Hyperacetylation in the Failing Hearts of Obese Patients Mediated Partly by a Reduction in SIRT3: The Involvement of the Mitochondrial Permeability Transition Pore.Cell Physiol Biochem. 2019;53(3):465-479. doi: 10.33594/000000151.
• [671] Design and synthesis of prolylcarboxypeptidase (PrCP) inhibitors to validate PrCP as a potential target for obesity.J Med Chem. 2010 Oct 14;53(19):7251-63. doi: 10.1021/jm101013m.
• [672] Peroxiredoxin 5 regulates adipogenesis-attenuating oxidative stress in obese mouse models induced by a high-fat diet.Free Radic Biol Med. 2018 Aug 1;123:27-38. doi: 10.1016/j.freeradbiomed.2018.05.061. Epub 2018 May 16.
• [673] Hypolipidemic Effect of Arthrospira (Spirulina) maxima Supplementation and a Systematic Physical Exercise Program in Overweight and Obese Men: A Double-Blind, Randomized, and Crossover Controlled Trial.Mar Drugs. 2019 May 7;17(5):270. doi: 10.3390/md17050270.
• [674] The differential plasma proteome of obese and overweight individuals undergoing a nutritional weight loss and maintenance intervention.Proteomics Clin Appl. 2018 Jan;12(1). doi: 10.1002/prca.201600150. Epub 2017 May 15.
• [675] Differentially regulated protein kinase A (PKA) activity in adipose tissue and liver is associated with resistance to diet-induced obesity and glucose intolerance in mice that lack PKA regulatory subunit type II.Endocrinology. 2014 Sep;155(9):3397-408. doi: 10.1210/en.2014-1122. Epub 2014 Jun 10.
• [676] Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity.Nat Genet. 2013 May;45(5):513-7. doi: 10.1038/ng.2607. Epub 2013 Apr 7.
• [677] Impaired HDL function in obese adolescents: impact of lifestyle intervention and bariatric surgery.Obesity (Silver Spring). 2013 Dec;21(12):E687-95. doi: 10.1002/oby.20538. Epub 2013 Aug 13.
• [678] Protein kinase D1 deletion in adipocytes enhances energy dissipation and protects against adiposity.EMBO J. 2018 Nov 15;37(22):e99182. doi: 10.15252/embj.201899182. Epub 2018 Nov 2.
• [679] Obesity alters phosphoramide mustard-induced ovarian DNA repair in mice.Biol Reprod. 2017 Feb 1;96(2):491-501. doi: 10.1095/biolreprod.116.143800.
• [680] Human Protein Kinases and Obesity.Adv Exp Med Biol. 2017;960:111-134. doi: 10.1007/978-3-319-48382-5_5.
• [681] Suppression of Prolactin Secretion Partially Explains the Antidiabetic Effect of Bromocriptine in ob/ob Mice.Endocrinology. 2019 Jan 1;160(1):193-204. doi: 10.1210/en.2018-00629.
• [682] Association of acrylamide hemoglobin biomarkers with obesity, abdominal obesity and overweight in general US population: NHANES 2003-2006.Sci Total Environ. 2018 Aug 1;631-632:589-596. doi: 10.1016/j.scitotenv.2018.02.338. Epub 2018 Mar 16.
• [683] Prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism and parameters of the metabolic syndrome.Mol Nutr Food Res. 2007 Dec;51(12):1447-51. doi: 10.1002/mnfr.200700144.
• [684] The Dualistic Effect of COX-2-Mediated Signaling in Obesity and Insulin Resistance.Int J Mol Sci. 2019 Jun 26;20(13):3115. doi: 10.3390/ijms20133115.
• [685] Children and adolescents with obesity have reduced serum bone turnover markers and 25-hydroxyvitamin D but increased parathyroid hormone concentrations - Results derived from new pediatric reference ranges.Bone. 2020 Mar;132:115124. doi: 10.1016/j.bone.2019.115124. Epub 2019 Dec 9.
• [686] Insulin regulates POMC neuronal plasticity to control glucose metabolism.Elife. 2018 Sep 19;7:e38704. doi: 10.7554/eLife.38704.
• [687] PTPRJ Inhibits Leptin Signaling, and Induction of PTPRJ in the Hypothalamus Is a Cause of the Development of Leptin Resistance.Sci Rep. 2017 Sep 14;7(1):11627. doi: 10.1038/s41598-017-12070-7.
• [688] PTPRS and PER3 methylation levels are associated with childhood obesity: results from a genome-wide methylation analysis.Pediatr Obes. 2018 Mar;13(3):149-158. doi: 10.1111/ijpo.12224. Epub 2017 Jun 14.
• [689] Epac2a-null mice exhibit obesity-prone nature more susceptible to leptin resistance.Int J Obes (Lond). 2017 Feb;41(2):279-288. doi: 10.1038/ijo.2016.208. Epub 2016 Nov 21.
• [690] PAP/HIP protein is an obesogenic factor.J Cell Physiol. 2014 Feb;229(2):225-31. doi: 10.1002/jcp.24438.
• [691] Obesity accelerates epigenetic aging in middle-aged but not in elderly individuals.Clin Epigenetics. 2017 Feb 14;9:20. doi: 10.1186/s13148-016-0301-7. eCollection 2017.
• [692] 15q26.1 microdeletion encompassing only CHD2 and RGMA in two adults with moderate intellectual disability, epilepsy and truncal obesity.Eur J Med Genet. 2014 Sep;57(9):520-3. doi: 10.1016/j.ejmg.2014.06.003. Epub 2014 Jun 13.
• [693] An RGS2 3'UTR polymorphism is associated with preeclampsia in overweight women.BMC Genet. 2016 Aug 24;17(1):121. doi: 10.1186/s12863-016-0428-8.
• [694] Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity.Mol Psychiatry. 2020 Sep;25(9):2058-2069. doi: 10.1038/s41380-018-0120-7. Epub 2018 Jun 28.
• [695] On the replication of genetic associations: timing can be everything!.Am J Hum Genet. 2008 Apr;82(4):849-58. doi: 10.1016/j.ajhg.2008.01.018.
• [696] Emotional eating and in vivo norepinephrine transporter availability in obesity: A [(11) C]MRB PET pilot study.Int J Eat Disord. 2017 Feb;50(2):152-156. doi: 10.1002/eat.22621. Epub 2016 Sep 9.
• [697] Ferulic Acid Produced by Lactobacillus fermentum Influences Developmental Growth Through a dTOR-Mediated Mechanism.Mol Biotechnol. 2019 Jan;61(1):1-11. doi: 10.1007/s12033-018-0119-y.
• [698] Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma.Carcinogenesis. 2014 Apr;35(4):822-7. doi: 10.1093/carcin/bgt485. Epub 2013 Dec 28.
• [699] Proximal radial artery arteriovenous fistula for hemodialysis vascular access.J Vasc Surg. 2018 Jan;67(1):244-253. doi: 10.1016/j.jvs.2017.06.114. Epub 2017 Sep 11.
• [700] S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery.Obes Facts. 2017;10(4):386-395. doi: 10.1159/000478097. Epub 2017 Aug 23.
• [701] Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes.Coron Artery Dis. 2013 Dec;24(8):642-50. doi: 10.1097/MCA.0000000000000033.
• [702] Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-B pathway.Mol Med. 2019 May 6;25(1):17. doi: 10.1186/s10020-019-0075-4.
• [703] Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women.J Clin Endocrinol Metab. 2009 May;94(5):1533-40. doi: 10.1210/jc.2008-2648. Epub 2009 Feb 17.
• [704] Interleukin-6 derived from cutaneous deficiency of stearoyl-CoA desaturase- 1 may mediate metabolic organ crosstalk among skin, adipose tissue and liver.Biochem Biophys Res Commun. 2019 Jan 1;508(1):87-91. doi: 10.1016/j.bbrc.2018.11.083. Epub 2018 Nov 22.
• [705] Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population.J Hum Genet. 2011 Sep;56(9):647-51. doi: 10.1038/jhg.2011.74. Epub 2011 Jul 28.
• [706] Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3.Cell. 2001 Jul 13;106(1):105-16. doi: 10.1016/s0092-8674(01)00415-9.
• [707] Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients.Thromb Haemost. 2011 Oct;106(4):683-92. doi: 10.1160/TH11-01-0030. Epub 2011 Aug 25.
• [708] Co-Expression Networks Reveal Potential Regulatory Roles of miRNAs in Fatty Acid Composition of Nelore Cattle.Front Genet. 2019 Jul 11;10:651. doi: 10.3389/fgene.2019.00651. eCollection 2019.
• [709] Genome-wide analysis identifies an african-specific variant in SEMA4D associated with body mass index.Obesity (Silver Spring). 2017 Apr;25(4):794-800. doi: 10.1002/oby.21804. Epub 2017 Mar 13.
• [710] Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.BMC Cancer. 2017 Nov 10;17(1):751. doi: 10.1186/s12885-017-3722-6.
• [711] Effect of long-term sodium nitrate administration on diabetes-induced anemia and glucose homeostasis in obese type 2 diabetic male rats.Nitric Oxide. 2019 May 1;86:21-30. doi: 10.1016/j.niox.2019.02.003. Epub 2019 Feb 14.
• [712] Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 Diabetes.J Clin Endocrinol Metab. 2017 Nov 1;102(11):4109-4116. doi: 10.1210/jc.2017-00913.
• [713] Sexual Dimorphism in Obesity-Associated Endothelial ENaC Activity and Stiffening in Mice.Endocrinology. 2019 Dec 1;160(12):2918-2928. doi: 10.1210/en.2019-00483.
• [714] Endophilin A2: A Potential Link to Adiposity and Beyond.Mol Cells. 2017 Nov 30;40(11):855-863. doi: 10.14348/molcells.2017.0137. Epub 2017 Nov 6.
• [715] Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.J Clin Invest. 2010 Dec;120(12):4316-31. doi: 10.1172/JCI41624. Epub 2010 Nov 15.
• [716] Amerindian-specific regions under positive selection harbour new lipid variants in Latinos.Nat Commun. 2014 Jun 2;5:3983. doi: 10.1038/ncomms4983.
• [717] Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity.Int J Obes (Lond). 2020 Feb;44(2):307-319. doi: 10.1038/s41366-019-0436-7. Epub 2019 Aug 28.
• [718] Glutathione as a mediator of cartilage oxidative stress resistance and resilience during aging and osteoarthritis.Connect Tissue Res. 2020 Jan;61(1):34-47. doi: 10.1080/03008207.2019.1665035. Epub 2019 Sep 15.
• [719] SIRT5 deacylates metabolism-related proteins and attenuates hepatic steatosis in ob/ob mice.EBioMedicine. 2018 Oct;36:347-357. doi: 10.1016/j.ebiom.2018.09.037. Epub 2018 Sep 29.
• [720] Gender-based differences on the association between salt-sensitive genes and obesity in Korean children aged between 8 and 9 years.PLoS One. 2015 Mar 13;10(3):e0120111. doi: 10.1371/journal.pone.0120111. eCollection 2015.
• [721] Physiological and therapeutic regulation of glucose homeostasis by upper small intestinal PepT1-mediated protein sensing.Nat Commun. 2018 Mar 16;9(1):1118. doi: 10.1038/s41467-018-03490-8.
• [722] Potential epigenetic biomarkers of obesity-related insulin resistance in human whole-blood.Epigenetics. 2017 Apr 3;12(4):254-263. doi: 10.1080/15592294.2017.1281501. Epub 2017 Jan 20.
• [723] Effects of SLC22A1 Polymorphisms on Metformin-Induced Reductions in Adiposity and Metformin Pharmacokinetics in Obese Children With Insulin Resistance.J Clin Pharmacol. 2017 Feb;57(2):219-229. doi: 10.1002/jcph.796. Epub 2016 Aug 23.
• [724] Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension.Kidney Blood Press Res. 2012;35(6):477-82. doi: 10.1159/000337370. Epub 2012 Jun 8.
• [725] Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity. Antimicrob Agents Chemother. 2016 Aug 22;60(9):5573-80. doi: 10.1128/AAC.00907-16. Print 2016 Sep.
• [726] Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance.Diabetologia. 2004 Jun;47(6):1118-25. doi: 10.1007/s00125-004-1417-4. Epub 2004 May 28.
• [727] Deficiency of ZnT8 Promotes Adiposity and Metabolic Dysfunction by Increasing Peripheral Serotonin Production.Diabetes. 2019 Jun;68(6):1197-1209. doi: 10.2337/db18-1321. Epub 2019 Apr 1.
• [728] AT1-receptor blockade attenuates outward aortic remodeling associated with diet-induced obesity in mice.Clin Sci (Lond). 2017 Jul 13;131(15):1989-2005. doi: 10.1042/CS20170131. Print 2017 Aug 1.
• [729] Liver-directed gene therapy for murine glycogen storage disease type Ib.Hum Mol Genet. 2017 Nov 15;26(22):4395-4405. doi: 10.1093/hmg/ddx325.
• [730] Hypoxic Stress Upregulates the Expression of Slc38a1 in Brown Adipocytes via Hypoxia-Inducible Factor-1.Pharmacology. 2018;101(1-2):64-71. doi: 10.1159/000480405. Epub 2017 Oct 25.
• [731] Inhibition of SNAT5 Induces Incretin-Responsive State From Incretin-Unresponsive State in Pancreatic -Cells: Study of -Cell Spheroid Clusters as a Model.Diabetes. 2018 Sep;67(9):1795-1806. doi: 10.2337/db17-1486. Epub 2018 Jun 28.
• [732] The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes.Diabetes Obes Metab. 2019 Jun;21(6):1311-1321. doi: 10.1111/dom.13654. Epub 2019 Mar 15.
• [733] Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity.Drugs. 2019 Feb;79(3):219-230. doi: 10.1007/s40265-019-1057-0.
• [734] Transgenic mice overexpressing gamma-aminobutyric acid transporter subtype I develop obesity.Cell Res. 2000 Dec;10(4):303-10. doi: 10.1038/sj.cr.7290057.
• [735] Missense mutation in SLIT2 associated with congenital myopia, anisometropia, connective tissue abnormalities, and obesity.Orphanet J Rare Dis. 2018 Aug 15;13(1):138. doi: 10.1186/s13023-018-0885-4.
• [736] The aberrant expression of Smad6 and TGF- in obesity linked cardiac disease.Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):138-142.
• [737] SNAP-25 Puts SNAREs at Center Stage in Metabolic Disease.Neuroscience. 2019 Nov 10;420:86-96. doi: 10.1016/j.neuroscience.2018.07.035. Epub 2018 Jul 31.
• [738] Gamma-synuclein is an adipocyte-neuron gene coordinately expressed with leptin and increased in human obesity.J Nutr. 2008 May;138(5):841-8. doi: 10.1093/jn/138.5.841.
• [739] The Association between SOCS1-1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients.J Clin Med. 2019 Nov 8;8(11):1912. doi: 10.3390/jcm8111912.
• [740] The correlation between oxidative stress level and intra-abdominal fat in obese males.Medicine (Baltimore). 2019 Feb;98(7):e14469. doi: 10.1097/MD.0000000000014469.
• [741] Regulatory Roles of Sortilin and SorLA in Immune-Related Processes.Front Pharmacol. 2019 Jan 7;9:1507. doi: 10.3389/fphar.2018.01507. eCollection 2018.
• [742] Promise(s) of mesenchymal stem cells as an in vitro model system to depict pre-diabetic/diabetic milieu in WNIN/GR-Ob mutant rats.PLoS One. 2012;7(10):e48061. doi: 10.1371/journal.pone.0048061. Epub 2012 Oct 29.
• [743] SPARC is required for the maintenance of glucose homeostasis and insulin secretion in mice.Clin Sci (Lond). 2019 Jan 30;133(2):351-365. doi: 10.1042/CS20180714. Print 2019 Jan 31.
• [744] Promoting Self-Regulation in Health Among Vulnerable Brazilian Children: Protocol Study.Front Psychol. 2018 May 7;9:651. doi: 10.3389/fpsyg.2018.00651. eCollection 2018.
• [745] Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance.Am J Physiol Endocrinol Metab. 2014 Apr 1;306(7):E756-68. doi: 10.1152/ajpendo.00549.2013. Epub 2014 Jan 28.
• [746] Association between the SPRY1 gene polymorphism and obesity-related traits and osteoporosis in Korean women.Mol Genet Metab. 2013 Jan;108(1):95-101. doi: 10.1016/j.ymgme.2012.10.017. Epub 2012 Oct 24.
• [747] Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.Obes Surg. 2017 Sep;27(9):2347-2353. doi: 10.1007/s11695-017-2606-9.
• [748] Metabolic endotoxemia promotes adipose dysfunction and inflammation in human obesity.Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E319-E332. doi: 10.1152/ajpendo.00277.2018. Epub 2018 Nov 13.
• [749] The gene-gene interaction of INSIG-SCAP-SREBP pathway on the risk of obesity in Chinese children.Biomed Res Int. 2014;2014:538564. doi: 10.1155/2014/538564. Epub 2014 Jun 17.
• [750] The rs1466113 polymorphism in the somatostatin receptor 2 gene is associated with obesity and food intake in a Mediterranean population.Ann Nutr Metab. 2010;57(2):124-31. doi: 10.1159/000319453. Epub 2010 Oct 19.
• [751] Indole Derivatives Isolated from Brown Alga Sargassum thunbergii Inhibit Adipogenesis through AMPK Activation in 3T3-L1 Preadipocytes.Mar Drugs. 2017 Apr 12;15(4):119. doi: 10.3390/md15040119.
• [752] The STK33-linked SNP rs4929949 is associated with obesity and BMI in two independent cohorts of Swedish and Greek children.PLoS One. 2013 Aug 15;8(8):e71353. doi: 10.1371/journal.pone.0071353. eCollection 2013.
• [753] Inactivation of SPAK kinase reduces body weight gain in mice fed a high-fat diet by improving energy expenditure and insulin sensitivity.Am J Physiol Endocrinol Metab. 2018 Jan 1;314(1):E53-E65. doi: 10.1152/ajpendo.00108.2017. Epub 2017 Oct 24.
• [754] Human omental adipose-derived stem cells from donors with different body mass index had similar effects on proliferation and migration of endometrial cancer cells in vitro.J Obstet Gynaecol Res. 2019 Feb;45(2):417-427. doi: 10.1111/jog.13820. Epub 2018 Oct 1.
• [755] SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity.Nat Immunol. 2019 May;20(5):581-592. doi: 10.1038/s41590-019-0372-7. Epub 2019 Apr 8.
• [756] SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.Obesity (Silver Spring). 2014 May;22(5):1309-16. doi: 10.1002/oby.20682. Epub 2014 Jan 9.
• [757] ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1 deacetylation.Int J Obes (Lond). 2018 Jun;42(5):1073-1087. doi: 10.1038/s41366-018-0030-4. Epub 2018 Mar 13.
• [758] ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes.Nat Commun. 2018 Sep 10;9(1):3659. doi: 10.1038/s41467-018-06091-7.
• [759] Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists.Eur J Med Chem. 2018 Feb 25;146:171-184. doi: 10.1016/j.ejmech.2018.01.059. Epub 2018 Feb 4.
• [760] Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKK for the treatment of obesity.Bioorg Med Chem. 2018 Nov 1;26(20):5443-5461. doi: 10.1016/j.bmc.2018.09.020. Epub 2018 Sep 20.
• [761] Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.Cell Metab. 2011 Apr 6;13(4):389-400. doi: 10.1016/j.cmet.2011.02.011.
• [762] Polymorphisms and high on-aspirin platelet reactivity after off-pump coronary artery bypass grafting.Scand Cardiovasc J. 2013 Aug;47(4):194-9. doi: 10.3109/14017431.2013.800640. Epub 2013 May 31.
• [763] Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity.Sci Rep. 2017 Aug 29;7(1):9807. doi: 10.1038/s41598-017-10240-1.
• [764] Obesity Is Associated with Changes in Iron Nutrition Status and Its Homeostatic Regulation in Pregnancy.Nutrients. 2019 Mar 23;11(3):693. doi: 10.3390/nu11030693.
• [765] The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor- (TGF) signaling.J Biol Chem. 2013 Feb 1;288(5):3036-47. doi: 10.1074/jbc.M112.440370. Epub 2012 Dec 17.
• [766] Thrombomodulin, alarmin signaling, and copeptin: cross-talk between obesity and acute ischemic stroke initiation and severity in Egyptians.Neurol Sci. 2018 Jun;39(6):1093-1104. doi: 10.1007/s10072-018-3396-0. Epub 2018 Apr 10.
• [767] Fibro-Adipogenic Remodeling of the Diaphragm in Obesity-Associated Respiratory Dysfunction.Diabetes. 2019 Jan;68(1):45-56. doi: 10.2337/db18-0209. Epub 2018 Oct 25.
• [768] Thyroid hormone receptor alpha gene variants increase the risk of developing obesity and show gene-diet interactions.Int J Obes (Lond). 2013 Nov;37(11):1499-505. doi: 10.1038/ijo.2013.11. Epub 2013 Feb 12.
• [769] Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.Am J Cancer Res. 2017 Mar 1;7(3):727-739. eCollection 2017.
• [770] Toll-like receptor signaling and serum levels of interferon and lipopolysaccharide binding protein are related to abdominal obesity: a case-control study between metabolically healthy and metabolically unhealthy obese individuals.Nutr Res. 2018 Jul;55:11-20. doi: 10.1016/j.nutres.2018.03.014. Epub 2018 Apr 6.
• [771] Endothelial overexpression of endothelin-1 modulates aortic, carotid, iliac and renal arterial responses in obese mice.Acta Pharmacol Sin. 2017 Apr;38(4):498-512. doi: 10.1038/aps.2016.138. Epub 2017 Feb 20.
• [772] Functional Gain and Pain Relief After Total Joint Replacement According to Obesity Status.J Bone Joint Surg Am. 2017 Jul 19;99(14):1183-1189. doi: 10.2106/JBJS.16.00960.
• [773] Decreased TLR3 in Hyperplastic Adipose Tissue, Blood and Inflamed Adipocytes is Related to Metabolic Inflammation.Cell Physiol Biochem. 2018;51(3):1051-1068. doi: 10.1159/000495487. Epub 2018 Nov 26.
• [774] Microparticles derived from obese adipose tissue elicit a pro-inflammatory phenotype of CD16(+), CCR5(+) and TLR8(+) monocytes.Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):139-151. doi: 10.1016/j.bbadis.2016.09.016. Epub 2016 Sep 25.
• [775] Rare genetic diseases with human lean and/or starvation phenotype open new avenues for obesity and type II diabetes treatment.Curr Pharm Biotechnol. 2014;14(13):1093-8. doi: 10.2174/1389201015666140408124559.
• [776] Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer.Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):193-200. doi: 10.1158/1055-9965.EPI-17-0547. Epub 2017 Nov 22.
• [777] Matriptase-2 deficiency protects from obesity by modulating iron homeostasis.Nat Commun. 2018 Apr 10;9(1):1350. doi: 10.1038/s41467-018-03853-1.
• [778] Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia.J Clin Endocrinol Metab. 2010 Jun;95(6):2983-92. doi: 10.1210/jc.2009-2481. Epub 2010 Apr 9.
• [779] Elevations of inflammatory proteins in neonatal blood are associated with obesity and overweight among 2-year-old children born extremely premature.Pediatr Res. 2018 Jun;83(6):1110-1119. doi: 10.1038/pr.2017.313. Epub 2018 Jan 10.
• [780] OX40 promotes obesity-induced adipose inflammation and insulin resistance.Cell Mol Life Sci. 2017 Oct;74(20):3827-3840. doi: 10.1007/s00018-017-2552-7. Epub 2017 Jun 13.
• [781] Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity.Cytokine. 2006 Feb 7;33(3):129-37. doi: 10.1016/j.cyto.2005.12.005. Epub 2006 Feb 28.
• [782] Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production.Immunol Cell Biol. 2018 Jan;96(1):41-53. doi: 10.1111/imcb.1002. Epub 2017 Nov 23.
• [783] No impact of obesity susceptibility loci on weight regain after a lifestyle intervention in overweight children.J Pediatr Endocrinol Metab. 2013;26(11-12):1209-13. doi: 10.1515/jpem-2013-0179.
• [784] Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly.Int J Cardiol. 2018 Apr 15;257:300-305. doi: 10.1016/j.ijcard.2017.10.095.
• [785] Increased expression of triggering receptor expressed on myeloid cells-1 in the population with obesity and insulin resistance.Obesity (Silver Spring). 2017 Mar;25(3):527-538. doi: 10.1002/oby.21714. Epub 2017 Jan 23.
• [786] Food deprivation during active phase induces skeletal muscle atrophy via IGF-1 reduction in mice.Arch Biochem Biophys. 2019 Nov 30;677:108160. doi: 10.1016/j.abb.2019.108160. Epub 2019 Oct 19.
• [787] TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice.J Hepatol. 2015 Feb;62(2):371-9. doi: 10.1016/j.jhep.2014.09.026. Epub 2014 Oct 2.
• [788] Trim28 Haploinsufficiency Triggers Bi-stable Epigenetic Obesity.Cell. 2016 Jan 28;164(3):353-64. doi: 10.1016/j.cell.2015.12.025.
• [789] TRPC1 regulates brown adipose tissue activity in a PPAR-dependent manner.Am J Physiol Endocrinol Metab. 2018 Nov 1;315(5):E825-E832. doi: 10.1152/ajpendo.00170.2017. Epub 2018 Jul 10.
• [790] COL9A3 gene polymorphism and obesity in intervertebral disc degeneration of the lumbar spine: evidence of gene-environment interaction.Spine (Phila Pa 1976). 2002 Dec 1;27(23):2691-6. doi: 10.1097/00007632-200212010-00008.
• [791] Free fatty acid-induced H(2)O(2) activates TRPM2 to aggravate endothelial insulin resistance via Ca(2+)-dependent PERK/ATF4/TRB3 cascade in obese mice.Free Radic Biol Med. 2019 Nov 1;143:288-299. doi: 10.1016/j.freeradbiomed.2019.08.018. Epub 2019 Aug 21.
• [792] TRPM5 in the battle against diabetes and obesity. Acta Physiol (Oxf). 2018 Feb;222(2).
• [793] Recent Progress in TRPM8 Modulation: An Update.Int J Mol Sci. 2019 May 28;20(11):2618. doi: 10.3390/ijms20112618.
• [794] Troglitazone activates TRPV1 and causes deacetylation of PPAR in 3T3-L1 cells.Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):445-453. doi: 10.1016/j.bbadis.2018.11.004. Epub 2018 Nov 26.
• [795] Mutations in MKKS cause Bardet-Biedl syndrome.Nat Genet. 2000 Sep;26(1):15-6. doi: 10.1038/79116.
• [796] Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity.Cell Metab. 2012 Dec 5;16(6):814-24. doi: 10.1016/j.cmet.2012.11.005.
• [797] UBE3A Suppresses Overnutrition-Induced Expression of the Steatosis Target Genes of MLL4 by Degrading MLL4.Hepatology. 2019 Mar;69(3):1122-1134. doi: 10.1002/hep.30284. Epub 2019 Feb 7.
• [798] Genome-wide analysis of hepatic lipid content in extreme obesity.Acta Diabetol. 2015 Apr;52(2):373-82. doi: 10.1007/s00592-014-0654-3. Epub 2014 Sep 23.
• [799] ULK1 prevents cardiac dysfunction in obesity through autophagy-meditated regulation of lipid metabolism.Cardiovasc Res. 2017 Aug 1;113(10):1137-1147. doi: 10.1093/cvr/cvx064.
• [800] Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.Hepatology. 2018 Nov;68(5):1786-1803. doi: 10.1002/hep.30062. Epub 2018 Sep 17.
• [801] Comparative understanding of UTS2 and UTS2R genes for their involvement in type 2 diabetes mellitus.Int J Biol Sci. 2008 Apr 23;4(2):96-102. doi: 10.7150/ijbs.4.96.
• [802] Late gestational testosterone exposure causes glucose deregulation and elevated cardiac VCAM-1 and DPP-4 activity in rats.Arch Physiol Biochem. 2021 Oct;127(5):445-452. doi: 10.1080/13813455.2019.1650068. Epub 2019 Aug 7.
• [803] Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population.Ther Clin Risk Manag. 2017 Mar 31;13:421-425. doi: 10.2147/TCRM.S130198. eCollection 2017.
• [804] Therapeutic potential of cannabinoids in CNS disease.CNS Drugs. 2003;17(3):179-202. doi: 10.2165/00023210-200317030-00004.
• [805] Adipose tissue-derived WNT5A regulates vascular redox signaling in obesity via USP17/RAC1-mediated activation of NADPH oxidases.Sci Transl Med. 2019 Sep 18;11(510):eaav5055. doi: 10.1126/scitranslmed.aav5055.
• [806] Wnt7a promotes wound healing by regulation of angiogenesis and inflammation: Issues on diabetes and obesity.J Dermatol Sci. 2018 Feb 15:S0923-1811(18)30103-8. doi: 10.1016/j.jdermsci.2018.02.007. Online ahead of print.
• [807] The non-synonymous polymorphism at position 114 of the WRN protein affects cholesterol efflux in vitro and correlates with cholesterol levels in vivo.Exp Gerontol. 2013 Jun;48(6):533-8. doi: 10.1016/j.exger.2013.03.003. Epub 2013 Mar 21.
• [808] Combination of WAGR and Potocki-Shaffer contiguous deletion syndromes in a patient with an 11p11.2-p14 deletion.Eur J Hum Genet. 2005 Apr;13(4):409-13. doi: 10.1038/sj.ejhg.5201358.
• [809] Independent links between plasma xanthine oxidoreductase activity and levels of adipokines.J Diabetes Investig. 2019 Jul;10(4):1059-1067. doi: 10.1111/jdi.12982. Epub 2019 Jan 28.
• [810] RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism.J Clin Invest. 2017 Oct 2;127(10):3741-3754. doi: 10.1172/JCI94029. Epub 2017 Sep 11.
• [811] The second point mutation in PREPL: a case report and literature review. J Hum Genet. 2018 May;63(5):677-681. doi: 10.1038/s10038-018-0426-y. Epub 2018 Feb 26.
• [812] Environmental Pollutants Effect on Brown Adipose Tissue.Front Physiol. 2019 Jan 9;9:1891. doi: 10.3389/fphys.2018.01891. eCollection 2018.
• [813] Abcc5 Knockout Mice Have Lower Fat Mass and Increased Levels of Circulating GLP-1.Obesity (Silver Spring). 2019 Aug;27(8):1292-1304. doi: 10.1002/oby.22521.
• [814] The Root of Atractylodes macrocephala Koidzumi Prevents Obesity and Glucose Intolerance and Increases Energy Metabolism in Mice.Int J Mol Sci. 2018 Jan 17;19(1):278. doi: 10.3390/ijms19010278.
• [815] P4 ATPases - lipid flippases and their role in disease.Biochim Biophys Acta. 2009 Jul;1791(7):628-35. doi: 10.1016/j.bbalip.2009.02.008. Epub 2009 Feb 27.
• [816] Genomic variants at 20p11 associated with body fat mass in the European population.Obesity (Silver Spring). 2017 Apr;25(4):757-764. doi: 10.1002/oby.21775. Epub 2017 Feb 22.
• [817] Single nucleotide polymorphisms in protein tyrosine phosphatase 1beta (PTPN1) are associated with essential hypertension and obesity.Hum Mol Genet. 2004 Sep 1;13(17):1885-92. doi: 10.1093/hmg/ddh196. Epub 2004 Jun 30.
• [818] Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity.Front Endocrinol (Lausanne). 2019 Aug 7;10:548. doi: 10.3389/fendo.2019.00548. eCollection 2019.
• [819] Adipose tissue transcriptomics and epigenomics in low birthweight men and controls: role of high-fat overfeeding.Diabetologia. 2016 Apr;59(4):799-812. doi: 10.1007/s00125-015-3852-9. Epub 2016 Jan 11.
• [820] Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue.Metabolism. 2014 Feb;63(2):250-62. doi: 10.1016/j.metabol.2013.10.001. Epub 2013 Oct 24.
• [821] Hypoglycemic Effects of Pyrodextrins with Different Molecular Weights and Digestibilities in Mice with Diet-Induced Obesity.J Agric Food Chem. 2018 Mar 21;66(11):2988-2995. doi: 10.1021/acs.jafc.8b00404. Epub 2018 Mar 6.
• [822] Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non-obese controls - a preliminary report. Oncotarget. 2018 May 22;9(39):25557-25571.
• [823] Understanding intestinal glucose transporter expression in obese compared to non-obese subjects.Surg Endosc. 2018 Apr;32(4):1755-1761. doi: 10.1007/s00464-017-5858-5. Epub 2017 Sep 21.
• [824] Deep congenic analysis identifies many strong, context-dependent QTLs, one of which, Slc35b4, regulates obesity and glucose homeostasis.Genome Res. 2011 Jul;21(7):1065-73. doi: 10.1101/gr.120741.111. Epub 2011 Apr 19.
• [825] Role of Zinc Homeostasis in the Pathogenesis of Diabetes and Obesity.Int J Mol Sci. 2018 Feb 6;19(2):476. doi: 10.3390/ijms19020476.
• [826] Global correlation analysis for microRNA and gene expression profiles in human obesity.Pathol Res Pract. 2015 May;211(5):361-8. doi: 10.1016/j.prp.2014.11.014. Epub 2015 Jan 14.
• [827] SGLT6 - A pharmacological target for the treatment of obesity?.Adipocyte. 2018;7(4):277-284. doi: 10.1080/21623945.2018.1516098. Epub 2018 Oct 11.
• [828] Modelling BMI trajectories in children for genetic association studies.PLoS One. 2013;8(1):e53897. doi: 10.1371/journal.pone.0053897. Epub 2013 Jan 17.
• [829] Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity.Diabetes. 2018 May;67(5):841-848. doi: 10.2337/db17-0788. Epub 2018 Feb 6.
• [830] Paraoxonases-1, -2 and -3: what are their functions? Chem Biol Interact. 2016 Nov 25;259(Pt B):51-62.
• [831] L-PGDS-produced PGD(2) in premature, but not in mature, adipocytes increases obesity and insulin resistance.Sci Rep. 2019 Feb 13;9(1):1931. doi: 10.1038/s41598-018-38453-y.
• [832] Familial clustering of metabolic phenotype in brothers of women with polycystic ovary syndrome.Gynecol Endocrinol. 2019 Jul;35(7):601-603. doi: 10.1080/09513590.2019.1566451. Epub 2019 Feb 6.
• [833] Diet-induced obese alters the expression and function of hepatic drug-metabolizing enzymes and transporters in rats.Biochem Pharmacol. 2019 Jun;164:368-376. doi: 10.1016/j.bcp.2019.05.002. Epub 2019 May 4.
• [834] Hypovitaminosis D: Is It Time to Consider the Use of Calcifediol?.Nutrients. 2019 May 6;11(5):1016. doi: 10.3390/nu11051016.
• [835] Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.PLoS One. 2019 Jun 27;14(6):e0218917. doi: 10.1371/journal.pone.0218917. eCollection 2019.
• [836] Outcomes in Cardiogenic Shock from Acute Coronary Syndrome Depending on Severity of Obesity.Am J Cardiol. 2019 Apr 15;123(8):1267-1272. doi: 10.1016/j.amjcard.2019.01.010. Epub 2019 Jan 24.
• [837] Transcriptomic identification of ADH1B as a novel candidate gene for obesity and insulin resistance in human adipose tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES).PLoS One. 2015 Apr 1;10(4):e0119941. doi: 10.1371/journal.pone.0119941. eCollection 2015.
• [838] Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity.Clin Endocrinol (Oxf). 2007 Mar;66(3):440-6. doi: 10.1111/j.1365-2265.2007.02755.x.
• [839] Knockout of arsenic (+3 oxidation state) methyltransferase is associated with adverse metabolic phenotype in mice: the role of sex and arsenic exposure.Arch Toxicol. 2017 Jul;91(7):2617-2627. doi: 10.1007/s00204-016-1890-9. Epub 2016 Nov 15.
• [840] HYPOTHesizing about central comBAT against obesity.J Physiol Biochem. 2020 May;76(2):193-211. doi: 10.1007/s13105-019-00719-y. Epub 2019 Dec 16.
• [841] Skeletal Muscle Phospholipid Metabolism Regulates Insulin Sensitivity and Contractile Function.Diabetes. 2016 Feb;65(2):358-70. doi: 10.2337/db15-0659. Epub 2015 Oct 28.
• [842] Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance.Cell Rep. 2017 Jan 17;18(3):636-646. doi: 10.1016/j.celrep.2016.12.070.
• [843] Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.Lipids Health Dis. 2019 Apr 11;18(1):95. doi: 10.1186/s12944-019-1042-3.
• [844] Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.Obes Res. 2004 Jan;12(1):9-17. doi: 10.1038/oby.2004.3.
• [845] Genetic obesity increases pancreatic expression of mitochondrial proteins which regulate cholesterol efflux in BRIN-BD11 insulinoma cells.Biosci Rep. 2019 Mar 22;39(3):BSR20181155. doi: 10.1042/BSR20181155. Print 2019 Mar 29.
• [846] Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting.Am J Med. 2017 Feb;130(2):222-228. doi: 10.1016/j.amjmed.2016.08.017. Epub 2016 Sep 2.
• [847] p53-Inducible DHRS3 is an endoplasmic reticulum protein associated with lipid droplet accumulation.J Biol Chem. 2011 Aug 12;286(32):28343-56. doi: 10.1074/jbc.M111.254227. Epub 2011 Jun 9.
• [848] A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J Mice.PLoS One. 2016 Nov 10;11(11):e0166198. doi: 10.1371/journal.pone.0166198. eCollection 2016.
• [849] Minor diplotypes of FMO3 might protect children and adolescents from obesity and insulin resistance.Int J Obes (Lond). 2018 Jun;42(6):1243-1248. doi: 10.1038/s41366-018-0100-7. Epub 2018 May 24.
• [850] Host susceptibility to severe influenza A virus infection.Crit Care. 2019 Sep 5;23(1):303. doi: 10.1186/s13054-019-2566-7.
• [851] Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction.Diabetes. 2010 May;59(5):1132-42. doi: 10.2337/db09-1105. Epub 2010 Feb 11.
• [852] Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.Tohoku J Exp Med. 2018 Sep;246(1):35-44. doi: 10.1620/tjem.246.35.
• [853] Interactions between RASA2, CADM1, HIF1AN gene polymorphisms and body fatness with breast cancer: a population-based case-control study in China.Oncotarget. 2017 Oct 5;8(58):98258-98269. doi: 10.18632/oncotarget.21530. eCollection 2017 Nov 17.
• [854] The Expression of Aldolase B in Islets Is Negatively Associated With Insulin Secretion in Humans.J Clin Endocrinol Metab. 2018 Dec 1;103(12):4373-4383. doi: 10.1210/jc.2018-00791.
• [855] Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks.Nat Genet. 2009 Apr;41(4):415-23. doi: 10.1038/ng.325. Epub 2009 Mar 8.
• [856] Genome-wide association study identifies novel loci association with fasting insulin and insulin resistance in African Americans.Hum Mol Genet. 2012 Oct 15;21(20):4530-6. doi: 10.1093/hmg/dds282. Epub 2012 Jul 12.
• [857] Analysis of Genes Involved in Body Weight Regulation by Targeted Re-Sequencing.PLoS One. 2016 Feb 1;11(2):e0147904. doi: 10.1371/journal.pone.0147904. eCollection 2016.
• [858] Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation.Exp Mol Med. 2006 Apr 30;38(2):162-72. doi: 10.1038/emm.2006.20.
• [859] Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase.Bioorg Med Chem Lett. 2018 Mar 1;28(5):922-925. doi: 10.1016/j.bmcl.2018.01.058. Epub 2018 Jan 31.
• [860] Aging and erectile function.Aging Male. 2020 Dec;23(5):1115-1124. doi: 10.1080/13685538.2019.1686756. Epub 2019 Nov 14.
• [861] Adipose hypothermia in obesity and its association with period homolog 1, insulin sensitivity, and inflammation in fat.PLoS One. 2014 Nov 14;9(11):e112813. doi: 10.1371/journal.pone.0112813. eCollection 2014.
• [862] The Effect of One Anastomosis Gastric Bypass on Branched-Chain Fatty Acid and Branched-Chain Amino Acid Metabolism in Subjects with Morbid Obesity.Obes Surg. 2020 Jan;30(1):304-312. doi: 10.1007/s11695-019-04157-z.
• [863] Combined Omics Reveals That Disruption of the Selenocysteine Lyase Gene Affects Amino Acid Pathways in Mice.Nutrients. 2019 Oct 26;11(11):2584. doi: 10.3390/nu11112584.
• [864] Pharmacogenetics of soluble sulfotransferases (SULTs).Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):55-68. doi: 10.1007/s00210-003-0826-0. Epub 2003 Nov 5.
• [865] Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in association with TNF-alpha and SOCS3.J Clin Endocrinol Metab. 2011 Jul;96(7):E1153-8. doi: 10.1210/jc.2010-2903. Epub 2011 May 4.
• [866] The Vitamin K Epoxide Reductase Vkorc1l1 Promotes Preadipocyte Differentiation in Mice.Obesity (Silver Spring). 2018 Aug;26(8):1303-1311. doi: 10.1002/oby.22206. Epub 2018 Jul 2.
• [867] Genetic obesity affects neural ketone body utilization in the rat brain.Obesity (Silver Spring). 2009 Mar;17(3):611-5. doi: 10.1038/oby.2008.566. Epub 2008 Dec 11.
• [868] Hypothalamic expression of the atypical chemokine receptor ACKR2 is involved in the systemic regulation of glucose tolerance.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1126-1137. doi: 10.1016/j.bbadis.2019.01.001. Epub 2019 Feb 7.
• [869] Insulin Regulates Lipolysis and Fat Mass by Upregulating Growth/Differentiation Factor 3 in Adipose Tissue Macrophages.Diabetes. 2018 Sep;67(9):1761-1772. doi: 10.2337/db17-1201. Epub 2018 Jun 26.
• [870] Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2.J Biol Chem. 2007 Aug 3;282(31):22448-59. doi: 10.1074/jbc.M700265200. Epub 2007 Jun 12.
• [871] New ADCY3 Variants Dance in Obesity Etiology.Trends Endocrinol Metab. 2018 Jun;29(6):361-363. doi: 10.1016/j.tem.2018.02.004. Epub 2018 Feb 14.
• [872] Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat.Metabolism. 1996 Sep;45(9):1056-8. doi: 10.1016/s0026-0495(96)90001-3.
• [873] Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification.J Lipid Res. 2007 Jun;48(6):1353-61. doi: 10.1194/jlr.M700024-JLR200. Epub 2007 Mar 5.
• [874] Healthy diet is associated with gene expression in blood: the Framingham Heart Study.Am J Clin Nutr. 2019 Sep 1;110(3):742-749. doi: 10.1093/ajcn/nqz060.
• [875] Pseudohypoparathyroidism vs. tricho-rhino-phalangeal syndrome: patient reclassification.J Pediatr Endocrinol Metab. 2014 Nov;27(11-12):1089-94. doi: 10.1515/jpem-2014-0020.
• [876] Gaps in provider lifestyle counseling and its adherence among obese adults with prediabetes and diabetes in the United States.Prev Med. 2019 Dec;129:105815. doi: 10.1016/j.ypmed.2019.105815. Epub 2019 Aug 24.
• [877] More activated cardiac mitochondrial-dependent apoptotic pathway in obese Zucker rats.Obesity (Silver Spring). 2007 Nov;15(11):2634-42. doi: 10.1038/oby.2007.315.
• [878] Association of CTRP13 With Liver Enzymes and Cognitive Symptoms in Nonalcoholic Fatty Liver Disease.Nurs Res. 2019 Jan/Feb;68(1):29-38. doi: 10.1097/NNR.0000000000000319.
• [879] Circulating CTRP6 Levels are Increased in Overweight or Obese Chinese Individuals and Associated with Insulin Resistance Parameters: A Pilot Study.Exp Clin Endocrinol Diabetes. 2021 Jul;129(7):535-541. doi: 10.1055/a-0929-6072. Epub 2019 Aug 14.
• [880] Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.Cardiovasc Diabetol. 2008 Jul 25;7:23. doi: 10.1186/1475-2840-7-23.
• [881] Dietary obesity increases NO and inhibits BKCa-mediated, endothelium-dependent dilation in rat cremaster muscle artery: association with caveolins and caveolae.Am J Physiol Heart Circ Physiol. 2012 Jun 15;302(12):H2464-76. doi: 10.1152/ajpheart.00965.2011. Epub 2012 Apr 6.
• [882] Serum CCN3 levels are increased in type 2 diabetes mellitus and associated with obesity, insulin resistance and inflammation.Clin Chim Acta. 2019 Jul;494:52-57. doi: 10.1016/j.cca.2019.03.006. Epub 2019 Mar 13.
• [883] Adipocyte CD1d determines adipose inflammation and insulin resistance in obesity.Adipocyte. 2018;7(2):129-136. doi: 10.1080/21623945.2018.1440928. Epub 2018 Mar 6.
• [884] Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case-control analyses.Clin Res Cardiol. 2020 Jan;109(1):22-33. doi: 10.1007/s00392-019-01480-4. Epub 2019 May 6.
• [885] The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.Mol Metab. 2019 Mar;21:36-50. doi: 10.1016/j.molmet.2018.12.008. Epub 2019 Jan 2.
• [886] Lentivirus-mediated CTRP6 silencing ameliorates diet-induced obesity in mice.Exp Cell Res. 2018 Jun 1;367(1):15-23. doi: 10.1016/j.yexcr.2018.01.027. Epub 2018 Jan 31.
• [887] Antiretroviral drug-induced endothelial dysfunction is improved by dual PPAR/ stimulation in obesity.Vascul Pharmacol. 2019 Oct;121:106577. doi: 10.1016/j.vph.2019.106577. Epub 2019 Jul 5.
• [888] CYP2W1, CYP4F11 and CYP8A1 polymorphisms and interaction of CYP2W1 genotypes with risk factors in Mexican women with breast cancer.Asian Pac J Cancer Prev. 2012;13(3):837-46. doi: 10.7314/apjcp.2012.13.3.837.
• [889] Oxidative Phosphorylation Impairment by DDT and DDE.Front Endocrinol (Lausanne). 2019 Mar 12;10:122. doi: 10.3389/fendo.2019.00122. eCollection 2019.
• [890] Nucleotide sequence and expression of rat beta-defensin-1: its significance in diabetic rodent models.Nephron. 2001 May;88(1):65-70. doi: 10.1159/000045961.
• [891] Roux-en-Y gastric bypass surgery restores insulin-mediated glucose partitioning and mitochondrial dynamics in primary myotubes from severely obese humans.Int J Obes (Lond). 2020 Mar;44(3):684-696. doi: 10.1038/s41366-019-0469-y. Epub 2019 Oct 17.
• [892] DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle.Diabetologia. 2019 May;62(5):845-859. doi: 10.1007/s00125-019-4824-2. Epub 2019 Feb 1.
• [893] Differential expression of adipose tissue proteins between obesity-susceptible and -resistant rats fed a high-fat diet.Proteomics. 2011 Apr;11(8):1429-48. doi: 10.1002/pmic.201000515. Epub 2011 Feb 25.
• [894] The role of bioactives in energy metabolism and metabolic syndrome.Proc Nutr Soc. 2019 Aug;78(3):340-350. doi: 10.1017/S0029665119000545. Epub 2019 Apr 10.
• [895] The coexistence of nocturnal sustained hypoxia and obesity additively increases cardiac apoptosis.J Appl Physiol (1985). 2008 Apr;104(4):1144-53. doi: 10.1152/japplphysiol.00152.2007. Epub 2008 Jan 17.
• [896] Increased adipose tissue heme levels and exportation are associated with altered systemic glucose metabolism.Sci Rep. 2017 Jul 13;7(1):5305. doi: 10.1038/s41598-017-05597-2.
• [897] High circulating follistatin-like protein 1 as a biomarker of a metabolically unhealthy state.Endocr J. 2019 Mar 28;66(3):241-251. doi: 10.1507/endocrj.EJ18-0352. Epub 2019 Feb 8.
• [898] Evaluation of Bacillus subtilis SPB1 biosurfactant effects on hyperglycemia, angiotensin I-converting enzyme (ACE) activity and kidney function in rats fed on high-fat-high-fructose diet.Arch Physiol Biochem. 2017 May;123(2):112-120. doi: 10.1080/13813455.2016.1261902. Epub 2016 Dec 25.
• [899] GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia.PLoS One. 2013 Jul 22;8(7):e70159. doi: 10.1371/journal.pone.0070159. Print 2013.
• [900] Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes.Aging (Albany NY). 2019 Mar 21;11(6):1733-1744. doi: 10.18632/aging.101865.
• [901] Regulated expression of Gemin5, Xrn1, Cpeb and Stau1 in the uterus and ovaries after superovulation and the effect of exogenous estradiol and leptin in rodents.Mol Biol Rep. 2019 Apr;46(2):2533-2540. doi: 10.1007/s11033-019-04606-z. Epub 2019 Jan 28.
• [902] Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.J Bone Miner Res. 2018 Aug;33(8):1480-1488. doi: 10.1002/jbmr.3450. Epub 2018 Jun 7.
• [903] Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.Diabetes. 1997 Mar;46(3):408-13. doi: 10.2337/diab.46.3.408.
• [904] Interaction between obesity and the Hypoxia Inducible Factor 3 Alpha Subunit rs3826795 polymorphism in relation with plasma alanine aminotransferase.BMC Med Genet. 2017 Jul 28;18(1):80. doi: 10.1186/s12881-017-0437-0.
• [905] Deficiency of heat shock protein A12A promotes browning of white adipose tissues in mice.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1451-1459. doi: 10.1016/j.bbadis.2019.02.017. Epub 2019 Feb 22.
• [906] TNF- Upregulates IKK Expression via the Lin28B/let-7a Pathway to Induce Catecholamine Resistance in Adipocytes.Obesity (Silver Spring). 2019 May;27(5):767-776. doi: 10.1002/oby.22434. Epub 2019 Apr 1.
• [907] Review: the Roles and Mechanisms of Glycoprotein 130 Cytokines in the Regulation of Adipocyte Biological Function.Inflammation. 2019 Jun;42(3):790-798. doi: 10.1007/s10753-019-00959-6.
• [908] Investigation of the association between obesity and insulin-induced gene 1 polymorphism at 7q36.3 region in Uygur population in Xinjiang, China.Biosci Rep. 2019 Dec 20;39(12):BSR20190498. doi: 10.1042/BSR20190498.
• [909] Akt activation: A potential strategy to ameliorate insulin resistance.Diabetes Res Clin Pract. 2019 Oct;156:107092. doi: 10.1016/j.diabres.2017.10.004. Epub 2017 Oct 28.
• [910] Increased Adipose Tissue Expression of Interferon Regulatory Factor (IRF)-5 in Obesity: Association with Metabolic Inflammation.Cells. 2019 Nov 11;8(11):1418. doi: 10.3390/cells8111418.
• [911] Affective Pavlovian motivation is enhanced in obesity susceptible populations: Implications for incentive motivation in obesity.Behav Brain Res. 2020 Feb 17;380:112318. doi: 10.1016/j.bbr.2019.112318. Epub 2019 Nov 21.
• [912] Adipose KLF15 Controls Lipid Handling to Adapt to Nutrient Availability.Cell Rep. 2017 Dec 12;21(11):3129-3140. doi: 10.1016/j.celrep.2017.11.032.
• [913] Leptin and Leptin receptor polymorphisms, plasma Leptin levels and obesity in Tunisian volunteers.Int J Exp Pathol. 2018 Jun;99(3):121-130. doi: 10.1111/iep.12271. Epub 2018 Jun 11.
• [914] Plasma levels of ghrelin, des-acyl ghrelin and LEAP2 in children with obesity: correlation with age and insulin resistance.Eur J Endocrinol. 2020 Feb;182(2):165-175. doi: 10.1530/EJE-19-0684.
• [915] Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages.J Biol Chem. 2012 Mar 30;287(14):10894-904. doi: 10.1074/jbc.M112.342915. Epub 2012 Feb 8.
• [916] The genetic and epigenetic association of LDL Receptor Related Protein 1B (LRP1B) gene with childhood obesity.Sci Rep. 2019 Feb 12;9(1):1815. doi: 10.1038/s41598-019-38538-2.
• [917] SWELL signalling in adipocytes: can fat 'feel' fat?.Adipocyte. 2019 Dec;8(1):223-228. doi: 10.1080/21623945.2019.1612223.
• [918] Multidisciplinary Roles of LRRFIP1/GCF2 in Human Biological Systems and Diseases.Cells. 2019 Jan 31;8(2):108. doi: 10.3390/cells8020108.
• [919] Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21.Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2125-2137. doi: 10.1016/j.bbadis.2019.04.010. Epub 2019 Apr 26.
• [920] MIP-1 Induction by Palmitate in the Human Monocytic Cells Implicates TLR4 Signaling Mechanism.Cell Physiol Biochem. 2019;52(2):212-224. doi: 10.33594/000000015. Epub 2019 Feb 28.
• [921] The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation.Mol Metab. 2019 May;23:14-23. doi: 10.1016/j.molmet.2019.02.003. Epub 2019 Feb 20.
• [922] Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension.Nat Med. 2019 Nov;25(11):1733-1738. doi: 10.1038/s41591-019-0622-0. Epub 2019 Nov 7.
• [923] Adipose-derived Mesenchymal Stem Cells in the Treatment of Obesity: A Systematic Review of Longitudinal Studies on Preclinical Evidence.Curr Stem Cell Res Ther. 2018;13(6):466-475. doi: 10.2174/1574888X13666180515160008.
• [924] The skeletal muscle Wnt pathway may modulate insulin resistance and muscle development in a diet-induced obese rat model.Obesity (Silver Spring). 2012 Aug;20(8):1577-84. doi: 10.1038/oby.2012.42. Epub 2012 Feb 21.
• [925] Satellite cell proliferation is reduced in muscles of obese Zucker rats but restored with loading.Am J Physiol Cell Physiol. 2008 Aug;295(2):C521-8. doi: 10.1152/ajpcell.00073.2008. Epub 2008 May 28.
• [926] Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction.Hypertension. 2007 Jul;50(1):248-54. doi: 10.1161/HYPERTENSIONAHA.107.088716. Epub 2007 May 21.
• [927] The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways.Hum Mol Genet. 2017 Nov 1;26(21):4215-4230. doi: 10.1093/hmg/ddx311.
• [928] A high-sucrose isocaloric pair-fed model induces obesity and impairs NDUFB6 gene function in rat adipose tissue.J Nutrigenet Nutrigenomics. 2009;2(6):267-72. doi: 10.1159/000308465. Epub 2010 Jun 19.
• [929] Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.J Clin Invest. 2017 Jan 3;127(1):293-305. doi: 10.1172/JCI88648. Epub 2016 Dec 12.
• [930] Temporal Control of Metabolic Amplitude by Nocturnin.Cell Rep. 2018 Jan 30;22(5):1225-1235. doi: 10.1016/j.celrep.2018.01.011.
• [931] The Extending Spectrum of NPC1-Related Human Disorders: From Niemann-Pick C1 Disease to Obesity.Endocr Rev. 2018 Apr 1;39(2):192-220. doi: 10.1210/er.2017-00176.
• [932] P110 in the ventromedial hypothalamus regulates glucose and energy metabolism.Exp Mol Med. 2019 Apr 26;51(4):1-9. doi: 10.1038/s12276-019-0249-8.
• [933] FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia.Sci Rep. 2017 Sep 22;7(1):12139. doi: 10.1038/s41598-017-11639-6.
• [934] Effect of NUCKS-1 overexpression on cytokine profiling in obese women with breast cancer.Asian Pac J Cancer Prev. 2014;15(2):837-45. doi: 10.7314/apjcp.2014.15.2.837.
• [935] Skeletal muscle O-GlcNAc transferase is important for muscle energy homeostasis and whole-body insulin sensitivity.Mol Metab. 2018 May;11:160-177. doi: 10.1016/j.molmet.2018.02.010. Epub 2018 Feb 24.
• [936] Quantitative bias analysis of the association of type 2 diabetes mellitus with 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153).Environ Int. 2019 Apr;125:291-299. doi: 10.1016/j.envint.2018.12.036. Epub 2019 Feb 5.
• [937] Obesity and diabetes in transgenic mice expressing proSAAS.J Endocrinol. 2004 Mar;180(3):357-68. doi: 10.1677/joe.0.1800357.
• [938] Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome.Fertil Steril. 2016 May;105(5):1330-1337.e3. doi: 10.1016/j.fertnstert.2016.01.020. Epub 2016 Feb 8.
• [939] CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake.Chronobiol Int. 2012 Nov;29(9):1180-94. doi: 10.3109/07420528.2012.719967. Epub 2012 Sep 24.
• [940] Phosphatidylinositol 3-kinase/Akt signaling stimulates colonic mucosal cell survival during aging.Am J Physiol Gastrointest Liver Physiol. 2006 Jan;290(1):G49-55. doi: 10.1152/ajpgi.00106.2005. Epub 2005 Aug 25.
• [941] Obesity is associated with altered gene expression in human tastebuds.Int J Obes (Lond). 2019 Jul;43(7):1475-1484. doi: 10.1038/s41366-018-0303-y. Epub 2019 Jan 29.
• [942] Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling.Diabetologia. 2011 Aug;54(8):2122-31. doi: 10.1007/s00125-011-2173-x. Epub 2011 May 12.
• [943] Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13296-301. doi: 10.1073/pnas.0405354101. Epub 2004 Aug 24.
• [944] Nociceptin/orphanin FQ modulates energy homeostasis through inhibition of neurotransmission at VMN SF-1/ARC POMC synapses in a sex- and diet-dependent manner.Biol Sex Differ. 2019 Feb 12;10(1):9. doi: 10.1186/s13293-019-0220-3.
• [945] Identification of a 1p21 independent functional variant for abdominal obesity.Int J Obes (Lond). 2019 Dec;43(12):2480-2490. doi: 10.1038/s41366-019-0350-z. Epub 2019 Apr 3.
• [946] Bioelectrical impedance vector analysis in obese and overweight children.PLoS One. 2019 Jan 24;14(1):e0211148. doi: 10.1371/journal.pone.0211148. eCollection 2019.
• [947] Sarcopenic obesity is associated with a faster decline in renal function in people with type 2 diabetes.Diabet Med. 2020 Jan;37(1):105-113. doi: 10.1111/dme.14153. Epub 2019 Oct 30.
• [948] Diet-induced macrophage inhibitory cytokine 1 promotes prostate cancer progression.Endocr Relat Cancer. 2013 Dec 16;21(1):39-50. doi: 10.1530/ERC-13-0227. Print 2014 Feb.
• [949] Mice without the regulator gene Rsc1A1 exhibit increased Na+-D-glucose cotransport in small intestine and develop obesity.Mol Cell Biol. 2005 Jan;25(1):78-87. doi: 10.1128/MCB.25.1.78-87.2005.
• [950] High-Fat-Diet-Induced Obesity Produces Spontaneous Ventricular Arrhythmias and Increases the Activity of Ryanodine Receptors in Mice.Int J Mol Sci. 2018 Feb 10;19(2):533. doi: 10.3390/ijms19020533.
• [951] Relationship between Selenium and Hematological Markers in Young Adults with Normal Weight or Overweight/Obesity.Antioxidants (Basel). 2019 Oct 8;8(10):463. doi: 10.3390/antiox8100463.
• [952] Peptide vaccine for semaphorin3E ameliorates systemic glucose intolerance in mice with dietary obesity.Sci Rep. 2019 Mar 7;9(1):3858. doi: 10.1038/s41598-019-40325-y.
• [953] Mechanism of SEMA3G knockdown-mediated attenuation of high-fat diet-induced obesity.J Endocrinol. 2020 Jan;244(1):223-236. doi: 10.1530/JOE-19-0029.
• [954] Insulin induces expression of the hepatic vaspin gene.Endocr J. 2020 Jan 28;67(1):9-14. doi: 10.1507/endocrj.EJ19-0276. Epub 2019 Sep 4.
• [955] Diminished lung compliance and elevated surfactant lipids and proteins in nutritionally obese young rats.Lung. 2004;182(2):101-17. doi: 10.1007/s00408-003-1048-4.
• [956] Morning exercise mitigates the impact of prolonged sitting on cerebral blood flow in older adults.J Appl Physiol (1985). 2019 Apr 1;126(4):1049-1055. doi: 10.1152/japplphysiol.00001.2019. Epub 2019 Feb 7.
• [957] Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study.PLoS One. 2014 Jun 6;9(6):e99509. doi: 10.1371/journal.pone.0099509. eCollection 2014.
• [958] Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins.J Clin Endocrinol Metab. 2004 Sep;89(9):4414-21. doi: 10.1210/jc.2004-0153.
• [959] Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.Front Immunol. 2019 Jan 22;10:17. doi: 10.3389/fimmu.2019.00017. eCollection 2019.
• [960] Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E175-87. doi: 10.1152/ajpendo.00203.2010. Epub 2010 Oct 26.
• [961] Liver kinase B1 induces browning phenotype in 3T3-L1 adipocytes.Gene. 2019 Jan 15;682:33-41. doi: 10.1016/j.gene.2018.10.012. Epub 2018 Oct 6.
• [962] Novel Adipokine, FAM19A5, Inhibits Neointima Formation After Injury Through Sphingosine-1-Phosphate Receptor 2.Circulation. 2018 Jul 3;138(1):48-63. doi: 10.1161/CIRCULATIONAHA.117.032398. Epub 2018 Feb 16.
• [963] Expression of the Bitter Taste Receptor, T2R38, in Enteroendocrine Cells of the Colonic Mucosa of Overweight/Obese vs. Lean Subjects.PLoS One. 2016 Feb 11;11(2):e0147468. doi: 10.1371/journal.pone.0147468. eCollection 2016.
• [964] Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice.Aging (Albany NY). 2019 Nov 7;11(21):9461-9477. doi: 10.18632/aging.102396. Epub 2019 Nov 7.
• [965] Thrap3 docks on phosphoserine 273 of PPAR and controls diabetic gene programming.Genes Dev. 2014 Nov 1;28(21):2361-9. doi: 10.1101/gad.249367.114. Epub 2014 Oct 14.
• [966] Thy1 (CD90) expression is regulated by DNA methylation during adipogenesis.FASEB J. 2019 Mar;33(3):3353-3363. doi: 10.1096/fj.201801481R. Epub 2018 Oct 30.
• [967] Loss of TLE3 promotes the mitochondrial program in beige adipocytes and improves glucose metabolism.Genes Dev. 2019 Jul 1;33(13-14):747-762. doi: 10.1101/gad.321059.118. Epub 2019 May 23.
• [968] Remodeling of the residual gastric mucosa after roux-en-y gastric bypass or vertical sleeve gastrectomy in diet-induced obese rats.PLoS One. 2015 Mar 30;10(3):e0121414. doi: 10.1371/journal.pone.0121414. eCollection 2015.
• [969] A combination of resveratrol and quercetin induces browning in white adipose tissue of rats fed an obesogenic diet.Obesity (Silver Spring). 2017 Jan;25(1):111-121. doi: 10.1002/oby.21706. Epub 2016 Nov 22.
• [970] NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.Diabetes. 2017 Jul;66(7):1819-1832. doi: 10.2337/db16-1172. Epub 2017 Apr 14.
• [971] The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes.J Pharmacol Exp Ther. 2017 Jul;362(1):24-30. doi: 10.1124/jpet.117.241281. Epub 2017 Apr 24.
• [972] Germline gain-of-function mutations in AFF4 cause a developmental syndrome functionally linking the super elongation complex and cohesin. Nat Genet. 2015 Apr;47(4):338-44. doi: 10.1038/ng.3229. Epub 2015 Mar 2.
• [973] Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistance.Diabetologia. 2019 Dec;62(12):2325-2339. doi: 10.1007/s00125-019-04983-x. Epub 2019 Sep 11.
• [974] Higher Levels of ANGPTL5 in the Circulation of Subjects With Obesity and Type 2 Diabetes Are Associated With Insulin Resistance.Front Endocrinol (Lausanne). 2019 Jul 24;10:495. doi: 10.3389/fendo.2019.00495. eCollection 2019.
• [975] Intron retention as an alternative splice variant of the cattle ANGPTL6 gene.Gene. 2019 Aug 15;709:17-24. doi: 10.1016/j.gene.2019.05.031. Epub 2019 May 15.
• [976] Protein hydrolysate from potato confers hepatic-protection in hamsters against high fat diet induced apoptosis and fibrosis by suppressing Caspase-3 and MMP2/9 and by enhancing Akt-survival pathway.BMC Complement Altern Med. 2019 Oct 25;19(1):283. doi: 10.1186/s12906-019-2700-8.
• [977] Identification of a novel ARL13B variant in a Joubert syndrome-affected patient with retinal impairment and obesity. Eur J Hum Genet. 2015 May;23(5):621-7. doi: 10.1038/ejhg.2014.156. Epub 2014 Aug 20.
• [978] A Proteomics-Based Approach Reveals Differential Regulation of Urine Proteins between Metabolically Healthy and Unhealthy Obese Patients.Int J Mol Sci. 2019 Oct 3;20(19):4905. doi: 10.3390/ijms20194905.
• [979] The risk of overweight and obesity in children with autism spectrum disorders: A systematic review and meta-analysis.Obes Rev. 2019 Dec;20(12):1667-1679. doi: 10.1111/obr.12933. Epub 2019 Oct 8.
• [980] Myeloid ATG16L1 does not affect adipose tissue inflammation or body mass in mice fed high fat diet.Obes Res Clin Pract. 2018 Mar-Apr;12(2):174-186. doi: 10.1016/j.orcp.2017.10.006. Epub 2017 Nov 2.
• [981] Platelet Functions are Decreased in Obesity and Restored after Weight Loss: Evidence for a Role of the SERCA3-Dependent ADP Secretion Pathway.Thromb Haemost. 2019 Mar;119(3):384-396. doi: 10.1055/s-0038-1677033. Epub 2019 Jan 16.
• [982] Downregulation of 1,4-galactosyltransferase 5 improves insulin resistance by promoting adipocyte commitment and reducing inflammation.Cell Death Dis. 2018 Feb 7;9(2):196. doi: 10.1038/s41419-017-0239-5.
• [983] Effect of dietary energy and polymorphisms in BRAP and GHRL on obesity and metabolic traits.Obes Res Clin Pract. 2018 Jan-Feb;12(Suppl 2):39-48. doi: 10.1016/j.orcp.2016.05.004. Epub 2016 May 27.
• [984] Decreased CTRP3 Plasma Concentrations Are Associated with Sepsis and Predict Mortality in Critically Ill Patients.Diagnostics (Basel). 2019 Jun 21;9(2):63. doi: 10.3390/diagnostics9020063.
• [985] Detecting epistasis within chromatin regulatory circuitry reveals CAND2 as a novel susceptibility gene for obesity.Int J Obes (Lond). 2019 Mar;43(3):450-456. doi: 10.1038/s41366-018-0069-2. Epub 2018 May 1.
• [986] Cytokine, Chemokine, and Cytokine Receptor Changes Are Associated With Metabolic Improvements After Bariatric Surgery.J Clin Endocrinol Metab. 2019 Mar 1;104(3):947-956. doi: 10.1210/jc.2018-02245.
• [987] CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity.Cell. 2019 May 30;177(6):1536-1552.e23. doi: 10.1016/j.cell.2019.05.008.
• [988] CILP-2 is a novel secreted protein and associated with insulin resistance.J Mol Cell Biol. 2019 Dec 19;11(12):1083-1094. doi: 10.1093/jmcb/mjz016.
• [989] Psychosocial and Cardiometabolic Health of Patients With Differing Body Mass Index Completing Cardiac Rehabilitation.Can J Cardiol. 2019 Jun;35(6):712-720. doi: 10.1016/j.cjca.2019.02.024. Epub 2019 Mar 6.
• [990] CPT1C in the ventromedial nucleus of the hypothalamus is necessary for brown fat thermogenesis activation in obesity.Mol Metab. 2019 Jan;19:75-85. doi: 10.1016/j.molmet.2018.10.010. Epub 2018 Nov 2.
• [991] Association of CREBRF variants with obesity and diabetes in Pacific Islanders from Guam and Saipan.Diabetologia. 2019 Sep;62(9):1647-1652. doi: 10.1007/s00125-019-4932-z. Epub 2019 Jul 6.
• [992] Increased levels of the megakaryocyte and platelet expressed cysteine proteases stefin A and cystatin A prevent thrombosis.Sci Rep. 2019 Jul 3;9(1):9631. doi: 10.1038/s41598-019-45805-9.
• [993] Metabolic and muscular factors limiting aerobic exercise in obese subjects.Eur J Appl Physiol. 2019 Aug;119(8):1779-1788. doi: 10.1007/s00421-019-04167-w. Epub 2019 Jun 11.
• [994] CXCL14 Inhibits Insulin Secretion Independently of CXCR4 or CXCR7 Receptor Activation or cAMP Inhibition.Cell Physiol Biochem. 2019;52(4):879-892. doi: 10.33594/000000061.
• [995] A Natural mtDNA Polymorphism in Complex III Is a Modifier of Healthspan in Mice.Int J Mol Sci. 2019 May 13;20(9):2359. doi: 10.3390/ijms20092359.
• [996] Identification of a rhodanine derivative BML-260 as a potent stimulator of UCP1 expression.Theranostics. 2019 May 26;9(12):3501-3514. doi: 10.7150/thno.31951. eCollection 2019.
• [997] Circulating Serum Myonectin Levels in Obesity and Type 2 Diabetes Mellitus.Exp Clin Endocrinol Diabetes. 2021 Jul;129(7):528-534. doi: 10.1055/a-0896-8548. Epub 2019 Jul 24.
• [998] Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI.Transl Psychiatry. 2019 Nov 21;9(1):315. doi: 10.1038/s41398-019-0652-x.
• [999] Genome-Wide Interaction and Pathway Association Studies for Body Mass Index.Front Genet. 2019 May 1;10:404. doi: 10.3389/fgene.2019.00404. eCollection 2019.
• [1000] Obesity-associated family with sequence similarity 13, member A (FAM13A) is dispensable for adipose development and insulin sensitivity.Int J Obes (Lond). 2019 Jun;43(6):1269-1280. doi: 10.1038/s41366-018-0222-y. Epub 2018 Oct 9.
• [1001] Overweight in the Elderly Induces a Switch in Energy Metabolism that Undermines Muscle Integrity.Aging Dis. 2019 Apr 1;10(2):217-230. doi: 10.14336/AD.2018.0430. eCollection 2019 Apr.
• [1002] Expression of apolipoprotein M and its association with adiponectin in an obese mouse model.Exp Ther Med. 2019 Sep;18(3):1685-1692. doi: 10.3892/etm.2019.7755. Epub 2019 Jul 9.
• [1003] Association of SNP rs7181866 in the nuclear respiratory factor-2 beta subunit encoding GABPB1 gene with obesity and type-2 diabetes mellitus in South Indian population.Int J Biol Macromol. 2019 Jul 1;132:606-614. doi: 10.1016/j.ijbiomac.2019.03.125. Epub 2019 Mar 20.
• [1004] Poor diet quality in pregnancy is associated with increased risk of excess fetal growth: a prospective multi-racial/ethnic cohort study.Int J Epidemiol. 2019 Apr 1;48(2):423-432. doi: 10.1093/ije/dyy285.
• [1005] Metabolic Syndrome is Associated with Ceramide Accumulation in Visceral Adipose Tissue of Women with Morbid Obesity.Obesity (Silver Spring). 2019 Mar;27(3):444-453. doi: 10.1002/oby.22405. Epub 2019 Feb 5.
• [1006] Prepregnancy Obesity, Maternal Dietary Intake, and Oxidative Stress Biomarkers in the Fetomaternal Unit.Biomed Res Int. 2019 Jun 13;2019:5070453. doi: 10.1155/2019/5070453. eCollection 2019.
• [1007] Inhibitor of Differentiation-3 and Estrogenic Endocrine Disruptors: Implications for Susceptibility to Obesity and Metabolic Disorders.Biomed Res Int. 2018 Jan 8;2018:6821601. doi: 10.1155/2018/6821601. eCollection 2018.
• [1008] Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation.J Biol Chem. 2019 Aug 2;294(31):11944-11951. doi: 10.1074/jbc.RA119.008778. Epub 2019 Jun 17.
• [1009] Insulin-like peptide 5 fails to improve metabolism or body weight in obese mice.Peptides. 2019 Oct;120:170116. doi: 10.1016/j.peptides.2019.170116. Epub 2019 Jul 23.
• [1010] Kbtbd11 gene expression in adipose tissue increases in response to feeding and affects adipocyte differentiation.J Diabetes Investig. 2019 Jul;10(4):925-932. doi: 10.1111/jdi.12995. Epub 2019 Jan 25.
• [1011] The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression.J Neural Transm (Vienna). 2019 Jan;126(1):35-45. doi: 10.1007/s00702-018-01966-x. Epub 2019 Jan 4.
• [1012] KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders.CNS Neurosci Ther. 2019 Jul;25(7):887-902. doi: 10.1111/cns.13156.
• [1013] Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.Nat Genet. 2018 Jan;50(1):26-41. doi: 10.1038/s41588-017-0011-x. Epub 2017 Dec 22.
• [1014] Increased Triacylglycerol Lipase Activity in Adipose Tissue of Lean and Obese Men During Endurance Exercise.J Clin Endocrinol Metab. 2017 Nov 1;102(11):3945-3952. doi: 10.1210/jc.2017-00168.
• [1015] Structure and Mechanism of the Divalent Anion/Na?Symporter.Int J Mol Sci. 2019 Jan 21;20(2):440. doi: 10.3390/ijms20020440.
• [1016] Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis.Mol Metab. 2019 Jan;19:97-106. doi: 10.1016/j.molmet.2018.10.007. Epub 2018 Oct 23.
• [1017] Bifidobacteria and its rice fermented products on diet induced obese mice: analysis of physical status, serum profile and gene expressions.Benef Microbes. 2018 Apr 25;9(3):441-452. doi: 10.3920/BM2017.0056. Epub 2018 Feb 7.
• [1018] The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs.Sci Transl Med. 2019 Jun 12;11(496):eaav1892. doi: 10.1126/scitranslmed.aav1892.
• [1019] Molecular Characterization of Microtubule Affinity-Regulating Kinase4 from Sus scrofa and Promotion of Lipogenesis in Primary Porcine Placental Trophoblasts.Int J Mol Sci. 2019 Mar 9;20(5):1206. doi: 10.3390/ijms20051206.
• [1020] Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children.Int J Mol Sci. 2019 Sep 9;20(18):4444. doi: 10.3390/ijms20184444.
• [1021] Mfn2 deletion in brown adipose tissue protects from insulin resistance and impairs thermogenesis.EMBO Rep. 2017 Jul;18(7):1123-1138. doi: 10.15252/embr.201643827. Epub 2017 May 24.
• [1022] Increased Alkaline Phosphatase in Cord Blood of Obese Diabetic Mothers Is Associated to Polyunstaurated Fatty Acid Levels.Ann Nutr Metab. 2019;75(3):153-162. doi: 10.1159/000504404. Epub 2019 Nov 13.
• [1023] Effects of the estrous cycle and ovarian hormones on cue-triggered motivation and intrinsic excitability of medium spiny neurons in the Nucleus Accumbens core of female rats.Horm Behav. 2019 Nov;116:104583. doi: 10.1016/j.yhbeh.2019.104583. Epub 2019 Sep 10.
• [1024] Mss51 deletion enhances muscle metabolism and glucose homeostasis in mice.JCI Insight. 2019 Oct 17;4(20):e122247. doi: 10.1172/jci.insight.122247.
• [1025] Naa10p Inhibits Beige Adipocyte-Mediated Thermogenesis through N--acetylation of Pgc1.Mol Cell. 2019 Nov 7;76(3):500-515.e8. doi: 10.1016/j.molcel.2019.07.026. Epub 2019 Aug 15.
• [1026] Association of breastfeeding and early exposure to sugar-sweetened beverages with obesity prevalence in offspring born to mothers with and without gestational diabetes mellitus.Pediatr Obes. 2019 Dec;14(12):e12569. doi: 10.1111/ijpo.12569. Epub 2019 Aug 6.
• [1027] Bariatric Surgery Reduces Elevated Urinary Mitochondrial DNA Copy Number in Patients With Obesity.J Clin Endocrinol Metab. 2019 Jun 1;104(6):2257-2266. doi: 10.1210/jc.2018-01935.
• [1028] TonEBP/NFAT5 promotes obesity and insulin resistance by epigenetic suppression of white adipose tissue beiging.Nat Commun. 2019 Aug 6;10(1):3536. doi: 10.1038/s41467-019-11302-w.
• [1029] Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4.Oncogene. 2019 Mar;38(13):2351-2363. doi: 10.1038/s41388-018-0592-6. Epub 2018 Dec 5.
• [1030] Effects of MC4R, FTO, and NMB gene variants to obesity, physical activity, and eating behavior phenotypes.IUBMB Life. 2016 Oct;68(10):806-16. doi: 10.1002/iub.1558. Epub 2016 Sep 15.
• [1031] Neuromedin B receptor disruption impairs adipogenesis in mice and 3T3-L1 cells.J Mol Endocrinol. 2019 Jul;63(1):93-102. doi: 10.1530/JME-19-0032.
• [1032] PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration.Peptides. 2017 Aug;94:99-105. doi: 10.1016/j.peptides.2017.04.001. Epub 2017 Apr 8.
• [1033] Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway.Eur J Pharmacol. 2019 Dec 1;864:172723. doi: 10.1016/j.ejphar.2019.172723. Epub 2019 Oct 3.
• [1034] Haptoglobin phenotypes with weak antioxidant capacity increase risk factors of cardiovascular disease in Ghanaian HIV-infected patients on highly active antiretroviral therapy.Trop Med Int Health. 2019 Jun;24(6):766-774. doi: 10.1111/tmi.13229. Epub 2019 Mar 21.
• [1035] PDIA1/P4HB is required for efficient proinsulin maturation and cell health in response to diet induced obesity.Elife. 2019 Jun 11;8:e44528. doi: 10.7554/eLife.44528.
• [1036] Perm1 regulates CaMKII activation and shapes skeletal muscle responses to endurance exercise training.Mol Metab. 2019 May;23:88-97. doi: 10.1016/j.molmet.2019.02.009. Epub 2019 Feb 27.
• [1037] The association between obesity and race among Brazilian adults is dependent on sex and socio-economic status.Public Health Nutr. 2018 Aug;21(11):2096-2102. doi: 10.1017/S1368980018000307. Epub 2018 Mar 4.
• [1038] Mechanosensitive Ion Channel Piezo1 Regulates Diet-Induced Adipose Inflammation and Systemic Insulin Resistance.Front Endocrinol (Lausanne). 2019 Jun 13;10:373. doi: 10.3389/fendo.2019.00373. eCollection 2019.
• [1039] Genetic architecture of human thinness compared to severe obesity.PLoS Genet. 2019 Jan 24;15(1):e1007603. doi: 10.1371/journal.pgen.1007603. eCollection 2019 Jan.
• [1040] Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment.Appl Microbiol Biotechnol. 2019 Aug;103(16):6711-6723. doi: 10.1007/s00253-019-09958-x. Epub 2019 Jun 15.
• [1041] Inhibition of miR-324-5p increases PM20D1-mediated white and brown adipose loss and reduces body weight in juvenile mice.Eur J Pharmacol. 2019 Nov 15;863:172708. doi: 10.1016/j.ejphar.2019.172708. Epub 2019 Sep 27.
• [1042] CPI-17-mediated contraction of vascular smooth muscle is essential for the development of hypertension in obese mice.J Genet Genomics. 2019 Mar 20;46(3):109-118. doi: 10.1016/j.jgg.2019.02.005. Epub 2019 Mar 15.
• [1043] Distribution of local ancestry and evidence of adaptation in admixed populations.Sci Rep. 2019 Sep 25;9(1):13900. doi: 10.1038/s41598-019-50362-2.
• [1044] Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneurons.Clin Sci (Lond). 2019 Jul 1;133(13):1367-1386. doi: 10.1042/CS20190180. Print 2019 Jul 15.
• [1045] FAM134B improves preadipocytes differentiation by enhancing mitophagy.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Dec;1864(12):158508. doi: 10.1016/j.bbalip.2019.08.004. Epub 2019 Aug 22.
• [1046] The Rho GTPase RND3 regulates adipocyte lipolysis.Metabolism. 2019 Dec;101:153999. doi: 10.1016/j.metabol.2019.153999. Epub 2019 Oct 28.
• [1047] Decreased RNF41 expression leads to insulin resistance in skeletal muscle of obese women.Metabolism. 2018 Jun;83:81-91. doi: 10.1016/j.metabol.2018.01.014. Epub 2018 Feb 2.
• [1048] S100A16-induced adipogenesis is associated with up-regulation of 11 -hydroxysteroid dehydrogenase type 1 (11-HSD1).Biosci Rep. 2019 Sep 9;39(9):BSR20182042. doi: 10.1042/BSR20182042. Print 2019 Sep 30.
• [1049] Early Life Displacement Due to Armed Conflict and Violence, Early Nutrition, and Older Adult Hypertension, Diabetes, and Obesity in the Middle-Income Country of Colombia.J Aging Health. 2019 Sep;31(8):1479-1502. doi: 10.1177/0898264318778111. Epub 2018 Jun 19.
• [1050] Morbid obesity-related changes in the expression of lipid receptors, transporters, and HSL in human sperm.J Assist Reprod Genet. 2019 Apr;36(4):777-786. doi: 10.1007/s10815-019-01406-z. Epub 2019 Jan 18.
• [1051] Maternal pre-pregnancy body mass index, smoking in pregnancy, and alcohol intake in pregnancy in relation to pubertal timing in the children.BMC Pediatr. 2019 Sep 16;19(1):338. doi: 10.1186/s12887-019-1715-0.
• [1052] Hypothalamic ER-associated degradation regulates POMC maturation, feeding, and age-associated obesity.J Clin Invest. 2018 Mar 1;128(3):1125-1140. doi: 10.1172/JCI96420. Epub 2018 Feb 19.
• [1053] Selenoprotein W deficiency does not affect oxidative stress and insulin sensitivity in the skeletal muscle of high-fat diet-fed obese mice.Am J Physiol Cell Physiol. 2019 Dec 1;317(6):C1172-C1182. doi: 10.1152/ajpcell.00064.2019. Epub 2019 Sep 11.
• [1054] Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice.Biomed Res Int. 2019 Jun 19;2019:6740616. doi: 10.1155/2019/6740616. eCollection 2019.
• [1055] Association between Transcription Factor AP-2B genotype, obesity, insulin resistance and dietary intake in a longitudinal birth cohort study.Int J Obes (Lond). 2019 Oct;43(10):2095-2106. doi: 10.1038/s41366-019-0396-y. Epub 2019 Jun 17.
• [1056] Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor--mediated fatty acid oxidation.Am J Physiol Endocrinol Metab. 2019 Sep 1;317(3):E436-E445. doi: 10.1152/ajpendo.00454.2018. Epub 2019 Jun 18.
• [1057] The RNA-Binding Protein A1CF Regulates Hepatic Fructose and Glycerol Metabolism via Alternative RNA Splicing.Cell Rep. 2019 Oct 8;29(2):283-300.e8. doi: 10.1016/j.celrep.2019.08.100.
• [1058] The genetic association between alpha-2-macroglobulin (A2M) gene deletion polymorphism and low serum A2M concentration in overweight/obese Thais.Nutr Neurosci. 2006 Feb-Apr;9(1-2):93-8. doi: 10.1080/10284150600771777.
• [1059] 2-Aminoadipic acid (2-AAA) as a potential biomarker for insulin resistance in childhood obesity.Sci Rep. 2019 Sep 20;9(1):13610. doi: 10.1038/s41598-019-49578-z.
• [1060] Loss of ABHD15 Impairs the Anti-lipolytic Action of Insulin by Altering PDE3B Stability and Contributes to Insulin Resistance.Cell Rep. 2018 May 15;23(7):1948-1961. doi: 10.1016/j.celrep.2018.04.055.
• [1061] Macrophage CGI-58 deficiency promotes IL-1 transcription by activating the SOCS3-FOXO1 pathway.Clin Sci (Lond). 2015 Apr;128(8):493-506. doi: 10.1042/CS20140414.
• [1062] Elevated Venous Thromboembolism Risk Following Colectomy for IBD Is Equal to Those for Colorectal Cancer for Ninety Days After Surgery.Dis Colon Rectum. 2018 Mar;61(3):375-381. doi: 10.1097/DCR.0000000000001036.
• [1063] The interaction between aggrecan gene VNTR polymorphism and obesity in predicting incident symptomatic lumbar disc herniation.Connect Tissue Res. 2014 Oct-Dec;55(5-6):384-90. doi: 10.3109/03008207.2014.959117. Epub 2014 Sep 22.
• [1064] Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2.Cell Oncol (Dordr). 2017 Dec;40(6):537-547. doi: 10.1007/s13402-017-0342-8. Epub 2017 Aug 2.
• [1065] BFIT, a unique acyl-CoA thioesterase induced in thermogenic brown adipose tissue: cloning, organization of the human gene and assessment of a potential link to obesity.Biochem J. 2001 Nov 15;360(Pt 1):135-42. doi: 10.1042/bj3600135.
• [1066] Acyl-CoA synthetase long-chain 5 genotype is associated with body composition changes in response to lifestyle interventions in postmenopausal women with overweight and obesity: a genetic association study on cohorts Montral-Ottawa New Emerging Team, and Complications Associated with Obesity.BMC Med Genet. 2016 Aug 11;17(1):56. doi: 10.1186/s12881-016-0320-4.
• [1067] Left ventricular structure in relation to the human SAH gene in the European Project on Genes in Hypertension.Hypertens Res. 2009 Feb;32(2):145-51. doi: 10.1038/hr.2008.30. Epub 2009 Jan 16.
• [1068] Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus.Metabolism. 1999 Aug;48(8):949-51. doi: 10.1016/s0026-0495(99)90187-7.
• [1069] ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice.Mediators Inflamm. 2017;2017:7281986. doi: 10.1155/2017/7281986. Epub 2017 Feb 7.
• [1070] The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice.Int J Mol Sci. 2017 Apr 21;18(4):884. doi: 10.3390/ijms18040884.
• [1071] Association between serum magnesium and blood count: influence of type 2 diabetes and central obesity.Br J Nutr. 2019 Jun;121(11):1287-1293. doi: 10.1017/S0007114519000862. Epub 2019 Apr 29.
• [1072] Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.Nat Genet. 2013 May;45(5):501-12. doi: 10.1038/ng.2606. Epub 2013 Apr 7.
• [1073] Associations between genetic obesity susceptibility and early postnatal fat and lean mass: an individual participant meta-analysis.JAMA Pediatr. 2014 Dec;168(12):1122-30. doi: 10.1001/jamapediatrics.2014.1619.
• [1074] Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta.Clin Epigenetics. 2019 Feb 7;11(1):20. doi: 10.1186/s13148-019-0612-6.
• [1075] Association of copy number variation in the AHI1 gene with risk of obesity in the Chinese population.Eur J Endocrinol. 2012 Apr;166(4):727-34. doi: 10.1530/EJE-11-0999. Epub 2012 Jan 27.
• [1076] Offspring DNA methylation of the aryl-hydrocarbon receptor repressor gene is associated with maternal BMI, gestational age, and birth weight.Epigenetics. 2015;10(10):913-21. doi: 10.1080/15592294.2015.1078963. Epub 2015 Aug 7.
• [1077] AIDA Selectively Mediates Downregulation of Fat Synthesis Enzymes by ERAD to Retard Intestinal Fat Absorption and Prevent Obesity.Cell Metab. 2018 Apr 3;27(4):843-853.e6. doi: 10.1016/j.cmet.2018.02.021.
• [1078] A combination of Lactobacillus mali APS1 and dieting improved the efficacy of obesity treatment via manipulating gut microbiome in mice.Sci Rep. 2018 Apr 18;8(1):6153. doi: 10.1038/s41598-018-23844-y.
• [1079] Mice deficient in AKAP13 (BRX) develop compulsive-like behavior and increased body weight.Brain Res Bull. 2018 Jun;140:72-79. doi: 10.1016/j.brainresbull.2018.04.005. Epub 2018 Apr 10.
• [1080] ALMS1 and Alstrm syndrome: a recessive form of metabolic, neurosensory and cardiac deficits.J Mol Med (Berl). 2019 Jan;97(1):1-17. doi: 10.1007/s00109-018-1714-x. Epub 2018 Nov 12.
• [1081] Hepatocyte ALOXE3 is induced during adaptive fasting and enhances insulin sensitivity by activating hepatic PPAR.JCI Insight. 2018 Aug 23;3(16):e120794. doi: 10.1172/jci.insight.120794. eCollection 2018 Aug 23.
• [1082] A genome-wide association meta-analysis identifies new childhood obesity loci.Nat Genet. 2012 May;44(5):526-31. doi: 10.1038/ng.2247.
• [1083] Do Patients with Pre-Existing Psychiatric Illness Have an Increased Risk of Infection after Injury?.Surg Infect (Larchmt). 2017 Jul;18(5):545-549. doi: 10.1089/sur.2016.218. Epub 2017 Mar 29.
• [1084] Distinctive Reproductive Phenotypes in Peripubertal Girls at Risk for Polycystic Ovary Syndrome.J Clin Endocrinol Metab. 2019 Aug 1;104(8):3355-3361. doi: 10.1210/jc.2018-02313.
• [1085] AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.J Appl Genet. 2011 Feb;52(1):67-76. doi: 10.1007/s13353-010-0009-x. Epub 2010 Nov 25.
• [1086] Knockdown of angiopoietin-like 2 mimics the benefits of intermittent fasting on insulin responsiveness and weight loss.Exp Biol Med (Maywood). 2018 Jan;243(1):45-49. doi: 10.1177/1535370217745505. Epub 2017 Dec 1.
• [1087] Cell-autonomous adiposity through increased cell surface GLUT4 due to ankyrin-B deficiency.Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):12743-12748. doi: 10.1073/pnas.1708865114. Epub 2017 Nov 13.
• [1088] Morphological and biochemical features of obesity are associated with mineralization genes' polymorphisms.Int J Obes (Lond). 2010 Aug;34(8):1308-18. doi: 10.1038/ijo.2010.53. Epub 2010 Mar 16.
• [1089] Complete sequence of the ANKK1 gene in Mexican-Mestizo individuals with obesity, with or without binge eating disorder.Eur Psychiatry. 2018 Oct;54:59-64. doi: 10.1016/j.eurpsy.2018.07.010. Epub 2018 Aug 16.
• [1090] Epigenetic silencing of the ANKRD26 gene correlates to the pro-inflammatory profile and increased cardio-metabolic risk factors in human obesity.Clin Epigenetics. 2019 Dec 4;11(1):181. doi: 10.1186/s13148-019-0768-0.
• [1091] Annexin A6 is highly abundant in monocytes of obese and type 2 diabetic individuals and is downregulated by adiponectin in vitro.Exp Mol Med. 2009 Jul 31;41(7):501-7. doi: 10.3858/emm.2009.41.7.055.
• [1092] Physical Interactions and Expression Quantitative Traits Loci Identify Regulatory Connections for Obesity and Type 2 Diabetes Associated SNPs.Front Genet. 2017 Oct 13;8:150. doi: 10.3389/fgene.2017.00150. eCollection 2017.
• [1093] Preadipocyte stimulating factor in rat serum: evidence for a discrete 63 kDa protein that promotes cell differentiation of rat preadipocytes in primary cultures.J Cell Physiol. 1989 Dec;141(3):543-57. doi: 10.1002/jcp.1041410313.
• [1094] New Insights into Apolipoprotein A5 and the Modulation of Human Adipose-derived Mesenchymal Stem Cells Adipogenesis.Curr Mol Med. 2020;20(2):144-156. doi: 10.2174/1566524019666190927155702.
• [1095] High ApoD protein level in the round ligament fat depot of severely obese women is associated with an improved inflammatory profile.Endocrine. 2018 Aug;61(2):248-257. doi: 10.1007/s12020-018-1621-5. Epub 2018 Jun 4.
• [1096] Apolipoprotein M: new connections with diet, adipose tissue and metabolic syndrome.Curr Opin Lipidol. 2020 Feb;31(1):8-14. doi: 10.1097/MOL.0000000000000654.
• [1097] Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart.J Clin Invest. 2014 May;124(5):2277-86. doi: 10.1172/JCI74668. Epub 2014 Apr 17.
• [1098] Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.Cancer Cell. 2017 Jul 10;32(1):57-70.e3. doi: 10.1016/j.ccell.2017.05.009. Epub 2017 Jun 22.
• [1099] GTRAP3-18 regulates food intake and body weight by interacting with pro-opiomelanocortin.FASEB J. 2018 Jan;32(1):330-341. doi: 10.1096/fj.201700421R. Epub 2017 Sep 13.
• [1100] A viable hypomorphic Arnt2 mutation causes hyperphagic obesity, diabetes and hepatic steatosis.Dis Model Mech. 2018 Dec 18;11(12):dmm035451. doi: 10.1242/dmm.035451.
• [1101] Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors.J Antimicrob Chemother. 2018 Aug 1;73(8):2177-2185. doi: 10.1093/jac/dky145.
• [1102] Effects of Providing High-Fat versus High-Carbohydrate Meals on Daily and Postprandial Physical Activity and Glucose Patterns: a Randomised Controlled Trial.Nutrients. 2018 Apr 30;10(5):557. doi: 10.3390/nu10050557.
• [1103] Developmental programming of appetite/satiety.Ann Nutr Metab. 2014;64 Suppl 1:36-44. doi: 10.1159/000360508. Epub 2014 Jul 23.
• [1104] Obesity challenges the hepatoprotective function of the integrated stress response to asparaginase exposure in mice.J Biol Chem. 2017 Apr 21;292(16):6786-6798. doi: 10.1074/jbc.M116.768408. Epub 2017 Feb 27.
• [1105] The GPR120 agonist TUG-891 promotes metabolic health by stimulating mitochondrial respiration in brown fat.EMBO Mol Med. 2018 Mar;10(3):e8047. doi: 10.15252/emmm.201708047.
• [1106] Huoxue Qianyang decoction ameliorates cardiac remodeling in obese spontaneously hypertensive rats in association with ATF6-CHOP endoplasmic reticulum stress signaling pathway regulation.Biomed Pharmacother. 2020 Jan;121:109518. doi: 10.1016/j.biopha.2019.109518. Epub 2019 Nov 2.
• [1107] Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function.PLoS One. 2017 May 25;12(5):e0178368. doi: 10.1371/journal.pone.0178368. eCollection 2017.
• [1108] Orosomucoid expression profiles in liver, adipose tissues and serum of lean and obese domestic pigs, Gttingen minipigs and Ossabaw minipigs.Vet Immunol Immunopathol. 2013 Feb 15;151(3-4):325-30. doi: 10.1016/j.vetimm.2012.11.002. Epub 2012 Nov 27.
• [1109] Mitochondrial ATP synthase -subunit production rate and ATP synthase specific activity are reduced in skeletal muscle of humans with obesity.Exp Physiol. 2019 Jan;104(1):126-135. doi: 10.1113/EP087278. Epub 2018 Nov 12.
• [1110] Tall stature and progressive overweight in mitochondrial encephalopathy.J Inherit Metab Dis. 2003;26(7):720-2. doi: 10.1023/b:boli.0000005647.71704.25.
• [1111] Mitochondrial DNA variants in obesity.PLoS One. 2014 May 2;9(5):e94882. doi: 10.1371/journal.pone.0094882. eCollection 2014.
• [1112] The (pro)renin receptor in health and disease.Nat Rev Nephrol. 2019 Nov;15(11):693-712. doi: 10.1038/s41581-019-0160-5.
• [1113] Attractin: cautionary tales for therapeutic intervention in molecules with pleiotropic functionality.J Environ Pathol Toxicol Oncol. 2004;23(1):1-11. doi: 10.1615/jenvpathtoxoncol.v23.i1.10.
• [1114] Investigation of common and rare genetic variation in the BAMBI genomic region in light of human obesity.Endocrine. 2016 May;52(2):277-86. doi: 10.1007/s12020-015-0778-4. Epub 2015 Oct 26.
• [1115] Next-generation sequence analysis of genes associated with obesity and nonalcoholic fatty liver disease-related cirrhosis in extreme obesity.Hum Hered. 2013;75(2-4):144-51. doi: 10.1159/000351719. Epub 2013 Sep 27.
• [1116] A novel test for recessive contributions to complex diseases implicates Bardet-Biedl syndrome gene BBS10 in idiopathic type 2 diabetes and obesity.Am J Hum Genet. 2014 Nov 6;95(5):509-20. doi: 10.1016/j.ajhg.2014.09.015. Epub 2014 Oct 16.
• [1117] Bardet-Biedl syndrome gene variants are associated with both childhood and adult common obesity in French Caucasians.Diabetes. 2006 Oct;55(10):2876-82. doi: 10.2337/db06-0337.
• [1118] Bardet-Biedl syndrome obesity: BBS4 regulates cellular ER stress in early adipogenesis.Mol Genet Metab. 2019 Apr;126(4):495-503. doi: 10.1016/j.ymgme.2019.03.006. Epub 2019 Mar 15.
• [1119] Screening of 31 genes involved in monogenic forms of obesity in 23 Pakistani probands with early-onset childhood obesity: a case report.BMC Med Genet. 2019 Sep 5;20(1):152. doi: 10.1186/s12881-019-0886-8.
• [1120] Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice.J Lipid Res. 2018 Jan;59(1):35-47. doi: 10.1194/jlr.M077016. Epub 2017 Nov 7.
• [1121] Sweet Killing in Obesity and Diabetes: The Metabolic Role of the BH3-only Protein BIM.J Mol Biol. 2018 Sep 14;430(18 Pt B):3041-3050. doi: 10.1016/j.jmb.2018.07.022. Epub 2018 Jul 21.
• [1122] Laminar inflammatory events in lean and obese ponies subjected to high carbohydrate feeding: Implications for pasture-associated laminitis.Equine Vet J. 2015 Jul;47(4):489-93. doi: 10.1111/evj.12314. Epub 2014 Sep 10.
• [1123] Deficiency of the basic helix-loop-helix transcription factor DEC1 prevents obesity induced by a high-fat diet in mice.Genes Cells. 2018 Jul 3. doi: 10.1111/gtc.12607. Online ahead of print.
• [1124] Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity?.J Endocrinol Invest. 2007 Oct;30(9):747-53. doi: 10.1007/BF03350812.
• [1125] Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study.Obesity (Silver Spring). 2017 May;25(5):857-865. doi: 10.1002/oby.21811.
• [1126] Reestablishment of Energy Balance in a Male Mouse Model With POMC Neuron Deletion of BMPR1A.Endocrinology. 2017 Dec 1;158(12):4233-4245. doi: 10.1210/en.2017-00212.
• [1127] Null variants and deletions in BRWD3 cause an X-linked syndrome of mild-moderate intellectual disability, macrocephaly, and obesity: A series of 17 patients.Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):638-643. doi: 10.1002/ajmg.c.31750. Epub 2019 Nov 12.
• [1128] Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma.Clin Transl Oncol. 2016 Jun;18(6):632-40. doi: 10.1007/s12094-015-1411-y. Epub 2015 Oct 16.
• [1129] Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1.Clin Kidney J. 2018 Oct 11;12(3):420-426. doi: 10.1093/ckj/sfy095. eCollection 2019 Jun.
• [1130] Lower circulating levels of CTRP12 and CTRP13 in polycystic ovarian syndrome: Irrespective of obesity.PLoS One. 2018 Dec 12;13(12):e0208059. doi: 10.1371/journal.pone.0208059. eCollection 2018.
• [1131] Circulating complement-1q tumor necrosis factor--related protein isoform5 levels are low in type2 diabetes patients and reduced by dapagliflozin.J Diabetes Investig. 2020 Jan;11(1):88-95. doi: 10.1111/jdi.13069. Epub 2019 Jun 6.
• [1132] CTRP7 deletion attenuates obesity-linked glucose intolerance, adipose tissue inflammation, and hepatic stress.Am J Physiol Endocrinol Metab. 2017 Apr 1;312(4):E309-E325. doi: 10.1152/ajpendo.00344.2016. Epub 2017 Feb 21.
• [1133] Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.Cytokine. 2018 Oct;110:52-57. doi: 10.1016/j.cyto.2018.04.019. Epub 2018 Apr 25.
• [1134] Membrane Trafficking Protein CDP138 Regulates Fat Browning and Insulin Sensitivity through Controlling Catecholamine Release.Mol Cell Biol. 2018 Mar 29;38(8):e00153-17. doi: 10.1128/MCB.00153-17. Print 2018 Apr 15.
• [1135] Genetic variation in CADM2 as a link between psychological traits and obesity.Sci Rep. 2019 May 14;9(1):7339. doi: 10.1038/s41598-019-43861-9.
• [1136] Obesity and ischemic stroke modulate the methylation levels of KCNQ1 in white blood cells.Hum Mol Genet. 2015 Mar 1;24(5):1432-40. doi: 10.1093/hmg/ddu559. Epub 2014 Nov 4.
• [1137] Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):16064-9. doi: 10.1073/pnas.0405041101. Epub 2004 Nov 1.
• [1138] The essential function of CARD9 in diet-induced inflammation and metabolic disorders in mice.J Cell Mol Med. 2018 Jun;22(6):2993-3004. doi: 10.1111/jcmm.13494. Epub 2018 Mar 25.
• [1139] Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index.Mol Psychiatry. 2017 Feb;22(2):192-201. doi: 10.1038/mp.2016.71. Epub 2016 May 17.
• [1140] Calpain Inhibition Attenuates Adipose Tissue Inflammation and Fibrosis in Diet-induced Obese Mice.Sci Rep. 2017 Oct 31;7(1):14398. doi: 10.1038/s41598-017-14719-9.
• [1141] Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability.FASEB J. 2014 Aug;28(8):3769-79. doi: 10.1096/fj.14-251165. Epub 2014 May 8.
• [1142] Identification of the inhibitory activity of walnut extract on the E3 ligase Syvn1.Mol Med Rep. 2018 Dec;18(6):5701-5708. doi: 10.3892/mmr.2018.9576. Epub 2018 Oct 23.
• [1143] Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.J Clin Invest. 2010 Feb;120(2):545-58. doi: 10.1172/JCI39319. Epub 2010 Jan 11.
• [1144] Loss of DRO1/CCDC80 results in obesity and promotes adipocyte differentiation.Mol Cell Endocrinol. 2017 Jan 5;439:286-296. doi: 10.1016/j.mce.2016.09.014. Epub 2016 Sep 16.
• [1145] Hypertension in aortic stenosis: relationship with revealed symptoms and functional measures on treadmill exercise.J Hypertens. 2019 Nov;37(11):2209-2215. doi: 10.1097/HJH.0000000000002149.
• [1146] Adipose and Circulating CCL18 Levels Associate With Metabolic Risk Factors in Women.J Clin Endocrinol Metab. 2016 Nov;101(11):4021-4029. doi: 10.1210/jc.2016-2390. Epub 2016 Jul 26.
• [1147] Adipose tissue expression of CCL19 chemokine is positively associated with insulin resistance.Diabetes Metab Res Rev. 2019 Feb;35(2):e3087. doi: 10.1002/dmrr.3087. Epub 2018 Nov 8.
• [1148] Innate lymphoid cells at the interface between obesity and asthma.Immunology. 2018 Jan;153(1):21-30. doi: 10.1111/imm.12832. Epub 2017 Sep 26.
• [1149] Exercise initiated after the onset of insulin resistance improves trabecular microarchitecture and cortical bone biomechanics of the tibia in hyperphagic Otsuka Long Evans Tokushima Fatty rats.Bone. 2017 Oct;103:188-199. doi: 10.1016/j.bone.2017.07.010. Epub 2017 Jul 12.
• [1150] Plasma immunological markers in pregnancy and cord blood: Apossible link between macrophage chemo-attractants and risk of childhood type 1 diabetes.Am J Reprod Immunol. 2018 Mar;79(3). doi: 10.1111/aji.12802. Epub 2017 Dec 20.
• [1151] Expression of monocyte chemotactic protein 3 following simulated birth trauma in a murine model of obesity.Urology. 2010 Dec;76(6):1517.e12-7. doi: 10.1016/j.urology.2010.07.466. Epub 2010 Oct 23.
• [1152] Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin.J Clin Endocrinol Metab. 2007 Jul;92(7):2688-95. doi: 10.1210/jc.2006-2814. Epub 2007 Apr 24.
• [1153] Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesity.J Cell Commun Signal. 2018 Sep;12(3):539-548. doi: 10.1007/s12079-017-0427-1. Epub 2017 Nov 11.
• [1154] CCN5/WISP2 and metabolic diseases.J Cell Commun Signal. 2018 Mar;12(1):309-318. doi: 10.1007/s12079-017-0437-z. Epub 2017 Dec 15.
• [1155] The radioprotective 105/MD-1 complex contributes to diet-induced obesity and adipose tissue inflammation.Diabetes. 2012 May;61(5):1199-209. doi: 10.2337/db11-1182. Epub 2012 Mar 6.
• [1156] Comparative genome analysis with the human genome reveals chicken genes associated with fatness and body weight.Anim Genet. 2011 Dec;42(6):642-9. doi: 10.1111/j.1365-2052.2011.02191.x. Epub 2011 Apr 13.
• [1157] Relationship between variants of the leptin gene and obesity and metabolic biomarkers in Brazilian individuals.Arq Bras Endocrinol Metabol. 2010 Mar;54(3):282-8. doi: 10.1590/s0004-27302010000300006.
• [1158] Putative targets of CNS melanocortin receptor activity.Ann N Y Acad Sci. 2003 Jun;994:211-7. doi: 10.1111/j.1749-6632.2003.tb03182.x.
• [1159] Influence of obesity, age, and comorbidities on the multi-biomarker disease activity test in rheumatoid arthritis.Semin Arthritis Rheum. 2018 Feb;47(4):472-477. doi: 10.1016/j.semarthrit.2017.07.010. Epub 2017 Aug 2.
• [1160] CDH13 abundance interferes with adipocyte differentiation and is a novel biomarker for adipose tissue health.Int J Obes (Lond). 2018 Jun;42(5):1039-1050. doi: 10.1038/s41366-018-0022-4. Epub 2018 Feb 21.
• [1161] Protective Effects of an Obesity-Associated Polymorphism (CDKAL1 rs9356744) on Prediabetes: The Cardiometabolic Risk in Chinese (CRC) Study.Exp Clin Endocrinol Diabetes. 2018 Sep;126(9):540-545. doi: 10.1055/s-0042-109607. Epub 2018 Jun 22.
• [1162] Artemisinic acid is a regulator of adipocyte differentiation and C/EBP expression.J Cell Biochem. 2012 Jul;113(7):2488-99. doi: 10.1002/jcb.24124.
• [1163] Haploinsufficiency of CELF4 at 18q12.2 is associated with developmental and behavioral disorders, seizures, eye manifestations, and obesity.Eur J Hum Genet. 2012 Dec;20(12):1315-9. doi: 10.1038/ejhg.2012.92. Epub 2012 May 23.
• [1164] Sleep-disordered breathing, circulating exosomes, and insulin sensitivity in adipocytes.Int J Obes (Lond). 2018 Jun;42(6):1127-1139. doi: 10.1038/s41366-018-0099-9. Epub 2018 Jun 11.
• [1165] Gating Ciliary Transport.Dev Cell. 2017 Jul 10;42(1):5-6. doi: 10.1016/j.devcel.2017.06.016.
• [1166] C21orf2 is mutated in recessive early-onset retinal dystrophy with macular staphyloma and encodes a protein that localises to the photoreceptor primary cilium.Br J Ophthalmol. 2015 Dec;99(12):1725-31. doi: 10.1136/bjophthalmol-2015-307277. Epub 2015 Aug 20.
• [1167] High molecular weight adiponectin reduces glucolipotoxicity-induced inflammation and improves lipid metabolism and insulin sensitivity via APPL1-AMPK-GLUT4 regulation in 3T3-L1 adipocytes.Atherosclerosis. 2019 Sep;288:67-75. doi: 10.1016/j.atherosclerosis.2019.07.011. Epub 2019 Jul 12.
• [1168] CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.Gynecol Oncol. 2014 Apr;133(1):83-9. doi: 10.1016/j.ygyno.2013.12.006.
• [1169] A cafeteria diet triggers intestinal inflammation and oxidative stress in obese rats.Br J Nutr. 2017 Jan;117(2):218-229. doi: 10.1017/S0007114516004608. Epub 2017 Jan 30.
• [1170] A case of 14q11.2 microdeletion with autistic features, severe obesity and facial dysmorphisms suggestive of Wolf-Hirschhorn syndrome.Am J Med Genet A. 2014 Jan;164A(1):190-3. doi: 10.1002/ajmg.a.36200. Epub 2013 Nov 15.
• [1171] The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis.Sci Rep. 2019 May 16;9(1):7501. doi: 10.1038/s41598-019-43928-7.
• [1172] FSP27 and Links to Obesity and Diabetes Mellitus.Curr Obes Rep. 2019 Sep;8(3):255-261. doi: 10.1007/s13679-019-00343-3.
• [1173] CISD1 in association with obesity-associated dysfunctional adipogenesis in human visceral adipose tissue.Obesity (Silver Spring). 2016 Jan;24(1):139-47. doi: 10.1002/oby.21334.
• [1174] Structure-function analysis of NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health and disease.Biochim Biophys Acta. 2015 Jun;1853(6):1294-315. doi: 10.1016/j.bbamcr.2014.10.014. Epub 2014 Oct 23.
• [1175] Insulin Downregulates the Transcriptional Coregulator CITED2, an Inhibitor of Proangiogenic Function in Endothelial Cells.Diabetes. 2016 Dec;65(12):3680-3690. doi: 10.2337/db16-0001. Epub 2016 Aug 25.
• [1176] Obesity is associated with shorter telomeres in 8 year-old children.Sci Rep. 2019 Dec 10;9(1):18739. doi: 10.1038/s41598-019-55283-8.
• [1177] Dectin-1 Activation Exacerbates Obesity and Insulin Resistance in the Absence of MyD88.Cell Rep. 2017 Jun 13;19(11):2272-2288. doi: 10.1016/j.celrep.2017.05.059.
• [1178] Genetic resistance to liver fibrosis on A/J mouse chromosome 17.Alcohol Clin Exp Res. 2013 Oct;37(10):1668-79. doi: 10.1111/acer.12157. Epub 2013 Jun 13.
• [1179] Opposite Genetic Effects of CMIP Polymorphisms on the Risk of Type 2 Diabetes and Obesity: A Family-Based Study in China.Int J Mol Sci. 2018 Mar 28;19(4):1011. doi: 10.3390/ijms19041011.
• [1180] Consumption of Ocimum sanctum L. and Citrus paradisi infusions modulates lipid metabolism and insulin resistance in obese rats.Food Funct. 2014 May;5(5):927-35. doi: 10.1039/c3fo60604j.
• [1181] The Combined Effects of Genetic Variation in the CNDP1 and CNDP2 Genes and Dietary Carbohydrate and Carotene Intake on Obesity Risk.J Nutrigenet Nutrigenomics. 2017;10(5-6):146-154. doi: 10.1159/000485798. Epub 2018 Jan 17.
• [1182] Obesity-insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J mice.Metabolism. 2012 Aug;61(8):1129-41. doi: 10.1016/j.metabol.2012.01.008. Epub 2012 Mar 3.
• [1183] Unexpected phenotypic effects of a transgene integration causing a knockout of the endogenous Contactin-5 gene in mice.Transgenic Res. 2018 Feb;27(1):1-13. doi: 10.1007/s11248-017-0053-y. Epub 2017 Dec 20.
• [1184] Alterations in circadian and meal-induced gut peptide levels in lean and obese rats.Exp Biol Med (Maywood). 2017 Dec;242(18):1786-1794. doi: 10.1177/1535370217732041. Epub 2017 Sep 15.
• [1185] Acute inflammation plays a limited role in the regulation of adipose tissue COL1A1 protein abundance.J Nutr Biochem. 2012 Jun;23(6):567-72. doi: 10.1016/j.jnutbio.2011.02.013. Epub 2011 Jul 19.
• [1186] Knocking out or pharmaceutical inhibition of fatty acid binding protein 4 (FABP4) alleviates osteoarthritis induced by high-fat diet in mice.Osteoarthritis Cartilage. 2018 Jun;26(6):824-833. doi: 10.1016/j.joca.2018.03.002. Epub 2018 Mar 13.
• [1187] Emerging therapeutic potential for xenin and related peptides in obesity and diabetes.Diabetes Metab Res Rev. 2018 Sep;34(6):e3006. doi: 10.1002/dmrr.3006. Epub 2018 Apr 26.
• [1188] Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode.Breast Cancer Res. 2016 Mar 8;18(1):29. doi: 10.1186/s13058-016-0689-1.
• [1189] Low cytochrome oxidase 4I1 links mitochondrial dysfunction to obesity and type 2 diabetes in humans and mice.Int J Obes (Lond). 2015 Aug;39(8):1254-63. doi: 10.1038/ijo.2015.58. Epub 2015 Apr 14.
• [1190] Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany.Hamostaseologie. 2019 Nov;39(4):355-359. doi: 10.1055/s-0039-1677874. Epub 2019 Feb 5.
• [1191] Genetic variants in the CPNE5 gene are associated with alcohol dependence and obesity in Caucasian populations.J Psychiatr Res. 2015 Dec;71:1-7. doi: 10.1016/j.jpsychires.2015.09.008. Epub 2015 Sep 14.
• [1192] Cellular retinoic acid binding protein 1 protects mice from high-fat diet-induced obesity by decreasing adipocyte hypertrophy.Int J Obes (Lond). 2020 Feb;44(2):466-474. doi: 10.1038/s41366-019-0379-z. Epub 2019 Jun 4.
• [1193] CREG1 stimulates brown adipocyte formation and ameliorates diet-induced obesity in mice.FASEB J. 2019 Jul;33(7):8069-8082. doi: 10.1096/fj.201802147RR. Epub 2019 Mar 27.
• [1194] Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function.Mol Metab. 2016 Oct 5;5(12):1200-1207. doi: 10.1016/j.molmet.2016.09.011. eCollection 2016 Dec.
• [1195] Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy.Biochim Biophys Acta. 2015 Jul;1852(7):1323-33. doi: 10.1016/j.bbadis.2015.03.010. Epub 2015 Mar 31.
• [1196] Regulation role of CRTC3 in skeletal muscle and adipose tissue.J Cell Physiol. 2018 Feb;233(2):818-821. doi: 10.1002/jcp.25917. Epub 2017 May 19.
• [1197] Lack of CUL4B in Adipocytes Promotes PPAR-Mediated Adipose Tissue Expansion and Insulin Sensitivity.Diabetes. 2017 Feb;66(2):300-313. doi: 10.2337/db16-0743. Epub 2016 Nov 29.
• [1198] The overweight increases circulating inflammatory mediators commonly associated with obesity in young individuals.Cytokine. 2018 Oct;110:169-173. doi: 10.1016/j.cyto.2018.04.024. Epub 2018 May 12.
• [1199] Implication of CXCL5 (epithelial neutrophil-activating peptide 78) in the development of insulin resistance in patients with rheumatoid arthritis.Clin Exp Rheumatol. 2019 May-Jun;37(3):373-379. Epub 2018 Sep 17.
• [1200] Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice.Hepatology. 2005 Dec;42(6):1280-90. doi: 10.1002/hep.20949.
• [1201] Statistical Binning for Barcoded Reads Improves Downstream Analyses.Cell Syst. 2018 Aug 22;7(2):219-226.e5. doi: 10.1016/j.cels.2018.07.005.
• [1202] Gut microbiota composition correlates with changes in body fat content due to weight loss.Benef Microbes. 2015;6(4):431-9. doi: 10.3920/BM2014.0104. Epub 2015 Feb 12.
• [1203] The gliotransmitter ACBP controls feeding and energy homeostasis via the melanocortin system.J Clin Invest. 2019 Apr 2;129(6):2417-2430. doi: 10.1172/JCI123454.
• [1204] Chromosome 17q23: a locus for cardiovascular disease.Clin Exp Pharmacol Physiol. 1993 May;20(5):279-82. doi: 10.1111/j.1440-1681.1993.tb01683.x.
• [1205] Protective role of DDAH2 (rs805304) gene polymorphism in patients with myocardial infarction.Exp Mol Pathol. 2014 Dec;97(3):393-8. doi: 10.1016/j.yexmp.2014.09.015. Epub 2014 Sep 16.
• [1206] Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation.Sci Rep. 2014 Nov 24;4:7132. doi: 10.1038/srep07132.
• [1207] The role of DENND1A and CYP19A1 gene variants in individual susceptibility to obesity in Turkish population-a preliminary study.Mol Biol Rep. 2018 Dec;45(6):2193-2199. doi: 10.1007/s11033-018-4380-8. Epub 2018 Sep 19.
• [1208] Insulin inhibits leptin receptor signalling in HEK293 cells at the level of janus kinase-2: a potential mechanism for hyperinsulinaemia-associated leptin resistance.Diabetologia. 2001 Sep;44(9):1125-32. doi: 10.1007/s001250100614.
• [1209] Deletion of diacylglycerol kinase confers susceptibility to obesity via reduced lipolytic activity in murine adipocytes.FASEB J. 2018 Aug;32(8):4121-4131. doi: 10.1096/fj.201701050R. Epub 2018 Mar 6.
• [1210] Risk factors for diabetic macular oedema in type 2 diabetes: A case-control study in a United Kingdom primary care setting.Prim Care Diabetes. 2017 Jun;11(3):288-296. doi: 10.1016/j.pcd.2017.03.002. Epub 2017 Apr 7.
• [1211] Prolonged Exposure of Primary Human Muscle Cells to Plasma Fatty Acids Associated with Obese Phenotype Induces Persistent Suppression of Muscle Mitochondrial ATP Synthase Subunit.PLoS One. 2016 Aug 17;11(8):e0160057. doi: 10.1371/journal.pone.0160057. eCollection 2016.
• [1212] DNAJB3/HSP-40 cochaperone is downregulated in obese humans and is restored by physical exercise.PLoS One. 2013 Jul 24;8(7):e69217. doi: 10.1371/journal.pone.0069217. Print 2013.
• [1213] MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis.Int J Biol Macromol. 2019 Dec 1;141:1013-1021. doi: 10.1016/j.ijbiomac.2019.09.007. Epub 2019 Sep 3.
• [1214] Increased Circulation and Adipose Tissue Levels of DNAJC27/RBJ in Obesity and Type 2-Diabetes.Front Endocrinol (Lausanne). 2018 Aug 7;9:423. doi: 10.3389/fendo.2018.00423. eCollection 2018.
• [1215] DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability.Parkinsonism Relat Disord. 2013 Mar;19(3):320-4. doi: 10.1016/j.parkreldis.2012.11.006. Epub 2012 Dec 2.
• [1216] DOCK2 deficiency mitigates HFD-induced obesity by reducing adipose tissue inflammation and increasing energy expenditure.J Lipid Res. 2017 Sep;58(9):1777-1784. doi: 10.1194/jlr.M073049. Epub 2017 Jul 17.
• [1217] Novel association approach for variable number tandem repeats (VNTRs) identifies DOCK5 as a susceptibility gene for severe obesity.Hum Mol Genet. 2012 Aug 15;21(16):3727-38. doi: 10.1093/hmg/dds187. Epub 2012 May 16.
• [1218] Evaluation of DOK5 as a susceptibility gene for type 2 diabetes and obesity in North Indian population.BMC Med Genet. 2010 Feb 27;11:35. doi: 10.1186/1471-2350-11-35.
• [1219] p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells.Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8370-8375. doi: 10.1073/pnas.1804243115. Epub 2018 Jul 30.
• [1220] Bisphenol A, phthalate metabolites and glucose homeostasis in healthy normal-weight children.Endocr Connect. 2018 Jan;7(1):232-238. doi: 10.1530/EC-17-0344. Epub 2017 Dec 13.
• [1221] Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice.PLoS One. 2017 Sep 5;12(9):e0183488. doi: 10.1371/journal.pone.0183488. eCollection 2017.
• [1222] Pleiotropy of cardiometabolic syndrome with obesity-related anthropometric traits determined using empirically derived kinships from the Busselton Health Study.Hum Genet. 2018 Jan;137(1):45-53. doi: 10.1007/s00439-017-1856-x. Epub 2017 Nov 27.
• [1223] Tissue cell stress response to obesity and its interaction with late gestation diet.Reprod Fertil Dev. 2018 Mar;30(3):430-441. doi: 10.1071/RD16494.
• [1224] A novel role for adipose ephrin-B1 in inflammatory response.PLoS One. 2013 Oct 1;8(10):e76199. doi: 10.1371/journal.pone.0076199. eCollection 2013.
• [1225] Dietary Intake of Curcumin Improves eIF2 Signaling and Reduces Lipid Levels in the White Adipose Tissue of Obese Mice.Sci Rep. 2018 Jun 13;8(1):9081. doi: 10.1038/s41598-018-27105-w.
• [1226] High levels of eukaryotic Initiation Factor 6 (eIF6) are required for immune system homeostasis and for steering the glycolytic flux of TCR-stimulated CD4(+) T cells in both mice and humans.Dev Comp Immunol. 2017 Dec;77:69-76. doi: 10.1016/j.dci.2017.07.022. Epub 2017 Jul 22.
• [1227] Reduction and fragmentation of elastic fibers in the skin of obese mice is associated with altered mRNA expression levels of fibrillin-1 and neprilysin.Connect Tissue Res. 2017 Sep;58(5):479-486. doi: 10.1080/03008207.2016.1255205. Epub 2016 Nov 28.
• [1228] Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.J Lipid Res. 2014 Jul;55(7):1448-64. doi: 10.1194/jlr.M050062. Epub 2014 May 9.
• [1229] Elovl6: a new player in fatty acid metabolism and insulin sensitivity.J Mol Med (Berl). 2009 Apr;87(4):379-84. doi: 10.1007/s00109-009-0449-0. Epub 2009 Mar 4.
• [1230] Metabolic and Cardiovascular Benefits and Risks of EMD386088-A 5-HT(6) Receptor Partial Agonist and Dopamine Transporter Inhibitor.Front Neurosci. 2017 Feb 8;11:50. doi: 10.3389/fnins.2017.00050. eCollection 2017.
• [1231] Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.Exp Mol Med. 2005 Apr 30;37(2):86-90. doi: 10.1038/emm.2005.12.
• [1232] Genome-wide screen of DNA methylation identifies novel markers in childhood obesity.Gene. 2015 Jul 15;566(1):74-83. doi: 10.1016/j.gene.2015.04.032. Epub 2015 Apr 12.
• [1233] Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease.J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:105-11. doi: 10.1111/jgh.12033.
• [1234] Targeting Sleep, Food, and Activity in Infants for Obesity Prevention: An RCT.Pediatrics. 2017 Mar;139(3):e20162037. doi: 10.1542/peds.2016-2037.
• [1235] Central obesity and the Mediterranean diet: A systematic review of intervention trials.Crit Rev Food Sci Nutr. 2018;58(18):3070-3084. doi: 10.1080/10408398.2017.1351917. Epub 2017 Oct 17.
• [1236] Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.Am J Gastroenterol. 2019 Jun;114(6):916-928. doi: 10.14309/ajg.0000000000000153.
• [1237] Serum asprosin levels and bariatric surgery outcomes in obese adults.Int J Obes (Lond). 2019 May;43(5):1019-1025. doi: 10.1038/s41366-018-0248-1. Epub 2018 Nov 20.
• [1238] Prenatal Exposure to Bisphenol A Disrupts Naturally Occurring Bimodal DNA Methylation at Proximal Promoter of fggy, an Obesity-Relevant Gene Encoding a Carbohydrate Kinase, in Gonadal White Adipose Tissues of CD-1 Mice.Endocrinology. 2018 Feb 1;159(2):779-794. doi: 10.1210/en.2017-00711.
• [1239] Discovery of a role of the novel hepatokine, hepassocin, in obesity.Biofactors. 2020 Jan;46(1):100-105. doi: 10.1002/biof.1574. Epub 2019 Oct 6.
• [1240] Mapping adipose and muscle tissue expression quantitative trait loci in African Americans to identify genes for type 2 diabetes and obesity.Hum Genet. 2016 Aug;135(8):869-80. doi: 10.1007/s00439-016-1680-8. Epub 2016 May 19.
• [1241] Obesity caused by a high-fat diet regulates the Sirt1/PGC-1/FNDC5/BDNF pathway to exacerbate isoflurane-induced postoperative cognitive dysfunction in older mice.Nutr Neurosci. 2020 Dec;23(12):971-982. doi: 10.1080/1028415X.2019.1581460. Epub 2019 Feb 22.
• [1242] Beneficial effects of metformin on muscle atrophy induced by obesity in rats.J Cell Biochem. 2019 Apr;120(4):5677-5686. doi: 10.1002/jcb.27852. Epub 2018 Oct 15.
• [1243] The role of the FTO (Fat Mass and Obesity Related) locus in regulating body size and composition.Mol Cell Endocrinol. 2014 Nov;397(1-2):34-41. doi: 10.1016/j.mce.2014.09.012. Epub 2014 Sep 16.
• [1244] Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome.Autophagy. 2019 Nov;15(11):1882-1898. doi: 10.1080/15548627.2019.1596482. Epub 2019 Apr 6.
• [1245] Uncoupling protein 2 polymorphisms as risk factors for NTDs.Birth Defects Res A Clin Mol Teratol. 2009 Feb;85(2):156-60. doi: 10.1002/bdra.20520.
• [1246] Regulation of G0/G1 switch gene 2 (G0S2) expression in human adipose tissue.Arch Physiol Biochem. 2016;122(2):47-53. doi: 10.3109/13813455.2015.1122066. Epub 2016 Jan 27.
• [1247] Deletion of Gab2 in mice protects against hepatic steatosis and steatohepatitis: a novel therapeutic target for fatty liver disease.J Mol Cell Biol. 2016 Dec;8(6):492-504. doi: 10.1093/jmcb/mjw028. Epub 2016 Jun 9.
• [1248] Obesity-induced sympathoexcitation is associated with Nrf2 dysfunction in the rostral ventrolateral medulla.Am J Physiol Regul Integr Comp Physiol. 2020 Feb 1;318(2):R435-R444. doi: 10.1152/ajpregu.00206.2019. Epub 2019 Dec 11.
• [1249] Association between a variant at the GABA(A)alpha6 receptor subunit gene, abdominal obesity, and cortisol secretion.Ann N Y Acad Sci. 2002 Jun;967:566-70. doi: 10.1111/j.1749-6632.2002.tb04318.x.
• [1250] Regulation of Feeding Behavior and Energy Metabolism by Galanin-like Peptide (GALP): A Novel Strategy to Fight Against Obesity.Curr Pharm Des. 2018;24(33):3926-3933. doi: 10.2174/1381612824666181106111623.
• [1251] Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.J Steroid Biochem Mol Biol. 2018 Mar;177:209-215. doi: 10.1016/j.jsbmb.2017.07.012. Epub 2017 Jul 19.
• [1252] Association of FTO polymorphisms with obesity and obesity-related outcomes in Portuguese children.PLoS One. 2013;8(1):e54370. doi: 10.1371/journal.pone.0054370. Epub 2013 Jan 14.
• [1253] Lipid regulatory genes polymorphism in children with and without obesity and cardiometabolic risk factors: The CASPIAN-III study.J Res Med Sci. 2018 Feb 20;23:11. doi: 10.4103/jrms.JRMS_911_17. eCollection 2018.
• [1254] Overexpression of bone morphogenetic protein-3b (BMP-3b) in adipose tissues protects against high-fat diet-induced obesity.Int J Obes (Lond). 2017 Apr;41(4):483-488. doi: 10.1038/ijo.2017.15. Epub 2017 Jan 20.
• [1255] Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs.Gynecol Endocrinol. 2017 Jan;33(1):75-78. doi: 10.1080/09513590.2016.1207165. Epub 2016 Oct 5.
• [1256] Obesity alters the long-term fitness of the hematopoietic stem cell compartment through modulation of Gfi1 expression.J Exp Med. 2018 Feb 5;215(2):627-644. doi: 10.1084/jem.20170690. Epub 2017 Dec 27.
• [1257] The -1438A/G polymorphism in the 5-hydroxytryptamine receptor 2A gene is related to hyperuricemia, increased gamma-glutamyl transpeptidase and decreased high-density lipoprotein cholesterol level in the Japanese population: a prospective cohort study over 5 years.Int J Mol Med. 2006 Jan;17(1):77-82.
• [1258] CCAAT-enhancer-binding protein (C/EBP) and downstream human placental growth hormone genes are targets for dysregulation in pregnancies complicated by maternal obesity.J Biol Chem. 2013 Aug 2;288(31):22849-61. doi: 10.1074/jbc.M113.474999. Epub 2013 Jun 19.
• [1259] Cold exposure promotes obesity and impairs glucose homeostasis in mice subjected to a highfat diet.Mol Med Rep. 2018 Oct;18(4):3923-3931. doi: 10.3892/mmr.2018.9382. Epub 2018 Aug 10.
• [1260] Implications of Aquaglyceroporin 7 in Energy Metabolism.Int J Mol Sci. 2018 Jan 4;19(1):154. doi: 10.3390/ijms19010154.
• [1261] Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.Cancer. 2015 Jul 1;121(13):2262-70. doi: 10.1002/cncr.29153. Epub 2015 May 11.
• [1262] G12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.J Clin Invest. 2018 Dec 3;128(12):5587-5602. doi: 10.1172/JCI97831. Epub 2018 Nov 12.
• [1263] G13 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism.J Clin Invest. 2017 Oct 2;127(10):3845-3860. doi: 10.1172/JCI92067. Epub 2017 Sep 18.
• [1264] Gustation genetics: sweet gustducin!.Chem Senses. 2010 Sep;35(7):549-50. doi: 10.1093/chemse/bjq059. Epub 2010 Jul 21.
• [1265] An evaluation of liraglutide including its efficacy and safety for the treatment of obesity.Expert Opin Pharmacother. 2020 Feb;21(3):275-285. doi: 10.1080/14656566.2019.1695779. Epub 2019 Dec 2.
• [1266] Greater Curvature Plication with Duodenal-Jejunal Bypass: a Novel Metabolic Surgery for Type 2 Diabetes Mellitus.Obes Surg. 2018 Jun;28(6):1595-1601. doi: 10.1007/s11695-017-3057-z.
• [1267] Genetic susceptibility, birth weight and obesity risk in young Chinese.Int J Obes (Lond). 2013 May;37(5):673-7. doi: 10.1038/ijo.2012.87. Epub 2012 Jun 19.
• [1268] Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis.Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19695-700. doi: 10.1073/pnas.0609140103. Epub 2006 Dec 14.
• [1269] Serum glypican 4 level in obese children and its relation to degree of obesity.Clin Endocrinol (Oxf). 2017 Dec;87(6):689-695. doi: 10.1111/cen.13435. Epub 2017 Aug 22.
• [1270] The Italian Version of the Inventory of Interpersonal Problems (IIP-32): Psychometric Properties and Factor Structure in Clinical and Non-clinical Groups.Front Psychol. 2018 Mar 19;9:341. doi: 10.3389/fpsyg.2018.00341. eCollection 2018.
• [1271] A Systems Genetics Approach Identified GPD1L and its Molecular Mechanism for Obesity in Human Adipose Tissue.Sci Rep. 2017 May 11;7(1):1799. doi: 10.1038/s41598-017-01517-6.
• [1272] The effect of combined diet and exercise intervention on body weight and the serum GPIHBP1 concentration in overweight/obese middle-aged women.Clin Chim Acta. 2017 Dec;475:109-115. doi: 10.1016/j.cca.2017.10.017. Epub 2017 Oct 19.
• [1273] Sequence variants in the melatonin-related receptor gene (GPR50) associate with circulating triglyceride and HDL levels.J Lipid Res. 2006 Apr;47(4):761-6. doi: 10.1194/jlr.M500338-JLR200. Epub 2006 Jan 25.
• [1274] The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms.Nat Commun. 2013;4:1968. doi: 10.1038/ncomms2968.
• [1275] G protein pathway suppressor 2 (GPS2) links inflammation and cholesterol efflux by controlling lipopolysaccharide-induced ATP-binding cassette transporter A1 expression in macrophages.FASEB J. 2019 Feb;33(2):1631-1643. doi: 10.1096/fj.201801123R. Epub 2018 Aug 28.
• [1276] Effects of Weight Loss on Glutathione Peroxidase 3 Serum Concentrations and Adipose Tissue Expression in Human Obesity.Obes Facts. 2018;11(6):475-490. doi: 10.1159/000494295. Epub 2018 Dec 11.
• [1277] Effect of six type II diabetes susceptibility loci and an FTO variant on obesity in Pakistani subjects.Eur J Hum Genet. 2016 Jun;24(6):903-10. doi: 10.1038/ejhg.2015.212. Epub 2015 Sep 23.
• [1278] Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes.Metabolism. 2015 Jun;64(6):677-88. doi: 10.1016/j.metabol.2015.02.004. Epub 2015 Feb 23.
• [1279] Guanylate Cyclase C: A Current Hot Target, from Physiology to Pathology.Curr Med Chem. 2018;25(16):1879-1908. doi: 10.2174/0929867325666171205150310.
• [1280] Increased level of DNA damage in some organs of obese Zucker rats by -H2AX analysis.Environ Mol Mutagen. 2017 Aug;58(7):477-484. doi: 10.1002/em.22115. Epub 2017 Jul 17.
• [1281] Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice.Clin Sci (Lond). 2019 Nov 15;133(21):2189-2202. doi: 10.1042/CS20190679.
• [1282] Adipocyte differentiation is regulated by mitochondrial trifunctional protein -subunit via sirtuin 1.Exp Cell Res. 2017 Aug 15;357(2):271-281. doi: 10.1016/j.yexcr.2017.05.020. Epub 2017 May 26.
• [1283] Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.Breast Cancer Res Treat. 2014 Jan;143(2):277-86. doi: 10.1007/s10549-013-2804-7. Epub 2013 Dec 14.
• [1284] Adapting the Healthy Eating Index 2010 for the Canadian Population: Evidence from the Canadian National Nutrition Survey.Nutrients. 2017 Aug 21;9(8):910. doi: 10.3390/nu9080910.
• [1285] Protection against high-fat diet-induced obesity in Helz2-deficient male mice due to enhanced expression of hepatic leptin receptor.Endocrinology. 2014 Sep;155(9):3459-72. doi: 10.1210/en.2013-2160. Epub 2014 Jul 8.
• [1286] Association study of 25 type 2 diabetes related Loci with measures of obesity in Indian sib pairs.PLoS One. 2013;8(1):e53944. doi: 10.1371/journal.pone.0053944. Epub 2013 Jan 17.
• [1287] Hhip inhibits proliferation and promotes differentiation of adipocytes through suppressing hedgehog signaling pathway.Biochem Biophys Res Commun. 2019 Jun 18;514(1):148-156. doi: 10.1016/j.bbrc.2019.04.047. Epub 2019 Apr 24.
• [1288] Novel genes on rat chromosome 10 are linked to body fat mass, preadipocyte number and adipocyte size.Int J Obes (Lond). 2016 Dec;40(12):1832-1840. doi: 10.1038/ijo.2016.127. Epub 2016 Jul 27.
• [1289] Hemojuvelin: a new link between obesity and iron homeostasis.Obesity (Silver Spring). 2011 Aug;19(8):1545-51. doi: 10.1038/oby.2011.12. Epub 2011 Feb 10.
• [1290] Association of HLA-DRB3*0202 and serum IgG antibodies to Chlamydia pneumoniae with essential hypertension in a highly homogeneous population from Majorca (Balearic Islands, Spain).J Hum Hypertens. 2005 Aug;19(8):615-22. doi: 10.1038/sj.jhh.1001872.
• [1291] Altered intragenic DNA methylation of HOOK2 gene in adipose tissue from individuals with obesity and type 2 diabetes.PLoS One. 2017 Dec 11;12(12):e0189153. doi: 10.1371/journal.pone.0189153. eCollection 2017.
• [1292] Fat depot-specific expression of HOXC9 and HOXC10 may contribute to adverse fat distribution and related metabolic traits.Obesity (Silver Spring). 2016 Jan;24(1):51-9. doi: 10.1002/oby.21317. Epub 2015 Dec 9.
• [1293] In utero and lactational exposure to BDE-47 promotes obesity development in mouse offspring fed a high-fat diet: impaired lipid metabolism and intestinal dysbiosis.Arch Toxicol. 2018 May;92(5):1847-1860. doi: 10.1007/s00204-018-2177-0. Epub 2018 Mar 9.
• [1294] Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets -carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide 4-desaturase 1.PLoS One. 2017 Apr 27;12(4):e0176487. doi: 10.1371/journal.pone.0176487. eCollection 2017.
• [1295] Autoimmunity to HSP60 during diet induced obesity in mice.Int J Obes (Lond). 2017 Feb;41(2):348-351. doi: 10.1038/ijo.2016.216. Epub 2016 Nov 30.
• [1296] Polymorphisms in the oxygen-regulated protein 150 gene (ORP150) are associated with insulin resistance in Pima Indians.Diabetes. 2002 May;51(5):1618-21. doi: 10.2337/diabetes.51.5.1618.
• [1297] Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures.Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):281-8. doi: 10.1161/01.atv.16.2.281.
• [1298] Genetic contribution to C-reactive protein levels in severe obesity.Mol Genet Metab. 2012 Mar;105(3):494-501. doi: 10.1016/j.ymgme.2011.11.198. Epub 2011 Dec 2.
• [1299] Obesity and Insulin Resistance Promote Atherosclerosis through an IFN-Regulated Macrophage Protein Network.Cell Rep. 2018 Jun 5;23(10):3021-3030. doi: 10.1016/j.celrep.2018.05.010.
• [1300] The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.Int J Mol Sci. 2017 Apr 17;18(4):846. doi: 10.3390/ijms18040846.
• [1301] Hydrodynamic delivery of IL-38 gene alleviates obesity-induced inflammation and insulin resistance.Biochem Biophys Res Commun. 2019 Jan 1;508(1):198-202. doi: 10.1016/j.bbrc.2018.11.114. Epub 2018 Nov 23.
• [1302] IL-34 promotes foam cell formation by enhancing CD36 expression through p38 MAPK pathway.Sci Rep. 2018 Nov 26;8(1):17347. doi: 10.1038/s41598-018-35485-2.
• [1303] Hepatic leptin receptor expression can partiallycompensate for IL-6R deficiency inDEN-induced hepatocellular carcinoma.Mol Metab. 2018 Nov;17:122-133. doi: 10.1016/j.molmet.2018.08.010. Epub 2018 Sep 5.
• [1304] Inhibition of 72 kDa inositol polyphosphate 5-phosphatase E improves insulin signal transduction in diet-induced obesity.J Endocrinol. 2013 Apr 15;217(2):131-40. doi: 10.1530/JOE-12-0562. Print 2013 May.
• [1305] INPPL1 gene mutations in opsismodysplasia.J Hum Genet. 2017 Feb;62(2):135-140. doi: 10.1038/jhg.2016.119. Epub 2016 Oct 6.
• [1306] The role of the genetic variants IRX3 rs3751723 and FTO rs9939609 in the obesity phenotypes of children and adolescents.Obes Res Clin Pract. 2019 Mar-Apr;13(2):137-142. doi: 10.1016/j.orcp.2019.01.005. Epub 2019 Jan 31.
• [1307] Inflammatory phenotyping identifies CD11d as a gene markedly induced in white adipose tissue in obese rodents and women.J Nutr. 2011 Jun;141(6):1172-80. doi: 10.3945/jn.110.127068. Epub 2011 Apr 20.
• [1308] Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines.PLoS One. 2019 Oct 2;14(10):e0223302. doi: 10.1371/journal.pone.0223302. eCollection 2019.
• [1309] ITIH-5 expression in human adipose tissue is increased in obesity.Obesity (Silver Spring). 2012 Apr;20(4):708-14. doi: 10.1038/oby.2011.268. Epub 2011 Aug 18.
• [1310] The association of Val109Asp polymorphic marker of intelectin 1 gene with abdominal obesity in Kyrgyz population.BMC Endocr Disord. 2018 Feb 27;18(1):15. doi: 10.1186/s12902-018-0242-6.
• [1311] KRAS-induced actin-interacting protein: a potent target for obesity, diabetes and cancer.Anticancer Res. 2011 Jul;31(7):2413-7.
• [1312] The caveolae-associated coiled-coil protein, NECC2, regulates insulin signalling in Adipocytes.J Cell Mol Med. 2018 Nov;22(11):5648-5661. doi: 10.1111/jcmm.13840. Epub 2018 Aug 30.
• [1313] Lack of sex differences in high density lipoproteins in Pima Indians. Studies of obesity, lipase activities, and steroid hormones.Arteriosclerosis. 1987 May-Jun;7(3):292-300. doi: 10.1161/01.atv.7.3.292.
• [1314] 85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. Am J Physiol Gastrointest Liver Physiol. 2002 Apr;282(4):G586-97.
• [1315] The kielin/chordin-like protein (KCP) attenuates high-fat diet-induced obesity and metabolic syndrome in mice.J Biol Chem. 2017 Jun 2;292(22):9051-9062. doi: 10.1074/jbc.M116.771428. Epub 2017 Apr 19.
• [1316] KDM4B protects against obesity and metabolic dysfunction.Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):E5566-E5575. doi: 10.1073/pnas.1721814115. Epub 2018 May 29.
• [1317] Genetic and Clinical Profile of Chinese Patients with Autosomal Dominant Spastic Paraplegia.Mol Diagn Ther. 2019 Dec;23(6):781-789. doi: 10.1007/s40291-019-00426-w.
• [1318] A DNA methylation site within the KLF13 gene is associated with orexigenic processes based on neural responses and ghrelin levels.Int J Obes (Lond). 2017 Jun;41(6):990-994. doi: 10.1038/ijo.2017.43. Epub 2017 Feb 14.
• [1319] DNA methylation of the Klf14 gene region in whole blood cells provides prediction for the chronic inflammation in the adipose tissue.Biochem Biophys Res Commun. 2018 Mar 11;497(3):908-915. doi: 10.1016/j.bbrc.2017.12.104. Epub 2018 Feb 6.
• [1320] Correlation of TLR4 and KLF7 in Inflammation Induced by Obesity.Inflammation. 2017 Feb;40(1):42-51. doi: 10.1007/s10753-016-0450-z.
• [1321] Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation.Cerebrovasc Dis. 2014;37(1):57-63. doi: 10.1159/000356839. Epub 2013 Dec 21.
• [1322] Novel Ultrasonographic Fatty Liver Indicator Can Predict Hepatitis in Children With Non-alcoholic Fatty Liver Disease.Front Pediatr. 2019 Jan 8;6:416. doi: 10.3389/fped.2018.00416. eCollection 2018.
• [1323] Analysis of MC4R rs17782313, POMC rs1042571, APOE-Hha1 and AGRP rs3412352 genetic variants with susceptibility to obesity risk in North Indians.Ann Hum Biol. 2016 May;43(3):285-8. doi: 10.3109/03014460.2015.1061597. Epub 2015 Jul 31.
• [1324] Variations in DNA elucidate molecular networks that cause disease.Nature. 2008 Mar 27;452(7186):429-35. doi: 10.1038/nature06757. Epub 2008 Mar 16.
• [1325] Biased signaling at neural melanocortin receptors in regulation of energy homeostasis.Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2486-2495. doi: 10.1016/j.bbadis.2017.04.010. Epub 2017 Apr 19.
• [1326] LDB1 Regulates Energy Homeostasis During Diet-Induced Obesity.Endocrinology. 2017 May 1;158(5):1289-1297. doi: 10.1210/en.2016-1791.
• [1327] New players in high fat diet-induced obesity: LETM1 and CTMP.Metabolism. 2014 Mar;63(3):318-27. doi: 10.1016/j.metabol.2013.10.012. Epub 2013 Oct 31.
• [1328] Allyl Isothiocyanate Ameliorates Obesity by Inhibiting Galectin-12.Mol Nutr Food Res. 2018 Mar;62(6):e1700616. doi: 10.1002/mnfr.201700616. Epub 2018 Mar 12.
• [1329] Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function.Comput Struct Biotechnol J. 2017 Sep 22;15:433-446. doi: 10.1016/j.csbj.2017.09.002. eCollection 2017.
• [1330] A genome-wide association study on obesity and obesity-related traits.PLoS One. 2011 Apr 28;6(4):e18939. doi: 10.1371/journal.pone.0018939.
• [1331] A genetic variant in LINGO2 contributes to the risk of gestational diabetes mellitus in a Chinese population.J Cell Physiol. 2019 May;234(5):7012-7018. doi: 10.1002/jcp.27454. Epub 2018 Nov 13.
• [1332] Differential expression of mRNA isoforms in the skeletal muscle of pigs with distinct growth and fatness profiles.BMC Genomics. 2018 Feb 14;19(1):145. doi: 10.1186/s12864-018-4515-2.
• [1333] Human but not mouse adipogenesis is critically dependent on LMO3.Cell Metab. 2013 Jul 2;18(1):62-74. doi: 10.1016/j.cmet.2013.05.020.
• [1334] Evidence for a role of LPGAT1 in influencing BMI and percent body fat in Native Americans.Obesity (Silver Spring). 2013 Jan;21(1):193-202. doi: 10.1002/oby.20243.
• [1335] Obesity- and age-related alterations in FAT/CD36 translocation and lipin-1 subcellular localization in skeletal muscle of the Zucker rats.Gen Physiol Biophys. 2017 Oct;36(4):399-406. doi: 10.4149/gpb_2017010. Epub 2017 Jun 27.
• [1336] Association of circulating proinflammatory marker, leucine-rich-2-glycoprotein (LRG1), following metabolic/bariatric surgery.Diabetes Metab Res Rev. 2018 Oct;34(7):e3029. doi: 10.1002/dmrr.3029. Epub 2018 Jul 23.
• [1337] Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants.PLoS One. 2007 Dec 26;2(12):e1361. doi: 10.1371/journal.pone.0001361.
• [1338] The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells.Oncotarget. 2016 May 10;7(19):27735-52. doi: 10.18632/oncotarget.8408.
• [1339] Impact of Different Estimation Methods on Obesity-Attributable Mortality Levels and Trends: The Case of The Netherlands.Int J Environ Res Public Health. 2018 Sep 29;15(10):2146. doi: 10.3390/ijerph15102146.
• [1340] DNA methylation of the LY86 gene is associated with obesity, insulin resistance, and inflammation.Twin Res Hum Genet. 2014 Jun;17(3):183-91. doi: 10.1017/thg.2014.22. Epub 2014 Apr 15.
• [1341] A Genomewide Integrative Analysis of GWAS and eQTLs Data Identifies Multiple Genes and Gene Sets Associated with Obesity.Biomed Res Int. 2018 May 8;2018:3848560. doi: 10.1155/2018/3848560. eCollection 2018.
• [1342] Gene-by-Sex Interactions in Mitochondrial Functions and Cardio-Metabolic Traits.Cell Metab. 2019 Apr 2;29(4):932-949.e4. doi: 10.1016/j.cmet.2018.12.013. Epub 2019 Jan 10.
• [1343] Molecular Characterization and Functional Analysis of Leucine Zipper Transcription Factor Like 1 in Zebrafish (Danio rerio).Front Physiol. 2019 Jun 25;10:801. doi: 10.3389/fphys.2019.00801. eCollection 2019.
• [1344] Mono-ADP-Ribosylhydrolase MACROD2 Is Dispensable for Murine Responses to Metabolic and Genotoxic Insults.Front Genet. 2018 Dec 12;9:654. doi: 10.3389/fgene.2018.00654. eCollection 2018.
• [1345] Polymorphisms in FTO and MAF Genes and Birth Weight, BMI, Ponderal Index, Weight Gain in a Large Cohort of Infants with a Birth Weight below 1500 Grams.PLoS One. 2013 Jun 26;8(6):e66331. doi: 10.1371/journal.pone.0066331. Print 2013.
• [1346] Emerging Roles for Maf1 beyond the Regulation of RNA Polymerase III Activity.J Mol Biol. 2015 Aug 14;427(16):2577-85. doi: 10.1016/j.jmb.2015.06.022. Epub 2015 Jul 11.
• [1347] Inhibition of PPAR, adipogenesis and insulin sensitivity by MAGED1.J Endocrinol. 2018 Nov 1;239(2):167-180. doi: 10.1530/JOE-18-0349.
• [1348] Schaaf-Yang syndrome shows a Prader-Willi syndrome-like phenotype during infancy.Orphanet J Rare Dis. 2019 Dec 2;14(1):277. doi: 10.1186/s13023-019-1249-4.
• [1349] MKK6 controls T3-mediated browning of white adipose tissue.Nat Commun. 2017 Oct 11;8(1):856. doi: 10.1038/s41467-017-00948-z.
• [1350] The -822G/A polymorphism in the promoter region of the MAP4K5 gene is associated with reduced risk of type 2 diabetes in Chinese Hans from Shanghai.J Hum Genet. 2006;51(7):605-10. doi: 10.1007/s10038-006-0402-9. Epub 2006 May 13.
• [1351] Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer.Oncotarget. 2017 Jun 29;8(58):99093-99103. doi: 10.18632/oncotarget.18858. eCollection 2017 Nov 17.
• [1352] MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels.Nat Commun. 2016 Aug 31;7:12639. doi: 10.1038/ncomms12639.
• [1353] Science-based solutions to obesity: what are the roles of academia, government, industry, and health care?.Am J Clin Nutr. 2005 Jul;82(1 Suppl):207S-210S. doi: 10.1093/ajcn/82.1.207S.
• [1354] Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFB signaling pathway in gastric cancer cells.J Biomed Sci. 2014 Jun 14;21(1):59. doi: 10.1186/1423-0127-21-59.
• [1355] Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells.Mol Oncol. 2019 Apr;13(4):894-908. doi: 10.1002/1878-0261.12444. Epub 2019 Mar 1.
• [1356] A cryptic microdeletion including MBD5 occurring within the breakpoint of a reciprocal translocation between chromosomes 2 and 5 in a patient with developmental delay and obesity.Am J Med Genet A. 2013 Apr;161A(4):850-5. doi: 10.1002/ajmg.a.35768. Epub 2013 Mar 12.
• [1357] Obesity and Co-morbid Conditions Are Associated with Specific Neuropsychiatric Symptoms in Mild Cognitive Impairment.Front Aging Neurosci. 2017 May 29;9:164. doi: 10.3389/fnagi.2017.00164. eCollection 2017.
• [1358] Evidence of linkage and association with body fatness and abdominal fat on chromosome 15q26.Obesity (Silver Spring). 2007 Aug;15(8):2061-70. doi: 10.1038/oby.2007.245.
• [1359] MCU-knockdown attenuates high glucose-induced inflammation through regulating MAPKs/NF-B pathways and ROS production in HepG2 cells.PLoS One. 2018 Apr 30;13(4):e0196580. doi: 10.1371/journal.pone.0196580. eCollection 2018.
• [1360] Global nutrition 1990-2015: A shrinking hungry, and expanding fat world.PLoS One. 2018 Mar 27;13(3):e0194821. doi: 10.1371/journal.pone.0194821. eCollection 2018.
• [1361] The association of a HOPA polymorphism with major depression and phobia.Compr Psychiatry. 2002 Sep-Oct;43(5):404-10. doi: 10.1053/comp.2002.33489.
• [1362] Mesoderm-specific transcript localization in the ER and ER-lipid droplet interface supports a role in adipocyte hypertrophy.J Cell Biochem. 2018 Mar;119(3):2636-2645. doi: 10.1002/jcb.26429. Epub 2017 Dec 4.
• [1363] Increased Expression of Meteorin-Like Hormone in Type 2 Diabetes and Obesity and Its Association with Irisin.Cells. 2019 Oct 19;8(10):1283. doi: 10.3390/cells8101283.
• [1364] Aerobic Exercise Increases Meteorin-Like Protein in Muscle and Adipose Tissue of Chronic High-Fat Diet-Induced Obese Mice.Biomed Res Int. 2018 Apr 30;2018:6283932. doi: 10.1155/2018/6283932. eCollection 2018.
• [1365] The RNA Methyltransferase Complex of WTAP, METTL3, and METTL14 Regulates Mitotic Clonal Expansion in Adipogenesis.Mol Cell Biol. 2018 Jul 30;38(16):e00116-18. doi: 10.1128/MCB.00116-18. Print 2018 Aug 15.
• [1366] Association between SNPs and haplotypes in the METTL21C gene and peak bone mineral density and body composition in Chinese male nuclear families.J Bone Miner Metab. 2017 Jul;35(4):437-447. doi: 10.1007/s00774-016-0774-7. Epub 2016 Sep 14.
• [1367] MFAP2 promotes epithelial-mesenchymal transition in gastric cancer cells by activating TGF-/SMAD2/3 signaling pathway.Onco Targets Ther. 2018 Jul 12;11:4001-4017. doi: 10.2147/OTT.S160831. eCollection 2018.
• [1368] MFAP5 is related to obesity-associated adipose tissue and extracellular matrix remodeling and inflammation.Obesity (Silver Spring). 2015 Jul;23(7):1371-8. doi: 10.1002/oby.21103. Epub 2015 Jun 5.
• [1369] Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.Arch Biochem Biophys. 2004 Jun 1;426(1):18-31. doi: 10.1016/j.abb.2003.12.039.
• [1370] Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids: IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES.J Biol Chem. 2016 Jan 15;291(3):1348-67. doi: 10.1074/jbc.M115.698191. Epub 2015 Nov 17.
• [1371] Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice.Mol Cell Biol. 2004 Jun;24(12):5304-13. doi: 10.1128/MCB.24.12.5304-5313.2004.
• [1372] Genetic modifiers of Leprfa associated with variability in insulin production and susceptibility to NIDDM.Genomics. 1997 May 1;41(3):332-44. doi: 10.1006/geno.1997.4672.
• [1373] An integrated approach of comparative genomics and heritability analysis of pig and human on obesity trait: evidence for candidate genes on human chromosome 2.BMC Genomics. 2012 Dec 19;13:711. doi: 10.1186/1471-2164-13-711.
• [1374] The MTHFD1 1958G>A variant is associated with elevated C-reactive protein and body mass index in Canadian women from a premature birth cohort.Mol Genet Metab. 2014 Mar;111(3):390-392. doi: 10.1016/j.ymgme.2013.12.004. Epub 2013 Dec 11.
• [1375] Recapitulation of genome-wide association studies on body mass index in the Korean population.Int J Obes (Lond). 2012 Aug;36(8):1127-30. doi: 10.1038/ijo.2011.202. Epub 2011 Nov 1.
• [1376] Mice lacking myotubularin-related protein 14 show accelerated high-fat diet-induced lipid accumulation and inflammation.J Physiol Biochem. 2017 Feb;73(1):17-28. doi: 10.1007/s13105-016-0520-6. Epub 2016 Nov 2.
• [1377] The MTMR9 rs2293855 polymorphism is associated with glucose tolerance, insulin secretion, insulin sensitivity and increased risk of prediabetes.Gene. 2014 Aug 10;546(2):150-5. doi: 10.1016/j.gene.2014.06.028. Epub 2014 Jun 14.
• [1378] Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-B signaling mediated inflammation.Nat Commun. 2019 Apr 17;10(1):1801. doi: 10.1038/s41467-019-09588-x.
• [1379] Reprogrammed Functional Brown Adipocytes Ameliorate Insulin Resistance and Dyslipidemia in Diet-Induced Obesity and Type 2 Diabetes.Stem Cell Reports. 2015 Oct 13;5(4):569-81. doi: 10.1016/j.stemcr.2015.08.007. Epub 2015 Sep 10.
• [1380] Effect of obesity on the association between MYL2 (rs3782889) and high-density lipoprotein cholesterol among Korean men.J Hum Genet. 2016 May;61(5):405-9. doi: 10.1038/jhg.2015.165. Epub 2016 Jan 14.
• [1381] MYT1L mutation in a patient causes intellectual disability and early onset of obesity: a case report and review of the literature.J Pediatr Endocrinol Metab. 2019 Apr 24;32(4):409-413. doi: 10.1515/jpem-2018-0505.
• [1382] Novel hormone-regulated genes in visceral adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the metabolic syndrome.Diabetologia. 2011 Sep;54(9):2368-80. doi: 10.1007/s00125-011-2212-7. Epub 2011 Jun 19.
• [1383] Diet diversity and nutritional status among adults in southwest China.PLoS One. 2017 Feb 23;12(2):e0172406. doi: 10.1371/journal.pone.0172406. eCollection 2017.
• [1384] Large copy-number variations are enriched in cases with moderate to extreme obesity.Diabetes. 2010 Oct;59(10):2690-4. doi: 10.2337/db10-0192. Epub 2010 Jul 9.
• [1385] Combined effect of established BMI loci on obesity-related traits in an Algerian population sample.BMC Genet. 2014 Nov 25;15:128. doi: 10.1186/s12863-014-0128-1.
• [1386] Association of NCOA2 gene polymorphisms with obesity and dyslipidemia in the Chinese Han population.Int J Clin Exp Pathol. 2015 Jun 1;8(6):7341-9. eCollection 2015.
• [1387] Role of NCoR1 in mitochondrial function and energy metabolism.Cell Biol Int. 2018 Jun;42(6):734-741. doi: 10.1002/cbin.10973. Epub 2018 May 8.
• [1388] Natural Killer Cells from the Subcutaneous Adipose Tissue Underexpress the NKp30 and NKp44 in Obese Persons and Are Less Active against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells.Front Immunol. 2017 Nov 7;8:1486. doi: 10.3389/fimmu.2017.01486. eCollection 2017.
• [1389] NCS-1 Deficiency Is Associated With Obesity and Diabetes Type 2 in Mice.Front Mol Neurosci. 2019 Apr 3;12:78. doi: 10.3389/fnmol.2019.00078. eCollection 2019.
• [1390] NDRG4 stratifies the prognostic value of body mass index in colorectal cancer.Oncotarget. 2016 Jan 12;7(2):1311-22. doi: 10.18632/oncotarget.6182.
• [1391] The impacts of the interaction of genetic variation, CYP112 and NEDD4L, with sodium intake on pediatric obesity with gender difference: a 3-year panel study.Int J Obes (Lond). 2017 Apr;41(4):542-550. doi: 10.1038/ijo.2016.232. Epub 2016 Dec 26.
• [1392] Variable penetrance of metabolic phenotypes and development of high-fat diet-induced adiposity in NEIL1-deficient mice.Am J Physiol Endocrinol Metab. 2011 Apr;300(4):E724-34. doi: 10.1152/ajpendo.00387.2010. Epub 2011 Feb 1.
• [1393] Autosomal inheritance of diabetes in two families characterized by obesity and a novel H241Q mutation in NEUROD1.Pediatr Diabetes. 2008 Aug;9(4 Pt 2):367-72. doi: 10.1111/j.1399-5448.2008.00379.x. Epub 2008 Mar 5.
• [1394] NFATc3 deficiency reduces the classical activation of adipose tissue macrophages.J Mol Endocrinol. 2018 Oct 1;61(3):79-89. doi: 10.1530/JME-18-0070.
• [1395] Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity.Nat Med. 2018 Mar;24(3):292-303. doi: 10.1038/nm.4481. Epub 2018 Feb 5.
• [1396] Obesity-induced endoplasmic reticulum stress suppresses nuclear factor-Y expression.Mol Cell Biochem. 2017 Feb;426(1-2):47-54. doi: 10.1007/s11010-016-2879-7. Epub 2016 Nov 12.
• [1397] Snoring and breathing pauses during sleep: interview survey of a United Kingdom population sample reveals a significant increase in the rates of sleep apnoea and obesity over the last 20 years - data from the UK sleep survey.Sleep Med. 2019 Feb;54:250-256. doi: 10.1016/j.sleep.2018.08.029. Epub 2018 Oct 9.
• [1398] Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity.Am J Med Genet A. 2017 Jan;173(1):213-216. doi: 10.1002/ajmg.a.37977. Epub 2016 Nov 16.
• [1399] The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis.Cell Host Microbe. 2018 Sep 12;24(3):364-378.e6. doi: 10.1016/j.chom.2018.08.009.
• [1400] Outcomes of aortic valve replacement via partial upper sternotomy versus conventional aortic valve replacement in obese patients.Interact Cardiovasc Thorac Surg. 2018 Oct 1;27(4):481-486. doi: 10.1093/icvts/ivy083.
• [1401] Neuronatin deletion causes postnatal growth restriction and adult obesity in 129S2/Sv mice.Mol Metab. 2018 Dec;18:97-106. doi: 10.1016/j.molmet.2018.09.001. Epub 2018 Sep 15.
• [1402] Diet-dependent obesity and hypercholesterolemia in the New Zealand obese mouse: identification of a quantitative trait locus for elevated serum cholesterol on the distal mouse chromosome 5.Biochem Biophys Res Commun. 2003 May 16;304(4):812-7. doi: 10.1016/s0006-291x(03)00664-8.
• [1403] Noggin depletion in adipocytes promotes obesity in mice.Mol Metab. 2019 Jul;25:50-63. doi: 10.1016/j.molmet.2019.04.004. Epub 2019 Apr 10.
• [1404] Endothelial dysfunction is associated with impaired lung function in two independent community cohorts.Respir Med. 2018 Oct;143:123-128. doi: 10.1016/j.rmed.2018.09.009. Epub 2018 Sep 12.
• [1405] A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA).PLoS One. 2017 Dec 18;12(12):e0189858. doi: 10.1371/journal.pone.0189858. eCollection 2017.
• [1406] 15q24.1 BP4-BP1 microdeletion unmasking paternally inherited functional polymorphisms combined with distal 15q24.2q24.3 duplication in a patient with epilepsy, psychomotor delay, overweight, ventricular arrhythmia.Eur J Med Genet. 2018 Aug;61(8):459-464. doi: 10.1016/j.ejmg.2018.03.005. Epub 2018 Mar 14.
• [1407] Sex-Biased Physiological Roles of NPFF1R, the Canonical Receptor of RFRP-3, in Food Intake and Metabolic Homeostasis Revealed by its Congenital Ablation in mice.Metabolism. 2018 Oct;87:87-97. doi: 10.1016/j.metabol.2018.07.003. Epub 2018 Jul 31.
• [1408] Distinct roles of TRAF6 and TAK1 in the regulation of adipocyte survival, thermogenesis program, and high-fat diet-induced obesity.Oncotarget. 2017 Nov 3;8(68):112565-112583. doi: 10.18632/oncotarget.22575. eCollection 2017 Dec 22.
• [1409] Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes.Int J Mol Sci. 2017 Apr 14;18(4):831. doi: 10.3390/ijms18040831.
• [1410] Long-Acting Neurotensin Synergizes With Liraglutide to Reverse Obesity Through a Melanocortin-Dependent Pathway.Diabetes. 2019 Jun;68(6):1329-1340. doi: 10.2337/db18-1009. Epub 2019 Apr 1.
• [1411] Can Nesfatin-1 Predict Hypertension in Obese Children?.J Clin Res Pediatr Endocrinol. 2020 Mar 19;12(1):29-36. doi: 10.4274/jcrpe.galenos.2019.2019.0072. Epub 2019 Jul 24.
• [1412] Nupr1 deletion protects against glucose intolerance by increasing beta cell mass.Diabetologia. 2013 Nov;56(11):2477-86. doi: 10.1007/s00125-013-3006-x. Epub 2013 Jul 31.
• [1413] Maternal BMI as a predictor of methylation of obesity-related genes in saliva samples from preschool-age Hispanic children at-risk for obesity.BMC Genomics. 2017 Jan 9;18(1):57. doi: 10.1186/s12864-016-3473-9.
• [1414] Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis.J Biol Chem. 2015 Mar 13;290(11):7097-113. doi: 10.1074/jbc.M114.617779. Epub 2015 Jan 16.
• [1415] Possible involvement of Opa-interacting protein 5 in adipose proliferation and obesity.PLoS One. 2014 Feb 6;9(2):e87661. doi: 10.1371/journal.pone.0087661. eCollection 2014.
• [1416] Upregulation of intestinal glucose transporters after Roux-en-Y gastric bypass to prevent carbohydrate malabsorption.Obesity (Silver Spring). 2014 Oct;22(10):2164-71. doi: 10.1002/oby.20829. Epub 2014 Jul 2.
• [1417] Association of OSBPL11 gene polymorphisms with cardiovascular disease risk factors in obesity.Obesity (Silver Spring). 2009 Jul;17(7):1466-72. doi: 10.1038/oby.2009.71. Epub 2009 Mar 26.
• [1418] Disruption of the homeodomain transcription factor orthopedia homeobox (Otp) is associated with obesity and anxiety.Mol Metab. 2017 Nov;6(11):1419-1428. doi: 10.1016/j.molmet.2017.08.006. Epub 2017 Aug 24.
• [1419] Association Study of Three Gene Polymorphisms Recently Identified by a Genome-Wide Association Study with Obesity-Related Phenotypes in Chinese Children.Obes Facts. 2017;10(3):179-190. doi: 10.1159/000471487. Epub 2017 Jun 1.
• [1420] Pannexin 1 regulates adipose stromal cell differentiation and fat accumulation.Sci Rep. 2018 Nov 1;8(1):16166. doi: 10.1038/s41598-018-34234-9.
• [1421] PAQR3 has modulatory roles in obesity, energy metabolism, and leptin signaling.Endocrinology. 2013 Dec;154(12):4525-35. doi: 10.1210/en.2013-1633. Epub 2013 Sep 13.
• [1422] The modifier effect of the BDNF gene in the phenotype of the WAGRO syndrome.Gene. 2013 Mar 10;516(2):285-90. doi: 10.1016/j.gene.2012.11.073. Epub 2012 Dec 21.
• [1423] Phosducin rs12402521 polymorphism predicts development of hypertension in young subjects with overweight or obesity.Nutr Metab Cardiovasc Dis. 2013 Apr;23(4):323-9. doi: 10.1016/j.numecd.2011.08.004. Epub 2012 Feb 23.
• [1424] Inhibition of pyruvate dehydrogenase kinase-4 by l-glutamine protects pregnant rats against fructose-induced obesity and hepatic lipid accumulation.Biomed Pharmacother. 2019 Feb;110:59-67. doi: 10.1016/j.biopha.2018.11.038. Epub 2018 Nov 19.
• [1425] Gene expression and epigenetic aberrations in F1-placentas fathered by obese males.Mol Reprod Dev. 2017 Apr;84(4):316-328. doi: 10.1002/mrd.22784. Epub 2017 Mar 3.
• [1426] Associations of metabolic parameters and ethanol consumption with messenger RNA expression of clock genes in healthy men.Chronobiol Int. 2010 Jan;27(1):194-203. doi: 10.3109/07420520903398617.
• [1427] Exome sequencing reveals novel genetic loci influencing obesity-related traits in Hispanic children.Obesity (Silver Spring). 2017 Jul;25(7):1270-1276. doi: 10.1002/oby.21869. Epub 2017 May 16.
• [1428] Pex11a deficiency causes dyslipidaemia and obesity in mice.J Cell Mol Med. 2019 Mar;23(3):2020-2031. doi: 10.1111/jcmm.14108. Epub 2018 Dec 25.
• [1429] The Ablation of Mitochondrial Protein Phosphatase Pgam5 Confers Resistance Against Metabolic Stress.EBioMedicine. 2016 Jan 29;5:82-92. doi: 10.1016/j.ebiom.2016.01.031. eCollection 2016 Mar.
• [1430] Epigenetic regulation of adipogenesis by PHF2 histone demethylase.Diabetes. 2013 May;62(5):1426-34. doi: 10.2337/db12-0628. Epub 2012 Dec 28.
• [1431] Protein and gene expression analysis of Phf6, the gene mutated in the Brjeson-Forssman-Lehmann Syndrome of intellectual disability and obesity.Gene Expr Patterns. 2007 Oct;7(8):858-71. doi: 10.1016/j.modgep.2007.06.007. Epub 2007 Jul 6.
• [1432] Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance.Diabetologia. 2011 Jul;54(7):1879-87. doi: 10.1007/s00125-011-2116-6. Epub 2011 Apr 1.
• [1433] A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.J Biol Chem. 2012 Nov 2;287(45):37973-85. doi: 10.1074/jbc.M112.403139. Epub 2012 Sep 11.
• [1434] Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity.Mol Endocrinol. 2013 Sep;27(9):1518-35. doi: 10.1210/me.2013-1048. Epub 2013 Aug 8.
• [1435] The adipocyte-inducible secreted phospholipases PLA2G5 and PLA2G2E play distinct roles in obesity.Cell Metab. 2014 Jul 1;20(1):119-32. doi: 10.1016/j.cmet.2014.05.002. Epub 2014 Jun 5.
• [1436] Group VIA phospholipase A2 deficiency in mice chronically fed with high-fat-diet attenuates hepatic steatosis by correcting a defect of phospholipid remodeling.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 May;1864(5):662-676. doi: 10.1016/j.bbalip.2019.01.012. Epub 2019 Feb 5.
• [1437] Newborns of obese parents have altered DNA methylation patterns at imprinted genes.Int J Obes (Lond). 2015 Apr;39(4):650-7. doi: 10.1038/ijo.2013.193. Epub 2013 Oct 25.
• [1438] Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.J Physiol. 2019 Mar;597(6):1565-1584. doi: 10.1113/JP277140. Epub 2019 Jan 2.
• [1439] The role of perilipin in human obesity and insulin resistance.Curr Opin Lipidol. 2007 Apr;18(2):152-6. doi: 10.1097/MOL.0b013e328086aeab.
• [1440] Relationship between perilipin gene polymorphisms and body weight and body composition during weight loss and weight maintenance.Physiol Behav. 2009 Mar 23;96(4-5):723-8. doi: 10.1016/j.physbeh.2009.01.011.
• [1441] Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development.Int J Mol Sci. 2017 Aug 15;18(8):1770. doi: 10.3390/ijms18081770.
• [1442] Deciphering adipose tissue heterogeneity.Ann N Y Acad Sci. 2018 Jan;1411(1):5-20. doi: 10.1111/nyas.13398. Epub 2017 Aug 1.
• [1443] Association between lifestyle and hematological parameters: A study of Chinese male steelworkers.J Clin Lab Anal. 2019 Sep;33(7):e22946. doi: 10.1002/jcla.22946. Epub 2019 Jun 26.
• [1444] Genetic variance in the adiponutrin gene family and childhood obesity.PLoS One. 2009;4(4):e5327. doi: 10.1371/journal.pone.0005327. Epub 2009 Apr 24.
• [1445] Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.Gene. 2018 Jun 30;661:85-94. doi: 10.1016/j.gene.2018.03.079. Epub 2018 Mar 28.
• [1446] Molecular and clinical genetics of mitochondrial diseases due to POLG mutations.Hum Mutat. 2008 Sep;29(9):E150-72. doi: 10.1002/humu.20824.
• [1447] Uncoupling protein gene: quantification of expression levels in adipose tissues of obese and non-obese humans.J Lipid Res. 1997 Oct;38(10):2125-33.
• [1448] Small 6q16.1 Deletions Encompassing POU3F2 Cause Susceptibility to Obesity and Variable Developmental Delay with Intellectual Disability.Am J Hum Genet. 2016 Feb 4;98(2):363-72. doi: 10.1016/j.ajhg.2015.12.014. Epub 2016 Jan 28.
• [1449] Lipidomic profiling of high-fat diet-induced obesity in mice: Importance of cytochrome P450-derived fatty acid epoxides.Obesity (Silver Spring). 2017 Jan;25(1):132-140. doi: 10.1002/oby.21692. Epub 2016 Nov 28.
• [1450] Integrated stress response activation by sleep fragmentation during late gestation in mice leads to emergence of adverse metabolic phenotype in offspring.Metabolism. 2017 Apr;69:188-198. doi: 10.1016/j.metabol.2017.01.026. Epub 2017 Jan 21.
• [1451] Ablation of PPP1R3G reduces glycogen deposition and mitigates high-fat diet induced obesity.Mol Cell Endocrinol. 2017 Jan 5;439:133-140. doi: 10.1016/j.mce.2016.10.036. Epub 2016 Nov 2.
• [1452] PPP2R5C Couples Hepatic Glucose and Lipid Homeostasis.PLoS Genet. 2015 Oct 6;11(10):e1005561. doi: 10.1371/journal.pgen.1005561. eCollection 2015 Oct.
• [1453] Long-term follow-up of the German post-market study for upper airway stimulation for obstructive sleep apnea.Sleep Breath. 2020 Sep;24(3):979-984. doi: 10.1007/s11325-019-01933-0. Epub 2019 Sep 4.
• [1454] Gain of Metabolic Benefit with Ablation of miR-149-3p from Subcutaneous Adipose Tissue in Diet-Induced Obese Mice.Mol Ther Nucleic Acids. 2019 Dec 6;18:194-203. doi: 10.1016/j.omtn.2019.07.024. Epub 2019 Aug 26.
• [1455] Repression of Akt3 gene transcription by the tumor suppressor RIZ1.Sci Rep. 2018 Jan 24;8(1):1528. doi: 10.1038/s41598-018-19943-5.
• [1456] PI3Ka-Akt1-mediated Prdm4 induction in adipose tissue increases energy expenditure, inhibits weight gain, and improves insulin resistance in diet-induced obese mice.Cell Death Dis. 2018 Aug 29;9(9):876. doi: 10.1038/s41419-018-0904-3.
• [1457] The combination of genetic variations in the PRDX3 gene and dietary fat intake contribute to obesity risk.Obesity (Silver Spring). 2011 Apr;19(4):882-7. doi: 10.1038/oby.2010.275. Epub 2010 Dec 2.
• [1458] Maternal obesity alters fatty acid oxidation, AMPK activity, and associated DNA methylation in mesenchymal stem cells from human infants.Mol Metab. 2017 Nov;6(11):1503-1516. doi: 10.1016/j.molmet.2017.08.012. Epub 2017 Sep 1.
• [1459] Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats.J Proteome Res. 2019 Apr 5;18(4):1735-1750. doi: 10.1021/acs.jproteome.8b00964. Epub 2019 Mar 11.
• [1460] Mutated G-protein-coupled receptor GPR10 is responsible for the hyperphagia/dyslipidaemia/obesity locus of Dmo1 in the OLETF rat.Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):355-66. doi: 10.1111/j.1440-1681.2005.04196.x.
• [1461] Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism.Sci Signal. 2014 Feb 25;7(314):ra19. doi: 10.1126/scisignal.2004479.
• [1462] New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans.Mol Metab. 2019 Nov;29:182-196. doi: 10.1016/j.molmet.2019.08.016. Epub 2019 Aug 28.
• [1463] Combined linkage and association analyses identify a novel locus for obesity near PROX1 in Asians.Obesity (Silver Spring). 2013 Nov;21(11):2405-12. doi: 10.1002/oby.20153. Epub 2013 Jul 2.
• [1464] Genetic association analysis of polymorphisms in PSD3 gene with obesity, type 2 diabetes, and HDL cholesterol.Diabetes Res Clin Pract. 2017 Apr;126:105-114. doi: 10.1016/j.diabres.2017.02.006. Epub 2017 Feb 10.
• [1465] Mutations in -secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa. J Clin Invest. 2017 Apr 3;127(4):1485-1490. doi: 10.1172/JCI90667. Epub 2017 Mar 13.
• [1466] Lifetime Self-Harm Behaviors Are Not More Prevalent in Bariatric Surgery Candidates than in Community Controls with Obesity.Obes Facts. 2018;11(2):109-115. doi: 10.1159/000486484. Epub 2018 Apr 10.
• [1467] Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.Curr Mol Med. 2016;16(3):252-65. doi: 10.2174/1566524016666160225153307.
• [1468] RNA-binding protein PSPC1 promotes the differentiation-dependent nuclear export of adipocyte RNAs.J Clin Invest. 2017 Mar 1;127(3):987-1004. doi: 10.1172/JCI89484. Epub 2017 Feb 13.
• [1469] Evaluation of common genetic variants identified by GWAS for early onset and morbid obesity in population-based samples.Int J Obes (Lond). 2013 Feb;37(2):191-6. doi: 10.1038/ijo.2012.34. Epub 2012 Mar 20.
• [1470] 2-OHOA supplementation reduced adiposity and improved cardiometabolic risk to a greater extent than n-3 PUFA in obese mice.Obes Res Clin Pract. 2019 Nov-Dec;13(6):579-585. doi: 10.1016/j.orcp.2019.10.009. Epub 2019 Nov 29.
• [1471] Inter-Tissue Gene Co-Expression Networks between Metabolically Healthy and Unhealthy Obese Individuals.PLoS One. 2016 Dec 1;11(12):e0167519. doi: 10.1371/journal.pone.0167519. eCollection 2016.
• [1472] The allelic variant of LAR gene promoter -127 bp T-->A is associated with reduced risk of obesity and other features related to insulin resistance.J Mol Med (Berl). 2004 Jul;82(7):459-66. doi: 10.1007/s00109-004-0544-1. Epub 2004 May 19.
• [1473] Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity.Cardiovasc Res. 2019 Nov 1;115(13):1861-1872. doi: 10.1093/cvr/cvz068.
• [1474] Pygo2 Regulates Adiposity and Glucose Homeostasis via -Catenin-Axin2-GSK3 Signaling Pathway.Diabetes. 2018 Dec;67(12):2569-2584. doi: 10.2337/db18-0311. Epub 2018 Oct 2.
• [1475] A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity.Int J Obes (Lond). 2015 Feb;39(2):295-302. doi: 10.1038/ijo.2014.96. Epub 2014 Jun 3.
• [1476] Association analysis indicates that a variant GATA-binding site in the PIK3CB promoter is a Cis-acting expression quantitative trait locus for this gene and attenuates insulin resistance in obese children.Diabetes. 2008 Feb;57(2):494-502. doi: 10.2337/db07-1273. Epub 2007 Oct 31.
• [1477] Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity.PLoS One. 2011;6(7):e22931. doi: 10.1371/journal.pone.0022931. Epub 2011 Jul 28.
• [1478] Rab4b Deficiency in T Cells Promotes Adipose Treg/Th17 Imbalance, Adipose Tissue Dysfunction, and Insulin Resistance.Cell Rep. 2018 Dec 18;25(12):3329-3341.e5. doi: 10.1016/j.celrep.2018.11.083.
• [1479] Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice.PLoS One. 2018 Oct 11;13(10):e0204909. doi: 10.1371/journal.pone.0204909. eCollection 2018.
• [1480] Chemerin Isoforms and Activity in Obesity.Int J Mol Sci. 2019 Mar 5;20(5):1128. doi: 10.3390/ijms20051128.
• [1481] Evaluation of A2BP1 as an obesity gene.Diabetes. 2010 Nov;59(11):2837-45. doi: 10.2337/db09-1604. Epub 2010 Aug 19.
• [1482] Modulation of genetic associations with serum urate levels by body-mass-index in humans.PLoS One. 2015 Mar 26;10(3):e0119752. doi: 10.1371/journal.pone.0119752. eCollection 2015.
• [1483] A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis.Mol Metab. 2019 Mar;21:82-89. doi: 10.1016/j.molmet.2018.12.002. Epub 2018 Dec 5.
• [1484] Rcan2 and estradiol independently regulate body weight in female mice.Oncotarget. 2017 Jul 18;8(29):48098-48109. doi: 10.18632/oncotarget.18259.
• [1485] Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regeneration.Sci Rep. 2018 Nov 15;8(1):16858. doi: 10.1038/s41598-018-35325-3.
• [1486] The effect of BMI on haemostasis: Implications for thrombosis in women's health.Thromb Res. 2017 Mar;151 Suppl 1:S53-S55. doi: 10.1016/S0049-3848(17)30068-3.
• [1487] Multiple genetic variations confer risks for obesity and type 2 diabetes mellitus in arab descendants from UAE.Int J Obes (Lond). 2018 Jul;42(7):1345-1353. doi: 10.1038/s41366-018-0057-6. Epub 2018 Mar 12.
• [1488] The CHIRPY DRAGON intervention in preventing obesity in Chinese primary-school--aged children: Acluster-randomised controlled trial.PLoS Med. 2019 Nov 26;16(11):e1002971. doi: 10.1371/journal.pmed.1002971. eCollection 2019 Nov.
• [1489] Enhanced longevity and metabolism by brown adipose tissue with disruption of the regulator of G protein signaling 14.Aging Cell. 2018 Aug;17(4):e12751. doi: 10.1111/acel.12751. Epub 2018 Apr 14.
• [1490] Identification of rs7350481 at chromosome 11q23.3 as a novel susceptibility locus for metabolic syndrome in Japanese individuals by an exome-wide association study.Oncotarget. 2017 Jun 13;8(24):39296-39308. doi: 10.18632/oncotarget.16945.
• [1491] Polymorphisms in endothelin system genes, arsenic levels and obesity risk.PLoS One. 2015 Mar 23;10(3):e0118471. doi: 10.1371/journal.pone.0118471. eCollection 2015.
• [1492] Expression of two inflammation-related genes (RIPK3 and RNF216) in mononuclear cells is associated with weight-loss regain in obese subjects.J Nutrigenet Nutrigenomics. 2009;2(2):78-84. doi: 10.1159/000210452. Epub 2009 Apr 2.
• [1493] Association of fat mass and obesity-associated and retinitis pigmentosa guanosine triphosphatase (GTPase) regulator-interacting protein-1 like polymorphisms with body mass index in Chinese women.Endocr J. 2018 Jul 28;65(7):783-791. doi: 10.1507/endocrj.EJ17-0554. Epub 2018 Apr 14.
• [1494] Ciliary gene RPGRIP1L is required for hypothalamic arcuate neuron development.JCI Insight. 2019 Feb 7;4(3):e123337. doi: 10.1172/jci.insight.123337.
• [1495] Protection against High-Fat-Diet-Induced Obesity in MDM2(C305F) Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure.Cell Rep. 2017 Jan 24;18(4):1005-1018. doi: 10.1016/j.celrep.2016.12.086.
• [1496] Seasonal effects of the UCP3 and the RPTOR gene polymorphisms on obesity traits in Japanese adults.J Physiol Anthropol. 2014 Dec 22;33(1):38. doi: 10.1186/1880-6805-33-38.
• [1497] Correlates and inequality of underweight and overweight among women of reproductive age: Evidence from the 2016 Nepal Demographic Health Survey.PLoS One. 2019 May 10;14(5):e0216644. doi: 10.1371/journal.pone.0216644. eCollection 2019.
• [1498] Maresin 1 inhibits TNF-alpha-induced lipolysis and autophagy in 3T3-L1 adipocytes.J Cell Physiol. 2018 Mar;233(3):2238-2246. doi: 10.1002/jcp.26096. Epub 2017 Aug 30.
• [1499] Increased Reticulon 3 (RTN3) Leads to Obesity and Hypertriglyceridemia by Interacting With Heat Shock Protein Family A (Hsp70) Member 5 (HSPA5).Circulation. 2018 Oct 23;138(17):1828-1838. doi: 10.1161/CIRCULATIONAHA.117.030718.
• [1500] Bidirectional Association Between Psoriasis and Obesity: Benefits and Risks.J Interferon Cytokine Res. 2018 Jan;38(1):12-19. doi: 10.1089/jir.2017.0105. Epub 2017 Dec 18.
• [1501] Serum amyloid A attenuates cellular insulin sensitivity by increasing JNK activity in 3T3-L1 adipocytes.J Endocrinol Invest. 2009 Jul;32(7):568-75. doi: 10.1007/BF03346510. Epub 2009 Mar 26.
• [1502] SCAPER localizes to primary cilia and its mutation affects cilia length, causing Bardet-Biedl syndrome. Eur J Hum Genet. 2019 Jun;27(6):928-940. doi: 10.1038/s41431-019-0347-z. Epub 2019 Feb 5.
• [1503] Genome-wide copy number variation analysis identifies novel candidate loci associated with pediatric obesity.Eur J Hum Genet. 2018 Nov;26(11):1588-1596. doi: 10.1038/s41431-018-0189-0. Epub 2018 Jul 5.
• [1504] Rapidly Progressive Nephronophthisis in a 2-Year-Old Boy with a Homozygous SDCCAG8 Mutation.Tohoku J Exp Med. 2019 Sep;249(1):29-32. doi: 10.1620/tjem.249.29.
• [1505] Selenate Prevents Adipogenesis through Induction of Selenoprotein S and Attenuation of Endoplasmic Reticulum Stress.Molecules. 2018 Nov 5;23(11):2882. doi: 10.3390/molecules23112882.
• [1506] Senp2 regulates adipose lipid storage by de-SUMOylation of Setdb1.J Mol Cell Biol. 2018 Jun 1;10(3):258-266. doi: 10.1093/jmcb/mjx055.
• [1507] The cytoskeletal protein septin 11 is associated with human obesity and is involved in adipocyte lipid storage and metabolism.Diabetologia. 2017 Feb;60(2):324-335. doi: 10.1007/s00125-016-4155-5. Epub 2016 Nov 19.
• [1508] Infectobesity: obesity of infectious origin.J Nutr. 2001 Oct;131(10):2794S-2797S. doi: 10.1093/jn/131.10.2794S.
• [1509] Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.Clin Endocrinol (Oxf). 2001 Aug;55(2):163-74. doi: 10.1046/j.1365-2265.2001.01277.x.
• [1510] Obesity paradox in the era of percutaneous coronary intervention with 2nd-generation drug-eluting stents: an analysis of a multicenter PCI registry.Heart Vessels. 2019 Feb;34(2):218-226. doi: 10.1007/s00380-018-1234-1. Epub 2018 Jul 31.
• [1511] Recent advances in molecular genetics of cardiovascular disorders. Implications for atherosclerosis and diseases of cellular lipid metabolism.Pathol Oncol Res. 1998;4(2):152-60.
• [1512] The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1.Mol Cancer. 2014 May 22;13:117. doi: 10.1186/1476-4598-13-117.
• [1513] Tissue restricted expression of two human Frzbs in preadipocytes and pancreas.Biochem Biophys Res Commun. 1998 Jun 18;247(2):287-93. doi: 10.1006/bbrc.1998.8784.
• [1514] Umbilical Cord SFRP5 Levels of Term Newborns in Relation to Normal and Excessive Gestational Weight Gain.Int J Mol Sci. 2019 Jan 30;20(3):595. doi: 10.3390/ijms20030595.
• [1515] Introduction: Impacting the Social Determinants of Health through a Regional Academic-Community Partnership: The Experience of the Mid-South Transdisciplinary Collaborative Center for Health Disparities Research.Ethn Dis. 2017 Nov 9;27(Suppl 1):277-286. doi: 10.18865/ed.27.S1.277. eCollection 2017.
• [1516] Genetic association studies of obesity in Africa: a systematic review.Obes Rev. 2015 Mar;16(3):259-72. doi: 10.1111/obr.12260. Epub 2015 Feb 2.
• [1517] Reducing plasma membrane sphingomyelin increases insulin sensitivity.Mol Cell Biol. 2011 Oct;31(20):4205-18. doi: 10.1128/MCB.05893-11. Epub 2011 Aug 15.
• [1518] Relation Between Lead Exposure and Trends in Blood Pressure in Children.Am J Cardiol. 2018 Dec 1;122(11):1890-1895. doi: 10.1016/j.amjcard.2018.08.033. Epub 2018 Sep 7.
• [1519] p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans.Diabetologia. 2015 Oct;58(10):2352-60. doi: 10.1007/s00125-015-3667-8. Epub 2015 Jun 30.
• [1520] Seabuckthorn Leaves Extract and Flavonoid Glycosides Extract from Seabuckthorn Leaves Ameliorates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obesity.Nutrients. 2017 Jun 2;9(6):569. doi: 10.3390/nu9060569.
• [1521] Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel Association.Oxid Med Cell Longev. 2017;2017:6101254. doi: 10.1155/2017/6101254. Epub 2017 Jun 15.
• [1522] SIRT7 functions in redox homeostasis and cytoskeletal organization during oocyte maturation.FASEB J. 2018 Jun 7:fj201800078RR. doi: 10.1096/fj.201800078RR. Online ahead of print.
• [1523] Phospholamban deficiency does not alter skeletal muscle SERCA pumping efficiency or predispose mice to diet-induced obesity.Am J Physiol Endocrinol Metab. 2019 Mar 1;316(3):E432-E442. doi: 10.1152/ajpendo.00288.2018. Epub 2019 Jan 2.
• [1524] Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study.Int J Obes (Lond). 2009 Oct;33(10):1143-52. doi: 10.1038/ijo.2009.152. Epub 2009 Aug 4.
• [1525] Identification of genetic loci associated with different responses to high-fat diet-induced obesity in C57BL/6N and C57BL/6J substrains.Physiol Genomics. 2014 Jun 1;46(11):377-84. doi: 10.1152/physiolgenomics.00014.2014. Epub 2014 Apr 1.
• [1526] Regulation of insulin-response element binding protein-1 in obesity and diabetes: potential role in impaired insulin-induced gene transcription.Endocrinology. 2008 Oct;149(10):4829-36. doi: 10.1210/en.2007-1693. Epub 2008 Jun 19.
• [1527] FTO rs 9939609 SNP Is Associated With Adiponectin and Leptin Levels and the Risk of Obesity in a Cohort of Romanian Children Population.Medicine (Baltimore). 2016 May;95(20):e3709. doi: 10.1097/MD.0000000000003709.
• [1528] Polymorphisms in the SNRPN gene are associated with obesity susceptibility in a Spanish population.J Gene Med. 2017 May;19(5). doi: 10.1002/jgm.2956.
• [1529] SOCS2 modulates adipose tissue inflammation and expansion in mice.J Nutr Biochem. 2020 Feb;76:108304. doi: 10.1016/j.jnutbio.2019.108304. Epub 2019 Nov 23.
• [1530] Common variants in SOCS7 gene predict obesity, disturbances in lipid metabolism and insulin resistance.Nutr Metab Cardiovasc Dis. 2013 May;23(5):424-31. doi: 10.1016/j.numecd.2011.10.005. Epub 2012 Mar 6.
• [1531] SOD3 Is Secreted by Adipocytes and Mitigates High-Fat Diet-Induced Obesity, Inflammation, and Insulin Resistance.Antioxid Redox Signal. 2020 Jan 20;32(3):193-212. doi: 10.1089/ars.2018.7628.
• [1532] Alterations of sorbin and SH3 domain containing 3 (SORBS3) in human skeletal muscle following Roux-en-Y gastric bypass surgery.Clin Epigenetics. 2017 Sep 2;9:96. doi: 10.1186/s13148-017-0396-5. eCollection 2017.
• [1533] The genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse models.Mamm Genome. 2014 Oct;25(9-10):401-12. doi: 10.1007/s00335-014-9514-2. Epub 2014 Apr 22.
• [1534] SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity.J Clin Invest. 2016 Jul 1;126(7):2706-20. doi: 10.1172/JCI84708. Epub 2016 Jun 20.
• [1535] SOX6 rs7117858 polymorphism is associated with osteoporosis and obesity-related phenotypes.Eur J Clin Invest. 2018 Oct;48(10):e13011. doi: 10.1111/eci.13011. Epub 2018 Aug 16.
• [1536] Transcription Factor Co-expression Networks of Adipose RNA-Seq Data Reveal Regulatory Mechanisms of Obesity.Curr Genomics. 2018 May;19(4):289-299. doi: 10.2174/1389202918666171005095059.
• [1537] Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.J Hepatol. 2008 Nov;49(5):810-20. doi: 10.1016/j.jhep.2008.05.016. Epub 2008 Jun 10.
• [1538] Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.Peptides. 2018 Feb;100:114-122. doi: 10.1016/j.peptides.2017.12.010.
• [1539] Chromosomal architecture and placental expression of the human growth hormone gene family are targeted by pre-pregnancy maternal obesity.Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E435-E445. doi: 10.1152/ajpendo.00042.2018. Epub 2018 May 15.
• [1540] Pharmacological modulation of LMNA SRSF1-dependent splicing abrogates diet-induced obesity in mice.Int J Obes (Lond). 2017 Mar;41(3):390-401. doi: 10.1038/ijo.2016.220. Epub 2016 Dec 5.
• [1541] Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance.Glycobiology. 2017 Jan;27(2):129-139. doi: 10.1093/glycob/cww098. Epub 2016 Sep 28.
• [1542] The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice.Int J Mol Sci. 2017 Oct 28;18(11):2268. doi: 10.3390/ijms18112268.
• [1543] STEAP4 expression in human islets is associated with differences in body mass index, sex, HbA1c, and inflammation.Endocrine. 2017 Jun;56(3):528-537. doi: 10.1007/s12020-017-1297-2. Epub 2017 Apr 12.
• [1544] DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway.Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):12196-12201. doi: 10.1073/pnas.1708744114. Epub 2017 Oct 30.
• [1545] Macrosomia, obesity, and macrocephaly as first clinical presentation of PHP1b caused by STX16 deletion.Am J Med Genet A. 2016 Sep;170(9):2431-5. doi: 10.1002/ajmg.a.37818. Epub 2016 Jun 23.
• [1546] Expression of syntaxin 8 in visceral adipose tissue is increased in obese patients with type 2 diabetes and related to markers of insulin resistance and inflammation.Arch Med Res. 2015 Jan;46(1):47-53. doi: 10.1016/j.arcmed.2014.12.003. Epub 2014 Dec 15.
• [1547] Munc18c in adipose tissue is downregulated in obesity and is associated with insulin.PLoS One. 2013 May 20;8(5):e63937. doi: 10.1371/journal.pone.0063937. Print 2013.
• [1548] Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.PLoS One. 2009 Dec 7;4(12):e8100. doi: 10.1371/journal.pone.0008100.
• [1549] Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans.Oncotarget. 2015 Oct 6;6(30):29818-32. doi: 10.18632/oncotarget.4904.
• [1550] Effects of Orchidectomy and Testosterone Replacement on Numbers of Kisspeptin-, Neurokinin B-, and Dynorphin A-Immunoreactive Neurones in the Arcuate Nucleus of the Hypothalamus in Obese and Diabetic Rats.J Neuroendocrinol. 2017 Feb;29(2). doi: 10.1111/jne.12453.
• [1551] Control of adipose tissue inflammation through TRB1.Diabetes. 2010 Aug;59(8):1991-2000. doi: 10.2337/db09-1537. Epub 2010 Jun 3.
• [1552] Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes.Mol Med Rep. 2018 Jun;17(6):7636-7644. doi: 10.3892/mmr.2018.8804. Epub 2018 Mar 28.
• [1553] RabGAPs in skeletal muscle function and exercise.J Mol Endocrinol. 2020 Jan;64(1):R1-R19. doi: 10.1530/JME-19-0143.
• [1554] Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution.PLoS Genet. 2009 Jun;5(6):e1000508. doi: 10.1371/journal.pgen.1000508. Epub 2009 Jun 26.
• [1555] Tbx15 is required for adipocyte browning induced by adrenergic signaling pathway.Mol Metab. 2019 Oct;28:48-57. doi: 10.1016/j.molmet.2019.07.004. Epub 2019 Jul 5.
• [1556] Socioeconomic inequality in childhood obesity and its determinants: a Blinder-Oaxaca decomposition.J Pediatr (Rio J). 2018 Mar-Apr;94(2):131-139. doi: 10.1016/j.jped.2017.03.009. Epub 2017 Aug 18.
• [1557] Increased Ifi202b/IFI16 expression stimulates adipogenesis in mice and humans.Diabetologia. 2018 May;61(5):1167-1179. doi: 10.1007/s00125-018-4571-9. Epub 2018 Feb 24.
• [1558] The TCN2 variant of rs9606756 [Ile23Val] acts as risk loci for obesity-related traits and mediates by interacting with Apo-A1.Obesity (Silver Spring). 2017 Jun;25(6):1098-1108. doi: 10.1002/oby.21826. Epub 2017 Apr 17.
• [1559] Energy and metabolic pathways in trefoil factor family member 2 (Tff2) KO mice beyond the protection from high-fat diet-induced obesity.Life Sci. 2018 Dec 15;215:190-197. doi: 10.1016/j.lfs.2018.11.006. Epub 2018 Nov 7.
• [1560] THADA Regulates the Organismal Balance between Energy Storage and Heat Production.Dev Cell. 2017 Apr 10;41(1):72-81.e6. doi: 10.1016/j.devcel.2017.03.016.
• [1561] Elevated Thrombospondin 2 Contributes to Delayed Wound Healing in Diabetes.Diabetes. 2019 Oct;68(10):2016-2023. doi: 10.2337/db18-1001. Epub 2019 Aug 7.
• [1562] Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.J Am Heart Assoc. 2018 Jun 26;7(13):e008654. doi: 10.1161/JAHA.118.008654.
• [1563] Identification of diabetes- and obesity-associated proteomic changes in human spermatozoa by difference gel electrophoresis.Reprod Biomed Online. 2009 Nov;19(5):660-70. doi: 10.1016/j.rbmo.2009.07.001.
• [1564] The serum level of a novel lipogenic protein Spot 14 was reduced in metabolic syndrome.PLoS One. 2019 Feb 14;14(2):e0212341. doi: 10.1371/journal.pone.0212341. eCollection 2019.
• [1565] A novel gene THSD7A is associated with obesity.Int J Obes (Lond). 2015 Nov;39(11):1662-5. doi: 10.1038/ijo.2015.144. Epub 2015 Aug 4.
• [1566] Loss of TIGAR Induces Oxidative Stress and Meiotic Defects in Oocytes from Obese Mice.Mol Cell Proteomics. 2018 Jul;17(7):1354-1364. doi: 10.1074/mcp.RA118.000620. Epub 2018 May 18.
• [1567] Absence of Tissue Inhibitor of Metalloproteinase-4 (TIMP4) ameliorates high fat diet-induced obesity in mice due to defective lipid absorption.Sci Rep. 2017 Jul 24;7(1):6210. doi: 10.1038/s41598-017-05951-4.
• [1568] Increased Expression of the Innate Immune Receptor TLR10 in Obesity and Type-2 Diabetes: Association with ROS-Mediated Oxidative Stress.Cell Physiol Biochem. 2018;45(2):572-590. doi: 10.1159/000487034. Epub 2018 Jan 30.
• [1569] Trans-anethole ameliorates obesity via induction of browning in white adipocytes and activation of brown adipocytes.Biochimie. 2018 Aug;151:1-13. doi: 10.1016/j.biochi.2018.05.009. Epub 2018 May 24.
• [1570] A follow-up study for left ventricular mass on chromosome 12p11 identifies potential candidate genes.BMC Med Genet. 2011 Jul 26;12:100. doi: 10.1186/1471-2350-12-100.
• [1571] The involvement of 4-1BB/4-1BBL signaling in glial cell-mediated hypothalamic inflammation in obesity.FEBS Open Bio. 2018 Apr 19;8(5):843-853. doi: 10.1002/2211-5463.12426. eCollection 2018 May.
• [1572] Effects of X-chromosome Tenomodulin Genetic Variants on Obesity in a Children's Cohort and Implications of the Gene in Adipocyte Metabolism.Sci Rep. 2019 Mar 8;9(1):3979. doi: 10.1038/s41598-019-40482-0.
• [1573] Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis.Cell Metab. 2011 Aug 3;14(2):208-18. doi: 10.1016/j.cmet.2011.06.007.
• [1574] Mutations that impair interaction properties of TRIM32 associated with limb-girdle muscular dystrophy 2H.Hum Mutat. 2008 Feb;29(2):240-7. doi: 10.1002/humu.20633.
• [1575] Electroacupuncture Reduces Weight in Diet-Induced Obese Rats via Hypothalamic Tsc1 Promoter Demethylation and Inhibition of the Activity of mTORC1 Signaling Pathway.Evid Based Complement Alternat Med. 2018 Apr 26;2018:3039783. doi: 10.1155/2018/3039783. eCollection 2018.
• [1576] Low expression of the GILZ may contribute to adipose inflammation and altered adipokine production in human obesity.J Lipid Res. 2016 Jul;57(7):1256-63. doi: 10.1194/jlr.M067728. Epub 2016 May 13.
• [1577] Obesity and diabetes genetic variants associated with gestational weight gain.Am J Obstet Gynecol. 2010 Sep;203(3):283.e1-17. doi: 10.1016/j.ajog.2010.06.069.
• [1578] Increased fibrosis: A novel means by which GH influences white adipose tissue function.Growth Horm IGF Res. 2018 Apr;39:45-53. doi: 10.1016/j.ghir.2017.12.010. Epub 2017 Dec 20.